assays_VARI,assays_CONSC,assays_BFOR,assays_ASTET,assays_ASSORGA,assays_ASSTI,assays_TISI,assays_CURAB,assays_DOI,assays_ASSSUBFRA,assays_T,assays_ASSSTR,assays_Descr,assays_RELATT,assays_SRASSI,assays_CHEI,assays_ASSCAT,assays_AST,assays_ASTAI,assays_SI,assays_ASCET,assays_CI,assays_ASI
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,CHEMBL618647,,A,10116.0,1,,,7524
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,N,,CHEMBL618648,,A,10116.0,1,,,7525
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,N,,CHEMBL618649,,A,10116.0,1,,,7526
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,CHEMBL618650,,A,10116.0,1,,,7527
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,N,,CHEMBL618651,,A,10116.0,1,,,7528
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,N,,CHEMBL876497,,A,10116.0,1,,,7529
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,9866,,50597,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,CHEMBL618652,,A,10116.0,1,,,7530
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,9866,,50597,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,N,,CHEMBL618653,,A,10116.0,1,,,7531
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,9866,,50597,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,N,,CHEMBL618654,,A,10116.0,1,,,7532
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6351,,50597,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,N,,CHEMBL618655,,A,10116.0,1,,,7533
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1465,,50597,,Compound was tested for solubility in water,N,,CHEMBL618656,,A,10116.0,1,,,7534
,0,BAO_0000100,,,,,Intermediate,5182,,22229,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),U,,CHEMBL618657,,P,,1,,,7535
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17847,,50597,,Solubility was determined,N,,CHEMBL618658,,A,10116.0,1,,,7536
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15339,,50597,,solubility in water (ug/mL) at 37 degree C.,N,,CHEMBL618659,,A,10116.0,1,,,7537
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5202,,50597,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,N,,CHEMBL618660,,A,10116.0,1,,,7538
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1088,,50597,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,N,,CHEMBL618661,,A,10116.0,1,,,7539
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3169,,50597,,Half life in rats,N,,CHEMBL873807,,A,10116.0,1,,,7540
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5353,,50597,,Half life in Dawley rat,N,,CHEMBL618662,,A,10116.0,1,,,7541
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2864,,50597,,Half life period after 3 mg/kg iv administration,N,,CHEMBL618663,,A,10116.0,1,,,7542
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2864,,50597,,Half life period after 3 mg/kg iv administration in rat,N,,CHEMBL618664,,A,10116.0,1,,,7543
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2864,,50597,,Half life period after 3 mg/kg iv administration in the rat,N,,CHEMBL618665,,A,10116.0,1,,,7544
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6362,,50597,,Half life period in female Sprague-Dawley rats,N,,CHEMBL876498,,A,10116.0,1,,,7545
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6249,,50597,,Half life period in rat,N,,CHEMBL618666,,A,10116.0,1,,,7546
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3169,,50597,,Half-life in rats was determined,N,,CHEMBL620440,,A,10116.0,1,,,7547
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3169,,50597,,Half-life in rats with metabolic oxidation,N,,CHEMBL620441,,A,10116.0,1,,,7548
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3169,,50597,,Half-life in rats,N,,CHEMBL620442,,A,10116.0,1,,,7549
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17260,,50597,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,CHEMBL620443,,A,10116.0,1,,,7550
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17260,,50597,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,CHEMBL620444,,A,10116.0,1,,,7551
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17260,,50597,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,CHEMBL620445,,A,10116.0,1,,,7552
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17260,,50597,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,CHEMBL620446,,A,10116.0,1,,,7553
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,2879,,50597,,Biological half-life measured in plasma of rat,N,,CHEMBL620447,,A,10116.0,1,,,7554
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,2879,,50597,,Biological half-life measured in plasma of rat; 22-25,N,,CHEMBL621129,,A,10116.0,1,,,7555
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,2879,,50597,,Biological half-life measured in plasma of rat; 9-16,N,,CHEMBL621130,,A,10116.0,1,,,7556
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3184,,50597,,Compound was evaluated for its half life when administered intravenously in rat,N,,CHEMBL873808,,A,10116.0,1,,,7557
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4891,,50597,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,N,,CHEMBL876598,,A,10116.0,1,,,7558
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,429,,50597,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,N,,CHEMBL621131,,A,10116.0,1,,,7559
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5656,,50597,,Half life (T1/2) after oral administration in rat,N,,CHEMBL621132,,A,10116.0,1,,,7560
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4413,,50597,,Half life of compound after iv administration of 20 mg/kg dose in rat,N,,CHEMBL621133,,A,10116.0,1,,,7561
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Expert,3598,,50597,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,CHEMBL621312,,A,10116.0,1,,,7562
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17267,,50597,,Half life of compound was determined in rat,N,,CHEMBL621313,,A,10116.0,1,,,7563
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,4727,,50597,,Half life of compound was determined in rat blood,N,,CHEMBL621314,,A,10116.0,1,,,7564
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17651,,50597,,Half life at 1 mg/kg was determined in rat,N,,CHEMBL621315,,A,10116.0,1,,,7565
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17651,,50597,,Half life at 10 mg/kg was determined in rat,N,,CHEMBL621316,,A,10116.0,1,,,7566
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,401,,50597,,Half life in rats,N,,CHEMBL621317,,A,10116.0,1,,,7567
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4942,,50597,,Half life in rats in hours,N,,CHEMBL621318,,A,10116.0,1,,,7568
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17735,,50597,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,,CHEMBL621319,,A,10116.0,1,,,7569
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6056,,50597,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,N,,CHEMBL621377,,A,10116.0,1,,,7570
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5213,,50597,,Half life was determined,N,,CHEMBL621378,,A,10116.0,1,,,7571
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6616,,50597,,Half life after i.v. administration,N,,CHEMBL876599,,A,10116.0,1,,,7572
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5937,,50597,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,N,,CHEMBL621379,,A,10116.0,1,,,7573
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,5819,,50597,,Half life in rat plasma,N,,CHEMBL621380,,A,10116.0,1,,,7574
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,5819,,50597,,Half life in rat plasma; Not detected,N,,CHEMBL621381,,A,10116.0,1,,,7575
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6803,,50597,,Half life in rats,N,,CHEMBL618515,,A,10116.0,1,,,7576
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17804,,50597,,Half life period of compound was determined after peroral administration,N,,CHEMBL618516,,A,10116.0,1,,,7577
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17804,,50597,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,N,,CHEMBL618517,,A,10116.0,1,,,7578
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5948,,50597,,Half life period in rat,N,,CHEMBL618518,,A,10116.0,1,,,7579
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1916,,50597,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,,CHEMBL618519,,A,10116.0,1,,,7580
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1916,,50597,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,,CHEMBL618698,,A,10116.0,1,,,7581
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1916,,50597,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,N,,CHEMBL618862,,A,10116.0,1,,,7582
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4890,,50597,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,CHEMBL618863,,A,10116.0,1,,,7583
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17764,,50597,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,N,,CHEMBL618864,,A,10116.0,1,,,7584
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4727,,50597,,Half life time in rat the dose of 2 mg/kg,N,,CHEMBL618865,,A,10116.0,1,,,7585
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17509,,50597,,Half-life 24 hr after 10 mg/kg iv administration in rats,N,,CHEMBL618866,,A,10116.0,1,,,7586
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17509,,50597,,Half-life 24 hr after 2 mg/kg iv administration in rats,N,,CHEMBL618867,,A,10116.0,1,,,7587
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6597,,50597,,Half-life consistent with the observed metabolic steady state in rats,N,,CHEMBL875828,,A,10116.0,1,,,7588
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17735,,50597,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,,CHEMBL618868,,A,10116.0,1,,,7589
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6597,,50597,,Half-life for oxidative metabolic stability was determined using male human,N,,CHEMBL618869,,A,10116.0,1,,,7590
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17670,,50597,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",N,,CHEMBL618870,,A,10116.0,1,,,7591
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1696,,50597,,Half-life in rat plasma,N,,CHEMBL618871,,A,10116.0,1,,,7592
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1742,,50597,,Half-life in rat plasma was determined,N,,CHEMBL618872,,A,10116.0,1,,,7593
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17800,,50597,,Half-life in rats was determined,N,,CHEMBL873816,,A,10116.0,1,,,7594
,0,BAO_0000218,,,,,Autocuration,12923,,22224,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,U,,CHEMBL618873,,A,,1,,,7595
,0,BAO_0000019,,,,,Autocuration,11954,,22224,,Area under curve after oral dose of 0.1 mg//kg,U,,CHEMBL621602,,A,,1,,,7596
,0,BAO_0000218,,,,,Autocuration,11954,,22224,,Area under curve after oral dose of 0.3 mg/kg,U,,CHEMBL621603,,A,,1,,,7597
,0,BAO_0000218,,,,,Autocuration,11954,,22224,,Area under curve after oral dose of 1 mg/kg,U,,CHEMBL621604,,A,,1,,,7598
,0,BAO_0000218,,,,,Autocuration,11954,,22224,,Area under curve after oral dose of 10 mg/kg,U,,CHEMBL621605,,A,,1,,,7599
,0,BAO_0000218,,,,,Autocuration,11954,,22224,,Area under curve after oral dose of 23.4 mg/kg,U,,CHEMBL621606,,A,,1,,,7600
,0,BAO_0000218,,,,,Autocuration,11954,,22224,,Area under curve after oral dose of 3 mg/kg,U,,CHEMBL621607,,A,,1,,,7601
,0,BAO_0000218,,,,,Autocuration,11954,,22224,,Area under curve after oral dose of 3.87 mg/kg,U,,CHEMBL621608,,A,,1,,,7602
,0,BAO_0000019,,,,,Autocuration,5237,,22224,,Area under curve was determined,U,,CHEMBL621609,,A,,1,,,7603
,0,BAO_0000218,,,,,Autocuration,4026,,22224,,Area under curve at a dose of 10 mg/kg,U,,CHEMBL621610,,A,,1,,,7604
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5237,,50597,,Area under curve was determined; ND=No data,N,,CHEMBL621611,,A,10116.0,1,,,7605
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14793,,50597,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,,CHEMBL621612,,A,10116.0,1,,,7606
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14793,,50597,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,,CHEMBL622308,,A,10116.0,1,,,7607
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14793,,50597,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,,CHEMBL622309,,A,10116.0,1,,,7608
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14793,,50597,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,N,,CHEMBL622310,,A,10116.0,1,,,7609
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14793,,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,,CHEMBL622311,,A,10116.0,1,,,7610
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14793,,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,N,,CHEMBL622312,,A,10116.0,1,,,7611
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14793,,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,,CHEMBL622931,,A,10116.0,1,,,7612
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14793,,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,N,,CHEMBL622932,,A,10116.0,1,,,7613
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,,CHEMBL622736,,A,10116.0,1,,,7614
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,,CHEMBL622737,,A,10116.0,1,,,7615
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,,CHEMBL622738,,A,10116.0,1,,,7616
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,N,,CHEMBL622739,,A,10116.0,1,,,7617
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,,CHEMBL622740,,A,10116.0,1,,,7618
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,N,,CHEMBL622741,,A,10116.0,1,,,7619
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,,CHEMBL622742,,A,10116.0,1,,,7620
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,N,,CHEMBL622743,,A,10116.0,1,,,7621
,1,BAO_0000218,,Mus musculus,Plasma,1969.0,Intermediate,11637,,50594,,AUC in mice,N,,CHEMBL622744,,A,10090.0,1,,,7622
,0,BAO_0000019,,,,,Autocuration,11149,,22224,,Area under curve was measured from the graph obtained from concentration Vs time,U,,CHEMBL624134,,A,,1,,,7623
,0,BAO_0000019,,,,,Autocuration,10016,,22224,,Area under curve value of compound per hour after oral administration,U,,CHEMBL624135,,A,,1,,,7624
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17796,,50597,,Area under curve was determined after oral administration in rats,N,,CHEMBL624136,,A,10116.0,1,,,7625
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17796,,50597,,Area under curve was determined after oral administration in rats; No data,N,,CHEMBL624137,,A,10116.0,1,,,7626
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17796,,50597,,Area under curve was determined after oral administration in rats;No data,N,,CHEMBL624320,,A,10116.0,1,,,7627
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,12923,,50588,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,,CHEMBL624321,,A,9615.0,1,,,7628
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15372,,50597,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,N,,CHEMBL624322,,A,10116.0,1,,,7629
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15372,,50597,,Area under curve was determined for the compound after iv dose of 5.06 in rats,N,,CHEMBL624323,,A,10116.0,1,,,7630
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15372,,50597,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,N,,CHEMBL624324,,A,10116.0,1,,,7631
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15372,,50597,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,N,,CHEMBL624325,,A,10116.0,1,,,7632
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15372,,50597,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,N,,CHEMBL624326,,A,10116.0,1,,,7633
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15372,,50597,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,N,,CHEMBL624327,,A,10116.0,1,,,7634
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15372,,50597,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,N,,CHEMBL624328,,A,10116.0,1,,,7635
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14169,,50588,,Area under curve was determined in Dogs after peroral administration,N,,CHEMBL627848,,A,9615.0,1,,,7636
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14169,,50597,,Area under curve was determined in Rats after peroral administration,N,,CHEMBL627849,,A,10116.0,1,,,7637
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14258,,50597,,Area under curve was determined in carotid blood of rat when administered intradermally,N,,CHEMBL627850,,A,10116.0,1,,,7638
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14258,,50597,,Area under curve was determined in portal blood of rat when administered intradermally,N,,CHEMBL627851,,A,10116.0,1,,,7639
,1,BAO_0000218,,Mus musculus,,,Intermediate,15011,,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,CHEMBL627852,,A,10090.0,1,,,7640
,1,BAO_0000218,,Mus musculus,,,Intermediate,15011,,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,,CHEMBL627853,,A,10090.0,1,,,7641
,1,BAO_0000218,,Mus musculus,,,Intermediate,15011,,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,,CHEMBL627854,,A,10090.0,1,,,7642
,1,BAO_0000218,,Mus musculus,,,Intermediate,15011,,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,CHEMBL627855,,A,10090.0,1,,,7643
,1,BAO_0000218,,Mus musculus,,,Intermediate,15011,,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),N,,CHEMBL627856,,A,10090.0,1,,,7644
,1,BAO_0000218,,Mus musculus,,,Intermediate,15011,,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,,CHEMBL875339,,A,10090.0,1,,,7645
,1,BAO_0000218,,Mus musculus,,,Intermediate,15011,,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),N,,CHEMBL627857,,A,10090.0,1,,,7646
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,N,,CHEMBL627858,,A,10116.0,1,,,7647
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,N,,CHEMBL627859,,A,10116.0,1,,,7648
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,N,,CHEMBL627860,,A,10116.0,1,,,7649
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,N,,CHEMBL627019,,A,10116.0,1,,,7650
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,N,,CHEMBL627020,,A,10116.0,1,,,7651
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,N,,CHEMBL627021,,A,10116.0,1,,,7652
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,N,,CHEMBL627022,,A,10116.0,1,,,7653
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,N,,CHEMBL627023,,A,10116.0,1,,,7654
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,N,,CHEMBL627024,,A,10116.0,1,,,7655
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,N,,CHEMBL627025,,A,10116.0,1,,,7656
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,N,,CHEMBL627026,,A,10116.0,1,,,7657
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,N,,CHEMBL627027,,A,10116.0,1,,,7658
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,N,,CHEMBL627028,,A,10116.0,1,,,7659
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,N,,CHEMBL627029,,A,10116.0,1,,,7660
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,N,,CHEMBL627030,,A,10116.0,1,,,7661
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,N,,CHEMBL627031,,A,10116.0,1,,,7662
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,N,,CHEMBL627032,,A,10116.0,1,,,7663
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,N,,CHEMBL627033,,A,10116.0,1,,,7664
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,N,,CHEMBL627034,,A,10116.0,1,,,7665
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,N,,CHEMBL627035,,A,10116.0,1,,,7666
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,N,,CHEMBL627036,,A,10116.0,1,,,7667
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,N,,CHEMBL875340,,A,10116.0,1,,,7668
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,N,,CHEMBL627037,,A,10116.0,1,,,7669
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,N,,CHEMBL627038,,A,10116.0,1,,,7670
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,N,,CHEMBL627039,,A,10116.0,1,,,7671
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,N,,CHEMBL627040,,A,10116.0,1,,,7672
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,N,,CHEMBL624663,,A,10116.0,1,,,7673
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,N,,CHEMBL625963,,A,10116.0,1,,,7674
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,N,,CHEMBL876799,,A,10116.0,1,,,7675
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,N,,CHEMBL626133,,A,10116.0,1,,,7676
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10130,,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,N,,CHEMBL626134,,A,10116.0,1,,,7677
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6295,,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,,CHEMBL626135,,A,10116.0,1,,,7678
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6296,,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,,CHEMBL626136,,A,10116.0,1,,,7679
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6296,,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,N,,CHEMBL626137,,A,10116.0,1,,,7680
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6295,,50597,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,,CHEMBL626138,,A,10116.0,1,,,7681
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6296,,50597,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,,CHEMBL626139,,A,10116.0,1,,,7682
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17260,,50597,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,CHEMBL626140,,A,10116.0,1,,,7683
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17260,,50597,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,CHEMBL626141,,A,10116.0,1,,,7684
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17686,,50597,,C24h in rat p.o. at 20 mg/kg concentration,N,,CHEMBL626142,,A,10116.0,1,,,7685
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,CHEMBL627930,,A,10116.0,1,,,7686
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,N,,CHEMBL627931,,A,10116.0,1,,,7687
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,N,,CHEMBL627932,,A,10116.0,1,,,7688
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,CHEMBL627933,,A,10116.0,1,,,7689
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,N,,CHEMBL627934,,A,10116.0,1,,,7690
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,N,,CHEMBL627935,,A,10116.0,1,,,7691
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,,CHEMBL627936,,A,10116.0,1,,,7692
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,N,,CHEMBL627937,,A,10116.0,1,,,7693
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,CHEMBL627938,,A,10116.0,1,,,7694
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,N,,CHEMBL627939,,A,10116.0,1,,,7695
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,N,,CHEMBL627940,,A,10116.0,1,,,7696
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,CHEMBL627941,,A,10116.0,1,,,7697
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,CHEMBL876800,,A,10116.0,1,,,7698
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,N,,CHEMBL627942,,A,10116.0,1,,,7699
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,,CHEMBL627943,,A,10116.0,1,,,7700
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,N,,CHEMBL627944,,A,10116.0,1,,,7701
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,N,,CHEMBL627945,,A,10116.0,1,,,7702
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,N,,CHEMBL628584,,A,10116.0,1,,,7703
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,N,,CHEMBL628585,,A,10116.0,1,,,7704
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,N,,CHEMBL628586,,A,10116.0,1,,,7705
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,N,,CHEMBL628587,,A,10116.0,1,,,7706
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,N,,CHEMBL628588,,A,10116.0,1,,,7707
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,N,,CHEMBL628589,,A,10116.0,1,,,7708
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,N,,CHEMBL625304,,A,10116.0,1,,,7709
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,N,,CHEMBL625305,,A,10116.0,1,,,7710
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,N,,CHEMBL625306,,A,10116.0,1,,,7711
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,N,,CHEMBL625307,,A,10116.0,1,,,7712
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,N,,CHEMBL625308,,A,10116.0,1,,,7713
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,N,,CHEMBL627740,,A,10116.0,1,,,7714
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,N,,CHEMBL627741,,A,10116.0,1,,,7715
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,CHEMBL627742,,A,10116.0,1,,,7716
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,N,,CHEMBL627743,,A,10116.0,1,,,7717
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9866,,50597,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,N,,CHEMBL627744,,A,10116.0,1,,,7718
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,N,,CHEMBL627745,,A,10116.0,1,,,7719
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,CHEMBL627746,,A,10116.0,1,,,7720
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,,CHEMBL627747,,A,10116.0,1,,,7721
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,N,,CHEMBL876810,,A,10116.0,1,,,7722
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,N,,CHEMBL627748,,A,10116.0,1,,,7723
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,CHEMBL627749,,A,10116.0,1,,,7724
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,CHEMBL627750,,A,10116.0,1,,,7725
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,N,,CHEMBL618728,,A,10116.0,1,,,7726
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,,CHEMBL618729,,A,10116.0,1,,,7727
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,N,,CHEMBL618730,,A,10116.0,1,,,7728
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,N,,CHEMBL618731,,A,10116.0,1,,,7729
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,N,,CHEMBL618732,,A,10116.0,1,,,7730
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,N,,CHEMBL618733,,A,10116.0,1,,,7731
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,N,,CHEMBL618734,,A,10116.0,1,,,7732
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,N,,CHEMBL618735,,A,10116.0,1,,,7733
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,N,,CHEMBL876602,,A,10116.0,1,,,7734
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,N,,CHEMBL618736,,A,10116.0,1,,,7735
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,N,,CHEMBL618737,,A,10116.0,1,,,7736
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,N,,CHEMBL618738,,A,10116.0,1,,,7737
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,N,,CHEMBL618739,,A,10116.0,1,,,7738
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,N,,CHEMBL618740,,A,10116.0,1,,,7739
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,CHEMBL618741,,A,10116.0,1,,,7740
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,N,,CHEMBL618742,,A,10116.0,1,,,7741
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,9866,,50597,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,N,,CHEMBL618743,,A,10116.0,1,,,7742
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17752,,50597,,Half-life from rat plasma at a single oral dose of 25 mg/kg,N,,CHEMBL618744,,A,10116.0,1,,,7743
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5610,,50597,,Half-life in male rat,N,,CHEMBL618745,,A,10116.0,1,,,7744
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5939,,50597,,Half-life in rat after peroral administration at 10 mg/kg concentration,N,,CHEMBL620479,,A,10116.0,1,,,7745
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5939,,50597,,Half-life in rat after peroral administration at 5 mg/kg concentration,N,,CHEMBL620480,,A,10116.0,1,,,7746
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17771,,50597,,Half-life in rat at a dose of 3 mg/kg,N,,CHEMBL620481,,A,10116.0,1,,,7747
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1974,,50597,,Half-life was evaluated in rats,N,,CHEMBL620482,,A,10116.0,1,,,7748
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4239,,50597,,Half-life was measured in rat,N,,CHEMBL876603,,A,10116.0,1,,,7749
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6681,,50597,,Half-life period for the compound was determined in rats at 50 mg/kg dose,N,,CHEMBL620483,,A,10116.0,1,,,7750
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17752,,50597,,Half-life period in rats after intravenous administration at 5 mg/kg,N,,CHEMBL620484,,A,10116.0,1,,,7751
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6046,,50597,,Half-life period in rat at 10 mg/kg,N,,CHEMBL620485,,A,10116.0,1,,,7752
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",N,,CHEMBL620486,,A,10116.0,1,,,7753
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",N,,CHEMBL620487,,A,10116.0,1,,,7754
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",N,,CHEMBL620488,,A,10116.0,1,,,7755
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4727,,50597,,Half-life time in rat the dose of 2 mg/kg,N,,CHEMBL620489,,A,10116.0,1,,,7756
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1088,,50597,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,N,,CHEMBL620490,,A,10116.0,1,,,7757
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5610,,50597,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,N,,CHEMBL620491,,A,10116.0,1,,,7758
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,3032,,50597,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,,CHEMBL876604,,A,10116.0,1,,,7759
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5199,,50597,,Oral half life was determined,N,,CHEMBL620492,,A,10116.0,1,,,7760
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14941,,50597,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",N,,CHEMBL620493,,A,10116.0,1,,,7761
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4408,,50597,,Pharmacokinetic property (t1/2) in rat,N,,CHEMBL620494,,A,10116.0,1,,,7762
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,2552,,50597,,Plasma elimination half-life was determined,N,,CHEMBL620495,,A,10116.0,1,,,7763
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5199,,50597,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,,CHEMBL620496,,A,10116.0,1,,,7764
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15662,,50597,,Plasma half life was observed after intravenous administration in rat,N,,CHEMBL620497,,A,10116.0,1,,,7765
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1465,,50597,,Plasma half-life was determined,N,,CHEMBL620498,,A,10116.0,1,,,7766
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1446,,50597,,Plasma half-life following oral administration in Fisher rats,N,,CHEMBL620499,,A,10116.0,1,,,7767
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6824,,50597,,Plasma half-life in rat,N,,CHEMBL620500,,A,10116.0,1,,,7768
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17533,,50597,,Plasmatic Half-life after intravenous administration to rat,N,,CHEMBL873809,,A,10116.0,1,,,7769
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5979,,50597,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,,CHEMBL620501,,A,10116.0,1,,,7770
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4689,,50597,,Terminal half life after intravenous administration (1 mg/kg) in rat,N,,CHEMBL620502,,A,10116.0,1,,,7771
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4689,,50597,,Terminal half life in Rat at a oral dose of 5 mg/kg,N,,CHEMBL620503,,A,10116.0,1,,,7772
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2463,,50597,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,,CHEMBL620504,,A,10116.0,1,,,7773
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4883,,50597,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,N,,CHEMBL876605,,A,10116.0,1,,,7774
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4883,,50597,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,N,,CHEMBL620505,,A,10116.0,1,,,7775
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15662,,50597,,plasma half life was observed after intravenous administration in rat,N,,CHEMBL873811,,A,10116.0,1,,,7776
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Expert,3598,,50597,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,CHEMBL624016,,A,10116.0,1,,,7777
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4576,,50597,,Half life of compound determined in rat,N,,CHEMBL624017,,A,10116.0,1,,,7778
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4576,,50597,,Mean residence time determined in rat,N,,CHEMBL624018,,A,10116.0,1,,,7779
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4576,,50597,,Plasma half life determined in rat,N,,CHEMBL624019,,A,10116.0,1,,,7780
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,4910,,50597,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,N,,CHEMBL624020,,A,10116.0,1,,,7781
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4891,,50597,,Compound was evaluated for pharmacokinetic parameter maximum time period,N,,CHEMBL624201,,A,10116.0,1,,,7782
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,429,,50597,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,,CHEMBL872528,,A,10116.0,1,,,7783
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL624202,,A,10116.0,1,,,7784
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL624203,,A,10116.0,1,,,7785
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL624350,,A,10116.0,1,,,7786
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL621320,,A,10116.0,1,,,7787
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17582,,50597,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,,CHEMBL621321,,A,10116.0,1,,,7788
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4026,,50597,,Maximum time (Tmax) required to reach Cmax in rats,N,,CHEMBL621322,,A,10116.0,1,,,7789
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4890,,50597,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,,CHEMBL621323,,A,10116.0,1,,,7790
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6571,,50597,,Maximum time of clearance of compound in rats after peroral administration,N,,CHEMBL621324,,A,10116.0,1,,,7791
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4727,,50597,,Maximum time at the dose of 2 mg/kg in rat,N,,CHEMBL621325,,A,10116.0,1,,,7792
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17651,,50597,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,N,,CHEMBL875837,,A,10116.0,1,,,7793
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17651,,50597,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,N,,CHEMBL621326,,A,10116.0,1,,,7794
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14465,,50597,,Tmax in Guinea pig (PO dose),N,,CHEMBL621327,,A,10116.0,1,,,7795
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14941,,50597,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",N,,CHEMBL621328,,A,10116.0,1,,,7796
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5960,,50597,,Pharmacokinetic parameter (Tmax) in rat,N,,CHEMBL621329,,A,10116.0,1,,,7797
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5022,,50597,,Pharmacokinetic parameter (Tmax) was estimated,N,,CHEMBL621330,,A,10116.0,1,,,7798
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4408,,50597,,Pharmacokinetic property (Tmax) in rat,N,,CHEMBL621331,,A,10116.0,1,,,7799
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5983,,50597,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,,CHEMBL621332,,A,10116.0,1,,,7800
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4689,,50597,,T max in Rat at a oral dose of 5 mg/kg,N,,CHEMBL621333,,A,10116.0,1,,,7801
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2792,,50597,,T max was determined at 10 mg/kg po dose in rats,N,,CHEMBL621334,,A,10116.0,1,,,7802
,1,BAO_0000218,,Mus musculus,,,Intermediate,15011,,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),N,,CHEMBL621335,,A,10090.0,1,,,7803
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14180,,50588,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,N,,CHEMBL621336,,A,9615.0,1,,,7804
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14180,,50597,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,N,,CHEMBL621337,,A,10116.0,1,,,7805
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14599,,50588,,Area under curve was measured after i.v. administration into Beagle dog.,N,,CHEMBL621338,,A,9615.0,1,,,7806
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14599,,50588,,Area under curve was measured after iv administration into Beagle dog,N,,CHEMBL875838,,A,9615.0,1,,,7807
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14599,,50588,,Area under curve was measured after po administration into Beagle dog,N,,CHEMBL621339,,A,9615.0,1,,,7808
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14599,,50588,,Area under curve was measured after po administration into Beagle dog.,N,,CHEMBL621340,,A,9615.0,1,,,7809
,0,BAO_0000218,,,,,Autocuration,15675,,22224,,Area under curve was measured at peroral dose of 3 mg/kg,U,,CHEMBL621341,,A,,1,,,7810
,0,BAO_0000019,,,,,Autocuration,12706,,22224,,Area under curve was measured by using concentration Vs time,U,,CHEMBL621342,,A,,1,,,7811
,0,BAO_0000019,,,,,Autocuration,12706,,22224,,Area under curve was measured by using concentration Vs time; not tested,U,,CHEMBL621343,,A,,1,,,7812
,1,BAO_0000218,,Mus musculus,,,Intermediate,9750,,50594,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),N,,CHEMBL621344,,A,10090.0,1,,,7813
,1,BAO_0000218,,Mus musculus,,,Intermediate,9750,,50594,,Area under curve(AUC) was measured in mice after oral administration.,N,,CHEMBL621345,,A,10090.0,1,,,7814
,0,BAO_0000019,,,,,Autocuration,14691,,22224,,Area under curve(AUC) value of the compound,U,,CHEMBL621346,,A,,1,,,7815
,0,BAO_0000218,,,,,Autocuration,14691,,22224,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,U,,CHEMBL621347,,A,,1,,,7816
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14691,,50588,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,N,,CHEMBL621348,,A,9615.0,1,,,7817
,0,BAO_0000019,,,Blood,178.0,Autocuration,2939,,22224,,Area under curve(carotid artery) was determined by the availability in blood,U,,CHEMBL621349,,A,,1,,,7818
,0,BAO_0000019,,,Blood,178.0,Autocuration,2939,,22224,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,U,,CHEMBL621350,,A,,1,,,7819
,0,BAO_0000019,,,Blood,178.0,Autocuration,2939,,22224,,Area under curve(carotid artery) was determined by the availability in blood; No data,U,,CHEMBL875839,,A,,1,,,7820
,0,BAO_0000019,,,Blood,178.0,Autocuration,2939,,22224,,Area under curve(portal vein) was determined by the availability in blood,U,,CHEMBL620211,,A,,1,,,7821
,0,BAO_0000019,,,Blood,178.0,Autocuration,2939,,22224,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,U,,CHEMBL620212,,A,,1,,,7822
,0,BAO_0000019,,,Blood,178.0,Autocuration,2939,,22224,,Area under curve(portal vein) was determined by the availability in blood; No data,U,,CHEMBL620213,,A,,1,,,7823
,1,BAO_0000218,,Macaca mulatta,Plasma,1969.0,Intermediate,9552,,50797,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,,CHEMBL620214,,A,9544.0,1,,,7824
,1,BAO_0000218,,Macaca mulatta,Plasma,1969.0,Intermediate,9552,,50797,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,,CHEMBL620215,,A,9544.0,1,,,7825
,1,BAO_0000218,,Macaca mulatta,Plasma,1969.0,Intermediate,9552,,50797,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,N,,CHEMBL620216,,A,9544.0,1,,,7826
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,9552,,50588,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",N,,CHEMBL620888,,A,9615.0,1,,,7827
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,9552,,50588,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",N,,CHEMBL620889,,A,9615.0,1,,,7828
,0,BAO_0000019,,,Plasma,1969.0,Autocuration,9552,,22224,,Area under plasma concentration vs time curve observed in rats for 0-3 h,U,,CHEMBL620890,,A,,1,,,7829
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,11911,,50597,,Area under plasma time curve determined in male rat,N,,CHEMBL620891,,A,10116.0,1,,,7830
,0,BAO_0000019,,,,,Autocuration,16618,,22224,,Area under the MAP curve measured over 5 min.,U,,CHEMBL620892,,A,,1,,,7831
,1,BAO_0000218,,Mus musculus,,,Intermediate,14387,,50594,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,N,,CHEMBL621079,,A,10090.0,1,,,7832
,1,BAO_0000218,,Mus musculus,,,Intermediate,14387,,50594,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,N,,CHEMBL621080,,A,10090.0,1,,,7833
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,12836,,50588,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,N,,CHEMBL621081,,A,9615.0,1,,,7834
,1,BAO_0000218,,Cricetinae,,,Intermediate,12836,,100712,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,N,,CHEMBL621082,,A,10026.0,1,,,7835
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12836,,50597,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,N,,CHEMBL621083,,A,10116.0,1,,,7836
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14339,,50588,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,N,,CHEMBL621084,,A,9615.0,1,,,7837
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14339,,50588,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,N,,CHEMBL621085,,A,9615.0,1,,,7838
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14339,,50588,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,N,,CHEMBL621086,,A,9615.0,1,,,7839
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,10524,,50588,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,,CHEMBL621087,,A,9615.0,1,,,7840
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,9994,,50588,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),N,,CHEMBL622607,,A,9615.0,1,,,7841
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,11325,,50588,,Serum AUC in marmosets (IV dose),N,,CHEMBL622608,,A,9615.0,1,,,7842
,0,BAO_0000019,,,,,Autocuration,12536,,22224,,Area under the curve after intravenous administration at a dose of 10 umol/kg,U,,CHEMBL624481,,A,,1,,,7843
,0,BAO_0000019,,,,,Autocuration,12536,,22224,,Area under the curve after intravenous administration at a dose of 2 umol/kg,U,,CHEMBL624482,,A,,1,,,7844
,0,BAO_0000019,,,,,Autocuration,12536,,22224,,Area under the curve after intravenous administration at a dose of 4 umol/kg,U,,CHEMBL624483,,A,,1,,,7845
,0,BAO_0000019,,,,,Autocuration,12536,,22224,,Area under the curve after intravenous administration at a dose of 40 umol/kg,U,,CHEMBL624484,,A,,1,,,7846
,0,BAO_0000019,,,,,Autocuration,12536,,22224,,Area under the curve after intravenous administration at a dose of 5 umol/kg,U,,CHEMBL624485,,A,,1,,,7847
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15556,,50597,,Area under the curve for fumarate salt was evaluated in F344 Rats.,N,,CHEMBL624486,,A,10116.0,1,,,7848
,0,BAO_0000019,,,,,Autocuration,2809,,22224,,Area under the curve for the compound was calculated.,U,,CHEMBL624487,,A,,1,,,7849
,0,BAO_0000019,,,,,Autocuration,9511,,22224,,Area under the curve in concentration/ time,U,,CHEMBL624488,,A,,1,,,7850
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12818,,50597,,Area under the curve administered intraintestinal in rats.,N,,CHEMBL624489,,A,10116.0,1,,,7851
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12818,,50597,,Area under the curve administered intravenously in rats.,N,,CHEMBL625184,,A,10116.0,1,,,7852
,0,BAO_0000019,,,,,Autocuration,15118,,22224,,Area under the curve during intravenous administration,U,,CHEMBL625185,,A,,1,,,7853
,0,BAO_0000019,,,,,Autocuration,15118,,22224,,Area under the curve during intravenous administration; Not determined,U,,CHEMBL875954,,A,,1,,,7854
,0,BAO_0000019,,,,,Autocuration,15118,,22224,,Area under the curve during systemic administration,U,,CHEMBL625186,,A,,1,,,7855
,0,BAO_0000019,,,,,Autocuration,15118,,22224,,Area under the curve during systemic administration; Not determined,U,,CHEMBL625187,,A,,1,,,7856
,0,BAO_0000019,,,,,Autocuration,2632,,22224,,Area under the curve was calculated for the compound.,U,,CHEMBL625188,,A,,1,,,7857
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14346,,50588,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,N,,CHEMBL625189,,A,9615.0,1,,,7858
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14346,,50588,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,N,,CHEMBL625190,,A,9615.0,1,,,7859
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14346,,50597,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,N,,CHEMBL621733,,A,10116.0,1,,,7860
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14346,,50597,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,N,,CHEMBL621734,,A,10116.0,1,,,7861
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11149,,50597,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,N,,CHEMBL621735,,A,10116.0,1,,,7862
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17796,,50597,,Clearance of the drug was measured in the plasma of rat; No data,N,,CHEMBL621736,,A,10116.0,1,,,7863
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,5247,,50597,,The pharmacokinetic parameter plasma clearance in vivo in rats,N,,CHEMBL621737,,A,10116.0,1,,,7864
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4727,,50597,,Plasma clearance at the dose of 2 mg/kg in rat,N,,CHEMBL621738,,A,10116.0,1,,,7865
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5654,,50597,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,CHEMBL622806,,A,10116.0,1,,,7866
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5654,,50597,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,CHEMBL623519,,A,10116.0,1,,,7867
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17260,,50597,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,CHEMBL623520,,A,10116.0,1,,,7868
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17065,,50597,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,CHEMBL623521,,A,10116.0,1,,,7869
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17671,,50597,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,CHEMBL623522,,A,10116.0,1,,,7870
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6672,,50597,,Clearance rate in rat,N,,CHEMBL623523,,A,10116.0,1,,,7871
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6673,,50597,,Clearance rate in rat,N,,CHEMBL623690,,A,10116.0,1,,,7872
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL623691,,A,10116.0,1,,,7873
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL623692,,A,10116.0,1,,,7874
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL623693,,A,10116.0,1,,,7875
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL623694,,A,10116.0,1,,,7876
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4413,,50597,,Clearance of compound after iv administration of 20 mg/kg dose in rat,N,,CHEMBL623695,,A,10116.0,1,,,7877
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,N,,CHEMBL623696,,A,10116.0,1,,,7878
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,N,,CHEMBL623697,,A,10116.0,1,,,7879
,0,BAO_0000218,In vivo,Macaca mulatta,Plasma,1969.0,Intermediate,5005,,22224,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,,CHEMBL623698,,A,9544.0,1,,,7880
,0,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5005,,22224,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,U,,CHEMBL623699,,A,10116.0,1,,,7881
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15765,,50597,,Mean (%CV) PK parameters for CL(mL/min/kg).,N,,CHEMBL623700,,A,10116.0,1,,,7882
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3747,,50597,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,N,,CHEMBL623701,,A,10116.0,1,,,7883
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,16366,,50597,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,N,,CHEMBL623702,,A,10116.0,1,,,7884
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4199,,50597,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,N,,CHEMBL623703,,A,10116.0,1,,,7885
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17267,,50597,,Plasma clearance in rat was determined,N,,CHEMBL623704,,A,10116.0,1,,,7886
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6535,,50597,,Plasma clearance in rat after administration of 2 mg/kg iv,N,,CHEMBL623705,,A,10116.0,1,,,7887
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6535,,50597,,Plasma clearance in rat after administration of 2 mg/kg iv,N,,CHEMBL623706,,A,10116.0,1,,,7888
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5041,,50597,,Plasma clearance was determined,N,,CHEMBL623707,,A,10116.0,1,,,7889
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5960,,50597,,Plasma clearance in rat,N,,CHEMBL623708,,A,10116.0,1,,,7890
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5937,,50597,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,N,,CHEMBL623709,,A,10116.0,1,,,7891
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5871,,50597,,Plasma clearance in rat by iv administration,N,,CHEMBL623710,,A,10116.0,1,,,7892
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5874,,50597,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,N,,CHEMBL623711,,A,10116.0,1,,,7893
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6504,,50597,,Plasma clearance in rat p.o.,N,,CHEMBL623712,,A,10116.0,1,,,7894
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6803,,50597,,Plasma clearance in rats,N,,CHEMBL623713,,A,10116.0,1,,,7895
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5041,,50597,,Plasma clearance was determined; ND denotes no data,N,,CHEMBL623714,,A,10116.0,1,,,7896
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5041,,50597,,Plasma clearance was determined; ND denotes not determined,N,,CHEMBL623715,,A,10116.0,1,,,7897
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1916,,50597,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,,CHEMBL623716,,A,10116.0,1,,,7898
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5199,,50597,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,,CHEMBL622980,,A,10116.0,1,,,7899
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16367,,50597,,Plasma administration to rats,N,,CHEMBL622981,,A,10116.0,1,,,7900
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6362,,50597,,Plasma clearance of the compound in female Sprague-Dawley rats,N,,CHEMBL622982,,A,10116.0,1,,,7901
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15662,,50597,,Plasma clearance was observed after intravenous administration in rat,N,,CHEMBL622983,,A,10116.0,1,,,7902
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6215,,50597,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,N,,CHEMBL622984,,A,10116.0,1,,,7903
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1466,,50597,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,N,,CHEMBL622985,,A,10116.0,1,,,7904
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15662,,50597,,plasma clearance was observed after intravenous administration in rat,N,,CHEMBL623631,,A,10116.0,1,,,7905
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4723,,50597,,In vivo CL/F determined,N,,CHEMBL623632,,A,10116.0,1,,,7906
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2792,,50597,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,N,,CHEMBL623633,,A,10116.0,1,,,7907
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2792,,50597,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,N,,CHEMBL623634,,A,10116.0,1,,,7908
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5213,,50597,,Compound was tested for the lower blood clearance in rat,N,,CHEMBL623635,,A,10116.0,1,,,7909
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4687,,50597,,Evaluated for the low clearance in rat (in vivo),N,,CHEMBL621195,,A,10116.0,1,,,7910
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3371,,50597,,Pharmacokinetic property (CLb)of the compound was determined in rat,N,,CHEMBL621196,,A,10116.0,1,,,7911
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4690,,50597,,Rapid clearance after intravenous administration in rat was determined,N,,CHEMBL875287,,A,10116.0,1,,,7912
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5702,,50597,,Clearance measured in rat,N,,CHEMBL621197,,A,10116.0,1,,,7913
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,740,,50597,,Compound was evaluated for plasma clearance in rat,N,,CHEMBL621198,,A,10116.0,1,,,7914
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4853,,50597,,Low plasma clearance was calculated in rat,N,,CHEMBL621199,,A,10116.0,1,,,7915
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5789,,50597,,Pharmacokinetic property (Clp) in rat,N,,CHEMBL621200,,A,10116.0,1,,,7916
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4527,,50597,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,N,,CHEMBL621201,,A,10116.0,1,,,7917
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4527,,50597,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,N,,CHEMBL621202,,A,10116.0,1,,,7918
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,N,,CHEMBL621203,,A,10116.0,1,,,7919
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Plasma clearance after IV dosing at 1 mg/kg in rat,N,,CHEMBL621204,,A,10116.0,1,,,7920
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,N,,CHEMBL621205,,A,10116.0,1,,,7921
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,N,,CHEMBL621206,,A,10116.0,1,,,7922
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,,CHEMBL621207,,A,10116.0,1,,,7923
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,N,,CHEMBL621208,,A,10116.0,1,,,7924
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,N,,CHEMBL621209,,A,10116.0,1,,,7925
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,N,,CHEMBL876484,,A,10116.0,1,,,7926
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,CHEMBL621210,,A,10116.0,1,,,7927
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,N,,CHEMBL621211,,A,10116.0,1,,,7928
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,,CHEMBL621212,,A,10116.0,1,,,7929
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,N,,CHEMBL621213,,A,10116.0,1,,,7930
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,N,,CHEMBL621214,,A,10116.0,1,,,7931
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,N,,CHEMBL621215,,A,10116.0,1,,,7932
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,N,,CHEMBL621216,,A,10116.0,1,,,7933
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,N,,CHEMBL621217,,A,10116.0,1,,,7934
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,N,,CHEMBL621218,,A,10116.0,1,,,7935
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,N,,CHEMBL621219,,A,10116.0,1,,,7936
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,N,,CHEMBL621220,,A,10116.0,1,,,7937
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,N,,CHEMBL621221,,A,10116.0,1,,,7938
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,N,,CHEMBL621222,,A,10116.0,1,,,7939
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,N,,CHEMBL621223,,A,10116.0,1,,,7940
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,N,,CHEMBL876485,,A,10116.0,1,,,7941
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,CHEMBL621224,,A,10116.0,1,,,7942
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,N,,CHEMBL621225,,A,10116.0,1,,,7943
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9866,,50597,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,N,,CHEMBL621226,,A,10116.0,1,,,7944
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,N,,CHEMBL621227,,A,10116.0,1,,,7945
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,CHEMBL621228,,A,10116.0,1,,,7946
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,,CHEMBL621229,,A,10116.0,1,,,7947
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,N,,CHEMBL621230,,A,10116.0,1,,,7948
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,,CHEMBL621231,,A,10116.0,1,,,7949
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,CHEMBL621232,,A,10116.0,1,,,7950
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,CHEMBL621233,,A,10116.0,1,,,7951
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,N,,CHEMBL621234,,A,10116.0,1,,,7952
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,,CHEMBL621235,,A,10116.0,1,,,7953
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,CHEMBL621236,,A,10116.0,1,,,7954
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,N,,CHEMBL621237,,A,10116.0,1,,,7955
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,9866,,50597,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,N,,CHEMBL876486,,A,10116.0,1,,,7956
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,9866,,50597,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,N,,CHEMBL622436,,A,10116.0,1,,,7957
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,9866,,50597,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,N,,CHEMBL622437,,A,10116.0,1,,,7958
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,9866,,50597,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,N,,CHEMBL622438,,A,10116.0,1,,,7959
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,N,,CHEMBL622439,,A,10116.0,1,,,7960
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,N,,CHEMBL622440,,A,10116.0,1,,,7961
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,N,,CHEMBL622441,,A,10116.0,1,,,7962
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,,CHEMBL622442,,A,10116.0,1,,,7963
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,N,,CHEMBL622443,,A,10116.0,1,,,7964
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,CHEMBL622444,,A,10116.0,1,,,7965
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,N,,CHEMBL622445,,A,10116.0,1,,,7966
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,CHEMBL622446,,A,10116.0,1,,,7967
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,CHEMBL622447,,A,10116.0,1,,,7968
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,N,,CHEMBL622448,,A,10116.0,1,,,7969
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,,CHEMBL622449,,A,10116.0,1,,,7970
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,N,,CHEMBL622450,,A,10116.0,1,,,7971
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,N,,CHEMBL622451,,A,10116.0,1,,,7972
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,N,,CHEMBL622452,,A,10116.0,1,,,7973
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,N,,CHEMBL622453,,A,10116.0,1,,,7974
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,N,,CHEMBL622454,,A,10116.0,1,,,7975
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,N,,CHEMBL622455,,A,10116.0,1,,,7976
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,N,,CHEMBL876024,,A,10116.0,1,,,7977
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2792,,50597,,T max was determined at 3 mg/kg po dose in rats,N,,CHEMBL622456,,A,10116.0,1,,,7978
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15078,,50597,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL622457,,A,10116.0,1,,,7979
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15078,,50597,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL622458,,A,10116.0,1,,,7980
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15022,,50597,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,N,,CHEMBL622459,,A,10116.0,1,,,7981
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15022,,50597,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,N,,CHEMBL873343,,A,10116.0,1,,,7982
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15022,,50597,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,N,,CHEMBL622460,,A,10116.0,1,,,7983
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4576,,50597,,Time for maximum plasma concentration determined in rat,N,,CHEMBL622461,,A,10116.0,1,,,7984
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6681,,50597,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,,CHEMBL622462,,A,10116.0,1,,,7985
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,N,,CHEMBL622463,,A,10116.0,1,,,7986
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,N,,CHEMBL622464,,A,10116.0,1,,,7987
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,N,,CHEMBL622465,,A,10116.0,1,,,7988
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,N,,CHEMBL622466,,A,10116.0,1,,,7989
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,N,,CHEMBL622467,,A,10116.0,1,,,7990
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6824,,50597,,Time of maximum plasma concentration in rat,N,,CHEMBL622468,,A,10116.0,1,,,7991
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6685,,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,,CHEMBL876025,,A,10116.0,1,,,7992
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6685,,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,,CHEMBL622469,,A,10116.0,1,,,7993
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6685,,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,,CHEMBL622470,,A,10116.0,1,,,7994
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15662,,50597,,Time required to reach maximum concentration (Cmax) after oral administration in rat,N,,CHEMBL622471,,A,10116.0,1,,,7995
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1742,,50597,,Time required to reach maximum concentration in rat plasma,N,,CHEMBL622472,,A,10116.0,1,,,7996
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2774,,50597,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,,CHEMBL622473,,A,10116.0,1,,,7997
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5199,,50597,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,,CHEMBL624282,,A,10116.0,1,,,7998
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12873,,50597,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,CHEMBL624283,,A,10116.0,1,,,7999
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12873,,50597,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,CHEMBL624284,,A,10116.0,1,,,8000
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1916,,50597,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,,CHEMBL624285,,A,10116.0,1,,,8001
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16367,,50597,,Time to reach Cmax after oral administration to rats,N,,CHEMBL624286,,A,10116.0,1,,,8002
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16366,,50597,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,N,,CHEMBL624287,,A,10116.0,1,,,8003
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,216,,50597,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,N,,CHEMBL624288,,A,10116.0,1,,,8004
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6410,,50597,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,N,,CHEMBL624289,,A,10116.0,1,,,8005
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6410,,50597,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,N,,CHEMBL873344,,A,10116.0,1,,,8006
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6215,,50597,,Tmax after peroral administration (10 mg/kg) was determined in rat,N,,CHEMBL619623,,A,10116.0,1,,,8007
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Expert,3598,,50597,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,CHEMBL621399,,A,10116.0,1,,,8008
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4527,,50597,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,N,,CHEMBL621400,,A,10116.0,1,,,8009
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17670,,50597,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",N,,CHEMBL621401,,A,10116.0,1,,,8010
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1465,,50597,,Tmax was determined,N,,CHEMBL621402,,A,10116.0,1,,,8011
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2552,,50597,,Tmax was determined,N,,CHEMBL621403,,A,10116.0,1,,,8012
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5656,,50597,,Tmax after oral administration in rat,N,,CHEMBL621121,,A,10116.0,1,,,8013
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17764,,50597,,Tmax after peroral administration in rats at 2.4 uM/kg,N,,CHEMBL872525,,A,10116.0,1,,,8014
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5610,,50597,,Tmax in male rat,N,,CHEMBL621122,,A,10116.0,1,,,8015
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6046,,50597,,Tmax in rat at 10 mg/kg,N,,CHEMBL621123,,A,10116.0,1,,,8016
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5874,,50597,,Tmax in rat by po administration at a dose of 40 mg/kg,N,,CHEMBL621124,,A,10116.0,1,,,8017
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17596,,50597,,Tmax in rats,N,,CHEMBL621125,,A,10116.0,1,,,8018
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17804,,50597,,Tmax was measured in rats after peroral administration at 5 mg/kg,N,,CHEMBL621126,,A,10116.0,1,,,8019
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1908,,50597,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,N,,CHEMBL621127,,A,10116.0,1,,,8020
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2959,,50597,,Tmax value after administration of 20 mg/Kg oral dose in rat,N,,CHEMBL621128,,A,10116.0,1,,,8021
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6757,,50597,,Tmax value at a dose of 10 mg/kg in male SD rats,N,,CHEMBL618263,,A,10116.0,1,,,8022
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6757,,50597,,Tmax value at a dose of 100 mg/kg in male SD rats,N,,CHEMBL618264,,A,10116.0,1,,,8023
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6757,,50597,,Tmax value at a dose of 50 mg/kg in male SD rats,N,,CHEMBL618265,,A,10116.0,1,,,8024
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4186,,50597,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,CHEMBL618266,,A,10116.0,1,,,8025
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15662,,50597,,time required to reach maximum concentration (Cmax) after oral administration in rat,N,,CHEMBL618267,,A,10116.0,1,,,8026
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,429,,50597,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),N,,CHEMBL618450,,A,10116.0,1,,,8027
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,429,,50597,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),N,,CHEMBL618451,,A,10116.0,1,,,8028
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5546,,50597,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,,CHEMBL618452,,A,10116.0,1,,,8029
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,3173,,50597,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,N,,CHEMBL618453,,A,10116.0,1,,,8030
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,3173,,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,N,,CHEMBL618454,,A,10116.0,1,,,8031
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,3173,,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,N,,CHEMBL618455,,A,10116.0,1,,,8032
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4257,,50597,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,N,,CHEMBL618456,,A,10116.0,1,,,8033
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6011,,50597,,Compound distribution in rat tissues was determined,N,,CHEMBL618457,,A,10116.0,1,,,8034
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5472,,50597,,Volume of distribution was evaluated in rat,N,,CHEMBL618458,,A,10116.0,1,,,8035
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14346,,50597,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,N,,CHEMBL618459,,A,10116.0,1,,,8036
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14346,,50597,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,N,,CHEMBL876733,,A,10116.0,1,,,8037
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14346,,50588,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,N,,CHEMBL618460,,A,9615.0,1,,,8038
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14346,,50597,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,N,,CHEMBL618461,,A,10116.0,1,,,8039
,0,BAO_0000019,,,,,Autocuration,15469,,22224,,Area under the curve was determined after oral administration (300 uM/Kg),U,,CHEMBL618462,,A,,1,,,8040
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14346,,50597,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,N,,CHEMBL618463,,A,10116.0,1,,,8041
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14346,,50597,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,N,,CHEMBL618464,,A,10116.0,1,,,8042
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14346,,50597,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,N,,CHEMBL618465,,A,10116.0,1,,,8043
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14346,,50597,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,N,,CHEMBL618466,,A,10116.0,1,,,8044
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14346,,50597,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,N,,CHEMBL618467,,A,10116.0,1,,,8045
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15372,,50597,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,N,,CHEMBL618468,,A,10116.0,1,,,8046
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,12935,,50588,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,N,,CHEMBL618469,,A,9615.0,1,,,8047
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,12935,,50588,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,N,,CHEMBL618470,,A,9615.0,1,,,8048
,0,BAO_0000218,,,,,Autocuration,14813,,22224,,Plasma drug AUC in rat (PO dose),U,,CHEMBL618471,,A,,1,,,8049
,1,BAO_0000218,,Mus musculus,,,Intermediate,15792,,50594,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,N,,CHEMBL618472,,A,10090.0,1,,,8050
,0,BAO_0000218,,,,,Autocuration,3579,,22224,,Area under was determined at a dose of 30 mg/kg,U,,CHEMBL618473,,A,,1,,,8051
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,12487,,50506,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,N,,CHEMBL621699,,A,9669.0,1,,,8052
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12487,,50597,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,N,,CHEMBL621700,,A,10116.0,1,,,8053
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12487,,50597,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,N,,CHEMBL621701,,A,10116.0,1,,,8054
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,12487,,50506,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,N,,CHEMBL621702,,A,9669.0,1,,,8055
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,12487,,50588,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,N,,CHEMBL621703,,A,9615.0,1,,,8056
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,12487,,50588,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,N,,CHEMBL621704,,A,9615.0,1,,,8057
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12902,,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",N,,CHEMBL624259,,A,10116.0,1,,,8058
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12902,,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",N,,CHEMBL624260,,A,10116.0,1,,,8059
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12902,,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",N,,CHEMBL624430,,A,10116.0,1,,,8060
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12902,,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",N,,CHEMBL624431,,A,10116.0,1,,,8061
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12902,,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",N,,CHEMBL624432,,A,10116.0,1,,,8062
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12902,,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",N,,CHEMBL624433,,A,10116.0,1,,,8063
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12902,,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",N,,CHEMBL624434,,A,10116.0,1,,,8064
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12902,,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",N,,CHEMBL624435,,A,10116.0,1,,,8065
,1,BAO_0000218,,Mus musculus,,,Intermediate,12745,,50594,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,N,,CHEMBL618570,,A,10090.0,1,,,8066
,1,BAO_0000218,,Mus musculus,,,Intermediate,12745,,50594,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,CHEMBL618571,,A,10090.0,1,,,8067
,1,BAO_0000218,,Mus musculus,,,Intermediate,12745,,50594,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,N,,CHEMBL618572,,A,10090.0,1,,,8068
,1,BAO_0000218,,Mus musculus,,,Intermediate,12745,,50594,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,CHEMBL618573,,A,10090.0,1,,,8069
,1,BAO_0000218,,Mus musculus,,,Intermediate,12745,,50594,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,N,,CHEMBL619267,,A,10090.0,1,,,8070
,1,BAO_0000218,,Mus musculus,,,Intermediate,12745,,50594,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,CHEMBL619431,,A,10090.0,1,,,8071
,1,BAO_0000218,,Mus musculus,,,Intermediate,12745,,50594,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,N,,CHEMBL619432,,A,10090.0,1,,,8072
,1,BAO_0000218,,Mus musculus,,,Intermediate,12745,,50594,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,CHEMBL619433,,A,10090.0,1,,,8073
,0,BAO_0000218,,,Plasma,1969.0,Autocuration,13298,,22224,,AUC in mice after oral dose (50 mg/kg),U,,CHEMBL619434,,A,,1,,,8074
,1,BAO_0000218,,Mus musculus,Serum,1977.0,Intermediate,12226,,50594,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,N,,CHEMBL619435,,A,10090.0,1,,,8075
,0,BAO_0000019,,,Plasma,1969.0,Autocuration,12634,,22224,,AUC (0-4 hr) ug/ml/h,U,,CHEMBL619436,,A,,1,,,8076
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14810,,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,N,,CHEMBL619437,,A,10116.0,1,,,8077
,0,BAO_0000218,,,,,Autocuration,13889,,22224,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,U,,CHEMBL619438,,A,,1,,,8078
,1,BAO_0000218,,Mus musculus,,,Intermediate,10018,,50594,,Compound was evaluated for Area under curve in mice,N,,CHEMBL619439,,A,10090.0,1,,,8079
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8758,,50597,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,,CHEMBL619440,,A,10116.0,1,,,8080
,0,BAO_0000218,,,,,Autocuration,8758,,22224,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,U,,CHEMBL619441,,F,,1,,,8081
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8758,,50597,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,,CHEMBL619442,,A,10116.0,1,,,8082
,0,BAO_0000019,,,,,Autocuration,2249,,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,U,,CHEMBL875156,,A,,1,,,8083
,0,BAO_0000019,,,,,Autocuration,2249,,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,U,,CHEMBL619443,,A,,1,,,8084
,0,BAO_0000019,,,,,Autocuration,2249,,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,U,,CHEMBL619444,,A,,1,,,8085
,0,BAO_0000019,,,,,Autocuration,2249,,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,U,,CHEMBL623464,,A,,1,,,8086
,1,BAO_0000218,,Mus musculus,,,Intermediate,15115,,50594,,Compound was evaluated for area under curve when administered through oral route in mouse,N,,CHEMBL623465,,A,10090.0,1,,,8087
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,N,,CHEMBL623466,,A,10116.0,1,,,8088
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,N,,CHEMBL623467,,A,10116.0,1,,,8089
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6249,,50597,,Plasma clearance in rat,N,,CHEMBL623468,,A,10116.0,1,,,8090
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2463,,50597,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,,CHEMBL622660,,A,10116.0,1,,,8091
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4969,,50597,,Plasma clearance rate in Sprague-Dawley rats,N,,CHEMBL622661,,A,10116.0,1,,,8092
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17720,,50597,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,CHEMBL622662,,F,10116.0,1,,,8093
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3457,,50597,,Pharmacokinetic property (total body clearance) in rat,N,,CHEMBL622663,,A,10116.0,1,,,8094
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5983,,50597,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,N,,CHEMBL622664,,A,10116.0,1,,,8095
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6295,,50597,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,,CHEMBL622665,,A,10116.0,1,,,8096
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6296,,50597,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,,CHEMBL622666,,A,10116.0,1,,,8097
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17686,,50597,,Cl in rat i.v. at 2 mg/kg concentration,N,,CHEMBL621615,,A,10116.0,1,,,8098
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17764,,50597,,Clearance of compound after intravenous administration in rats at 24 uM/kg,N,,CHEMBL621616,,A,10116.0,1,,,8099
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5503,,50597,,Clearance was determined,N,,CHEMBL621617,,A,10116.0,1,,,8100
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4368,,50597,,Clearance by intravenous administration of 3.4 mg/kg in rat,N,,CHEMBL621618,,A,10116.0,1,,,8101
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6005,,50597,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,,CHEMBL621619,,A,10116.0,1,,,8102
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5031,,50597,,Clearance rate after i.v. administration in rats,N,,CHEMBL621620,,A,10116.0,1,,,8103
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4890,,50597,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,CHEMBL621786,,A,10116.0,1,,,8104
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5182,,50597,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,,CHEMBL621787,,A,10116.0,1,,,8105
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5979,,50597,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,N,,CHEMBL621788,,A,10116.0,1,,,8106
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5656,,50597,,Clearance (Cl) after oral administration in rat,N,,CHEMBL621789,,A,10116.0,1,,,8107
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17804,,50597,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,N,,CHEMBL621790,,A,10116.0,1,,,8108
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4839,,50597,,Compound was tested for plasma clearance in rat,N,,CHEMBL621791,,A,10116.0,1,,,8109
,1,BAO_0000218,In vitro,Rattus norvegicus,,,Intermediate,5041,Microsomes,50597,,In vitro microsome metabolism clearance in rat was determined,N,,CHEMBL621792,,A,10116.0,1,,,8110
,1,BAO_0000218,In vitro,Rattus norvegicus,,,Intermediate,5041,Microsomes,50597,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,N,,CHEMBL621793,,A,10116.0,1,,,8111
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL621794,,A,10116.0,1,,,8112
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5496,,50597,,In vivo plasma clearance was determined,N,,CHEMBL621795,,A,10116.0,1,,,8113
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5739,,50597,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,N,,CHEMBL621796,,A,10116.0,1,,,8114
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,5676,,50597,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,N,,CHEMBL621797,,A,10116.0,1,Hepatocyte,401.0,8115
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4239,,50597,,Pharmacokinetic property (Plasma clearance) was measured in rat,N,,CHEMBL621798,,A,10116.0,1,,,8116
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5676,,50597,,Pharmacokinetic property (clearance) in rat i.v.,N,,CHEMBL621799,,A,10116.0,1,,,8117
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1918,,50597,,"Plasma Clearance was evaluated in rats, iv",N,,CHEMBL621800,,A,10116.0,1,,,8118
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17800,,50597,,Plasma clearance (in vivo) in rats was determined,N,,CHEMBL621801,,A,10116.0,1,,,8119
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6056,,50597,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,N,,CHEMBL621802,,A,10116.0,1,,,8120
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5496,,50597,,Plasma clearance was determined,N,,CHEMBL618596,,A,10116.0,1,,,8121
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5939,,50597,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,N,,CHEMBL618597,,A,10116.0,1,,,8122
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5939,,50597,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,N,,CHEMBL618598,,A,10116.0,1,,,8123
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17752,,50597,,Plasma clearance in rats,N,,CHEMBL618599,,A,10116.0,1,,,8124
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4576,,50597,,Plasma clearance rate determined in rat,N,,CHEMBL618600,,A,10116.0,1,,,8125
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6011,,50597,,Plasma clearance was determined in rat,N,,CHEMBL618601,,A,10116.0,1,,,8126
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5510,,50597,,Plasma clearance was determined,N,,CHEMBL618602,,A,10116.0,1,,,8127
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5948,,50597,,Plasma clearance value in rat,N,,CHEMBL618603,,A,10116.0,1,,,8128
,1,BAO_0000218,Ex vivo,Rattus norvegicus,Liver,2107.0,Intermediate,6125,,50597,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,,CHEMBL618604,,A,10116.0,1,,,8129
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4839,,50597,,Clearance in rat,N,,CHEMBL618605,,A,10116.0,1,,,8130
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17686,,50597,,Total body clearance in rat i.v. at 2 mg/kg concentration,N,,CHEMBL618606,,A,10116.0,1,,,8131
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6571,,50597,,Clearance of compound in rats after intravenous administration,N,,CHEMBL618607,,A,10116.0,1,,,8132
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3364,,50597,,Clearance after iv administration to rats,N,,CHEMBL618608,,A,10116.0,1,,,8133
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,,CHEMBL618609,,A,10116.0,1,,,8134
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,,CHEMBL618610,,A,10116.0,1,,,8135
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,N,,CHEMBL618611,,A,10116.0,1,,,8136
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,,CHEMBL618612,,A,10116.0,1,,,8137
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,,CHEMBL618613,,A,10116.0,1,,,8138
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,,CHEMBL621076,,A,10116.0,1,,,8139
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,,CHEMBL621077,,A,10116.0,1,,,8140
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17670,,50597,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",N,,CHEMBL621078,,A,10116.0,1,,,8141
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5970,,50597,,Clearance in rat,N,,CHEMBL621251,,A,10116.0,1,,,8142
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6495,,50597,,Clearance in rat after oral administration at 10 mg/kg,N,,CHEMBL621252,,A,10116.0,1,,,8143
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4590,,50597,,Clearance in rat.,N,,CHEMBL621253,,A,10116.0,1,,,8144
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6193,,50597,,Clearance rate following an oral dose of 20 mg/kg in rats,N,,CHEMBL621254,,A,10116.0,1,,,8145
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2832,,50597,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,N,,CHEMBL621255,,A,10116.0,1,,,8146
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1052,,50597,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,N,,CHEMBL621256,,A,10116.0,1,,,8147
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,N,,CHEMBL621257,,A,10116.0,1,,,8148
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,N,,CHEMBL621258,,A,10116.0,1,,,8149
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,N,,CHEMBL621259,,A,10116.0,1,,,8150
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,N,,CHEMBL621260,,A,10116.0,1,,,8151
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,N,,CHEMBL876494,,A,10116.0,1,,,8152
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,N,,CHEMBL621261,,A,10116.0,1,,,8153
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,N,,CHEMBL621262,,A,10116.0,1,,,8154
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,CHEMBL621263,,A,10116.0,1,,,8155
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9866,,50597,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,N,,CHEMBL621264,,A,10116.0,1,,,8156
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,N,,CHEMBL621265,,A,10116.0,1,,,8157
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,N,,CHEMBL621266,,A,10116.0,1,,,8158
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,N,,CHEMBL621267,,A,10116.0,1,,,8159
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,N,,CHEMBL621268,,A,10116.0,1,,,8160
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,N,,CHEMBL621269,,A,10116.0,1,,,8161
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,N,,CHEMBL621270,,A,10116.0,1,,,8162
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,N,,CHEMBL621271,,A,10116.0,1,,,8163
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,N,,CHEMBL621272,,A,10116.0,1,,,8164
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,N,,CHEMBL621273,,A,10116.0,1,,,8165
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,N,,CHEMBL621274,,A,10116.0,1,,,8166
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,N,,CHEMBL876495,,A,10116.0,1,,,8167
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,N,,CHEMBL621275,,A,10116.0,1,,,8168
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,N,,CHEMBL621276,,A,10116.0,1,,,8169
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9866,,50597,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,N,,CHEMBL621277,,A,10116.0,1,,,8170
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,9866,,50597,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,N,,CHEMBL621278,,A,10116.0,1,,,8171
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,9866,,50597,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,N,,CHEMBL621279,,A,10116.0,1,,,8172
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,9866,,50597,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),N,,CHEMBL621280,,A,10116.0,1,,,8173
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,N,,CHEMBL621281,,A,10116.0,1,,,8174
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,N,,CHEMBL621282,,A,10116.0,1,,,8175
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,,CHEMBL621283,,A,10116.0,1,,,8176
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,N,,CHEMBL621284,,A,10116.0,1,,,8177
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,N,,CHEMBL621285,,A,10116.0,1,,,8178
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,N,,CHEMBL621286,,A,10116.0,1,,,8179
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,N,,CHEMBL623220,,A,10116.0,1,,,8180
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,N,,CHEMBL623221,,A,10116.0,1,,,8181
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,9866,,50597,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,N,,CHEMBL876029,,A,10116.0,1,,,8182
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,9866,,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,N,,CHEMBL623222,,A,10116.0,1,,,8183
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,9866,,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,N,,CHEMBL623223,,A,10116.0,1,,,8184
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,9866,,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,N,,CHEMBL621445,,A,10116.0,1,,,8185
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621446,,A,10116.0,1,,,8186
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621447,,A,10116.0,1,,,8187
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619681,,A,10116.0,1,,,8188
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619682,,A,10116.0,1,,,8189
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619683,,A,10116.0,1,,,8190
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619684,,A,10116.0,1,,,8191
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619685,,A,10116.0,1,,,8192
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619686,,A,10116.0,1,,,8193
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619687,,A,10116.0,1,,,8194
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619688,,A,10116.0,1,,,8195
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619689,,A,10116.0,1,,,8196
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619690,,A,10116.0,1,,,8197
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619691,,A,10116.0,1,,,8198
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6062,,50597,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,,CHEMBL619692,,A,10116.0,1,,,8199
,1,BAO_0000218,,Rattus norvegicus,,,Expert,3598,,50597,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,CHEMBL619693,,A,10116.0,1,,,8200
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1908,,50597,,Vc value after IV dose at a dose of 5 mg/kg in rats.,N,,CHEMBL619694,,A,10116.0,1,,,8201
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17596,,50597,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,N,,CHEMBL619695,,A,10116.0,1,,,8202
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4891,,50597,,Compound was evaluated for pharmacokinetic parameter volume of distribution,N,,CHEMBL619696,,A,10116.0,1,,,8203
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,740,,50597,,Compound was evaluated for volume of distribution in rat,N,,CHEMBL619697,,A,10116.0,1,,,8204
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16366,,50597,,Steady state volume distribution was determined; steady state(ss),N,,CHEMBL619698,,A,10116.0,1,,,8205
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3364,,50597,,Steady state volume of distribution after iv administration to rats,N,,CHEMBL619699,,A,10116.0,1,,,8206
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2552,,50597,,Steady state volume of distribution dosing at 3 mg/kg iv,N,,CHEMBL619700,,A,10116.0,1,,,8207
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,406,,50597,,The compound was evaluated for volume of distribution in rat,N,,CHEMBL619701,,A,10116.0,1,,,8208
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12500,,50597,,The compound was tested for volume of distribution in rat,N,,CHEMBL619702,,A,10116.0,1,,,8209
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12500,,50597,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,N,,CHEMBL620335,,A,10116.0,1,,,8210
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5656,,50597,,Volume distribution (VD) after oral administration in rat,N,,CHEMBL620336,,A,10116.0,1,,,8211
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17671,,50597,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,CHEMBL620337,,A,10116.0,1,,,8212
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1094,,50597,,Volume distribution in rat,N,,CHEMBL620520,,A,10116.0,1,,,8213
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5833,,50597,,Volume distribution in rat,N,,CHEMBL620521,,A,10116.0,1,,,8214
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5939,,50597,,Volume distribution in rat after peroral administration at 10 mg/kg,N,,CHEMBL875825,,A,10116.0,1,,,8215
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5939,,50597,,Volume distribution in rat after peroral administration at 5 mg/kg,N,,CHEMBL620522,,A,10116.0,1,,,8216
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6005,,50597,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,,CHEMBL620523,,A,10116.0,1,,,8217
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1696,,50597,,Volume of distribution in rat.,N,,CHEMBL620524,,A,10116.0,1,,,8218
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6672,,50597,,Volume of distribution in rat,N,,CHEMBL620525,,A,10116.0,1,,,8219
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6673,,50597,,Volume of distribution in rat,N,,CHEMBL620526,,A,10116.0,1,,,8220
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5871,,50597,,Volume of distribution in rat by iv administration,N,,CHEMBL620527,,A,10116.0,1,,,8221
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6803,,50597,,Volume of distribution in rats,N,,CHEMBL620528,,A,10116.0,1,,,8222
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5199,,50597,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,,CHEMBL620529,,A,10116.0,1,,,8223
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4727,,50597,,Volume distribution at the dose of 2 mg/kg in rat,N,,CHEMBL620530,,A,10116.0,1,,,8224
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16367,,50597,,Steady state volume of distribution was determined,N,,CHEMBL620531,,A,10116.0,1,,,8225
,0,BAO_0000218,In vivo,Macaca mulatta,,,Intermediate,5005,,22224,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,,CHEMBL620532,,A,9544.0,1,,,8226
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5005,,22224,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,U,,CHEMBL620533,,A,10116.0,1,,,8227
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5005,,22224,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,U,,CHEMBL620534,,A,10116.0,1,,,8228
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15765,,50597,,Mean (%CV) PK parameters for Vdss(mL/kg).,N,,CHEMBL620535,,A,10116.0,1,,,8229
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2792,,50597,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,N,,CHEMBL875826,,A,10116.0,1,,,8230
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2792,,50597,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,N,,CHEMBL620536,,A,10116.0,1,,,8231
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5334,,50597,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,,CHEMBL620537,,A,10116.0,1,,,8232
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5334,,50597,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,N,,CHEMBL618526,,A,10116.0,1,,,8233
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5739,,50597,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,N,,CHEMBL618527,,A,10116.0,1,,,8234
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5789,,50597,,Pharmacokinetic property (Vdss) in rat,N,,CHEMBL618528,,A,10116.0,1,,,8235
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4239,,50597,,Pharmacokinetic property (vdss) was measured in rat,N,,CHEMBL618529,,A,10116.0,1,,,8236
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4709,,50597,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,N,,CHEMBL618530,,A,10116.0,1,,,8237
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6642,,50597,,Volume of distribution in rat,N,,CHEMBL618531,,A,10116.0,1,,,8238
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5247,,50597,,The pharmacokinetic parameter volume of distribution in vivo in rats,N,,CHEMBL618532,,A,10116.0,1,,,8239
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17720,,50597,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,CHEMBL618533,,F,10116.0,1,,,8240
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17686,,50597,,Vdss in rat i.v. at 2 mg/kg concentration,N,,CHEMBL618534,,A,10116.0,1,,,8241
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4689,,50597,,Volume distribution after intravenous administration (1 mg/kg) in rat,N,,CHEMBL618535,,A,10116.0,1,,,8242
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5654,,50597,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,CHEMBL618536,,A,10116.0,1,,,8243
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5654,,50597,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,CHEMBL618537,,A,10116.0,1,,,8244
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4527,,50597,,Volume distribution at a dose of 10 uM/kg in rat was determined,N,,CHEMBL618538,,A,10116.0,1,,,8245
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4521,,50597,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,CHEMBL618539,,A,10116.0,1,,,8246
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6057,,50597,,Volume distribution was calculated in rat,N,,CHEMBL618540,,A,10116.0,1,,,8247
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5510,,50597,,Volume distribution was determined,N,,CHEMBL618541,,A,10116.0,1,,,8248
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2938,,50597,,Volume of distribution after intravenous administration was evaluated in rat,N,,CHEMBL618542,,A,10116.0,1,,,8249
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6679,,50597,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,CHEMBL622544,,A,10116.0,1,,,8250
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",N,,CHEMBL622545,,A,10116.0,1,,,8251
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,,CHEMBL622546,,A,10116.0,1,,,8252
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",N,,CHEMBL622547,,A,10116.0,1,,,8253
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5145,,50597,,Volume of distribution in steady state was determined in rat,N,,CHEMBL622548,,A,10116.0,1,,,8254
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6467,,50597,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,N,,CHEMBL622549,,A,10116.0,1,,,8255
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6467,,50597,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,,CHEMBL622550,,A,10116.0,1,,,8256
,1,BAO_0000218,,Mus musculus,,,Intermediate,15115,,50594,,Compound was evaluated for area under curve when administered through oral route to mouse,N,,CHEMBL622551,,A,10090.0,1,,,8257
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8758,,50597,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,,CHEMBL622552,,A,10116.0,1,,,8258
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8758,,50597,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,,CHEMBL622553,,A,10116.0,1,,,8259
,0,BAO_0000218,In vivo,,,,Autocuration,8267,,22224,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,U,,CHEMBL622554,,F,,1,,,8260
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8267,,50588,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,N,,CHEMBL622555,,A,9615.0,1,,,8261
,1,BAO_0000218,,Mus musculus,,,Intermediate,14239,,50594,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,N,,CHEMBL622556,,A,10090.0,1,,,8262
,1,BAO_0000218,,Mus musculus,,,Intermediate,14239,,50594,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,N,,CHEMBL622557,,A,10090.0,1,,,8263
,1,BAO_0000218,,Mus musculus,Blood,178.0,Intermediate,10754,,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,N,,CHEMBL622558,,A,10090.0,1,,,8264
,1,BAO_0000218,,Mus musculus,Blood,178.0,Intermediate,10754,,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,N,,CHEMBL622559,,A,10090.0,1,,,8265
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,10754,,50588,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,N,,CHEMBL622560,,A,9615.0,1,,,8266
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14681,,50597,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,,CHEMBL622561,,A,10116.0,1,,,8267
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14681,,50597,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,N,,CHEMBL622562,,A,10116.0,1,,,8268
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14681,,50597,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,,CHEMBL622563,,A,10116.0,1,,,8269
,0,BAO_0000019,,,,,Autocuration,13118,,22224,,Concentration of compound in Central nervous system,U,,CHEMBL622564,,A,,1,,,8270
,0,BAO_0000019,,,,,Autocuration,13118,,22224,,Concentration of compound in Central nervous system; Not detectable,U,,CHEMBL622565,,A,,1,,,8271
,1,BAO_0000218,,Mus musculus,,,Intermediate,13318,,50594,,"Concentration of diester in the blood, following oral administration in mice",N,,CHEMBL622566,,A,10090.0,1,,,8272
,1,BAO_0000218,,Mus musculus,,,Intermediate,13318,,50594,,"Concentration of monoester in the blood, following oral administration in mice",N,,CHEMBL624515,,A,10090.0,1,,,8273
,1,BAO_0000218,,Mus musculus,,,Intermediate,13318,,50594,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,N,,CHEMBL624516,,A,10090.0,1,,,8274
,0,BAO_0000019,,,,,Autocuration,15692,,22224,,Evaluated for Pharmacokinetic property: Area under the curve,U,,CHEMBL624517,,A,,1,,,8275
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,N,,CHEMBL624518,,A,10090.0,1,,,8276
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,N,,CHEMBL624519,,A,9541.0,1,,,8277
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,N,,CHEMBL624520,,A,9541.0,1,,,8278
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,N,,CHEMBL624521,,A,9541.0,1,,,8279
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,N,,CHEMBL624522,,A,9541.0,1,,,8280
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,N,,CHEMBL624523,,A,9541.0,1,,,8281
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,,CHEMBL624409,,A,9541.0,1,,,8282
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",N,,CHEMBL624410,,A,9541.0,1,,,8283
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,,CHEMBL624411,,A,9541.0,1,,,8284
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",N,,CHEMBL623531,,A,9541.0,1,,,8285
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",N,,CHEMBL623532,,A,9541.0,1,,,8286
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",N,,CHEMBL623533,,A,9541.0,1,,,8287
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14839,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,,CHEMBL623534,,A,9541.0,1,,,8288
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,N,,CHEMBL623535,,A,10090.0,1,,,8289
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,N,,CHEMBL623536,,A,10090.0,1,,,8290
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,N,,CHEMBL623537,,A,10090.0,1,,,8291
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,N,,CHEMBL623538,,A,10090.0,1,,,8292
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,N,,CHEMBL623539,,A,10090.0,1,,,8293
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,N,,CHEMBL623540,,A,10090.0,1,,,8294
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",N,,CHEMBL623541,,A,10090.0,1,,,8295
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",N,,CHEMBL623542,,A,10090.0,1,,,8296
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",N,,CHEMBL623543,,A,10090.0,1,,,8297
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",N,,CHEMBL623544,,A,10090.0,1,,,8298
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",N,,CHEMBL623545,,A,10090.0,1,,,8299
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",N,,CHEMBL623546,,A,10090.0,1,,,8300
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5408,,50597,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,,CHEMBL623547,,A,10116.0,1,,,8301
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6827,,50597,,High i.v. clearance in Dawley rats,N,,CHEMBL623548,,A,10116.0,1,,,8302
,1,BAO_0000218,In vitro,Rattus norvegicus,Liver,2107.0,Intermediate,17538,Microsomes,50597,,In vitro clearance in rat liver microsomes,N,,CHEMBL623549,,A,10116.0,1,,,8303
,1,BAO_0000218,In vitro,Rattus norvegicus,Liver,2107.0,Intermediate,6331,Microsomes,50597,,Intrinsic clearance in rat liver microsomes was determined,N,,CHEMBL623550,,A,10116.0,1,,,8304
,1,BAO_0000218,In vitro,Rattus norvegicus,Liver,2107.0,Intermediate,5948,,50597,,Intrinsic clearance in rat hepatocytes was determined,N,,CHEMBL875276,,A,10116.0,1,Hepatocyte,401.0,8305
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4026,,50597,,Plasma Clearance was determined,N,,CHEMBL621872,,A,10116.0,1,,,8306
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6647,,50597,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,N,,CHEMBL621873,,A,10116.0,1,,,8307
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1696,,50597,,Plasma clearance in rat.,N,,CHEMBL621874,,A,10116.0,1,,,8308
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6597,,50597,,Plasma clearance in rats,N,,CHEMBL621875,,A,10116.0,1,,,8309
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,347,,50597,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,N,,CHEMBL621876,,A,10116.0,1,,,8310
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16423,,50597,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,N,,CHEMBL621877,,A,10116.0,1,,,8311
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2879,,50597,,Plasma clearance was measured in rat,N,,CHEMBL621878,,A,10116.0,1,,,8312
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4883,,50597,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,,CHEMBL621879,,A,10116.0,1,,,8313
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5328,,50597,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",N,,CHEMBL621880,,A,10116.0,1,,,8314
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5160,,50597,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,N,,CHEMBL621881,,A,10116.0,1,,,8315
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17582,,50597,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,CHEMBL621882,,A,10116.0,1,,,8316
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17651,,50597,,Total clearance at 1 mg/kg was determined in rat,N,,CHEMBL875283,,A,10116.0,1,,,8317
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17651,,50597,,Total clearance at 10 mg/kg was determined in rat,N,,CHEMBL621883,,A,10116.0,1,,,8318
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6596,,50597,,Clearance in rat,N,,CHEMBL621884,,A,10116.0,1,,,8319
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4796,,50597,,Plasma clearance rate determined in rats,N,,CHEMBL621885,,A,10116.0,1,,,8320
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6850,,50597,,Clearance of compound in rat was evaluated,N,,CHEMBL621886,,A,10116.0,1,,,8321
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5932,,50597,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,,CHEMBL621887,,A,10116.0,1,,,8322
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3371,,50597,,Pharmacokinetic property (blood clearance) in rat,N,,CHEMBL621888,,A,10116.0,1,,,8323
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2083,,50597,,Plasma clearance in rat,N,,CHEMBL621889,,A,10116.0,1,,,8324
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4942,,50597,,Plasma clearance in rats,N,,CHEMBL621890,,A,10116.0,1,,,8325
,1,BAO_0000218,In vitro,Rattus norvegicus,Liver,2107.0,Intermediate,6838,Microsomes,50597,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,N,,CHEMBL621891,,A,10116.0,1,,,8326
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5353,,50597,,Clearance in Dawley rat,N,,CHEMBL621892,,A,10116.0,1,,,8327
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6641,,50597,,Clearance rat,N,,CHEMBL621893,,A,10116.0,1,,,8328
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6641,,50597,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),N,,CHEMBL621894,,A,10116.0,1,,,8329
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6641,,50597,,Clearance rat; Not determined,N,,CHEMBL621895,,A,10116.0,1,,,8330
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6444,,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,N,,CHEMBL875284,,A,10116.0,1,,,8331
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6444,,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,,CHEMBL618699,,A,10116.0,1,,,8332
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6444,,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,,CHEMBL618700,,A,10116.0,1,,,8333
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6211,,50597,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,,CHEMBL618701,,A,10116.0,1,,,8334
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12873,,50597,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,,CHEMBL876600,,A,10116.0,1,,,8335
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6570,,50597,,Clearance of compound in rat after 1 mg/kg i.v. administration,N,,CHEMBL618702,,A,10116.0,1,,,8336
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3341,,50597,,Compound was evaluated for Hepatic clearance in rat,N,,CHEMBL618703,,A,10116.0,1,,,8337
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4891,,50597,,In vivo clearance after 5 mg/kg dose,N,,CHEMBL618704,,A,10116.0,1,,,8338
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1094,,50597,,Compound was tested for plasma clearance in rats,N,,CHEMBL618705,,A,10116.0,1,,,8339
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2938,,50597,,Hepatic clearance after intravenous administration was evaluated in rat,N,,CHEMBL618706,,A,10116.0,1,,,8340
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17853,,50597,,Lower clearance in rat (i.v.) at 0.5 mpk,N,,CHEMBL618707,,A,10116.0,1,,,8341
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6049,,50597,,Pharmacokinetic parameter expressed as plasma clearance in rat,N,,CHEMBL618708,,A,10116.0,1,,,8342
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5789,,50597,,Pharmacokinetic property (Clp) in rat,N,,CHEMBL618709,,A,10116.0,1,,,8343
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4514,,50597,,Plasma clearance in Sprague-Dawley rats,N,,CHEMBL618710,,A,10116.0,1,,,8344
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6448,,50597,,Plasma clearance (Clp) in rat,N,,CHEMBL618711,,A,10116.0,1,,,8345
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6062,,50597,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,N,,CHEMBL618712,,A,10116.0,1,,,8346
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5710,,50597,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,N,,CHEMBL618713,,A,10116.0,1,,,8347
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4709,,50597,,Plasma clearance after intravenous administration of 1 mg/kg in rat,N,,CHEMBL618714,,A,10116.0,1,,,8348
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4521,,50597,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,CHEMBL618715,,A,10116.0,1,,,8349
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1742,,50597,,Plasma clearance in rat was determined,N,,CHEMBL618716,,A,10116.0,1,,,8350
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6057,,50597,,Plasma clearance measured in rat,N,,CHEMBL876601,,A,10116.0,1,,,8351
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6057,,50597,,Plasma clearance was calculated in rat,N,,CHEMBL618717,,A,10116.0,1,,,8352
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5145,,50597,,Plasma clearance in rat,N,,CHEMBL618718,,A,10116.0,1,,,8353
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5833,,50597,,Plasma clearance in rat,N,,CHEMBL618719,,A,10116.0,1,,,8354
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6453,,50597,,Plasma clearance in rat,N,,CHEMBL618720,,A,10116.0,1,,,8355
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6640,,50597,,Plasma clearance in rat,N,,CHEMBL618721,,A,10116.0,1,,,8356
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6305,,50597,,Plasma clearance in rats,N,,CHEMBL621477,,A,10116.0,1,,,8357
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6642,,50597,,Plasma clearance in rat,N,,CHEMBL621478,,A,10116.0,1,,,8358
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5472,,50597,,Plasma clearance was evaluated in rat,N,,CHEMBL621479,,A,10116.0,1,,,8359
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5472,,50597,,Plasma clearance was evaluated in rat; Not tested,N,,CHEMBL621480,,A,10116.0,1,,,8360
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5144,,50597,,Plasma clearance rate was determined for the compound in rat,N,,CHEMBL621481,,A,10116.0,1,,,8361
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",N,,CHEMBL621482,,A,10116.0,1,,,8362
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,,CHEMBL621483,,A,10116.0,1,,,8363
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",N,,CHEMBL621484,,A,10116.0,1,,,8364
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621485,,A,10116.0,1,,,8365
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621486,,A,10116.0,1,,,8366
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621487,,A,10116.0,1,,,8367
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621488,,A,10116.0,1,,,8368
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621489,,A,10116.0,1,,,8369
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621490,,A,10116.0,1,,,8370
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621491,,A,10116.0,1,,,8371
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621492,,A,10116.0,1,,,8372
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,N,,CHEMBL621493,,A,10116.0,1,,,8373
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621494,,A,10116.0,1,,,8374
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621495,,A,10116.0,1,,,8375
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621496,,A,10116.0,1,,,8376
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621497,,A,10116.0,1,,,8377
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621498,,A,10116.0,1,,,8378
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL621499,,A,10116.0,1,,,8379
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,N,,CHEMBL618634,,A,10116.0,1,,,8380
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL618635,,A,10116.0,1,,,8381
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL618636,,A,10116.0,1,,,8382
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619737,,A,10116.0,1,,,8383
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL619738,,A,10116.0,1,,,8384
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL624329,,A,10116.0,1,,,8385
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL624330,,A,10116.0,1,,,8386
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL624331,,A,10116.0,1,,,8387
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL624332,,A,10116.0,1,,,8388
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL624333,,A,10116.0,1,,,8389
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL624334,,A,10116.0,1,,,8390
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL624335,,A,10116.0,1,,,8391
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL620016,,A,10116.0,1,,,8392
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL620169,,A,10116.0,1,,,8393
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL620170,,A,10116.0,1,,,8394
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,N,,CHEMBL620171,,A,10116.0,1,,,8395
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL620172,,A,10116.0,1,,,8396
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL620173,,A,10116.0,1,,,8397
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,N,,CHEMBL620174,,A,10116.0,1,,,8398
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL620175,,A,10116.0,1,,,8399
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL620176,,A,10116.0,1,,,8400
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,13950,,50597,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,CHEMBL620177,,A,10116.0,1,,,8401
,1,BAO_0000218,,Rattus norvegicus,Cerebellum,2037.0,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620178,,A,10116.0,1,,,8402
,1,BAO_0000218,,Rattus norvegicus,Cerebellum,2037.0,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620179,,A,10116.0,1,,,8403
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620180,,A,10116.0,1,,,8404
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6570,,50597,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,N,,CHEMBL620181,,A,10116.0,1,,,8405
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6571,,50597,,Volume of distribution of compound in rats after intravenous administration,N,,CHEMBL620182,,A,10116.0,1,,,8406
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6453,,50597,,Volume of distribution in rat,N,,CHEMBL620183,,A,10116.0,1,,,8407
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6444,,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,N,,CHEMBL620184,,A,10116.0,1,,,8408
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6444,,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,,CHEMBL620185,,A,10116.0,1,,,8409
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6444,,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,,CHEMBL620186,,A,10116.0,1,,,8410
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5353,,50597,,Volume of distribution was determined in Dawley rat,N,,CHEMBL620187,,A,10116.0,1,,,8411
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5334,,50597,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,,CHEMBL620188,,A,10116.0,1,,,8412
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5334,,50597,,Volume of distribution was reported in Sprague-Dawley rat,N,,CHEMBL620189,,A,10116.0,1,,,8413
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6641,,50597,,Volumes of distribution in rat after peroral administration,N,,CHEMBL620190,,A,10116.0,1,,,8414
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6641,,50597,,Volumes of distribution in rat after po administration,N,,CHEMBL620191,,A,10116.0,1,,,8415
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6641,,50597,,Volumes of distribution in rat after po administration; Not determined,N,,CHEMBL620192,,A,10116.0,1,,,8416
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5676,,50597,,Pharmacokinetic property (Volume) in rat i.v.,N,,CHEMBL620193,,A,10116.0,1,,,8417
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6410,,50597,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,N,,CHEMBL620194,,A,10116.0,1,,,8418
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17670,,50597,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",N,,CHEMBL876730,,A,10116.0,1,,,8419
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6495,,50597,,Volume distribution in rat after oral administration at 10 mg/kg,N,,CHEMBL620195,,A,10116.0,1,,,8420
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5408,,50597,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,,CHEMBL620196,,A,10116.0,1,,,8421
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4883,,50597,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,,CHEMBL620197,,A,10116.0,1,,,8422
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6647,,50597,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,N,,CHEMBL620198,,A,10116.0,1,,,8423
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6495,,50597,,Volume of distribution in rats,N,,CHEMBL620199,,A,10116.0,1,,,8424
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,N,,CHEMBL620200,,A,10116.0,1,,,8425
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,N,,CHEMBL620201,,A,10116.0,1,,,8426
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL620202,,A,10116.0,1,,,8427
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL620203,,A,10116.0,1,,,8428
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,N,,CHEMBL620204,,A,10116.0,1,,,8429
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL620205,,A,10116.0,1,,,8430
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5960,,50597,,Pharmacokinetic parameter (Vss) in rat,N,,CHEMBL624664,,A,10116.0,1,,,8431
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5676,,50597,,Pharmacokinetic property (Volume) in rat i.v.,N,,CHEMBL624665,,A,10116.0,1,,,8432
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5948,,50597,,Pharmacokinetic property (Vss) in rat,N,,CHEMBL624666,,A,10116.0,1,,,8433
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5979,,50597,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,,CHEMBL624667,,A,10116.0,1,,,8434
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL624668,,A,10116.0,1,,,8435
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL624669,,A,10116.0,1,,,8436
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL624670,,A,10116.0,1,,,8437
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL624671,,A,10116.0,1,,,8438
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6448,,50597,,Steady state volume distribution in rat,N,,CHEMBL624672,,A,10116.0,1,,,8439
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12873,,50597,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",N,,CHEMBL624673,,A,10116.0,1,,,8440
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4576,,50597,,Steady state volume of distribution determined in rat,N,,CHEMBL624674,,A,10116.0,1,,,8441
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17582,,50597,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,CHEMBL624675,,A,10116.0,1,,,8442
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1466,,50597,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,N,,CHEMBL621728,,A,10116.0,1,,,8443
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5182,,50597,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,N,,CHEMBL621729,,A,10116.0,1,,,8444
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5182,,50597,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,N,,CHEMBL621730,,A,10116.0,1,,,8445
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6535,,50597,,Volume distribution in rat after administration of 2 mg/kg iv,N,,CHEMBL621731,,A,10116.0,1,,,8446
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6535,,50597,,Volume distribution in rat after administration of 2 mg/kg iv,N,,CHEMBL621732,,A,10116.0,1,,,8447
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5041,,50597,,Volume in steady state distribution value was determined,N,,CHEMBL621908,,A,10116.0,1,,,8448
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5041,,50597,,Volume in steady state distribution value was determined; ND denotes no data,N,,CHEMBL875347,,A,10116.0,1,,,8449
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5041,,50597,,Volume in steady state distribution value was determined; ND denotes not determined,N,,CHEMBL621909,,A,10116.0,1,,,8450
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17065,,50597,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,CHEMBL621910,,A,10116.0,1,,,8451
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6597,,50597,,Volume of distribution at steady state was evaluated in rats,N,,CHEMBL621911,,A,10116.0,1,,,8452
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15662,,50597,,Volume of distribution at steady state was observed after intravenous administration in rat,N,,CHEMBL621912,,A,10116.0,1,,,8453
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6485,,50597,,Volume of distribution in steady state was determined in rat,N,,CHEMBL621913,,A,10116.0,1,,,8454
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17655,,50597,,Volume of distribution in steady state was determined in rat,N,,CHEMBL621914,,A,10116.0,1,,,8455
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6616,,50597,,Volume of distribution after i.v. administration,N,,CHEMBL621915,,A,10116.0,1,,,8456
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1916,,50597,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,,CHEMBL621916,,A,10116.0,1,,,8457
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,16438,,50594,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,,CHEMBL621917,,A,10090.0,1,,,8458
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,16438,,50594,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,,CHEMBL621918,,A,10090.0,1,,,8459
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,16438,,50594,,Biodistribution of compound (oxidized form) in spleen tissue,N,,CHEMBL621919,,A,10090.0,1,,,8460
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,16438,,50594,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",N,,CHEMBL621920,,A,10090.0,1,,,8461
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,16438,,50594,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",N,,CHEMBL621921,,A,10090.0,1,,,8462
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,16438,,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,CHEMBL622401,,A,10090.0,1,,,8463
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,16438,,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,,CHEMBL875348,,A,10090.0,1,,,8464
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,16438,,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,,CHEMBL622402,,A,10090.0,1,,,8465
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,16438,,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,N,,CHEMBL622403,,A,10090.0,1,,,8466
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,16438,,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,CHEMBL622404,,A,10090.0,1,,,8467
,1,BAO_0000218,In vivo,Mus musculus,Brain,955.0,Intermediate,16438,,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,N,,CHEMBL622405,,A,10090.0,1,,,8468
,1,BAO_0000218,In vivo,Mus musculus,Brain,955.0,Intermediate,16438,,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,,CHEMBL622406,,A,10090.0,1,,,8469
,1,BAO_0000218,In vivo,Mus musculus,Brain,955.0,Intermediate,16438,,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,CHEMBL622407,,A,10090.0,1,,,8470
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,16438,,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,N,,CHEMBL622408,,A,10090.0,1,,,8471
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,16438,,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,,CHEMBL622409,,A,10090.0,1,,,8472
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,16438,,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,CHEMBL622410,,A,10090.0,1,,,8473
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,16438,,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,N,,CHEMBL622411,,A,10090.0,1,,,8474
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,16438,,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,,CHEMBL627864,,A,10090.0,1,,,8475
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,16438,,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,CHEMBL627865,,A,10090.0,1,,,8476
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,16438,,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,N,,CHEMBL627866,,A,10090.0,1,,,8477
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,16438,,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,CHEMBL627751,,A,10090.0,1,,,8478
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,16438,,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,N,,CHEMBL627752,,A,10090.0,1,,,8479
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,16438,,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,,CHEMBL627753,,A,10090.0,1,,,8480
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,16438,,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,CHEMBL627754,,A,10090.0,1,,,8481
,1,BAO_0000218,,Mus musculus,,,Intermediate,12467,,50594,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,N,,CHEMBL627755,,A,10090.0,1,,,8482
,1,BAO_0000218,In vivo,Mus musculus,Brain,955.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627756,,A,10090.0,1,,,8483
,1,BAO_0000218,In vivo,Mus musculus,Brain,955.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627757,,A,10090.0,1,,,8484
,1,BAO_0000218,In vivo,Mus musculus,Brain,955.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627758,,A,10090.0,1,,,8485
,1,BAO_0000218,In vivo,Mus musculus,Brain,955.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627759,,A,10090.0,1,,,8486
,1,BAO_0000218,In vivo,Mus musculus,Brain,955.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627760,,A,10090.0,1,,,8487
,1,BAO_0000218,In vivo,Mus musculus,Brain,955.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627761,,A,10090.0,1,,,8488
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),N,,CHEMBL876811,,A,10090.0,1,,,8489
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627762,,A,10090.0,1,,,8490
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627763,,A,10090.0,1,,,8491
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627764,,A,10090.0,1,,,8492
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627765,,A,10090.0,1,,,8493
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627766,,A,10090.0,1,,,8494
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627767,,A,10090.0,1,,,8495
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627768,,A,10090.0,1,,,8496
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL628422,,A,10090.0,1,,,8497
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL628423,,A,10090.0,1,,,8498
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5089,,50597,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,N,,CHEMBL628424,,A,10116.0,1,,,8499
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5089,,50597,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,N,,CHEMBL628425,,A,10116.0,1,,,8500
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4257,,50597,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,N,,CHEMBL628426,,A,10116.0,1,,,8501
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6679,,50597,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,CHEMBL628427,,A,10116.0,1,,,8502
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5546,,50597,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,,CHEMBL626938,,A,10116.0,1,,,8503
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6141,,50597,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,,CHEMBL626939,,A,10116.0,1,,,8504
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5334,,50597,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,,CHEMBL626940,,A,10116.0,1,,,8505
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5334,,50597,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,,CHEMBL626941,,A,10116.0,1,,,8506
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5334,,50597,,Plasma clearance was reported in Sprague-Dawley rat,N,,CHEMBL626942,,A,10116.0,1,,,8507
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4689,,50597,,Plasma clearance after intravenous administration (1 mg/kg) in rat,N,,CHEMBL876812,,A,10116.0,1,,,8508
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6848,,50597,,Plasma clearance of compound in rats was evaluated,N,,CHEMBL626943,,A,10116.0,1,,,8509
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6848,,50597,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,N,,CHEMBL626944,,A,10116.0,1,,,8510
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6467,,50597,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,N,,CHEMBL626945,,A,10116.0,1,,,8511
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6467,,50597,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,,CHEMBL626946,,A,10116.0,1,,,8512
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4956,,50597,,Plasma clearance rate in Sprague-Dawley rats,N,,CHEMBL626856,,A,10116.0,1,,,8513
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5529,,50597,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),N,,CHEMBL626857,,A,10116.0,1,,,8514
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,406,,50597,,The compound was evaluated for plasma clearance in rat,N,,CHEMBL626858,,A,10116.0,1,,,8515
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17655,,50597,,Total plasma clearance in rat,N,,CHEMBL627018,,A,10116.0,1,,,8516
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,3293,,50597,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,N,,CHEMBL625331,,A,10116.0,1,,,8517
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,4075,,50597,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,N,,CHEMBL625332,,A,10116.0,1,,,8518
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2792,,50597,,C max was determined at 10 mg/kg po dose in rats,N,,CHEMBL877590,,A,10116.0,1,,,8519
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2792,,50597,,C max was determined at 3 mg/kg po dose in rats,N,,CHEMBL625333,,A,10116.0,1,,,8520
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17594,,50597,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,N,,CHEMBL625334,,A,10116.0,1,,,8521
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17594,,50597,,Cmax after single intravenous bolus of 1 mg/kg in rats,N,,CHEMBL625335,,A,10116.0,1,,,8522
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4762,,50597,,Cmax of compound at 5 mg/kg after po administration was determined in rat,N,,CHEMBL625336,,A,10116.0,1,,,8523
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17509,,50597,,Cmax 24 hr after 10 mg/kg oral administration in rats,N,,CHEMBL625337,,A,10116.0,1,,,8524
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17509,,50597,,Cmax 24 hr after 2 mg/kg oral administration in rats,N,,CHEMBL625338,,A,10116.0,1,,,8525
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1466,,50597,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,N,,CHEMBL625339,,A,10116.0,1,,,8526
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6535,,50597,,Cmax in rat after administration of 2 mg/kg iv,N,,CHEMBL625340,,A,10116.0,1,,,8527
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6535,,50597,,Cmax in rat after administration of 2 mg/kg iv,N,,CHEMBL625341,,A,10116.0,1,,,8528
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3169,,50597,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,N,,CHEMBL622687,,A,10116.0,1,,,8529
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6515,,50597,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,N,,CHEMBL622688,,A,10116.0,1,,,8530
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,11149,,50597,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,N,,CHEMBL622689,,A,10116.0,1,,,8531
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,11149,,50597,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,N,,CHEMBL620295,,A,10116.0,1,,,8532
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17858,,50597,,Cmax after 10 mg/kg oral administration in rat,N,,CHEMBL620296,,A,10116.0,1,,,8533
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,N,,CHEMBL620297,,A,10116.0,1,,,8534
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Cmax after IV dosing at 1 mg/kg in rat; no data,N,,CHEMBL620298,,A,10116.0,1,,,8535
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4426,,50597,,Cmax after oral administration at 20 mpk in rats,N,,CHEMBL620299,,A,10116.0,1,,,8536
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4426,,50597,,Cmax after oral administration at 20 mpk in rats; Not performed.,N,,CHEMBL620300,,A,10116.0,1,,,8537
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4426,,50597,,Cmax after oral administration at 20 mpk in rats d; Not performed.,N,,CHEMBL620301,,A,10116.0,1,,,8538
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5656,,50597,,Cmax after oral administration in rat,N,,CHEMBL620302,,A,10116.0,1,,,8539
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Cmax after oral administration at a dose of 2 mg/kg in rat,N,,CHEMBL620303,,A,10116.0,1,,,8540
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Cmax after oral administration at a dose of 4 mg/kg in rat,N,,CHEMBL620304,,A,10116.0,1,,,8541
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6113,,50597,,Cmax in rats after 20 mg/kg oral dose,N,,CHEMBL620305,,A,10116.0,1,,,8542
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17764,,50597,,Cmax after peroral administration in rats at 2.4 uM/kg,N,,CHEMBL620306,,A,10116.0,1,,,8543
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4756,,50597,,Cmax at the dose of 2 mg/Kg administered perorally in rats,N,,CHEMBL620307,,A,10116.0,1,,,8544
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4756,,50597,,Cmax at the dose of 5 mg/Kg administered perorally in rats,N,,CHEMBL620308,,A,10116.0,1,,,8545
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6402,,50597,,Cmax by administering at 20 mg/kg p.o. in rats,N,,CHEMBL620309,,A,10116.0,1,,,8546
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5610,,50597,,Cmax in male rat,N,,CHEMBL620310,,A,10116.0,1,,,8547
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5207,,50597,,Cmax in rat,N,,CHEMBL620311,,A,10116.0,1,,,8548
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6011,,50597,,Cmax in rat,N,,CHEMBL620312,,A,10116.0,1,,,8549
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6504,,50597,,Cmax in rat,N,,CHEMBL620313,,A,10116.0,1,,,8550
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6046,,50597,,Cmax in rat at 10 mg/kg,N,,CHEMBL620314,,A,10116.0,1,,,8551
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6504,,50597,,Cmax in rat at the dose of 1 mg/kg i.v.,N,,CHEMBL620315,,A,10116.0,1,,,8552
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5874,,50597,,Cmax in rat by po administration at a dose of 40 mg/kg,N,,CHEMBL620316,,A,10116.0,1,,,8553
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17686,,50597,,Cmax in rat p.o. at 20 mg/kg concentration,N,,CHEMBL620317,,A,10116.0,1,,,8554
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5836,,50597,,Cmax in rats,N,,CHEMBL620318,,A,10116.0,1,,,8555
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17596,,50597,,Cmax in rats,N,,CHEMBL620319,,A,10116.0,1,,,8556
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16423,,50597,,Cmax was evaluated after 20 uM/kg of peroral administration,N,,CHEMBL620320,,A,10116.0,1,,,8557
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17804,,50597,,Cmax was measured in rats after peroral administration at 3 mg/kg,N,,CHEMBL620321,,A,10116.0,1,,,8558
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1908,,50597,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,N,,CHEMBL620322,,A,10116.0,1,,,8559
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620323,,A,10116.0,1,,,8560
,1,BAO_0000218,,Rattus norvegicus,Frontal cortex,1870.0,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620324,,A,10116.0,1,,,8561
,1,BAO_0000218,,Rattus norvegicus,Frontal cortex,1870.0,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620325,,A,10116.0,1,,,8562
,1,BAO_0000218,,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620326,,A,10116.0,1,,,8563
,1,BAO_0000218,,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620327,,A,10116.0,1,,,8564
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620328,,A,10116.0,1,,,8565
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620329,,A,10116.0,1,,,8566
,1,BAO_0000218,,Rattus norvegicus,Midbrain,1891.0,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620330,,A,10116.0,1,,,8567
,1,BAO_0000218,,Rattus norvegicus,Midbrain,1891.0,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL875286,,A,10116.0,1,,,8568
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620331,,A,10116.0,1,,,8569
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620332,,A,10116.0,1,,,8570
,1,BAO_0000218,,Rattus norvegicus,Striatum,2435.0,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620333,,A,10116.0,1,,,8571
,1,BAO_0000218,,Rattus norvegicus,Striatum,2435.0,Intermediate,13950,,50597,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,CHEMBL620334,,A,10116.0,1,,,8572
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16434,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL621015,,A,10116.0,1,,,8573
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16434,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,CHEMBL621016,,A,10116.0,1,,,8574
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16434,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL621191,,A,10116.0,1,,,8575
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16434,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL621192,,A,10116.0,1,,,8576
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16434,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,CHEMBL621193,,A,10116.0,1,,,8577
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16434,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,CHEMBL621194,,A,10116.0,1,,,8578
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16434,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,CHEMBL624204,,A,10116.0,1,,,8579
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16434,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,CHEMBL624205,,A,10116.0,1,,,8580
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,CHEMBL624206,,A,10116.0,1,,,8581
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,CHEMBL624207,,A,10116.0,1,,,8582
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,CHEMBL624208,,A,10116.0,1,,,8583
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,CHEMBL624209,,A,10116.0,1,,,8584
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,CHEMBL624210,,A,10116.0,1,,,8585
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,CHEMBL624211,,A,10116.0,1,,,8586
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,CHEMBL624212,,A,10116.0,1,,,8587
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,CHEMBL624213,,A,10116.0,1,,,8588
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16434,,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL876611,,A,10116.0,1,,,8589
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16434,,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL624214,,A,10116.0,1,,,8590
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16434,,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL624215,,A,10116.0,1,,,8591
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL624216,,A,10116.0,1,,,8592
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL624217,,A,10116.0,1,,,8593
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL624218,,A,10116.0,1,,,8594
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL624219,,A,10116.0,1,,,8595
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL624220,,A,10116.0,1,,,8596
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,16435,,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL624221,,A,10116.0,1,,,8597
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL624222,,A,10116.0,1,,,8598
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,CHEMBL624223,,A,10116.0,1,,,8599
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL624224,,A,10116.0,1,,,8600
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL624225,,A,10116.0,1,,,8601
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17764,,50597,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,N,,CHEMBL622420,,A,10116.0,1,,,8602
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5031,,50597,,Volume of steady state distribution after i.v. administration in rats,N,,CHEMBL622421,,A,10116.0,1,,,8603
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6215,,50597,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,N,,CHEMBL622422,,A,10116.0,1,,,8604
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17671,,50597,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,CHEMBL622423,,A,10116.0,1,,,8605
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17752,,50597,,Vss was determined,N,,CHEMBL622424,,A,10116.0,1,,,8606
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6596,,50597,,Vss in rat,N,,CHEMBL622425,,A,10116.0,1,,,8607
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16423,,50597,,Vss was evaluated after 10 uM/kg of intra arterial administration,N,,CHEMBL876612,,A,10116.0,1,,,8608
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15662,,50597,,volume of distribution at steady state was observed after intravenous administration in rat,N,,CHEMBL622426,,A,10116.0,1,,,8609
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6062,,50597,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,,CHEMBL622427,,A,10116.0,1,,,8610
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5874,,50597,,Pharmacokinetic (PK) parameter Vz in rat,N,,CHEMBL622428,,A,10116.0,1,,,8611
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4942,,50597,,Volume distribution in rats,N,,CHEMBL622429,,A,10116.0,1,,,8612
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17796,,50597,,Volume of distribution in rat; No data,N,,CHEMBL622430,,A,10116.0,1,,,8613
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4890,,50597,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,CHEMBL622431,,A,10116.0,1,,,8614
,1,BAO_0000218,,Rattus norvegicus,Ileum,2116.0,Intermediate,15765,,50597,,% absorption predicted from in vitro rat ileum transport studies,N,,CHEMBL622432,,A,10116.0,1,,,8615
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,,CHEMBL622433,,A,10116.0,1,,,8616
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,,CHEMBL622434,,A,10116.0,1,,,8617
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,N,,CHEMBL622435,,A,10116.0,1,,,8618
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),N,,CHEMBL618748,,A,10116.0,1,,,8619
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,,CHEMBL618749,,A,10116.0,1,,,8620
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,,CHEMBL618750,,A,10116.0,1,,,8621
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,,CHEMBL618751,,A,10116.0,1,,,8622
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13569,,50597,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,,CHEMBL618752,,A,10116.0,1,,,8623
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4576,,50597,,Oral bioavailability in rat,N,,CHEMBL618753,,A,10116.0,1,,,8624
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,750,,50597,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,N,,CHEMBL618754,,A,10116.0,1,,,8625
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,750,,50597,,Oral bioavailability in rat,N,,CHEMBL618755,,A,10116.0,1,,,8626
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4590,,50597,,Oral bioavailability in rat,N,,CHEMBL618756,,A,10116.0,1,,,8627
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1716,,50597,,Oral bioavailability in rat,N,,CHEMBL618757,,A,10116.0,1,,,8628
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1974,,50597,,Bioavailability in rat,N,,CHEMBL618758,,A,10116.0,1,,,8629
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4502,,50597,,Oral bioavailability in rat (dose 30 mg/kg),N,,CHEMBL621088,,A,10116.0,1,,,8630
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3371,,50597,,Pharmacokinetic property (cLogP) in rat,N,,CHEMBL621089,,A,10116.0,1,,,8631
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,9099,,50597,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,N,,CHEMBL621090,,F,10116.0,1,,,8632
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,9099,,50597,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,N,,CHEMBL621091,,F,10116.0,1,,,8633
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4590,,50597,,Clearance in rat.,N,,CHEMBL876731,,A,10116.0,1,,,8634
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3184,,50597,,Compound was evaluated for its clearance when administered intravenously in rat,N,,CHEMBL621092,,A,10116.0,1,,,8635
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16456,,50597,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,CHEMBL621093,,A,10116.0,1,,,8636
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4199,,50597,,Blood: Brain distribution ratio is determined in rat,N,,CHEMBL621094,,A,10116.0,1,,,8637
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4199,,50597,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,N,,CHEMBL621095,,A,10116.0,1,,,8638
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4199,,50597,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,N,,CHEMBL621096,,A,10116.0,1,,,8639
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL621097,,A,10116.0,1,,,8640
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7449,,50597,,Percent dose excreted in 0-48 hours administered ip to male rat,N,,CHEMBL621098,,F,10116.0,1,,,8641
,1,BAO_0000218,,Rattus norvegicus,Cerebellum,2037.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL621099,,A,10116.0,1,,,8642
,1,BAO_0000218,,Rattus norvegicus,Cerebellum,2037.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL621100,,A,10116.0,1,,,8643
,1,BAO_0000218,,Rattus norvegicus,Cerebellum,2037.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL621101,,A,10116.0,1,,,8644
,1,BAO_0000218,,Rattus norvegicus,Cerebellum,2037.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL621102,,A,10116.0,1,,,8645
,1,BAO_0000218,,Rattus norvegicus,Cerebellum,2037.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL876732,,A,10116.0,1,,,8646
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11977,,50597,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL621103,,A,10116.0,1,,,8647
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL621104,,A,10116.0,1,,,8648
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL621105,,A,10116.0,1,,,8649
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11977,,50597,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL621106,,A,10116.0,1,,,8650
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL621107,,A,10116.0,1,,,8651
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL621108,,A,10116.0,1,,,8652
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL621109,,A,10116.0,1,,,8653
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL621110,,A,10090.0,1,,,8654
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL621111,,A,10090.0,1,,,8655
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),N,,CHEMBL622541,,A,10090.0,1,,,8656
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL622542,,A,10090.0,1,,,8657
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL622543,,A,10090.0,1,,,8658
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624412,,A,10090.0,1,,,8659
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624413,,A,10090.0,1,,,8660
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624414,,A,10090.0,1,,,8661
,1,BAO_0000218,In vivo,Mus musculus,Lung,2048.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624415,,A,10090.0,1,,,8662
,1,BAO_0000218,In vivo,Mus musculus,Lung,2048.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624416,,A,10090.0,1,,,8663
,1,BAO_0000218,In vivo,Mus musculus,Lung,2048.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624417,,A,10090.0,1,,,8664
,1,BAO_0000218,In vivo,Mus musculus,Lung,2048.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624418,,A,10090.0,1,,,8665
,1,BAO_0000218,In vivo,Mus musculus,Lung,2048.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624419,,A,10090.0,1,,,8666
,1,BAO_0000218,In vivo,Mus musculus,Lung,2048.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624420,,A,10090.0,1,,,8667
,1,BAO_0000218,In vivo,Mus musculus,Muscle tissue,2385.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624421,,A,10090.0,1,,,8668
,1,BAO_0000218,In vivo,Mus musculus,Muscle tissue,2385.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624422,,A,10090.0,1,,,8669
,1,BAO_0000218,In vivo,Mus musculus,Muscle tissue,2385.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL624423,,A,10090.0,1,,,8670
,1,BAO_0000218,In vivo,Mus musculus,Muscle tissue,2385.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL625123,,A,10090.0,1,,,8671
,1,BAO_0000218,In vivo,Mus musculus,Muscle tissue,2385.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL625124,,A,10090.0,1,,,8672
,1,BAO_0000218,In vivo,Mus musculus,Muscle tissue,2385.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL625125,,A,10090.0,1,,,8673
,1,BAO_0000218,In vivo,Mus musculus,Zone of skin,14.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),N,,CHEMBL625126,,A,10090.0,1,,,8674
,1,BAO_0000218,In vivo,Mus musculus,Zone of skin,14.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626947,,A,10090.0,1,,,8675
,1,BAO_0000218,In vivo,Mus musculus,Zone of skin,14.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626948,,A,10090.0,1,,,8676
,1,BAO_0000218,In vivo,Mus musculus,Zone of skin,14.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626949,,A,10090.0,1,,,8677
,1,BAO_0000218,In vivo,Mus musculus,Zone of skin,14.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626950,,A,10090.0,1,,,8678
,1,BAO_0000218,In vivo,Mus musculus,Zone of skin,14.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626951,,A,10090.0,1,,,8679
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626952,,A,10090.0,1,,,8680
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626953,,A,10090.0,1,,,8681
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626954,,A,10090.0,1,,,8682
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626955,,A,10090.0,1,,,8683
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626956,,A,10090.0,1,,,8684
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626957,,A,10090.0,1,,,8685
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626958,,A,10090.0,1,,,8686
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626959,,A,10090.0,1,,,8687
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626960,,A,10090.0,1,,,8688
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL626961,,A,10090.0,1,,,8689
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627589,,A,10090.0,1,,,8690
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,17208,,50594,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),N,,CHEMBL627590,,A,10090.0,1,,,8691
,1,BAO_0000218,,Mus musculus,,,Intermediate,3132,,50594,,Time taken for EC90 was determined when tested in mouse,N,,CHEMBL627591,,A,10090.0,1,,,8692
,1,BAO_0000218,,Mus musculus,,,Intermediate,3132,,50594,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,N,,CHEMBL627592,,A,10090.0,1,,,8693
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,16597,,50594,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),N,,CHEMBL627593,,A,10090.0,1,,,8694
,1,BAO_0000218,,Mus musculus,,,Intermediate,5727,,50594,,Half life in mice,N,,CHEMBL627594,,A,10090.0,1,,,8695
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,5302,,50594,,Half life period in mouse after 10 mg/Kg dose,N,,CHEMBL876813,,A,10090.0,1,,,8696
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,5302,,50594,,Half life period in mouse after 10 mg/kg dose,N,,CHEMBL627595,,A,10090.0,1,,,8697
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,6348,,50594,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,N,,CHEMBL627596,,A,10090.0,1,,,8698
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5964,,50597,,Cmax value at 5 mg/kg po was determined in rat,N,,CHEMBL627597,,A,10116.0,1,,,8699
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6078,,50597,,Cmax value evaluated in rat,N,,CHEMBL627598,,A,10116.0,1,,,8700
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,5206,,50597,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,N,,CHEMBL627599,,A,10116.0,1,,,8701
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2959,,50597,,Cmax value after administration of 20 mg/Kg oral dose in rat,N,,CHEMBL627600,,A,10116.0,1,,,8702
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5964,,50597,,Cmax value at 1 mg/kg po in rat,N,,CHEMBL627601,,A,10116.0,1,,,8703
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5964,,50597,,Cmax value at 5 mg/kg po in rat,N,,CHEMBL627776,,A,10116.0,1,,,8704
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6757,,50597,,Cmax value at a dose of 10 mg/kg in male SD rats,N,,CHEMBL627777,,A,10116.0,1,,,8705
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6757,,50597,,Cmax value at a dose of 100 mg/kg in male SD rats,N,,CHEMBL627778,,A,10116.0,1,,,8706
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6757,,50597,,Cmax value at a dose of 50 mg/kg in male SD rats,N,,CHEMBL627779,,A,10116.0,1,,,8707
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17617,,50597,,Cmax value in rats at 10 mg/kg,N,,CHEMBL876814,,A,10116.0,1,,,8708
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1445,,50597,,Cmax value was evaluated in rats at a dose of 20 mg/kg,N,,CHEMBL627780,,A,10116.0,1,,,8709
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6082,,50597,,Cmax value was determined after peroral administration of 20 mg/kg in rat,N,,CHEMBL627781,,A,10116.0,1,,,8710
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1446,,50597,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,,CHEMBL627782,,A,10116.0,1,,,8711
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5407,,50597,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,N,,CHEMBL627783,,A,10116.0,1,,,8712
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2690,,50597,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,N,,CHEMBL627784,,A,10116.0,1,,,8713
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,N,,CHEMBL627785,,A,10116.0,1,,,8714
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,N,,CHEMBL627786,,A,10116.0,1,,,8715
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4891,,50597,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,N,,CHEMBL627787,,A,10116.0,1,,,8716
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2807,,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,N,,CHEMBL627788,,A,10116.0,1,,,8717
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2807,,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,N,,CHEMBL626579,,A,10116.0,1,,,8718
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2807,,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,N,,CHEMBL626580,,A,10116.0,1,,,8719
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3634,,50597,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,N,,CHEMBL876815,,A,10116.0,1,,,8720
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1881,,50597,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,N,,CHEMBL626581,,A,10116.0,1,,,8721
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1881,,50597,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,N,,CHEMBL626582,,A,10116.0,1,,,8722
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,429,,50597,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,N,,CHEMBL626583,,A,10116.0,1,,,8723
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL626205,,A,10116.0,1,,,8724
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL626206,,A,10116.0,1,,,8725
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL626207,,A,10116.0,1,,,8726
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL623882,,A,10116.0,1,,,8727
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17582,,50597,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,N,,CHEMBL623883,,A,10116.0,1,,,8728
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17582,,50597,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,N,,CHEMBL623884,,A,10116.0,1,,,8729
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,3032,,50597,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,,CHEMBL623885,,A,10116.0,1,,,8730
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6295,,50597,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,N,,CHEMBL623886,,A,10116.0,1,,,8731
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6619,,50597,,Maximal concentration in rat was determined,N,,CHEMBL623887,,A,10116.0,1,,,8732
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6616,,50597,,Maximal concentration after i.v. administration,N,,CHEMBL623888,,A,10116.0,1,,,8733
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,3249,,50597,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,N,,CHEMBL623889,,A,10116.0,1,,,8734
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17791,,50597,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,N,,CHEMBL623890,,A,10116.0,1,,,8735
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17791,,50597,,Cmax in rat plasma after oral dose (50 mg/Kg),N,,CHEMBL623891,,A,10116.0,1,,,8736
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1360,,50597,,Maximal plasma concentration was determined.,N,,CHEMBL623892,,A,10116.0,1,,,8737
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2552,,50597,,Maximal plasma drug concentration was determined,N,,CHEMBL623893,,A,10116.0,1,,,8738
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6571,,50597,,Maximal concentration in rats after peroral administration,N,,CHEMBL877616,,A,10116.0,1,,,8739
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6570,,50597,,Maximum concentration in rat after 2 mg/kg peroral administration,N,,CHEMBL623894,,A,10116.0,1,,,8740
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6567,,50597,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,N,,CHEMBL623895,,A,10116.0,1,,,8741
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3031,,50597,,Maximum concentration of compound in rat was evaluated.,N,,CHEMBL623896,,A,10116.0,1,,,8742
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3436,,50597,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,N,,CHEMBL623897,,A,10116.0,1,,,8743
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3436,,50597,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,N,,CHEMBL623898,,A,10116.0,1,,,8744
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2083,,50597,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,N,,CHEMBL623899,,A,10116.0,1,,,8745
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3436,,50597,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,N,,CHEMBL623900,,A,10116.0,1,,,8746
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4527,,50597,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,N,,CHEMBL623901,,A,10116.0,1,,,8747
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1974,,50597,,Maximum concentration was evaluated in rats,N,,CHEMBL623902,,A,10116.0,1,,,8748
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebrospinal fluid,1359.0,Intermediate,3307,,50597,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,N,,CHEMBL623903,,A,10116.0,1,,,8749
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,3307,,50597,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,N,,CHEMBL623904,,A,10116.0,1,,,8750
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1916,,50597,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,,CHEMBL877617,,A,10116.0,1,,,8751
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1500,,50597,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,N,,CHEMBL623905,,A,10116.0,1,,,8752
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1500,,50597,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,N,,CHEMBL623906,,A,10116.0,1,,,8753
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4186,,50597,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,CHEMBL623907,,A,10116.0,1,,,8754
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,CHEMBL623908,,A,10116.0,1,,,8755
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,N,,CHEMBL623909,,A,10116.0,1,,,8756
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,CHEMBL623910,,A,10116.0,1,,,8757
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,CHEMBL623911,,A,10116.0,1,,,8758
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,CHEMBL623912,,A,10116.0,1,,,8759
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,CHEMBL624616,,A,10116.0,1,,,8760
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,CHEMBL624617,,A,10116.0,1,,,8761
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,CHEMBL624618,,A,10116.0,1,,,8762
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,CHEMBL624619,,A,10116.0,1,,,8763
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,CHEMBL624794,,A,10116.0,1,,,8764
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,CHEMBL624795,,A,10116.0,1,,,8765
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,CHEMBL623921,,A,10116.0,1,,,8766
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL623922,,A,10116.0,1,,,8767
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL623923,,A,10116.0,1,,,8768
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL623924,,A,10116.0,1,,,8769
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL623925,,A,10116.0,1,,,8770
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL623926,,A,10116.0,1,,,8771
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL623927,,A,10116.0,1,,,8772
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL623928,,A,10116.0,1,,,8773
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL623929,,A,10116.0,1,,,8774
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL623930,,A,10116.0,1,,,8775
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16434,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL623931,,A,10116.0,1,,,8776
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16434,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,CHEMBL622165,,A,10116.0,1,,,8777
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16434,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL621249,,A,10116.0,1,,,8778
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16434,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL621250,,A,10116.0,1,,,8779
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16434,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,CHEMBL621448,,A,10116.0,1,,,8780
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16434,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,CHEMBL621449,,A,10116.0,1,,,8781
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16434,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,CHEMBL621450,,A,10116.0,1,,,8782
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16434,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,CHEMBL621451,,A,10116.0,1,,,8783
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,CHEMBL621452,,A,10116.0,1,,,8784
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,CHEMBL621453,,A,10116.0,1,,,8785
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,CHEMBL621454,,A,10116.0,1,,,8786
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,CHEMBL621455,,A,10116.0,1,,,8787
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,CHEMBL621456,,A,10116.0,1,,,8788
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,CHEMBL625145,,A,10116.0,1,,,8789
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,CHEMBL875847,,A,10116.0,1,,,8790
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,CHEMBL625146,,A,10116.0,1,,,8791
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16434,,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL625147,,A,10116.0,1,,,8792
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16434,,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL625148,,A,10116.0,1,,,8793
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16434,,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL625149,,A,10116.0,1,,,8794
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL625150,,A,10116.0,1,,,8795
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL625151,,A,10116.0,1,,,8796
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL625152,,A,10116.0,1,,,8797
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL625153,,A,10116.0,1,,,8798
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL625154,,A,10116.0,1,,,8799
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,16435,,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL625155,,A,10116.0,1,,,8800
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL625156,,A,10116.0,1,,,8801
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11977,,50597,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624354,,A,10116.0,1,,,8802
,1,BAO_0000218,,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624355,,A,10116.0,1,,,8803
,1,BAO_0000218,,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624356,,A,10116.0,1,,,8804
,1,BAO_0000218,,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624357,,A,10116.0,1,,,8805
,1,BAO_0000218,,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624358,,A,10116.0,1,,,8806
,1,BAO_0000218,,Rattus norvegicus,Striatum,2435.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624359,,A,10116.0,1,,,8807
,1,BAO_0000218,,Rattus norvegicus,Striatum,2435.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624360,,A,10116.0,1,,,8808
,1,BAO_0000218,,Rattus norvegicus,Striatum,2435.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL624361,,A,10116.0,1,,,8809
,1,BAO_0000218,,Rattus norvegicus,Striatum,2435.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624362,,A,10116.0,1,,,8810
,1,BAO_0000218,,Rattus norvegicus,Striatum,2435.0,Intermediate,11977,,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624363,,A,10116.0,1,,,8811
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624364,,A,10116.0,1,,,8812
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624365,,A,10116.0,1,,,8813
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624366,,A,10116.0,1,,,8814
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624367,,A,10116.0,1,,,8815
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624368,,A,10116.0,1,,,8816
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL624369,,A,10116.0,1,,,8817
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL624370,,A,10116.0,1,,,8818
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL625069,,A,10116.0,1,,,8819
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL625070,,A,10116.0,1,,,8820
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL626051,,A,10116.0,1,,,8821
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL626052,,A,10116.0,1,,,8822
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL626053,,A,10116.0,1,,,8823
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL626054,,A,10116.0,1,,,8824
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL626055,,A,10116.0,1,,,8825
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL626056,,A,10116.0,1,,,8826
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL626057,,A,10116.0,1,,,8827
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL625193,,A,10116.0,1,,,8828
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL625194,,A,10116.0,1,,,8829
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL625195,,A,10116.0,1,,,8830
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL625196,,A,10116.0,1,,,8831
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL625197,,A,10116.0,1,,,8832
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL625198,,A,10116.0,1,,,8833
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL627929,,A,10116.0,1,,,8834
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL627074,,A,10116.0,1,,,8835
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL627075,,A,10116.0,1,,,8836
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL627076,,A,10116.0,1,,,8837
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL627077,,A,10116.0,1,,,8838
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL627078,,A,10116.0,1,,,8839
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL627079,,A,10116.0,1,,,8840
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,4573,,50594,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,N,,CHEMBL873824,,A,10090.0,1,,,8841
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,3132,,50594,,Half life in mouse plasma was determined at dose 25 mg/kg,N,,CHEMBL627080,,A,10090.0,1,,,8842
,1,BAO_0000218,,Mus musculus,,,Intermediate,17718,,50594,,Half life was determined,N,,CHEMBL627081,,A,10090.0,1,,,8843
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,17728,,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,,CHEMBL627082,,A,10090.0,1,,,8844
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,5961,,50594,,Half-life in male mice after 1 mg/kg intravenous dose,N,,CHEMBL627083,,A,10090.0,1,,,8845
,1,BAO_0000218,,Mus musculus,Plasma,1969.0,Intermediate,17731,,50594,,Half life in mice plasma,N,,CHEMBL627085,,A,10090.0,1,,,8847
,1,BAO_0000218,,Mus musculus,,,Intermediate,17592,,50594,,Half life in mouse,N,,CHEMBL627086,,A,10090.0,1,,,8848
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,3132,,50594,,Half life in mouse plasma at dose 25 mg/kg,N,,CHEMBL627087,,A,10090.0,1,,,8849
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,17729,,50594,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,N,,CHEMBL627088,,A,10090.0,1,,,8850
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,17729,,50594,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,N,,CHEMBL627089,,A,10090.0,1,,,8851
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,17729,,50594,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,N,,CHEMBL627090,,A,10090.0,1,,,8852
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,3277,,50594,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),N,,CHEMBL627091,,A,10090.0,1,,,8853
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,3760,,50594,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",N,,CHEMBL627092,,A,10090.0,1,,,8854
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,3760,,50594,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",N,,CHEMBL876785,,A,10090.0,1,,,8855
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,2862,,50594,,Half-life by iv administration in mouse,N,,CHEMBL627093,,A,10090.0,1,,,8856
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,2862,,50594,,Half-life by oral administration in mouse,N,,CHEMBL627094,,A,10090.0,1,,,8857
,1,BAO_0000218,,Mus musculus,,,Intermediate,5980,,50594,,Half-life in mice,N,,CHEMBL627095,,A,10090.0,1,,,8858
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,6159,,50594,,Half-life using mouse brain homogenate,N,,CHEMBL627096,,A,10090.0,1,,,8859
,1,BAO_0000218,,Mus musculus,,,Intermediate,6254,,50594,,Half-life was measured in mice,N,,CHEMBL627097,,A,10090.0,1,,,8860
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,6062,,50594,,Half-life was measured in mouse after an iv dose of 1 mg/kg,N,,CHEMBL627098,,A,10090.0,1,,,8861
,1,BAO_0000218,,Mus musculus,Blood,178.0,Intermediate,1574,,50594,,Half-life period was determined in mouse blood,N,,CHEMBL627099,,A,10090.0,1,,,8862
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,56,,50594,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",N,,CHEMBL627100,,A,10090.0,1,,,8863
,1,BAO_0000218,,Mus musculus,Plasma,1969.0,Intermediate,993,,50594,,Plasma half life in mouse,N,,CHEMBL627101,,A,10090.0,1,,,8864
,1,BAO_0000218,,Mus musculus,,,Intermediate,6652,,50594,,Stability of the peptide in the presence of mouse serum,N,,CHEMBL627102,,A,10090.0,1,,,8865
,1,BAO_0000218,,Mus musculus,,,Intermediate,17852,,50594,,Terminal half life of compound was determined in mouse,N,,CHEMBL627103,,A,10090.0,1,,,8866
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,2675,,50594,,Terminal half life was evaluated in mice after intravenous administration,N,,CHEMBL627104,,A,10090.0,1,,,8867
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,2675,,50594,,Terminal half life was evaluated in mice after oral administration,N,,CHEMBL627105,,A,10090.0,1,,,8868
,1,BAO_0000218,,Mus musculus,,,Intermediate,499,,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,N,,CHEMBL876786,,A,10090.0,1,,,8869
,1,BAO_0000218,,Mus musculus,,,Intermediate,499,,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,N,,CHEMBL873825,,A,10090.0,1,,,8870
,1,BAO_0000218,,Mus musculus,,,Intermediate,499,,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,N,,CHEMBL627106,,A,10090.0,1,,,8871
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14239,,50594,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,N,,CHEMBL626336,,A,10090.0,1,,,8872
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,5506,,50594,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",N,,CHEMBL877462,,A,10090.0,1,,,8873
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,5506,,50594,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",N,,CHEMBL626337,,A,10090.0,1,,,8874
,1,BAO_0000218,,Mus musculus,,,Intermediate,17734,,50594,,Half life after intraperitoneal administration of 100 mg/kg in mice,N,,CHEMBL626338,,A,10090.0,1,,,8875
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,17728,,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,N,,CHEMBL626339,,A,10090.0,1,,,8876
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,17728,,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,,CHEMBL626340,,A,10090.0,1,,,8877
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,17728,,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,N,,CHEMBL625377,,A,10090.0,1,,,8878
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,17728,,50594,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,N,,CHEMBL625378,,A,10090.0,1,,,8879
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,17728,,50594,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,N,,CHEMBL625379,,A,10090.0,1,,,8880
,0,BAO_0000251,,Sus scrofa,,,Autocuration,14294,Microsomes,22224,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),U,,CHEMBL625380,,A,9823.0,1,,,8881
,0,BAO_0000251,,Sus scrofa,,,Autocuration,14294,Microsomes,22224,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),U,,CHEMBL625381,,A,9823.0,1,,,8882
,0,BAO_0000019,,Sus scrofa,,,Autocuration,6056,,22224,,Stability to porcine renal DHP-I,U,,CHEMBL625382,,A,9823.0,1,,,8883
,0,BAO_0000218,In vivo,Sus scrofa,,,Autocuration,1317,,22224,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,U,,CHEMBL873828,,A,9823.0,1,,,8884
,0,BAO_0000218,In vivo,Sus scrofa,,,Autocuration,1317,,22224,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,U,,CHEMBL625383,,A,9823.0,1,,,8885
,0,BAO_0000019,,Sus scrofa,,,Autocuration,5229,,22224,,Half-life of the parent prodrug in porcine esterase solution,U,,CHEMBL625384,,A,9823.0,1,,,8886
,0,BAO_0000019,,Sus scrofa,,,Autocuration,4231,,22224,,"First order rate constant, k was determined in in pig liver Esterase",U,,CHEMBL625385,,A,9823.0,1,,,8887
,0,BAO_0000221,,Sus scrofa,Liver,2107.0,Autocuration,4231,,22224,,Half life of the in pig liver Esterase,U,,CHEMBL625386,,A,9823.0,1,,,8888
,0,BAO_0000221,,Sus scrofa,Liver,2107.0,Autocuration,5318,,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,U,,CHEMBL623571,,A,9823.0,1,,,8889
,0,BAO_0000221,,Sus scrofa,Liver,2107.0,Autocuration,5318,,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,U,,CHEMBL623572,,A,9823.0,1,,,8890
,0,BAO_0000221,,Sus scrofa,Liver,2107.0,Autocuration,5318,,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,U,,CHEMBL623573,,A,9823.0,1,,,8891
,0,BAO_0000221,,Sus scrofa,Liver,2107.0,Autocuration,3305,,22224,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,U,,CHEMBL623574,,A,9823.0,1,,,8892
,0,BAO_0000221,,Sus scrofa,Liver,2107.0,Autocuration,3305,,22224,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,U,,CHEMBL623575,,A,9823.0,1,,,8893
,0,BAO_0000221,,Sus scrofa,Liver,2107.0,Autocuration,2842,,22224,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,U,,CHEMBL623749,,A,9823.0,1,,,8894
,0,BAO_0000221,,Sus scrofa,Liver,2107.0,Autocuration,2842,,22224,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,U,,CHEMBL623750,,A,9823.0,1,,,8895
,0,BAO_0000221,In vitro,Sus scrofa,Liver,2107.0,Autocuration,889,,22224,,Half-life in vitro in pig liver,U,,CHEMBL623751,,A,9823.0,1,,,8896
,0,BAO_0000221,,Sus scrofa,Liver,2107.0,Autocuration,1904,,22224,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,U,,CHEMBL623752,,A,9823.0,1,,,8897
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4186,,50597,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,N,,CHEMBL623753,,A,10116.0,1,,,8898
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2774,,50597,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,,CHEMBL623754,,A,10116.0,1,,,8899
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1742,,50597,,Maximum concentration in rat plasma was determined,N,,CHEMBL623755,,A,10116.0,1,,,8900
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3169,,50597,,Maximum concentration in rats,N,,CHEMBL623756,,A,10116.0,1,,,8901
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3169,,50597,,Maximum concentration in rats at 1-2 hours,N,,CHEMBL623757,,A,10116.0,1,,,8902
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2081,,50597,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,N,,CHEMBL623758,,A,10116.0,1,,,8903
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,3307,,50597,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,N,,CHEMBL623759,,A,10116.0,1,,,8904
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4727,,50597,,Maximum concentration at the dose of 2 mg/kg in rat,N,,CHEMBL623760,,A,10116.0,1,,,8905
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6597,,50597,,Maximum concentration was evaluated in rats,N,,CHEMBL623761,,A,10116.0,1,,,8906
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,16365,,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,N,,CHEMBL623762,,A,10116.0,1,,,8907
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,16365,,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,N,,CHEMBL877594,,A,10116.0,1,,,8908
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,16365,,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,N,,CHEMBL623763,,A,10116.0,1,,,8909
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,16365,,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,N,,CHEMBL623764,,A,10116.0,1,,,8910
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,16365,,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,N,,CHEMBL623765,,A,10116.0,1,,,8911
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,2591,,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,N,,CHEMBL623766,,A,10116.0,1,,,8912
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,2591,,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,N,,CHEMBL623767,,A,10116.0,1,,,8913
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,2591,,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,N,,CHEMBL623768,,A,10116.0,1,,,8914
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5978,,50597,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,N,,CHEMBL623769,,A,10116.0,1,,,8915
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5978,,50597,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,N,,CHEMBL623770,,A,10116.0,1,,,8916
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5978,,50597,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,N,,CHEMBL623771,,A,10116.0,1,,,8917
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5978,,50597,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,N,,CHEMBL623772,,A,10116.0,1,,,8918
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5978,,50597,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,N,,CHEMBL623773,,A,10116.0,1,,,8919
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5978,,50597,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,N,,CHEMBL623774,,A,10116.0,1,,,8920
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5978,,50597,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,N,,CHEMBL623775,,A,10116.0,1,,,8921
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14465,,50597,,Cmax in rat (PO dose),N,,CHEMBL623776,,A,10116.0,1,,,8922
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4723,,50597,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL622191,,A,10116.0,1,,,8923
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4723,,50597,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL622192,,A,10116.0,1,,,8924
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4576,,50597,,Maximum plasma concentration determined in rat,N,,CHEMBL622193,,A,10116.0,1,,,8925
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12873,,50597,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,CHEMBL622194,,A,10116.0,1,,,8926
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12873,,50597,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,CHEMBL622195,,A,10116.0,1,,,8927
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6824,,50597,,Maximum plasma concentration in rat,N,,CHEMBL622196,,A,10116.0,1,,,8928
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17065,,50597,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,CHEMBL622197,,A,10116.0,1,,,8929
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2932,,50597,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,N,,CHEMBL622198,,A,10116.0,1,,,8930
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2932,,50597,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,N,,CHEMBL622199,,A,10116.0,1,,,8931
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2879,,50597,,Maximum plasma concentration of compound was measured in rat,N,,CHEMBL622200,,A,10116.0,1,,,8932
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2864,,50597,,Maximum plasma concentration after 20 mg/kg oral administration in rat,N,,CHEMBL622201,,A,10116.0,1,,,8933
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,16367,,50597,,Maximum plasma concentration after oral administration to rats,N,,CHEMBL623990,,A,10116.0,1,,,8934
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17717,,50597,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,CHEMBL623991,,A,10116.0,1,,,8935
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17717,,50597,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",N,,CHEMBL623992,,A,10116.0,1,,,8936
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17717,,50597,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,CHEMBL623993,,A,10116.0,1,,,8937
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17717,,50597,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,N,,CHEMBL623994,,A,10116.0,1,,,8938
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17720,,50597,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,N,,CHEMBL623995,,F,10116.0,1,,,8939
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17720,,50597,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,CHEMBL623996,,F,10116.0,1,,,8940
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17720,,50597,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,N,,CHEMBL623997,,F,10116.0,1,,,8941
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4516,,50597,,Maximum plasma concentration dosed orally in rats,N,,CHEMBL623998,,A,10116.0,1,,,8942
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4516,,50597,,Maximum plasma concentration dosed orally in rats after 6 hours,N,,CHEMBL623999,,A,10116.0,1,,,8943
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4516,,50597,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,N,,CHEMBL624000,,A,10116.0,1,,,8944
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5199,,50597,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,,CHEMBL624001,,A,10116.0,1,,,8945
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17538,,50597,,Maximum plasma concentration in rat after po administration,N,,CHEMBL624002,,A,10116.0,1,,,8946
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6685,,50597,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",N,,CHEMBL624003,,A,10116.0,1,,,8947
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6685,,50597,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",N,,CHEMBL624004,,A,10116.0,1,,,8948
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16434,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL624005,,A,10116.0,1,,,8949
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16434,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,CHEMBL624006,,A,10116.0,1,,,8950
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16434,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL624007,,A,10116.0,1,,,8951
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16434,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL624008,,A,10116.0,1,,,8952
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16434,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,CHEMBL624009,,A,10116.0,1,,,8953
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16434,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,CHEMBL874387,,A,10116.0,1,,,8954
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16434,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,CHEMBL624010,,A,10116.0,1,,,8955
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16434,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,,CHEMBL624011,,A,10116.0,1,,,8956
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,CHEMBL624012,,A,10116.0,1,,,8957
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,CHEMBL624013,,A,10116.0,1,,,8958
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,CHEMBL624736,,A,10116.0,1,,,8959
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,CHEMBL624737,,A,10116.0,1,,,8960
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16434,,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL624738,,A,10116.0,1,,,8961
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16434,,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL624739,,A,10116.0,1,,,8962
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16434,,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL624740,,A,10116.0,1,,,8963
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL624896,,A,10116.0,1,,,8964
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL624897,,A,10116.0,1,,,8965
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL624108,,A,10116.0,1,,,8966
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL624109,,A,10116.0,1,,,8967
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL624110,,A,10116.0,1,,,8968
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL624111,,A,10116.0,1,,,8969
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,CHEMBL624112,,A,10116.0,1,,,8970
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,CHEMBL624113,,A,10116.0,1,,,8971
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,CHEMBL619709,,A,10116.0,1,,,8972
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,16435,,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,CHEMBL619710,,A,10116.0,1,,,8973
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16434,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL619711,,A,10116.0,1,,,8974
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16434,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,CHEMBL619712,,A,10116.0,1,,,8975
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16434,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL619713,,A,10116.0,1,,,8976
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16434,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL619714,,A,10116.0,1,,,8977
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16434,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,CHEMBL619715,,A,10116.0,1,,,8978
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16434,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,CHEMBL619716,,A,10116.0,1,,,8979
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16434,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,CHEMBL619717,,A,10116.0,1,,,8980
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16434,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,CHEMBL619718,,A,10116.0,1,,,8981
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,CHEMBL619719,,A,10116.0,1,,,8982
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,CHEMBL875329,,A,10116.0,1,,,8983
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,CHEMBL619720,,A,10116.0,1,,,8984
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,CHEMBL619721,,A,10116.0,1,,,8985
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,CHEMBL619722,,A,10116.0,1,,,8986
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,CHEMBL619723,,A,10116.0,1,,,8987
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,CHEMBL619724,,A,10116.0,1,,,8988
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,CHEMBL619725,,A,10116.0,1,,,8989
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16434,,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL619726,,A,10116.0,1,,,8990
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16434,,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL619727,,A,10116.0,1,,,8991
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16434,,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL619728,,A,10116.0,1,,,8992
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL619729,,A,10116.0,1,,,8993
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL619730,,A,10116.0,1,,,8994
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL619731,,A,10116.0,1,,,8995
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL619732,,A,10116.0,1,,,8996
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL619733,,A,10116.0,1,,,8997
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL619734,,A,10116.0,1,,,8998
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL619735,,A,10116.0,1,,,8999
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL875330,,A,10116.0,1,,,9000
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL628465,,A,10116.0,1,,,9001
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL628466,,A,10116.0,1,,,9002
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL628467,,A,10116.0,1,,,9003
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL628468,,A,10116.0,1,,,9004
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL628469,,A,10116.0,1,,,9005
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL628470,,A,10116.0,1,,,9006
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL628471,,A,10116.0,1,,,9007
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL628472,,A,10116.0,1,,,9008
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL625191,,A,10116.0,1,,,9009
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL625192,,A,10116.0,1,,,9010
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,CHEMBL875337,,A,10116.0,1,,,9011
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL626341,,A,10116.0,1,,,9012
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL626342,,A,10116.0,1,,,9013
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,11977,,50597,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,CHEMBL621943,,A,10116.0,1,,,9014
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3748,,50597,,Half life in rats,N,,CHEMBL621944,,A,10116.0,1,,,9015
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15765,,50597,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,N,,CHEMBL621945,,A,10116.0,1,,,9016
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4871,,50597,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),N,,CHEMBL621946,,A,10116.0,1,,,9017
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4871,,50597,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,,CHEMBL621947,,A,10116.0,1,,,9018
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4872,,50597,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),N,,CHEMBL621948,,A,10116.0,1,,,9019
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4872,,50597,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,,CHEMBL621949,,A,10116.0,1,,,9020
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5413,,50597,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),N,,CHEMBL621950,,A,10116.0,1,,,9021
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5413,,50597,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,N,,CHEMBL621951,,A,10116.0,1,,,9022
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,15272,,50597,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,N,,CHEMBL621952,,A,10116.0,1,,,9023
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,4689,,50597,,Stability (%) in rat liver microsomes,N,,CHEMBL621953,,A,10116.0,1,,,9024
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6057,,50597,,Area under curve was calculated after intravenous administration,N,,CHEMBL621954,,A,10116.0,1,,,9025
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6057,,50597,,Area under the curve was calculated after iv administration in rat,N,,CHEMBL621955,,A,10116.0,1,,,9026
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6057,,50597,,Area under the curve was calculated in rat after peroral administration,N,,CHEMBL621956,,A,10116.0,1,,,9027
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6211,,50597,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,,CHEMBL621957,,A,10116.0,1,,,9028
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5710,,50597,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,N,,CHEMBL621958,,A,10116.0,1,,,9029
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5710,,50597,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,N,,CHEMBL621959,,A,10116.0,1,,,9030
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17853,,50597,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,N,,CHEMBL621960,,A,10116.0,1,,,9031
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17853,,50597,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,N,,CHEMBL621961,,A,10116.0,1,,,9032
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15765,,50597,,p value of the compound,N,,CHEMBL621962,,A,10116.0,1,,,9033
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15765,,50597,,p value of the compound,N,,CHEMBL876787,,F,10116.0,1,,,9034
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15765,,50597,,p value of the compound,N,,CHEMBL621963,,A,10116.0,1,,,9035
,1,BAO_0000218,,Rattus norvegicus,Stomach,945.0,Intermediate,6175,,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,CHEMBL622637,,A,10116.0,1,,,9036
,1,BAO_0000218,,Rattus norvegicus,Stomach,945.0,Intermediate,6175,,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,CHEMBL622638,,A,10116.0,1,,,9037
,1,BAO_0000218,,Rattus norvegicus,Stomach,945.0,Intermediate,6175,,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,CHEMBL626561,,A,10116.0,1,,,9038
,0,BAO_0000019,,Oryctolagus cuniculus,,,Autocuration,7991,,22224,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),U,,CHEMBL626562,,F,9986.0,1,,,9039
,0,BAO_0000218,,Oryctolagus cuniculus,,,Autocuration,429,,22224,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),U,,CHEMBL626563,,A,9986.0,1,,,9040
,0,BAO_0000218,,Oryctolagus cuniculus,,,Autocuration,429,,22224,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),U,,CHEMBL626564,,A,9986.0,1,,,9041
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,6253,,22224,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,,CHEMBL626565,,A,9986.0,1,,,9042
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,6253,,22224,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,,CHEMBL626566,,A,9986.0,1,,,9043
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,3615,,22224,,Clearance rate in rabbits,U,,CHEMBL626567,,A,9986.0,1,,,9044
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,4059,,22224,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,,CHEMBL626568,,A,9986.0,1,,,9045
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,5124,,22224,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,,CHEMBL626569,,A,9986.0,1,,,9046
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,5124,,22224,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,,CHEMBL626570,,A,9986.0,1,,,9047
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,5124,,22224,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,,CHEMBL626571,,A,9986.0,1,,,9048
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,429,,22224,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,U,,CHEMBL626572,,A,9986.0,1,,,9049
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,Plasma,1969.0,Autocuration,4059,,22224,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,,CHEMBL626573,,A,9986.0,1,,,9050
,0,BAO_0000251,,Oryctolagus cuniculus,Liver,2107.0,Autocuration,9659,Microsomes,22224,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,U,,CHEMBL626574,,A,9986.0,1,,,9051
,0,BAO_0000251,,Oryctolagus cuniculus,Liver,2107.0,Autocuration,9659,Microsomes,22224,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,U,,CHEMBL626575,,A,9986.0,1,,,9052
,0,BAO_0000218,,Oryctolagus cuniculus,,,Autocuration,3639,,22224,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,U,,CHEMBL626576,,A,9986.0,1,,,9053
,0,BAO_0000218,,Oryctolagus cuniculus,,,Autocuration,3639,,22224,,Dose at which bioavailability of perorally administered compound was tested in rabbit,U,,CHEMBL626577,,A,9986.0,1,,,9054
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,3639,,22224,,The compound was tested for its bioavailability in rabbit (by oral dosage).,U,,CHEMBL626578,,A,9986.0,1,,,9055
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,5124,,22224,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,,CHEMBL625263,,A,9986.0,1,,,9056
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,5124,,22224,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,,CHEMBL625264,,A,9986.0,1,,,9057
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,5124,,22224,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,,CHEMBL625265,,A,9986.0,1,,,9058
,0,BAO_0000251,,Oryctolagus cuniculus,,,Autocuration,14294,Microsomes,22224,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),U,,CHEMBL625266,,A,9986.0,1,,,9059
,0,BAO_0000251,,Oryctolagus cuniculus,,,Autocuration,14294,Microsomes,22224,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),U,,CHEMBL876796,,A,9986.0,1,,,9060
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,429,,22224,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,U,,CHEMBL625267,,A,9986.0,1,,,9061
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,Plasma,1969.0,Autocuration,5124,,22224,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,,CHEMBL625268,,A,9986.0,1,,,9062
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,Plasma,1969.0,Autocuration,5124,,22224,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,,CHEMBL625269,,A,9986.0,1,,,9063
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,Plasma,1969.0,Autocuration,5124,,22224,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,,CHEMBL624689,,A,9986.0,1,,,9064
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,429,,22224,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,U,,CHEMBL624690,,A,9986.0,1,,,9065
,0,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Autocuration,429,,22224,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),U,,CHEMBL624691,,A,9986.0,1,,,9066
,0,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Autocuration,429,,22224,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),U,,CHEMBL624692,,A,9986.0,1,,,9067
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,4059,,22224,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,U,,CHEMBL624693,,A,9986.0,1,,,9068
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,4137,,22224,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,U,,CHEMBL624694,,A,9986.0,1,,,9069
,0,BAO_0000221,In vitro,Oryctolagus cuniculus,,,Autocuration,11672,,22224,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,U,,CHEMBL877596,,A,9986.0,1,,,9070
,0,BAO_0000019,,Oryctolagus cuniculus,,,Autocuration,12886,,22224,,Time within which only 10% of the drug was degraded,U,,CHEMBL624695,,A,9986.0,1,,,9071
,0,BAO_0000221,,Oryctolagus cuniculus,Liver,2107.0,Autocuration,3853,,22224,,Half life period in rabbit liver homogenate,U,,CHEMBL624696,,A,9986.0,1,,,9072
,0,BAO_0000019,,Oryctolagus cuniculus,,,Autocuration,3615,,22224,,Half life value in rabbits,U,,CHEMBL624697,,A,9986.0,1,,,9073
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,Blood,178.0,Autocuration,6253,,22224,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,,CHEMBL624698,,A,9986.0,1,,,9074
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,Blood,178.0,Autocuration,6253,,22224,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,,CHEMBL624699,,A,9986.0,1,,,9075
,0,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Autocuration,6077,,22224,,Half-life period in rabbits following intravenous administration at 2 mg/kg,U,,CHEMBL624700,,A,9986.0,1,,,9076
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17617,,50597,,AUC 0-8 hr value in rats at 10 mg/kg,N,,CHEMBL622903,,A,10116.0,1,,,9077
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17594,,50597,,AUC after administration at 2000 mg/kg/day in rats,N,,CHEMBL622904,,A,10116.0,1,,,9078
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6149,,50597,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,N,,CHEMBL622905,,A,10116.0,1,,,9079
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17260,,50597,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,CHEMBL622906,,A,10116.0,1,,,9080
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17260,,50597,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,CHEMBL622907,,A,10116.0,1,,,9081
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6644,,50597,,AUC in rat after oral administration at 10.5 mg/kg dose,N,,CHEMBL622908,,A,10116.0,1,,,9082
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6644,,50597,,AUC in rat after oral administration at 11.2 mg/kg dose,N,,CHEMBL622909,,A,10116.0,1,,,9083
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6644,,50597,,AUC in rat after oral administration at 9.7 mg/kg dose,N,,CHEMBL622910,,A,10116.0,1,,,9084
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,6495,,50597,,AUC in rat brain after oral administration at 10 mg/kg,N,,CHEMBL622911,,A,10116.0,1,,,9085
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6504,,50597,,AUC in rat p.o.,N,,CHEMBL622912,,A,10116.0,1,,,9086
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17686,,50597,,AUC in rat p.o. at 20 mg/kg concentration,N,,CHEMBL622913,,A,10116.0,1,,,9087
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6495,,50597,,AUC in rat plasma after oral administration at 10 mg/kg,N,,CHEMBL622914,,A,10116.0,1,,,9088
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,216,,50597,,AUC in rats,N,,CHEMBL622915,,A,10116.0,1,,,9089
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1908,,50597,,AUC value after IV dose at a dose of 5 mg/kg in rats.,N,,CHEMBL622916,,A,10116.0,1,,,9090
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1908,,50597,,AUC value after oral dose at a dose of 10 mg/kg in rats.,N,,CHEMBL622917,,A,10116.0,1,,,9091
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6685,,50597,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,,CHEMBL622918,,A,10116.0,1,,,9092
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,216,,50597,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,N,,CHEMBL622919,,A,10116.0,1,,,9093
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6049,,50597,,Maximum plasma concentration was evaluated in rat,N,,CHEMBL622920,,A,10116.0,1,,,9094
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2463,,50597,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,,CHEMBL622921,,A,10116.0,1,,,9095
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6679,,50597,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,N,,CHEMBL622922,,A,10116.0,1,,,9096
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6681,,50597,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,,CHEMBL622923,,A,10116.0,1,,,9097
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4890,,50597,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,,CHEMBL877604,,A,10116.0,1,,,9098
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6410,,50597,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,N,,CHEMBL622924,,A,10116.0,1,,,9099
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6410,,50597,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,N,,CHEMBL622925,,A,10116.0,1,,,9100
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,16366,,50597,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,N,,CHEMBL622926,,A,10116.0,1,,,9101
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6227,,50597,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,N,,CHEMBL623625,,A,10116.0,1,,,9102
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Expert,3598,,50597,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,CHEMBL623626,,A,10116.0,1,,,9103
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1465,,50597,,Maximum plasma drug concentration was determined,N,,CHEMBL623627,,A,10116.0,1,,,9104
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4368,,50597,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,N,,CHEMBL623628,,A,10116.0,1,,,9105
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15662,,50597,,Mean peak plasma concentration was observed after intravenous administration in rat,N,,CHEMBL623629,,A,10116.0,1,,,9106
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15662,,50597,,Mean peak plasma concentration was observed after oral administration in rat,N,,CHEMBL623630,,A,10116.0,1,,,9107
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5355,,50597,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,N,,CHEMBL623804,,A,10116.0,1,,,9108
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5355,,50597,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,N,,CHEMBL623805,,A,10116.0,1,,,9109
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,1567,,50597,,Peak oral plasma concentration was determined in rats by oral administration,N,,CHEMBL623806,,A,10116.0,1,,,9110
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4026,,50597,,Peak plasma concentration (Cmax) was determined,N,,CHEMBL623807,,A,10116.0,1,,,9111
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6193,,50597,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,N,,CHEMBL623808,,A,10116.0,1,,,9112
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4026,,50597,,Peak plasma concentration (Cmax) in rats,N,,CHEMBL623809,,A,10116.0,1,,,9113
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6485,,50597,,Peak plasma concentration at 1 mg/kg peroral administration,N,,CHEMBL623810,,A,10116.0,1,,,9114
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17655,,50597,,Peak plasma concentration in rat,N,,CHEMBL623811,,A,10116.0,1,,,9115
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14941,,50597,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",N,,CHEMBL623812,,A,10116.0,1,,,9116
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5394,,50597,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,N,,CHEMBL877605,,A,10116.0,1,,,9117
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4408,,50597,,Pharmacokinetic property (Cmax) in rat,N,,CHEMBL623813,,A,10116.0,1,,,9118
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5983,,50597,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,,CHEMBL623814,,A,10116.0,1,,,9119
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4878,,50597,,Cmax in rat after 3mg/kg oral dose,N,,CHEMBL623815,,A,10116.0,1,,,9120
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5862,,50597,Sprague-Dawley,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,N,,CHEMBL623816,,A,10116.0,1,,,9121
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4517,,50597,,Cmax in rats after 20 mg/kg oral dose,N,,CHEMBL623145,,A,10116.0,1,,,9122
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5932,,50597,,Cmax in rat plasma after 30mg/kg oral dose,N,,CHEMBL623146,,A,10116.0,1,,,9123
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5436,,50597,,Plasma concentration after oral administration of 100 mg/kg to rats,N,,CHEMBL623147,,A,10116.0,1,,,9124
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,4910,,50597,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,,CHEMBL623042,,A,10116.0,1,,,9125
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4950,,50597,,Tested for the Cmax in rat at 10 mg/kg per orally,N,,CHEMBL623043,,A,10116.0,1,,,9126
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15078,,50597,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL623044,,A,10116.0,1,,,9127
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15078,,50597,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL623045,,A,10116.0,1,,,9128
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3360,,50597,,Bioavailability as oral Cmax in rats at 30 mins,N,,CHEMBL623046,,A,10116.0,1,,,9129
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3360,,50597,,Bioavailability as oral Cmax in rats at 6hr,N,,CHEMBL623226,,A,10116.0,1,,,9130
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15022,,50597,,The maximum concentration of compound was measured at the dose of 100 umol/kg,N,,CHEMBL623227,,A,10116.0,1,,,9131
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15022,,50597,,The maximum concentration of compound was measured at the dose of 300 umol/kg,N,,CHEMBL623228,,A,10116.0,1,,,9132
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15022,,50597,,The maximum concentration of compound was measured at the dose of 30 umol/kg,N,,CHEMBL623229,,A,10116.0,1,,,9133
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5160,,50597,,The maximum plasma levels for the compounds were determined by LC-MS.,N,,CHEMBL623230,,A,10116.0,1,,,9134
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15662,,50597,,mean peak plasma concentration was observed after intravenous administration in rat,N,,CHEMBL623231,,A,10116.0,1,,,9135
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15662,,50597,,mean peak plasma concentration was observed after oral administration in rat,N,,CHEMBL623232,,A,10116.0,1,,,9136
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4709,,50597,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,N,,CHEMBL623233,,A,10116.0,1,,,9137
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3535,,50597,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,N,,CHEMBL623234,,A,10116.0,1,,,9138
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3535,,50597,,Concentration in plasma (portal) following oral dose in rats at 1 hr,N,,CHEMBL623235,,A,10116.0,1,,,9139
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3535,,50597,,Concentration in plasma (portal) following oral dose in rats at 2 hr,N,,CHEMBL623236,,A,10116.0,1,,,9140
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3535,,50597,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,N,,CHEMBL623237,,A,10116.0,1,,,9141
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3535,,50597,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,N,,CHEMBL623238,,A,10116.0,1,,,9142
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3535,,50597,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,N,,CHEMBL623239,,A,10116.0,1,,,9143
,0,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5005,,22224,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,U,,CHEMBL623240,,A,10116.0,1,,,9144
,1,BAO_0000218,,Rattus norvegicus,Hypothalamus,1898.0,Intermediate,6326,,50597,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",N,,CHEMBL623241,,A,10116.0,1,,,9145
,1,BAO_0000218,,Rattus norvegicus,Hypothalamus,1898.0,Intermediate,6326,,50597,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",N,,CHEMBL623242,,A,10116.0,1,,,9146
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6326,,50597,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",N,,CHEMBL874394,,A,10116.0,1,,,9147
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6326,,50597,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",N,,CHEMBL623243,,A,10116.0,1,,,9148
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17411,,50597,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL623244,,A,10116.0,1,,,9149
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL623245,,A,10116.0,1,,,9150
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL623246,,A,10116.0,1,,,9151
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL623247,,A,10116.0,1,,,9152
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL623248,,A,10116.0,1,,,9153
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,16435,,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL623249,,A,10116.0,1,,,9154
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16434,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL625072,,A,10116.0,1,,,9155
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16434,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,CHEMBL625073,,A,10116.0,1,,,9156
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16434,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL625074,,A,10116.0,1,,,9157
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16434,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL625075,,A,10116.0,1,,,9158
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16434,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,N,,CHEMBL625076,,A,10116.0,1,,,9159
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16434,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,CHEMBL625077,,A,10116.0,1,,,9160
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16434,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,CHEMBL625078,,A,10116.0,1,,,9161
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16434,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,CHEMBL874395,,A,10116.0,1,,,9162
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,CHEMBL625079,,A,10116.0,1,,,9163
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,CHEMBL625080,,A,10116.0,1,,,9164
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,CHEMBL625081,,A,10116.0,1,,,9165
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,CHEMBL625082,,A,10116.0,1,,,9166
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,CHEMBL625083,,A,10116.0,1,,,9167
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,CHEMBL625084,,A,10116.0,1,,,9168
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,CHEMBL625085,,A,10116.0,1,,,9169
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,CHEMBL625086,,A,10116.0,1,,,9170
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16434,,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL625087,,A,10116.0,1,,,9171
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16434,,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL625088,,A,10116.0,1,,,9172
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16434,,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL622205,,A,10116.0,1,,,9173
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL622206,,A,10116.0,1,,,9174
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL622207,,A,10116.0,1,,,9175
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL622366,,A,10116.0,1,,,9176
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL622367,,A,10116.0,1,,,9177
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL875331,,A,10116.0,1,,,9178
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,16435,,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL622368,,A,10116.0,1,,,9179
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16434,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL622369,,A,10116.0,1,,,9180
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16434,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,CHEMBL622370,,A,10116.0,1,,,9181
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16434,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL622371,,A,10116.0,1,,,9182
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16434,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL622372,,A,10116.0,1,,,9183
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16434,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,CHEMBL622373,,A,10116.0,1,,,9184
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16434,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,CHEMBL622374,,A,10116.0,1,,,9185
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16434,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,CHEMBL622375,,A,10116.0,1,,,9186
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16434,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,,CHEMBL622376,,A,10116.0,1,,,9187
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,CHEMBL622377,,A,10116.0,1,,,9188
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,CHEMBL622378,,A,10116.0,1,,,9189
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,CHEMBL622379,,A,10116.0,1,,,9190
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,CHEMBL622380,,A,10116.0,1,,,9191
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,CHEMBL622381,,A,10116.0,1,,,9192
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,CHEMBL622382,,A,10116.0,1,,,9193
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16434,,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL622383,,A,10116.0,1,,,9194
,1,BAO_0000218,,Rattus norvegicus,Stomach,945.0,Intermediate,6175,,50597,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,CHEMBL875332,,A,10116.0,1,,,9195
,1,BAO_0000218,,Rattus norvegicus,Stomach,945.0,Intermediate,6175,,50597,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,CHEMBL622384,,A,10116.0,1,,,9196
,1,BAO_0000218,,Rattus norvegicus,Stomach,945.0,Intermediate,6175,,50597,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,CHEMBL622385,,A,10116.0,1,,,9197
,1,BAO_0000218,,Rattus norvegicus,Stomach,945.0,Intermediate,6175,,50597,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,CHEMBL622386,,A,10116.0,1,,,9198
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10839,,50597,,The compound was tested for the plasma binding in rat,N,,CHEMBL622387,,A,10116.0,1,,,9199
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16459,,50597,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",N,,CHEMBL622388,,A,10116.0,1,,,9200
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16459,,50597,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",N,,CHEMBL622389,,A,10116.0,1,,,9201
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16459,,50597,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",N,,CHEMBL622390,,A,10116.0,1,,,9202
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16459,,50597,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),N,,CHEMBL622391,,A,10116.0,1,,,9203
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16459,,50597,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),N,,CHEMBL622392,,A,10116.0,1,,,9204
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16459,,50597,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),N,,CHEMBL622393,,A,10116.0,1,,,9205
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3278,,50597,,Plasma level at 2 hr after administration of the compound,N,,CHEMBL622394,,A,10116.0,1,,,9206
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3278,,50597,,plasma level at 2 hr after administration of the compound,N,,CHEMBL622395,,A,10116.0,1,,,9207
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,4684,,50597,,Stability in rat serum measured as % recovery at 1 min,N,,CHEMBL622396,,A,10116.0,1,,,9208
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,4684,,50597,,Stability in rat serum measured as % recovery at 10 min,N,,CHEMBL624894,,A,10116.0,1,,,9209
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,4684,,50597,,Stability in rat serum measured as % recovery at 10 mins,N,,CHEMBL624895,,A,10116.0,1,,,9210
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,4684,,50597,,Stability in rat serum measured as % recovery at 2 hr,N,,CHEMBL624058,,A,10116.0,1,,,9211
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,4684,,50597,,Stability in rat serum measured as % recovery at 3 min,N,,CHEMBL624059,,A,10116.0,1,,,9212
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,4684,,50597,,Stability in rat serum measured as % recovery at 3 mins,N,,CHEMBL624060,,A,10116.0,1,,,9213
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,4684,,50597,,Stability in rat serum measured as % recovery at 5 min,N,,CHEMBL624061,,A,10116.0,1,,,9214
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,4684,,50597,,Stability in rat serum measured as % recovery at 5 mins,N,,CHEMBL624062,,A,10116.0,1,,,9215
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16456,,50597,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,CHEMBL624063,,A,10116.0,1,,,9216
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16456,,50597,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,CHEMBL624064,,A,10116.0,1,,,9217
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,723,,50597,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,N,,CHEMBL624065,,A,10116.0,1,,,9218
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,723,,50597,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,N,,CHEMBL624066,,A,10116.0,1,,,9219
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5160,,50597,,Half life tested in mature male rat at a dose of 30 mg/kg,N,,CHEMBL877490,,A,10116.0,1,,,9220
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4709,,50597,,Half life after intravenous administration of 1 mg/kg in rat,N,,CHEMBL874442,,A,10116.0,1,,,9221
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5633,,50597,,Half life period after administration (30 mg/kg) in rat,N,,CHEMBL626890,,A,10116.0,1,,,9222
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5302,,50597,,Half life period in rat after 5 mg/Kg dose,N,,CHEMBL626891,,A,10116.0,1,,,9223
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5302,,50597,,Half life period in rat after 5 mg/kg dose,N,,CHEMBL626892,,A,10116.0,1,,,9224
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17791,,50597,,Half life period was determined,N,,CHEMBL626893,,A,10116.0,1,,,9225
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17791,,50597,,Half life period was evaluated in rat,N,,CHEMBL626894,,A,10116.0,1,,,9226
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17791,,50597,,Half life period was evaluated in rat; 0.5-1.0,N,,CHEMBL626895,,A,10116.0,1,,,9227
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17791,,50597,,Half life period was evaluated in rat; 5.9-7.5,N,,CHEMBL626896,,A,10116.0,1,,,9228
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14512,,50597,,Half-life in rat plasma,N,,CHEMBL626897,,A,10116.0,1,,,9229
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6230,,50597,,Half-life time in rat was determined,N,,CHEMBL626898,,A,10116.0,1,,,9230
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3364,,50597,,Terminal half-life after iv administration to rats,N,,CHEMBL626899,,A,10116.0,1,,,9231
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6874,,50597,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,N,,CHEMBL626900,,A,10116.0,1,,,9232
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,857,,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,N,,CHEMBL626901,,A,10116.0,1,,,9233
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,858,,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),N,,CHEMBL626902,,A,10116.0,1,,,9234
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,858,,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),N,,CHEMBL626903,,A,10116.0,1,,,9235
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5355,,50597,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,N,,CHEMBL874443,,A,10116.0,1,,,9236
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5355,,50597,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,N,,CHEMBL626904,,A,10116.0,1,,,9237
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6305,,50597,,Half life in rats,N,,CHEMBL626905,,A,10116.0,1,,,9238
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,13501,,50597,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,,CHEMBL873830,,A,10116.0,1,,,9239
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17594,,50597,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,N,,CHEMBL626906,,A,10116.0,1,,,9240
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4186,,50597,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,CHEMBL631076,,A,10116.0,1,,,9241
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,2932,,50597,,Biological half-life was measured in plasma of rats,N,,CHEMBL631077,,A,10116.0,1,,,9242
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17065,,50597,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,CHEMBL631078,,A,10116.0,1,,,9243
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15765,,50597,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,N,,CHEMBL631079,,A,10116.0,1,,,9244
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2713,,50597,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,N,,CHEMBL631080,,A,10116.0,1,,,9245
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,N,,CHEMBL631081,,A,10116.0,1,,,9246
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,N,,CHEMBL631239,,A,10116.0,1,,,9247
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,740,,50597,,Compound was evaluated for plasma half life in rat,N,,CHEMBL631240,,A,10116.0,1,,,9248
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6597,,50597,,AUC value at a dose of 5 mg/kg (p.o.) in rats,N,,CHEMBL631241,,A,10116.0,1,,,9249
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,2959,,50597,,AUC value after administration of 20 mg/Kg oral dose in rat,N,,CHEMBL631242,,A,10116.0,1,,,9250
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17594,,50597,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,N,,CHEMBL631243,,A,10116.0,1,,,9251
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17596,,50597,,AUC0-96 after administration at 50 mg/kg,N,,CHEMBL874444,,A,10116.0,1,,,9252
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17594,,50597,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,N,,CHEMBL631244,,A,10116.0,1,,,9253
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3293,,50597,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",N,,CHEMBL631245,,A,10116.0,1,,,9254
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6757,,50597,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,N,,CHEMBL627162,,A,10116.0,1,,,9255
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6757,,50597,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,N,,CHEMBL627163,,A,10116.0,1,,,9256
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6757,,50597,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,N,,CHEMBL627164,,A,10116.0,1,,,9257
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,5979,,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,N,,CHEMBL627165,,A,10116.0,1,,,9258
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5979,,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,N,,CHEMBL627166,,A,10116.0,1,,,9259
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5979,,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,N,,CHEMBL627167,,A,10116.0,1,,,9260
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4026,,50597,,Area under curve (AUC) at a dose of 30 mg/kg in rats,N,,CHEMBL627822,,A,10116.0,1,,,9261
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5355,,50597,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,,CHEMBL627823,,A,10116.0,1,,,9262
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5355,,50597,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,N,,CHEMBL627824,,A,10116.0,1,,,9263
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5355,,50597,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,,CHEMBL627825,,A,10116.0,1,,,9264
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5633,,50597,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,N,,CHEMBL627826,,A,10116.0,1,,,9265
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1716,,50597,,Area under curve (Pharmacokinetic property) was determined,N,,CHEMBL627827,,A,10116.0,1,,,9266
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1716,,50597,,Area under curve (Pharmacokinetic property) of the compound; Not determined,N,,CHEMBL627828,,A,10116.0,1,,,9267
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4689,,50597,,Area under curve after intravenous administration (1 mg/kg) in rat,N,,CHEMBL627829,,A,10116.0,1,,,9268
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4527,,50597,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,N,,CHEMBL627830,,A,10116.0,1,,,9269
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4527,,50597,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,N,,CHEMBL627831,,A,10116.0,1,,,9270
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15662,,50597,,Area under curve in male SD rats was observed after oral administration in rat,N,,CHEMBL627832,,A,10116.0,1,,,9271
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4413,,50597,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,N,,CHEMBL627833,,A,10116.0,1,,,9272
,1,BAO_0000218,,Rattus norvegicus,,,Expert,3598,,50597,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,CHEMBL627834,,A,10116.0,1,,,9273
,1,BAO_0000218,,Rattus norvegicus,,,Expert,3598,,50597,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,N,,CHEMBL628004,,A,10116.0,1,,,9274
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5964,,50597,,Area under curve at 5 mg/kg po was determined in rat,N,,CHEMBL628005,,A,10116.0,1,,,9275
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4689,,50597,,Area under curve in Rat at a oral dose of 5 mg/kg,N,,CHEMBL628006,,A,10116.0,1,,,9276
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4186,,50597,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,CHEMBL628007,,A,10116.0,1,,,9277
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5510,,50597,,Area under curve was determined,N,,CHEMBL625676,,A,10116.0,1,,,9278
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17858,,50597,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,N,,CHEMBL631309,,A,10116.0,1,,,9279
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17804,,50597,,Area under curve after intravenous administration at 3 mg/kg,N,,CHEMBL631310,,A,10116.0,1,,,9280
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6106,,50597,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,N,,CHEMBL631311,,A,10116.0,1,,,9281
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5964,,50597,,Area under curve at 4 hr in rat,N,,CHEMBL631312,,A,10116.0,1,,,9282
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4026,,50597,,Area under curve at a dose of 30 mg/kg,N,,CHEMBL631313,,A,10116.0,1,,,9283
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4756,,50597,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,N,,CHEMBL631314,,A,10116.0,1,,,9284
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4756,,50597,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,N,,CHEMBL631315,,A,10116.0,1,,,9285
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5862,,50597,,Area under curve for a 2-mpk po dose in SD rats,N,,CHEMBL631316,,A,10116.0,1,,,9286
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5862,,50597,,Area under curve in SD rats,N,,CHEMBL631317,,A,10116.0,1,,,9287
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6644,,50597,,Area under curve in rat after oral administration at 13 mg/kg dose,N,,CHEMBL874471,,A,10116.0,1,,,9288
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5871,,50597,,Area under curve in rat by po administration at 0-24 hr,N,,CHEMBL631318,,A,10116.0,1,,,9289
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,5919,,50597,,Area under curve in rat plasma,N,,CHEMBL631319,,A,10116.0,1,,,9290
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5939,,50597,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,N,,CHEMBL631320,,A,10116.0,1,,,9291
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5939,,50597,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,N,,CHEMBL631321,,A,10116.0,1,,,9292
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10,,50597,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,N,,CHEMBL631322,,A,10116.0,1,,,9293
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11149,,50597,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,N,,CHEMBL631323,,A,10116.0,1,,,9294
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5302,,50597,,Area under curve value in rat at a dose of 5 mg/kg,N,,CHEMBL631324,,A,10116.0,1,,,9295
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17796,,50597,,Area under curve was determined after oral administration in rats,N,,CHEMBL631325,,A,10116.0,1,,,9296
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4890,,50597,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,,CHEMBL631326,,A,10116.0,1,,,9297
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6011,,50597,,Area under curve was determined after peroral administration in rat,N,,CHEMBL631327,,A,10116.0,1,,,9298
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5375,,50597,,Area under curve was determined at a dose 30 mpk administered orally.,N,,CHEMBL631328,,A,10116.0,1,,,9299
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17764,,50597,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,N,,CHEMBL631329,,A,10116.0,1,,,9300
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4368,,50597,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,N,,CHEMBL627217,,A,10116.0,1,,,9301
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5610,,50597,,Area under curve was determined in male rat,N,,CHEMBL626352,,A,10116.0,1,,,9302
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5833,,50597,,Area under curve was determined in rat after PO administration,N,,CHEMBL626353,,A,10116.0,1,,,9303
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4257,,50597,,Area under curve was determined in rat after a 3 mg/kg of oral dose,N,,CHEMBL626354,,A,10116.0,1,,,9304
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5937,,50597,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,N,,CHEMBL626355,,A,10116.0,1,,,9305
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5932,,50597,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,N,,CHEMBL626356,,A,10116.0,1,,,9306
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5932,,50597,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,N,,CHEMBL626357,,A,10116.0,1,,,9307
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17411,,50597,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL626358,,A,10116.0,1,,,9308
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17411,,50597,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL626359,,A,10116.0,1,,,9309
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17771,,50597,,Peak plasma concentration in rat at a dose of 3 mg/kg,N,,CHEMBL626360,,A,10116.0,1,,,9310
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1628,,50597,,Plasma concentration at 2 hr in rats was evaluated.,N,,CHEMBL626361,,A,10116.0,1,,,9311
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1628,,50597,,Plasma concentration at 2 hr in rats was evaluated; Not available,N,,CHEMBL626362,,A,10116.0,1,,,9312
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17411,,50597,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL626363,,A,10116.0,1,,,9313
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4910,,50597,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,CHEMBL626970,,A,10116.0,1,,,9314
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4910,,50597,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,CHEMBL626971,,A,10116.0,1,,,9315
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4910,,50597,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,CHEMBL626972,,A,10116.0,1,,,9316
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4910,,50597,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,CHEMBL626973,,A,10116.0,1,,,9317
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4910,,50597,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,CHEMBL626974,,A,10116.0,1,,,9318
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4910,,50597,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,CHEMBL874592,,A,10116.0,1,,,9319
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5510,,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,N,,CHEMBL626975,,A,10116.0,1,,,9320
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5510,,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,N,,CHEMBL626976,,A,10116.0,1,,,9321
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5510,,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,N,,CHEMBL626977,,A,10116.0,1,,,9322
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5510,,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,N,,CHEMBL626978,,A,10116.0,1,,,9323
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16427,,50597,,PK study was carried to determine the relative absorption ranking in rat.,N,,CHEMBL626979,,A,10116.0,1,,,9324
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4689,,50597,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,N,,CHEMBL626980,,A,10116.0,1,,,9325
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",N,,CHEMBL626981,,A,10116.0,1,,,9326
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",N,,CHEMBL626982,,A,10116.0,1,,,9327
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",N,,CHEMBL626983,,A,10116.0,1,,,9328
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",N,,CHEMBL622522,,A,10116.0,1,,,9329
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",N,,CHEMBL622523,,A,10116.0,1,,,9330
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",N,,CHEMBL622524,,A,10116.0,1,,,9331
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",N,,CHEMBL622525,,A,10116.0,1,,,9332
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",N,,CHEMBL622526,,A,10116.0,1,,,9333
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",N,,CHEMBL619849,,A,10116.0,1,,,9334
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",N,,CHEMBL619850,,A,10116.0,1,,,9335
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",N,,CHEMBL623864,,A,10116.0,1,,,9336
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",N,,CHEMBL623865,,A,10116.0,1,,,9337
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",N,,CHEMBL623866,,A,10116.0,1,,,9338
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",N,,CHEMBL623867,,A,10116.0,1,,,9339
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",N,,CHEMBL877615,,A,10116.0,1,,,9340
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",N,,CHEMBL623868,,A,10116.0,1,,,9341
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",N,,CHEMBL623869,,A,10116.0,1,,,9342
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",N,,CHEMBL623870,,A,10116.0,1,,,9343
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16434,,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL623871,,A,10116.0,1,,,9344
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16434,,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL623872,,A,10116.0,1,,,9345
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL622129,,A,10116.0,1,,,9346
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL622130,,A,10116.0,1,,,9347
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL622131,,A,10116.0,1,,,9348
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL622132,,A,10116.0,1,,,9349
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL622133,,A,10116.0,1,,,9350
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL622134,,A,10116.0,1,,,9351
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,CHEMBL622135,,A,10116.0,1,,,9352
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,16435,,50597,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,CHEMBL622136,,A,10116.0,1,,,9353
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16434,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL622137,,A,10116.0,1,,,9354
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16434,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,CHEMBL622138,,A,10116.0,1,,,9355
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16434,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL623017,,A,10116.0,1,,,9356
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16434,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL623018,,A,10116.0,1,,,9357
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16434,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,CHEMBL623019,,A,10116.0,1,,,9358
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16434,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,CHEMBL623020,,A,10116.0,1,,,9359
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16434,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,N,,CHEMBL623021,,A,10116.0,1,,,9360
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16434,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,,CHEMBL623022,,A,10116.0,1,,,9361
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,CHEMBL623023,,A,10116.0,1,,,9362
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,CHEMBL623024,,A,10116.0,1,,,9363
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,CHEMBL623025,,A,10116.0,1,,,9364
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,CHEMBL620545,,A,10116.0,1,,,9365
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,CHEMBL620546,,A,10116.0,1,,,9366
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,CHEMBL620547,,A,10116.0,1,,,9367
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,CHEMBL620548,,A,10116.0,1,,,9368
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,CHEMBL620549,,A,10116.0,1,,,9369
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16434,,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL620550,,A,10116.0,1,,,9370
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16434,,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL620551,,A,10116.0,1,,,9371
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16434,,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL620552,,A,10116.0,1,,,9372
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL620553,,A,10116.0,1,,,9373
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL620554,,A,10116.0,1,,,9374
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL875845,,A,10116.0,1,,,9375
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL620555,,A,10116.0,1,,,9376
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL620556,,A,10116.0,1,,,9377
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,16435,,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL620557,,A,10116.0,1,,,9378
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL620558,,A,10116.0,1,,,9379
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,CHEMBL620559,,A,10116.0,1,,,9380
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL622939,,A,10116.0,1,,,9381
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL622940,,A,10116.0,1,,,9382
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,CHEMBL622941,,A,10116.0,1,,,9383
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,CHEMBL622942,,A,10116.0,1,,,9384
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,CHEMBL622943,,A,10116.0,1,,,9385
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,CHEMBL622944,,A,10116.0,1,,,9386
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,CHEMBL622945,,A,10116.0,1,,,9387
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,CHEMBL622946,,A,10116.0,1,,,9388
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3341,,50597,,Compound was evaluated for terminal half life in rat,N,,CHEMBL622947,,A,10116.0,1,,,9389
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,3634,,50597,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,N,,CHEMBL622948,,A,10116.0,1,,,9390
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,3634,,50597,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,N,,CHEMBL622949,,A,10116.0,1,,,9391
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4839,,50597,,Compound was tested for its half life in rat,N,,CHEMBL622950,,A,10116.0,1,,,9392
,0,BAO_0000218,In vivo,Macaca mulatta,Plasma,1969.0,Intermediate,5005,,22224,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,U,,CHEMBL622951,,A,9544.0,1,,,9393
,0,BAO_0000366,,Rattus norvegicus,Plasma,1969.0,Intermediate,5005,,22224,,Compound was tested for its plasma half life in Sprague Dawley rats,U,,CHEMBL622952,,A,10116.0,1,,,9394
,0,BAO_0000366,,Rattus norvegicus,Plasma,1969.0,Intermediate,5005,,22224,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,U,,CHEMBL622953,,A,10116.0,1,,,9395
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1094,,50597,,Compound was tested for plasma half-life period in rat,N,,CHEMBL873818,,A,10116.0,1,,,9396
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5031,,50597,,Elimination half life after i.v. administration of compound in rats,N,,CHEMBL622954,,A,10116.0,1,,,9397
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,N,,CHEMBL622955,,A,10116.0,1,,,9398
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Elimination half-life after IV dosing at 1 mg/kg in rat,N,,CHEMBL875229,,A,10116.0,1,,,9399
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,N,,CHEMBL622956,,A,10116.0,1,,,9400
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,N,,CHEMBL622957,,A,10116.0,1,,,9401
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,5408,,50597,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,,CHEMBL622958,,A,10116.0,1,,,9402
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5408,,50597,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,,CHEMBL622959,,A,10116.0,1,,,9403
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,5408,,50597,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,,CHEMBL622960,,A,10116.0,1,,,9404
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5408,,50597,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,,CHEMBL622961,,A,10116.0,1,,,9405
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4687,,50597,,Evaluated for the half life in rat (in vivo),N,,CHEMBL622962,,A,10116.0,1,,,9406
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6640,,50597,,Hafl life in rat,N,,CHEMBL622963,,A,10116.0,1,,,9407
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6640,,50597,,Hafl life rat,N,,CHEMBL622964,,A,10116.0,1,,,9408
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6641,,50597,,Hafl life rat,N,,CHEMBL622965,,A,10116.0,1,,,9409
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6640,,50597,,Hafl life rat; Not determined,N,,CHEMBL622966,,A,10116.0,1,,,9410
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6641,,50597,,Hafl life rat; Not determined,N,,CHEMBL622967,,A,10116.0,1,,,9411
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,17411,,50597,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL622968,,A,10116.0,1,,,9412
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,17411,,50597,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL622969,,A,10116.0,1,,,9413
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,17411,,50597,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL875327,,A,10116.0,1,,,9414
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6570,,50597,,Half life in rat after 1 mg/kg i.v. administration,N,,CHEMBL628638,,A,10116.0,1,,,9415
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6570,,50597,,Half life in rat after 2 mg/kg peroral administration,N,,CHEMBL628639,,A,10116.0,1,,,9416
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17411,,50597,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL625840,,A,10116.0,1,,,9417
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4722,,50597,,Half life of 10 mg/kg oral dose determined in rats,N,,CHEMBL625841,,A,10116.0,1,,,9418
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL625842,,A,10116.0,1,,,9419
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL625843,,A,10116.0,1,,,9420
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL625844,,A,10116.0,1,,,9421
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL873822,,A,10116.0,1,,,9422
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL625845,,A,10116.0,1,,,9423
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL627059,,A,10116.0,1,,,9424
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL627060,,A,10116.0,1,,,9425
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,CHEMBL627061,,A,10116.0,1,,,9426
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4762,,50597,,Half life of compound at 5 mg/kg after po administration was determined in rat,N,,CHEMBL627709,,A,10116.0,1,,,9427
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5327,,50597,,Half life of compound determined after intravenous administration to rat,N,,CHEMBL627710,,A,10116.0,1,,,9428
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4847,,50597,,Half life of compound was determined in rat,N,,CHEMBL627711,,A,10116.0,1,,,9429
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17720,,50597,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,CHEMBL627712,,A,10116.0,1,,,9430
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4723,,50597,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL627713,,A,10116.0,1,,,9431
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4723,,50597,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL627714,,A,10116.0,1,,,9432
,0,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,4256,,22224,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,U,,CHEMBL627889,,A,9541.0,1,,,9433
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4256,,22224,,Half life determined in rat by intravenous administration,U,,CHEMBL627890,,A,10116.0,1,,,9434
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4722,,50597,,Half life determined in rats after iv administration,N,,CHEMBL627891,,A,10116.0,1,,,9435
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6535,,50597,,Half life in rat plasma after administration of 2 mg/kg iv,N,,CHEMBL627892,,A,10116.0,1,,,9436
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6535,,50597,,Half life in rat plasma after administration of 2 mg/kg iv,N,,CHEMBL627893,,A,10116.0,1,,,9437
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1435,,50597,,Half life in rat plasma was determined,N,,CHEMBL627894,,A,10116.0,1,,,9438
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1435,,50597,,Half life in rat plasma was determined; NA means not applicable,N,,CHEMBL627895,,A,10116.0,1,,,9439
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5206,,50597,,Half life in rat was tested,N,,CHEMBL627896,,A,10116.0,1,,,9440
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6080,,50597,,Half life measured in rat plasma,N,,CHEMBL627897,,A,10116.0,1,,,9441
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4449,,50597,,Half life recorded in rats,N,,CHEMBL627898,,A,10116.0,1,,,9442
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6057,,50597,,Half life was calculated,N,,CHEMBL627899,,A,10116.0,1,,,9443
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6057,,50597,,Half life was calculated in rat,N,,CHEMBL873823,,A,10116.0,1,,,9444
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3747,,50597,,Half life was determined,N,,CHEMBL627900,,A,10116.0,1,,,9445
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17858,,50597,,Half life after 10 mg/kg oral administration in rat,N,,CHEMBL627901,,A,10116.0,1,,,9446
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,N,,CHEMBL627902,,A,10116.0,1,,,9447
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Half life after administering orally a dose of 30 mg/kg,N,,CHEMBL627903,,A,10116.0,1,,,9448
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5031,,50597,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,N,,CHEMBL627904,,A,10116.0,1,,,9449
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4722,,50597,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,N,,CHEMBL627905,,A,10116.0,1,,,9450
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6078,,50597,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,N,,CHEMBL627906,,A,10116.0,1,,,9451
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6078,,50597,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,N,,CHEMBL627907,,A,10116.0,1,,,9452
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6078,,50597,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,N,,CHEMBL876783,,A,10116.0,1,,,9453
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6078,,50597,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,N,,CHEMBL627908,,A,10116.0,1,,,9454
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17065,,50597,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,CHEMBL627909,,A,10116.0,1,,,9455
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1353,,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,N,,CHEMBL627910,,A,10116.0,1,,,9456
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1353,,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),N,,CHEMBL627911,,A,10116.0,1,,,9457
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1353,,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),N,,CHEMBL627912,,A,10116.0,1,,,9458
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1353,,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),N,,CHEMBL627913,,A,10116.0,1,,,9459
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1353,,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),N,,CHEMBL627914,,A,10116.0,1,,,9460
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16423,,50597,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,N,,CHEMBL627915,,A,10116.0,1,,,9461
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16423,,50597,,Area under the curve was evaluated after 20 uM/kg of peroral administration,N,,CHEMBL627916,,A,10116.0,1,,,9462
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6062,,50597,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,N,,CHEMBL627917,,A,10116.0,1,,,9463
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6056,,50597,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,N,,CHEMBL627918,,A,10116.0,1,,,9464
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5182,,50597,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,N,,CHEMBL627919,,A,10116.0,1,,,9465
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6410,,50597,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,N,,CHEMBL627920,,A,10116.0,1,,,9466
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6410,,50597,,Area under the curve was evaluated at an oral dose of 30 mg/kg,N,,CHEMBL627921,,A,10116.0,1,,,9467
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4723,,50597,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL627922,,A,10116.0,1,,,9468
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4723,,50597,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL876784,,A,10116.0,1,,,9469
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4723,,50597,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL627923,,A,10116.0,1,,,9470
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4723,,50597,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL626208,,A,10116.0,1,,,9471
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4723,,50597,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL626209,,A,10116.0,1,,,9472
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4723,,50597,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL626210,,A,10116.0,1,,,9473
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,2463,,50597,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,,CHEMBL627994,,A,10116.0,1,,,9474
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4709,,50597,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,N,,CHEMBL627995,,A,10116.0,1,,,9475
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4075,,50597,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,N,,CHEMBL627996,,A,10116.0,1,,,9476
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5394,,50597,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,N,,CHEMBL627997,,A,10116.0,1,,,9477
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,N,,CHEMBL627998,,A,10116.0,1,,,9478
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,N,,CHEMBL628640,,A,10116.0,1,,,9479
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,N,,CHEMBL628641,,A,10116.0,1,,,9480
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,N,,CHEMBL628642,,A,10116.0,1,,,9481
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17791,,50597,,Compound was evaluated for area under the curve expressed as (h*ug/ml),N,,CHEMBL628643,,A,10116.0,1,,,9482
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2591,,50597,,Compound was tested for area under curve in rat,N,,CHEMBL628644,,A,10116.0,1,,,9483
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6567,,50597,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,N,,CHEMBL628645,,A,10116.0,1,,,9484
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6211,,50597,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,,CHEMBL628646,,A,10116.0,1,,,9485
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5529,,50597,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),N,,CHEMBL628647,,A,10116.0,1,,,9486
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5408,,50597,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,,CHEMBL628648,,A,10116.0,1,,,9487
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5408,,50597,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,,CHEMBL625358,,A,10116.0,1,,,9488
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5408,,50597,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,,CHEMBL625359,,A,10116.0,1,,,9489
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5408,,50597,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,,CHEMBL625360,,A,10116.0,1,,,9490
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,429,,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),N,,CHEMBL625361,,A,10116.0,1,,,9491
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,429,,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),N,,CHEMBL625362,,A,10116.0,1,,,9492
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,429,,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),N,,CHEMBL625363,,A,10116.0,1,,,9493
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4796,,50597,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,,CHEMBL625364,,A,10116.0,1,,,9494
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL625365,,A,10116.0,1,,,9495
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL625366,,A,10116.0,1,,,9496
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL625367,,A,10116.0,1,,,9497
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",N,,CHEMBL625368,,A,10116.0,1,,,9498
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",N,,CHEMBL625369,,A,10116.0,1,,,9499
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",N,,CHEMBL625370,,A,10116.0,1,,,9500
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",N,,CHEMBL625371,,A,10116.0,1,,,9501
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",N,,CHEMBL625372,,A,10116.0,1,,,9502
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",N,,CHEMBL625373,,A,10116.0,1,,,9503
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",N,,CHEMBL625374,,A,10116.0,1,,,9504
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",N,,CHEMBL877593,,A,10116.0,1,,,9505
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",N,,CHEMBL625375,,A,10116.0,1,,,9506
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",N,,CHEMBL625376,,A,10116.0,1,,,9507
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",N,,CHEMBL621973,,A,10116.0,1,,,9508
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",N,,CHEMBL621974,,A,10116.0,1,,,9509
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",N,,CHEMBL621975,,A,10116.0,1,,,9510
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",N,,CHEMBL622166,,A,10116.0,1,,,9511
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",N,,CHEMBL622167,,A,10116.0,1,,,9512
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",N,,CHEMBL622168,,A,10116.0,1,,,9513
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",N,,CHEMBL622169,,A,10116.0,1,,,9514
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",N,,CHEMBL622170,,A,10116.0,1,,,9515
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",N,,CHEMBL622171,,A,10116.0,1,,,9516
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",N,,CHEMBL622172,,A,10116.0,1,,,9517
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",N,,CHEMBL622173,,A,10116.0,1,,,9518
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",N,,CHEMBL622174,,A,10116.0,1,,,9519
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",N,,CHEMBL622175,,A,10116.0,1,,,9520
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",N,,CHEMBL622176,,A,10116.0,1,,,9521
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",N,,CHEMBL622177,,A,10116.0,1,,,9522
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",N,,CHEMBL622178,,A,10116.0,1,,,9523
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",N,,CHEMBL622179,,A,10116.0,1,,,9524
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",N,,CHEMBL622180,,A,10116.0,1,,,9525
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,CHEMBL622181,,A,10116.0,1,,,9526
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,CHEMBL622182,,A,10116.0,1,,,9527
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,CHEMBL622183,,A,10116.0,1,,,9528
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,CHEMBL622184,,A,10116.0,1,,,9529
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,CHEMBL622185,,A,10116.0,1,,,9530
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,CHEMBL622186,,A,10116.0,1,,,9531
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL622187,,A,10116.0,1,,,9532
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL625002,,A,10116.0,1,,,9533
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL622090,,A,10116.0,1,,,9534
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL622091,,A,10116.0,1,,,9535
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL622092,,A,10116.0,1,,,9536
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL622093,,A,10116.0,1,,,9537
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL622094,,A,10116.0,1,,,9538
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL622095,,A,10116.0,1,,,9539
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL622264,,A,10116.0,1,,,9540
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16434,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL622265,,A,10116.0,1,,,9541
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16434,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,CHEMBL622266,,A,10116.0,1,,,9542
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16434,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL622267,,A,10116.0,1,,,9543
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16434,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL622268,,A,10116.0,1,,,9544
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16434,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,CHEMBL622269,,A,10116.0,1,,,9545
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16434,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,CHEMBL625071,,A,10116.0,1,,,9546
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16434,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,CHEMBL621621,,A,10116.0,1,,,9547
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16434,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,CHEMBL621622,,A,10116.0,1,,,9548
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,CHEMBL621623,,A,10116.0,1,,,9549
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,CHEMBL621624,,A,10116.0,1,,,9550
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,CHEMBL621625,,A,10116.0,1,,,9551
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,CHEMBL621626,,A,10116.0,1,,,9552
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,CHEMBL621627,,A,10116.0,1,,,9553
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,CHEMBL621628,,A,10116.0,1,,,9554
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,CHEMBL875328,,A,10116.0,1,,,9555
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,CHEMBL621629,,A,10116.0,1,,,9556
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16434,,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL621630,,A,10116.0,1,,,9557
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16434,,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL621631,,A,10116.0,1,,,9558
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16434,,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL621632,,A,10116.0,1,,,9559
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL621633,,A,10116.0,1,,,9560
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL621634,,A,10116.0,1,,,9561
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL621635,,A,10116.0,1,,,9562
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL621636,,A,10116.0,1,,,9563
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL621637,,A,10116.0,1,,,9564
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,16435,,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL621638,,A,10116.0,1,,,9565
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL618883,,A,10116.0,1,,,9566
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,CHEMBL618884,,A,10116.0,1,,,9567
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL628627,,A,10116.0,1,,,9568
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL628628,,A,10116.0,1,,,9569
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,CHEMBL628629,,A,10116.0,1,,,9570
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Half life after administering orally a dose of 3 mg/kg,N,,CHEMBL628630,,A,10116.0,1,,,9571
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,N,,CHEMBL628631,,A,10116.0,1,,,9572
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Half life after administering intravenously a dose of 1 mg/kg,N,,CHEMBL628632,,A,10116.0,1,,,9573
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,526,,50597,,Half life after oral dosing in rats,N,,CHEMBL628633,,A,10116.0,1,,,9574
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,N,,CHEMBL628634,,A,10116.0,1,,,9575
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4368,,50597,,Half life by intravenous administration of 3.4 mg/kg in rat,N,,CHEMBL627789,,A,10116.0,1,,,9576
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3371,,50597,,Half life in rat,N,,CHEMBL627790,,A,10116.0,1,,,9577
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6448,,50597,,Half life in rat,N,,CHEMBL627791,,A,10116.0,1,,,9578
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6453,,50597,,Half life in rat,N,,CHEMBL627792,,A,10116.0,1,,,9579
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4353,,50597,,Half life in rat after intravenous administration of the compound,N,,CHEMBL627793,,A,10116.0,1,,,9580
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4353,,50597,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,N,,CHEMBL627794,,A,10116.0,1,,,9581
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4353,,50597,,Half life in rat after po administration of the compound,N,,CHEMBL627795,,A,10116.0,1,,,9582
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4353,,50597,,Half life in rat after po administration of the compound; ND means Not determined,N,,CHEMBL627796,,A,10116.0,1,,,9583
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4353,,50597,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,N,,CHEMBL875335,,A,10116.0,1,,,9584
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4353,,50597,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,N,,CHEMBL627797,,A,10116.0,1,,,9585
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5789,,50597,,Half life in rat i.v.,N,,CHEMBL627798,,A,10116.0,1,,,9586
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17686,,50597,,Half life in rat i.v. at 2 mg/kg concentration,N,,CHEMBL627799,,A,10116.0,1,,,9587
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6495,,50597,,Half life in rats,N,,CHEMBL627800,,A,10116.0,1,,,9588
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,484,,50597,,Half life in rats after intravenous administration,N,,CHEMBL627801,,A,10116.0,1,,,9589
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6467,,50597,,Half life in rats at the dose of 1.0 mpk by i.v. administration,N,,CHEMBL627802,,A,10116.0,1,,,9590
,1,BAO_0000218,,Rattus norvegicus,,,Expert,6642,,50597,,Half life in rat,N,,CHEMBL627803,,A,10116.0,1,,,9591
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16367,,50597,,Half life was evaluated after intravenous administration to rats,N,,CHEMBL873820,,A,10116.0,1,,,9592
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1369,,50597,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),N,,CHEMBL627804,,A,10116.0,1,,,9593
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5472,,50597,,Half life was evaluated in rat,N,,CHEMBL627805,,A,10116.0,1,,,9594
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6049,,50597,,Half life was evaluated in rat,N,,CHEMBL627806,,A,10116.0,1,,,9595
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5472,,50597,,Half life was evaluated in rat; Not tested,N,,CHEMBL627107,,A,10116.0,1,,,9596
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16366,,50597,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,N,,CHEMBL627108,,A,10116.0,1,,,9597
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,11149,,50597,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,N,,CHEMBL627109,,A,10116.0,1,,,9598
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,11149,,50597,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,N,,CHEMBL627110,,A,10116.0,1,,,9599
,0,BAO_0000218,In vivo,Primates,,,Intermediate,2891,,22224,,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,,CHEMBL627111,,A,9443.0,1,,,9600
,0,BAO_0000218,In vivo,Primates,,,Intermediate,2891,,22224,,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,,CHEMBL627112,,A,9443.0,1,,,9601
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2891,,22224,,Half life was measured in rat at dose of 30 mg/kg by iv administration,U,,CHEMBL627113,,A,10116.0,1,,,9602
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2891,,22224,,Half life was measured in rat at dose of 30 mg/kg by po administration,U,,CHEMBL627114,,A,10116.0,1,,,9603
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4026,,50597,,Half life (t1/2) was determined,N,,CHEMBL627115,,A,10116.0,1,,,9604
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4527,,50597,,Half life period at a dose of 10 uM/kg in rat was determined,N,,CHEMBL627116,,A,10116.0,1,,,9605
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4527,,50597,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,N,,CHEMBL627117,,A,10116.0,1,,,9606
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5503,,50597,,Half life period was determined,N,,CHEMBL627118,,A,10116.0,1,,,9607
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4426,,50597,,Half life period after intravenous administration at 20 mpk in rats,N,,CHEMBL627119,,A,10116.0,1,,,9608
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4426,,50597,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,N,,CHEMBL627120,,A,10116.0,1,,,9609
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6109,,50597,,Half life period after intravenous administration in rat,N,,CHEMBL626922,,A,10116.0,1,,,9610
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5654,,50597,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,CHEMBL626923,,A,10116.0,1,,,9611
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5654,,50597,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,CHEMBL626924,,A,10116.0,1,,,9612
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4755,,50597,,Half life period in 80% rat plasma at 37 degree Centigrade,N,,CHEMBL626925,,A,10116.0,1,,,9613
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5862,,50597,,Half life period in SD rats,N,,CHEMBL626926,,A,10116.0,1,,,9614
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1515,,50597,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),N,,CHEMBL626927,,A,10116.0,1,,,9615
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1515,,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),N,,CHEMBL626928,,A,10116.0,1,,,9616
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1515,,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,CHEMBL626929,,A,10116.0,1,,,9617
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1515,,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,CHEMBL626930,,A,10116.0,1,,,9618
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5960,,50597,,Half life period in rat,N,,CHEMBL626931,,A,10116.0,1,,,9619
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6103,,50597,,Half life period in rat,N,,CHEMBL626932,,A,10116.0,1,,,9620
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6317,,50597,,Half life period in rat,N,,CHEMBL626933,,A,10116.0,1,,,9621
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6644,,50597,,Half life period in rat after oral administration at 10.5 mg/kg dose,N,,CHEMBL873826,,A,10116.0,1,,,9622
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6644,,50597,,Half life period in rat after oral administration at 11.2 mg/kg dose,N,,CHEMBL626934,,A,10116.0,1,,,9623
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6644,,50597,,Half life period in rat after oral administration at 13 mg/kg dose,N,,CHEMBL626935,,A,10116.0,1,,,9624
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6644,,50597,,Half life period in rat after oral administration at 9.7 mg/kg dose,N,,CHEMBL626936,,A,10116.0,1,,,9625
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL626937,,A,10116.0,1,,,9626
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6295,,50597,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,,CHEMBL625906,,A,10116.0,1,,,9627
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6296,,50597,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,,CHEMBL625907,,A,10116.0,1,,,9628
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16427,,50597,,PK study was carried to determine AUC (area under curve) value in rat,N,,CHEMBL625908,,A,10116.0,1,,,9629
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16367,,50597,,Pharmacokinetic parameter AUC after intravenous administration to rats,N,,CHEMBL625909,,A,10116.0,1,,,9630
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16367,,50597,,Pharmacokinetic parameter AUC after oral administration to rats,N,,CHEMBL625910,,A,10116.0,1,,,9631
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16365,,50597,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,N,,CHEMBL625911,,A,10116.0,1,,,9632
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16365,,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,N,,CHEMBL625912,,A,10116.0,1,,,9633
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16365,,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,N,,CHEMBL626538,,A,10116.0,1,,,9634
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16365,,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,N,,CHEMBL876794,,A,10116.0,1,,,9635
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16365,,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,N,,CHEMBL626539,,A,10116.0,1,,,9636
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16365,,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,N,,CHEMBL626540,,A,10116.0,1,,,9637
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5394,,50597,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,N,,CHEMBL626541,,A,10116.0,1,,,9638
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5394,,50597,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,N,,CHEMBL626542,,A,10116.0,1,,,9639
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2792,,50597,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,N,,CHEMBL626543,,A,10116.0,1,,,9640
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2792,,50597,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,N,,CHEMBL626544,,A,10116.0,1,,,9641
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2792,,50597,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,N,,CHEMBL626545,,A,10116.0,1,,,9642
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2792,,50597,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,N,,CHEMBL626546,,A,10116.0,1,,,9643
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5334,,50597,,Pharmacokinetic parameter area under curve was reported,N,,CHEMBL626547,,A,10116.0,1,,,9644
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4408,,50597,,Pharmacokinetic property (AUC) in rat,N,,CHEMBL626548,,A,10116.0,1,,,9645
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5983,,50597,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,N,,CHEMBL626549,,A,10116.0,1,,,9646
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4397,,50597,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,N,,CHEMBL626550,,A,10116.0,1,,,9647
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4397,,50597,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,N,,CHEMBL626551,,A,10116.0,1,,,9648
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5491,,50597,,Pharmacokinetic property was determined,N,,CHEMBL623777,,A,10116.0,1,,,9649
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5491,,50597,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,N,,CHEMBL623778,,A,10116.0,1,,,9650
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5491,,50597,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,N,,CHEMBL623779,,A,10116.0,1,,,9651
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4199,,50597,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,,CHEMBL623780,,A,10116.0,1,,,9652
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4199,,50597,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,N,,CHEMBL622015,,A,10116.0,1,,,9653
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4199,,50597,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,N,,CHEMBL622016,,A,10116.0,1,,,9654
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5173,,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",N,,CHEMBL622017,,A,10116.0,1,,,9655
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5173,,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",N,,CHEMBL622018,,A,10116.0,1,,,9656
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5173,,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",N,,CHEMBL622019,,A,10116.0,1,,,9657
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5173,,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",N,,CHEMBL622020,,A,10116.0,1,,,9658
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16366,,50597,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,N,,CHEMBL622021,,A,10116.0,1,,,9659
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16366,,50597,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,N,,CHEMBL622022,,A,10116.0,1,,,9660
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5327,,50597,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,N,,CHEMBL622023,,A,10116.0,1,,,9661
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6681,,50597,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,N,,CHEMBL622024,,A,10116.0,1,,,9662
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12873,,50597,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),N,,CHEMBL622693,,A,10116.0,1,,,9663
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12873,,50597,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),N,,CHEMBL622694,,A,10116.0,1,,,9664
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6685,,50597,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,,CHEMBL622695,,A,10116.0,1,,,9665
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6685,,50597,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,,CHEMBL622696,,A,10116.0,1,,,9666
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6685,,50597,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",N,,CHEMBL622697,,A,10116.0,1,,,9667
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6619,,50597,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",N,,CHEMBL622874,,A,10116.0,1,,,9668
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6619,,50597,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",N,,CHEMBL622875,,A,10116.0,1,,,9669
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10363,,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,,CHEMBL622876,,A,10116.0,1,,,9670
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4796,,50597,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,,CHEMBL622877,,A,10116.0,1,,,9671
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4910,,50597,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,,CHEMBL622878,,A,10116.0,1,,,9672
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4910,,50597,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,N,,CHEMBL622879,,A,10116.0,1,,,9673
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4839,,50597,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,N,,CHEMBL877602,,A,10116.0,1,,,9674
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15078,,50597,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL622880,,A,10116.0,1,,,9675
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15078,,50597,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL622881,,A,10116.0,1,,,9676
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15078,,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL622882,,A,10116.0,1,,,9677
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15078,,50597,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL622883,,A,10116.0,1,,,9678
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",N,,CHEMBL622884,,A,10116.0,1,,,9679
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,11450,,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",N,,CHEMBL622885,,A,10116.0,1,,,9680
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8151,,50597,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,,CHEMBL622886,,A,10116.0,1,,,9681
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8151,,50597,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,,CHEMBL622887,,A,10116.0,1,,,9682
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8151,,50597,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,,CHEMBL622888,,A,10116.0,1,,,9683
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622889,,A,10116.0,1,,,9684
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622890,,A,10116.0,1,,,9685
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622891,,A,10116.0,1,,,9686
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL877603,,A,10116.0,1,,,9687
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622892,,A,10116.0,1,,,9688
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622893,,A,10116.0,1,,,9689
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622894,,A,10116.0,1,,,9690
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622895,,A,10116.0,1,,,9691
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,8677,,50597,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,N,,CHEMBL622896,,A,10116.0,1,,,9692
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622897,,A,10116.0,1,,,9693
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622898,,A,10116.0,1,,,9694
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622899,,A,10116.0,1,,,9695
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622900,,A,10116.0,1,,,9696
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL624114,,A,10116.0,1,,,9697
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL624115,,A,10116.0,1,,,9698
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL624116,,A,10116.0,1,,,9699
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL624117,,A,10116.0,1,,,9700
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL624118,,A,10116.0,1,,,9701
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL624119,,A,10116.0,1,,,9702
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL624120,,A,10116.0,1,,,9703
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL624121,,A,10116.0,1,,,9704
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL624122,,A,10116.0,1,,,9705
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL624123,,A,10116.0,1,,,9706
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL624124,,A,10116.0,1,,,9707
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL624125,,A,10116.0,1,,,9708
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL624126,,A,10116.0,1,,,9709
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL624127,,A,10116.0,1,,,9710
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL624128,,A,10116.0,1,,,9711
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL624129,,A,10116.0,1,,,9712
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL624130,,A,10116.0,1,,,9713
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622340,,A,10116.0,1,,,9714
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622341,,A,10116.0,1,,,9715
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622342,,A,10116.0,1,,,9716
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622343,,A,10116.0,1,,,9717
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622344,,A,10116.0,1,,,9718
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622345,,A,10116.0,1,,,9719
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622346,,A,10116.0,1,,,9720
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622347,,A,10116.0,1,,,9721
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622348,,A,10116.0,1,,,9722
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622349,,A,10116.0,1,,,9723
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,CHEMBL622350,,A,10116.0,1,,,9724
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,CHEMBL622351,,A,10116.0,1,,,9725
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,CHEMBL622352,,A,10116.0,1,,,9726
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,CHEMBL622353,,A,10116.0,1,,,9727
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,CHEMBL622354,,A,10116.0,1,,,9728
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,CHEMBL622355,,A,10116.0,1,,,9729
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,CHEMBL622356,,A,10116.0,1,,,9730
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,CHEMBL622357,,A,10116.0,1,,,9731
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,CHEMBL622358,,A,10116.0,1,,,9732
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,CHEMBL622359,,A,10116.0,1,,,9733
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,CHEMBL874393,,A,10116.0,1,,,9734
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL622872,,A,10116.0,1,,,9735
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL622873,,A,10116.0,1,,,9736
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL623047,,A,10116.0,1,,,9737
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL623048,,A,10116.0,1,,,9738
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL623049,,A,10116.0,1,,,9739
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL623050,,A,10116.0,1,,,9740
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL623051,,A,10116.0,1,,,9741
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL623052,,A,10116.0,1,,,9742
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL626343,,A,10116.0,1,,,9743
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,CHEMBL626344,,A,10116.0,1,,,9744
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,CHEMBL626345,,A,10116.0,1,,,9745
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,CHEMBL626346,,A,10116.0,1,,,9746
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,CHEMBL626347,,A,10116.0,1,,,9747
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,CHEMBL626348,,A,10116.0,1,,,9748
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16434,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,CHEMBL626349,,A,10116.0,1,,,9749
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,CHEMBL626350,,F,10116.0,1,,,9750
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,CHEMBL626351,,A,10116.0,1,,,9751
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,CHEMBL627650,,A,10116.0,1,,,9752
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,CHEMBL627651,,F,10116.0,1,,,9753
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,CHEMBL627652,,A,10116.0,1,,,9754
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16435,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,CHEMBL627653,,A,10116.0,1,,,9755
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,N,,CHEMBL627654,,A,10116.0,1,,,9756
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,N,,CHEMBL627835,,A,10116.0,1,,,9757
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,N,,CHEMBL627836,,A,10116.0,1,,,9758
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,N,,CHEMBL627837,,A,10116.0,1,,,9759
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,N,,CHEMBL627838,,A,10116.0,1,,,9760
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,N,,CHEMBL875338,,A,10116.0,1,,,9761
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,N,,CHEMBL627839,,A,10116.0,1,,,9762
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,N,,CHEMBL627840,,A,10116.0,1,,,9763
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,N,,CHEMBL627841,,A,10116.0,1,,,9764
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,N,,CHEMBL627842,,A,10116.0,1,,,9765
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,N,,CHEMBL627843,,A,10116.0,1,,,9766
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,N,,CHEMBL627844,,A,10116.0,1,,,9767
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,N,,CHEMBL627845,,A,10116.0,1,,,9768
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5874,,50597,,Half life period in rat by iv administration at a dose of 3 mg/kg,N,,CHEMBL627846,,A,10116.0,1,,,9769
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1515,,50597,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),N,,CHEMBL627847,,A,10116.0,1,,,9770
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1515,,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),N,,CHEMBL873821,,A,10116.0,1,,,9771
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1515,,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,CHEMBL626079,,A,10116.0,1,,,9772
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1515,,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,CHEMBL626080,,A,10116.0,1,,,9773
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,5491,,50597,,Half life period was evaluated in rat plasma,N,,CHEMBL626081,,A,10116.0,1,,,9774
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,5491,,50597,,Half life period was evaluated in rat plasma; Not tested,N,,CHEMBL875344,,A,10116.0,1,,,9775
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1918,,50597,,Half life period was evaluated in rats,N,,CHEMBL626082,,A,10116.0,1,,,9776
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1918,,50597,,"Half life period was evaluated in rats, iv",N,,CHEMBL626250,,A,10116.0,1,,,9777
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6113,,50597,,Half life period after intravenous administration at 5 mg/kg in rat,N,,CHEMBL626251,,A,10116.0,1,,,9778
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5546,,50597,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,,CHEMBL626252,,A,10116.0,1,,,9779
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5553,,50597,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,N,,CHEMBL626253,,A,10116.0,1,,,9780
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4188,,50597,,Half life stability of compound was evaluated in rat plasma,N,,CHEMBL626254,,A,10116.0,1,,,9781
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6215,,50597,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,N,,CHEMBL626255,,A,10116.0,1,,,9782
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6141,,50597,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,,CHEMBL626256,,A,10116.0,1,,,9783
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5182,,50597,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,,CHEMBL626257,,A,10116.0,1,,,9784
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5182,,50597,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,N,,CHEMBL626258,,A,10116.0,1,,,9785
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5710,,50597,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,N,,CHEMBL626259,,A,10116.0,1,,,9786
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5789,,50597,,Half in rat i.v.,N,,CHEMBL626260,,A,10116.0,1,,,9787
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6011,,50597,,Half period in rat after intravenous administration,N,,CHEMBL875345,,A,10116.0,1,,,9788
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17594,,50597,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,N,,CHEMBL626261,,A,10116.0,1,,,9789
,1,BAO_0000218,In vitro,Rattus norvegicus,Liver,2107.0,Intermediate,12357,,50597,,Half-life measured in in vitro Cathepsin B assay in rat liver,N,,CHEMBL626262,,A,10116.0,1,,,9790
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5210,,50597,,Half-life of compound was determined in rats,N,,CHEMBL626263,,A,10116.0,1,,,9791
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17596,,50597,,Half-life at 10 mg/kg in rat upon intravenous administration,N,,CHEMBL625270,,A,10116.0,1,,,9792
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6672,,50597,,Half-life determined in rat,N,,CHEMBL625271,,A,10116.0,1,,,9793
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6673,,50597,,Half-life determined in rat,N,,CHEMBL625272,,A,10116.0,1,,,9794
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,4910,,50597,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,N,,CHEMBL625273,,A,10116.0,1,,,9795
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,3741,,50597,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",N,,CHEMBL625274,,A,10116.0,1,,,9796
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17671,,50597,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,CHEMBL625275,,A,10116.0,1,,,9797
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4910,,50597,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,N,,CHEMBL625276,,A,10116.0,1,,,9798
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17537,,50597,,Half-life in rat plasma,N,,CHEMBL625277,,A,10116.0,1,,,9799
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4965,,50597,,Half-life in rat plasma was determined,N,,CHEMBL625278,,A,10116.0,1,,,9800
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17537,,50597,,Half-life in rat plasma; Not tested,N,,CHEMBL625279,,A,10116.0,1,,,9801
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,6124,,50597,,Half-life in rat serum,N,,CHEMBL625280,,A,10116.0,1,,,9802
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,6124,,50597,,Half-life in rat serum; na is not available,N,,CHEMBL876797,,A,10116.0,1,,,9803
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6078,,50597,,Half-life was calculated in rat,N,,CHEMBL625281,,A,10116.0,1,,,9804
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17668,,50597,,Half-life was calculated in rat plasma,N,,CHEMBL873827,,A,10116.0,1,,,9805
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3185,,50597,,Half-life was determined,N,,CHEMBL625282,,A,10116.0,1,,,9806
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4883,,50597,,Half-life was determined,N,,CHEMBL625283,,A,10116.0,1,,,9807
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2959,,50597,,Half-life after administration of 20 mg/Kg oral dose in rat,N,,CHEMBL625284,,A,10116.0,1,,,9808
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4029,,50597,,Half-life after administration of 3.2 mg/kg intravenously in male rat,N,,CHEMBL625285,,A,10116.0,1,,,9809
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4029,,50597,,Half-life after intravenous administration in female rat,N,,CHEMBL625286,,A,10116.0,1,,,9810
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4029,,50597,,Half-life after intravenous administration in male rat,N,,CHEMBL625287,,A,10116.0,1,,,9811
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6180,,50597,,Half-life after intravenous dose in rat,N,,CHEMBL625288,,A,10116.0,1,,,9812
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,1557,,50597,,Half-life in a rat liver homogenate preparation,N,,CHEMBL625289,,A,10116.0,1,,,9813
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,12500,,50597,,Half-life in plasma of rat,N,,CHEMBL625290,,A,10116.0,1,,,9814
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,12500,,50597,,Half-life in plasma of rat at dose of 3-10 mgkg,N,,CHEMBL876798,,A,10116.0,1,,,9815
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5064,,50597,,Half-life in rat,N,,CHEMBL625291,,A,10116.0,1,,,9816
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5145,,50597,,Half-life in rat,N,,CHEMBL625292,,A,10116.0,1,,,9817
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5147,,50597,,Half-life in rat,N,,CHEMBL625293,,A,10116.0,1,,,9818
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5833,,50597,,Half-life in rat,N,,CHEMBL622832,,A,10116.0,1,,,9819
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6596,,50597,,Half-life in rat,N,,CHEMBL622833,,A,10116.0,1,,,9820
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17655,,50597,,Half-life in rat,N,,CHEMBL622834,,A,10116.0,1,,,9821
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6495,,50597,,Half-life in rat after oral administration at 10 mg/kg,N,,CHEMBL622835,,A,10116.0,1,,,9822
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17538,,50597,,Half-life in rat after po administration at a dose of 10 mg/kg,N,,CHEMBL622836,,A,10116.0,1,,,9823
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17538,,50597,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,,CHEMBL622837,,A,10116.0,1,,,9824
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,10,,50597,,Half-life in rat at 3 mg/kg dose administered intravenously,N,,CHEMBL622838,,A,10116.0,1,,,9825
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,17669,,50597,,Half-life in rat brain homogenate,N,,CHEMBL622839,,A,10116.0,1,,,9826
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17065,,50597,,Half-life in rat plasma,N,,CHEMBL622840,,A,10116.0,1,,,9827
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4333,,50597,,Half-life in rats,N,,CHEMBL622841,,A,10116.0,1,,,9828
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6827,,50597,,Half-life in Dawley rats,N,,CHEMBL622842,,A,10116.0,1,,,9829
,1,BAO_0000218,In vitro,Rattus norvegicus,Plasma,1969.0,Intermediate,889,,50597,,Half-life in vitro in rat plasma,N,,CHEMBL622843,,A,10116.0,1,,,9830
,1,BAO_0000218,In vitro,Rattus norvegicus,Plasma,1969.0,Intermediate,889,,50597,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,N,,CHEMBL622844,,A,10116.0,1,,,9831
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3747,,50597,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",N,,CHEMBL622845,,A,10116.0,1,,,9832
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15022,,50597,,The area under the curve of compound was measured at the dose of 100 umol/kg,N,,CHEMBL622846,,A,10116.0,1,,,9833
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15022,,50597,,The area under the curve of compound was measured at the dose of 300 umol/kg,N,,CHEMBL622847,,A,10116.0,1,,,9834
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15022,,50597,,The area under the curve of compound was measured at the dose of 30 umol/kg,N,,CHEMBL622848,,A,10116.0,1,,,9835
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3360,,50597,,Bioavailability as oral AUC in rats,N,,CHEMBL622849,,A,10116.0,1,,,9836
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,5334,,50597,,The plasma concentration versus time curve (AUC) was determined,N,,CHEMBL622850,,A,10116.0,1,,,9837
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17411,,50597,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL876807,,A,10116.0,1,,,9838
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17411,,50597,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL622851,,A,10116.0,1,,,9839
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17411,,50597,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL622852,,A,10116.0,1,,,9840
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6570,,50597,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,N,,CHEMBL622853,,A,10116.0,1,,,9841
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6570,,50597,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,N,,CHEMBL622854,,A,10116.0,1,,,9842
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17411,,50597,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,CHEMBL622855,,A,10116.0,1,,,9843
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14941,,50597,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",N,,CHEMBL622856,,A,10116.0,1,,,9844
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14941,,50597,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",N,,CHEMBL622857,,A,10116.0,1,,,9845
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17538,,50597,,AUC in rat after po administration at a dose of 10 mg/kg,N,,CHEMBL622858,,A,10116.0,1,,,9846
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17752,,50597,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,N,,CHEMBL622859,,A,10116.0,1,,,9847
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17509,,50597,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,N,,CHEMBL622860,,A,10116.0,1,,,9848
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17509,,50597,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,N,,CHEMBL622861,,A,10116.0,1,,,9849
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17509,,50597,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,N,,CHEMBL622862,,A,10116.0,1,,,9850
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17509,,50597,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,N,,CHEMBL622863,,A,10116.0,1,,,9851
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17509,,50597,,Area under curve value 6 hr after po administration in rat,N,,CHEMBL623817,,A,10116.0,1,,,9852
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17717,,50597,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,CHEMBL623818,,A,10116.0,1,,,9853
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17717,,50597,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",N,,CHEMBL623819,,A,10116.0,1,,,9854
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17717,,50597,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,CHEMBL623820,,A,10116.0,1,,,9855
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17717,,50597,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,N,,CHEMBL623821,,A,10116.0,1,,,9856
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6642,,50597,,AUC normalized for dose (AUCN) in rat,N,,CHEMBL623822,,A,10116.0,1,,,9857
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6640,,50597,,Area under curve in rat after p.o. administration,N,,CHEMBL623823,,A,10116.0,1,,,9858
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6641,,50597,,Area under curve in rat after p.o. administration,N,,CHEMBL623824,,A,10116.0,1,,,9859
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6641,,50597,,Area under curve in rat after p.o. administration; Not determined,N,,CHEMBL623825,,A,10116.0,1,,,9860
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6641,,50597,,Area under curve in rat after peroral administration,N,,CHEMBL622070,,A,10116.0,1,,,9861
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3603,,50597,,Area under curve (carotid artery) value of the compound,N,,CHEMBL622071,,A,10116.0,1,,,9862
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3550,,50597,,Bioavailability expressed as the area under curve of rat carotid artery,N,,CHEMBL622072,,A,10116.0,1,,,9863
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15662,,50597,,Area under curve in male SD rats was observed after intravenous administration in rat,N,,CHEMBL622073,,A,10116.0,1,,,9864
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17720,,50597,,Area under curve of the compound was determined,N,,CHEMBL622074,,A,10116.0,1,,,9865
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5407,,50597,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,N,,CHEMBL622075,,A,10116.0,1,,,9866
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17752,,50597,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,N,,CHEMBL622076,,A,10116.0,1,,,9867
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17752,,50597,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,N,,CHEMBL622077,,A,10116.0,1,,,9868
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3603,,50597,,Area under curve (portal vein) value of the compound,N,,CHEMBL622078,,A,10116.0,1,,,9869
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3550,,50597,,Bioavailability expressed as the area under curve of rat portal vein,N,,CHEMBL622079,,A,10116.0,1,,,9870
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17655,,50597,,Area Under plasma concentration time curve in rat upon peroral administration,N,,CHEMBL622080,,A,10116.0,1,,,9871
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17582,,50597,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,N,,CHEMBL877612,,A,10116.0,1,,,9872
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17582,,50597,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,N,,CHEMBL622081,,A,10116.0,1,,,9873
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17791,,50597,,Compound was evaluated for oral bioavailability in rats,N,,CHEMBL622082,,A,10116.0,1,,,9874
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17791,,50597,,Compound was evaluated for oral bioavailability in rats after iv administration,N,,CHEMBL622083,,A,10116.0,1,,,9875
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17791,,50597,,Compound was evaluated for oral bioavailability in rats; 30-80,N,,CHEMBL622084,,A,10116.0,1,,,9876
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17791,,50597,,Compound was evaluated for oral bioavailability in rats; 50-60,N,,CHEMBL622085,,A,10116.0,1,,,9877
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17791,,50597,,Compound was evaluated for oral bioavailability in rats; no data,N,,CHEMBL622086,,A,10116.0,1,,,9878
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17791,,50597,,Compound was evaluated for oral bioavailability in rats; peptide,N,,CHEMBL622087,,A,10116.0,1,,,9879
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,7768,,50597,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",N,,CHEMBL622088,,A,10116.0,1,,,9880
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,7768,,50597,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",N,,CHEMBL622089,,A,10116.0,1,,,9881
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,7768,,50597,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",N,,CHEMBL623685,,A,10116.0,1,,,9882
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,7768,,50597,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",N,,CHEMBL623686,,A,10116.0,1,,,9883
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL623687,,A,10116.0,1,,,9884
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL623688,,A,10116.0,1,,,9885
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL623689,,A,10116.0,1,,,9886
,1,BAO_0000218,In vivo,Rattus norvegicus,Stomach,945.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622485,,A,10116.0,1,,,9887
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622486,,A,10116.0,1,,,9888
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL877613,,A,10116.0,1,,,9889
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622487,,A,10116.0,1,,,9890
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622488,,A,10116.0,1,,,9891
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,8677,,50597,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,CHEMBL622489,,A,10116.0,1,,,9892
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,6899,,50597,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,,CHEMBL622490,,A,10116.0,1,,,9893
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,6899,,50597,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,,CHEMBL622491,,A,10116.0,1,,,9894
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,6899,,50597,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,N,,CHEMBL622492,,A,10116.0,1,,,9895
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,6899,,50597,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,,CHEMBL622493,,A,10116.0,1,,,9896
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,6899,,50597,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,,CHEMBL622494,,A,10116.0,1,,,9897
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8677,,50597,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,CHEMBL622495,,A,10116.0,1,,,9898
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6899,,50597,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,N,,CHEMBL622496,,A,10116.0,1,,,9899
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,6899,,50597,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,,CHEMBL622497,,A,10116.0,1,,,9900
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2189,,50597,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,N,,CHEMBL622498,,A,10116.0,1,,,9901
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,2189,,50597,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,N,,CHEMBL624918,,A,10116.0,1,,,9902
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,2189,,50597,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,N,,CHEMBL624919,,A,10116.0,1,,,9903
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,10839,,50597,,Biodistribution of compound in rat blood after 5 min of administration,N,,CHEMBL624920,,A,10116.0,1,,,9904
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,10839,,50597,,Biodistribution of compound in rat blood after 5 min of administration.,N,,CHEMBL624921,,A,10116.0,1,,,9905
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,10839,,50597,,Biodistribution of compound in rat brain after 5 min of administration,N,,CHEMBL624922,,A,10116.0,1,,,9906
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,10839,,50597,,Biodistribution of compound in rat heart after 5 min of administration,N,,CHEMBL624923,,A,10116.0,1,,,9907
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,10839,,50597,,Biodistribution of compound in rat heart after 5 min of administration.,N,,CHEMBL624924,,A,10116.0,1,,,9908
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,10839,,50597,,Biodistribution of compound in rat kidney after 5 min of administration,N,,CHEMBL624925,,A,10116.0,1,,,9909
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,10839,,50597,,Biodistribution of compound in rat kidney after 5 min of administration.,N,,CHEMBL624926,,A,10116.0,1,,,9910
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,10839,,50597,,Biodistribution of compound in rat liver after 5 min of administration,N,,CHEMBL624927,,A,10116.0,1,,,9911
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,10839,,50597,,Biodistribution of compound in rat liver after 5 min of administration.,N,,CHEMBL874402,,A,10116.0,1,,,9912
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,10839,,50597,,Biodistribution of compound in rat lung after 5 min of administration,N,,CHEMBL624928,,A,10116.0,1,,,9913
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,10839,,50597,,Biodistribution of compound in rat lung after 5 min of administration.,N,,CHEMBL624929,,A,10116.0,1,,,9914
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10839,,50597,,Biodistribution of compound in rat muscle after 5 min of administration,N,,CHEMBL624930,,A,10116.0,1,,,9915
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10839,,50597,,Biodistribution of compound in rat muscle after 5 min of administration.,N,,CHEMBL624931,,A,10116.0,1,,,9916
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,4043,,50597,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,CHEMBL624932,,A,10116.0,1,,,9917
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,4043,,50597,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,CHEMBL624933,,A,10116.0,1,,,9918
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,4043,,50597,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,CHEMBL624934,,A,10116.0,1,,,9919
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,4043,,50597,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,CHEMBL624935,,A,10116.0,1,,,9920
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4043,,50597,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,CHEMBL624936,,A,10116.0,1,,,9921
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4043,,50597,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,CHEMBL624937,,A,10116.0,1,,,9922
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,4043,,50597,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,CHEMBL624938,,A,10116.0,1,,,9923
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,4043,,50597,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,CHEMBL624939,,A,10116.0,1,,,9924
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4043,,50597,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,CHEMBL624940,,A,10116.0,1,,,9925
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4043,,50597,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,CHEMBL874403,,A,10116.0,1,,,9926
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1446,,50597,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,N,,CHEMBL624941,,A,10116.0,1,,,9927
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,9971,,50597,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,N,,CHEMBL624942,,A,10116.0,1,,,9928
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,9971,,50597,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,N,,CHEMBL624943,,A,10116.0,1,,,9929
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5765,,50597,,% Bioavailability after 1 day of the drug administration in rats,N,,CHEMBL624944,,A,10116.0,1,,,9930
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5765,,50597,,% Bioavailability after 4 day of the drug administration in rats,N,,CHEMBL624945,,A,10116.0,1,,,9931
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4257,,50597,,Absolute bioavailability was evaluated in rat,N,,CHEMBL624946,,A,10116.0,1,,,9932
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,N,,CHEMBL624947,,A,10116.0,1,,,9933
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,N,,CHEMBL624948,,A,10116.0,1,,,9934
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,N,,CHEMBL624949,,A,10116.0,1,,,9935
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,N,,CHEMBL622025,,A,10116.0,1,,,9936
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,N,,CHEMBL622026,,A,10116.0,1,,,9937
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,N,,CHEMBL622027,,A,10116.0,1,,,9938
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,N,,CHEMBL622028,,A,10116.0,1,,,9939
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,N,,CHEMBL622029,,A,10116.0,1,,,9940
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,N,,CHEMBL622208,,A,10116.0,1,,,9941
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,N,,CHEMBL622209,,A,10116.0,1,,,9942
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,N,,CHEMBL622210,,A,10116.0,1,,,9943
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,N,,CHEMBL622211,,A,10116.0,1,,,9944
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,N,,CHEMBL622212,,A,10116.0,1,,,9945
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,N,,CHEMBL622213,,A,10116.0,1,,,9946
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,N,,CHEMBL874404,,A,10116.0,1,,,9947
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,N,,CHEMBL620452,,A,10116.0,1,,,9948
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,N,,CHEMBL620453,,A,10116.0,1,,,9949
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,N,,CHEMBL620454,,A,10116.0,1,,,9950
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,N,,CHEMBL624067,,A,10116.0,1,,,9951
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,N,,CHEMBL624068,,A,10116.0,1,,,9952
,1,BAO_0000218,,Rattus norvegicus,Female gonad,992.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,N,,CHEMBL624069,,A,10116.0,1,,,9953
,1,BAO_0000218,,Rattus norvegicus,Female gonad,992.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,N,,CHEMBL624070,,A,10116.0,1,,,9954
,1,BAO_0000218,,Rattus norvegicus,Female gonad,992.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,N,,CHEMBL624071,,A,10116.0,1,,,9955
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,N,,CHEMBL624072,,A,10116.0,1,,,9956
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,N,,CHEMBL624073,,A,10116.0,1,,,9957
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,N,,CHEMBL624788,,A,10116.0,1,,,9958
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,N,,CHEMBL624789,,A,10116.0,1,,,9959
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,N,,CHEMBL624790,,A,10116.0,1,,,9960
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,N,,CHEMBL624791,,A,10116.0,1,,,9961
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,N,,CHEMBL624792,,A,10116.0,1,,,9962
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,N,,CHEMBL624793,,A,10116.0,1,,,9963
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,N,,CHEMBL877491,,A,10116.0,1,,,9964
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,N,,CHEMBL624957,,A,10116.0,1,,,9965
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,N,,CHEMBL624958,,A,10116.0,1,,,9966
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13091,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,N,,CHEMBL624959,,A,10116.0,1,,,9967
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11977,,50597,,Dissociation constant was determined,N,,CHEMBL624960,,A,10116.0,1,,,9968
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14941,,50597,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",N,,CHEMBL624961,,A,10116.0,1,,,9969
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15078,,50597,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL624962,,A,10116.0,1,,,9970
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15078,,50597,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL624963,,A,10116.0,1,,,9971
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4755,,50597,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,N,,CHEMBL624964,,A,10116.0,1,,,9972
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,589,,50597,,LogP value was evaluated in the in situ rat gut perfusion assay,N,,CHEMBL624965,,A,10116.0,1,,,9973
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17582,,50597,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,CHEMBL624966,,A,10116.0,1,,,9974
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5031,,50597,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,N,,CHEMBL624967,,A,10116.0,1,,,9975
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17764,,50597,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,N,,CHEMBL624968,,A,10116.0,1,,,9976
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17720,,50597,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,CHEMBL624969,,A,10116.0,1,,,9977
,1,BAO_0000218,,Rattus norvegicus,,,Expert,2862,,50597,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,N,,CHEMBL624970,,F,10116.0,1,,,9978
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16423,,50597,,Half-life was evaluated after 10 uM/kg of intra arterial administration,N,,CHEMBL624971,,A,10116.0,1,,,9979
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16423,,50597,,Half-life was evaluated after 20 uM/kg of peroral administration,N,,CHEMBL624972,,A,10116.0,1,,,9980
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6005,,50597,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,,CHEMBL624973,,A,10116.0,1,,,9981
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,2938,,50597,,Half-life was evaluated in plasma of rat,N,,CHEMBL624974,,A,10116.0,1,,,9982
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6410,,50597,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,N,,CHEMBL624975,,A,10116.0,1,,,9983
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6410,,50597,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,N,,CHEMBL877492,,A,10116.0,1,,,9984
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6062,,50597,,Half-life was measured in rat after an iv dose of 1 mg/kg,N,,CHEMBL624976,,A,10116.0,1,,,9985
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6571,,50597,,Half-life period of compound in rats after peroral administration,N,,CHEMBL624977,,A,10116.0,1,,,9986
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,3136,,50597,,Half-life period of compound was measured in rat plasma.,N,,CHEMBL626848,,A,10116.0,1,,,9987
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,3136,,50597,,Half-life period of compound was measured in rat plasma; ND is not determined,N,,CHEMBL626849,,A,10116.0,1,,,9988
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,3136,,50597,,Half-life period of compound was measured in rat plasma; not determined,N,,CHEMBL626850,,A,10116.0,1,,,9989
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4521,,50597,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,CHEMBL626851,,A,10116.0,1,,,9990
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5871,,50597,,Half-life period in rat by iv administration,N,,CHEMBL626852,,A,10116.0,1,,,9991
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6077,,50597,,Half-life period in rats following intravenous administration at 2 mg/kg,N,,CHEMBL626853,,A,10116.0,1,,,9992
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6679,,50597,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,CHEMBL626854,,A,10116.0,1,,,9993
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5144,,50597,,Half-life period was determined for the compound in rat,N,,CHEMBL627486,,A,10116.0,1,,,9994
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4498,,50597,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",N,,CHEMBL627487,,A,10116.0,1,,,9995
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4498,,50597,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",N,,CHEMBL627488,,A,10116.0,1,,,9996
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1908,,50597,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,N,,CHEMBL627489,,A,10116.0,1,,,9997
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6211,,50597,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,,CHEMBL627490,,A,10116.0,1,,,9998
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5529,,50597,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),N,,CHEMBL873829,,A,10116.0,1,,,9999
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6444,,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.,N,,CHEMBL627655,,A,10116.0,1,,,10000
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6444,,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,,CHEMBL625994,,A,10116.0,1,,,10001
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6444,,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,,CHEMBL625995,,A,10116.0,1,,,10002
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5207,,50597,,Half-life in rat,N,,CHEMBL625996,,A,10116.0,1,,,10003
,1,BAO_0000218,In vitro,Rattus norvegicus,Plasma,1969.0,Intermediate,530,,50597,,In vitro half life in rat plasma,N,,CHEMBL625850,,A,10116.0,1,,,10004
,1,BAO_0000218,In vitro,Rattus norvegicus,Plasma,1969.0,Intermediate,1116,,50597,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",N,,CHEMBL625851,,A,10116.0,1,,,10005
,1,BAO_0000218,In vitro,Rattus norvegicus,,,Intermediate,3219,,50597,,In vitro half life in rat,N,,CHEMBL625852,,A,10116.0,1,,,10006
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6109,,50597,,In vivo half life period after intravenous administration in rat,N,,CHEMBL625853,,A,10116.0,1,,,10007
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17582,,50597,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,CHEMBL625854,,A,10116.0,1,,,10008
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17582,,50597,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,,CHEMBL874450,,A,10116.0,1,,,10009
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL625855,,A,10116.0,1,,,10010
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL625856,,A,10116.0,1,,,10011
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL625857,,A,10116.0,1,,,10012
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL873831,,A,10116.0,1,,,10013
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17853,,50597,,Longer half-life in rat (i.v.) at 0.5 mpk,N,,CHEMBL625858,,A,10116.0,1,,,10014
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17853,,50597,,Longer half-life in rat (p.o.) at 2.0 mpk,N,,CHEMBL625859,,A,10116.0,1,,,10015
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3457,,50597,,Pharmacokinetic property (half life) in rat,N,,CHEMBL625860,,A,10116.0,1,,,10016
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2792,,50597,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,N,,CHEMBL625861,,A,10116.0,1,,,10017
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2792,,50597,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,N,,CHEMBL625862,,A,10116.0,1,,,10018
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2792,,50597,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,N,,CHEMBL625863,,A,10116.0,1,,,10019
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2792,,50597,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,N,,CHEMBL625864,,A,10116.0,1,,,10020
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5739,,50597,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,N,,CHEMBL625865,,A,10116.0,1,,,10021
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15765,,50597,,Pharmacokinetic half time was determined intravenously in rats.,N,,CHEMBL625866,,A,10116.0,1,,,10022
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,6567,,50597,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,N,,CHEMBL625867,,A,10116.0,1,,,10023
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,2448,,50597,,Plasma half life of hydrolysis of the compound,N,,CHEMBL625868,,A,10116.0,1,,,10024
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5423,,50597,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,N,,CHEMBL625869,,A,10116.0,1,,,10025
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4853,,50597,,Plasma half life period was calculated in rat,N,,CHEMBL874451,,A,10116.0,1,,,10026
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4514,,50597,,Plasma half-life in Sprague-Dawley rats,N,,CHEMBL625870,,A,10116.0,1,,,10027
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4514,,50597,,Plasma half-life in Sprague-Dawley rats; Not determined,N,,CHEMBL625871,,A,10116.0,1,,,10028
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1500,,50597,,Plasma half-life in rats,N,,CHEMBL625872,,A,10116.0,1,,,10029
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,1500,,50597,,Plasma half-life in rats; <MQL,N,,CHEMBL625873,,A,10116.0,1,,,10030
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,5334,,50597,,Plasma half-life period (0-8 h) was determined,N,,CHEMBL625874,,A,10116.0,1,,,10031
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,5334,,50597,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,N,,CHEMBL625875,,A,10116.0,1,,,10032
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5334,,50597,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,,CHEMBL625876,,A,10116.0,1,,,10033
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5334,,50597,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,,CHEMBL631258,,A,10116.0,1,,,10034
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4956,,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,N,,CHEMBL631259,,A,10116.0,1,,,10035
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4956,,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,N,,CHEMBL631260,,A,10116.0,1,,,10036
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,7768,,50597,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",N,,CHEMBL631261,,A,10116.0,1,,,10037
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,7768,,50597,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",N,,CHEMBL631262,,A,10116.0,1,,,10038
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,7768,,50597,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",N,,CHEMBL631263,,A,10116.0,1,,,10039
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7768,,50597,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",N,,CHEMBL631264,,A,10116.0,1,,,10040
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7768,,50597,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",N,,CHEMBL631265,,A,10116.0,1,,,10041
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7768,,50597,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",N,,CHEMBL631266,,A,10116.0,1,,,10042
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7768,,50597,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",N,,CHEMBL631267,,A,10116.0,1,,,10043
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7768,,50597,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",N,,CHEMBL631268,,A,10116.0,1,,,10044
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7768,,50597,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",N,,CHEMBL631269,,A,10116.0,1,,,10045
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7768,,50597,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",N,,CHEMBL631270,,A,10116.0,1,,,10046
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,7768,,50597,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,,CHEMBL631271,,A,10116.0,1,,,10047
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,7768,,50597,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",N,,CHEMBL631272,,A,10116.0,1,,,10048
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,7768,,50597,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",N,,CHEMBL631273,,A,10116.0,1,,,10049
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,7768,,50597,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",N,,CHEMBL631274,,A,10116.0,1,,,10050
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,7768,,50597,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",N,,CHEMBL631275,,A,10116.0,1,,,10051
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,7768,,50597,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",N,,CHEMBL626984,,A,10116.0,1,,,10052
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,7768,,50597,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",N,,CHEMBL626985,,A,10116.0,1,,,10053
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,7768,,50597,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,,CHEMBL626986,,A,10116.0,1,,,10054
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,7768,,50597,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",N,,CHEMBL626987,,A,10116.0,1,,,10055
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,7768,,50597,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",N,,CHEMBL626988,,A,10116.0,1,,,10056
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,7768,,50597,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",N,,CHEMBL626989,,A,10116.0,1,,,10057
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,7768,,50597,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",N,,CHEMBL626990,,A,10116.0,1,,,10058
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,7768,,50597,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",N,,CHEMBL626991,,A,10116.0,1,,,10059
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,7768,,50597,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",N,,CHEMBL626992,,A,10116.0,1,,,10060
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,7768,,50597,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",N,,CHEMBL626993,,A,10116.0,1,,,10061
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,7768,,50597,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",N,,CHEMBL874593,,A,10116.0,1,,,10062
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,7768,,50597,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",N,,CHEMBL626994,,A,10116.0,1,,,10063
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,7768,,50597,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",N,,CHEMBL626995,,A,10116.0,1,,,10064
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,7768,,50597,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",N,,CHEMBL626190,,A,10116.0,1,,,10065
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,7768,,50597,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",N,,CHEMBL626191,,A,10116.0,1,,,10066
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,7768,,50597,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",N,,CHEMBL626364,,A,10116.0,1,,,10067
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,7768,,50597,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",N,,CHEMBL626365,,A,10116.0,1,,,10068
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,7768,,50597,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",N,,CHEMBL626366,,A,10116.0,1,,,10069
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,7768,,50597,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",N,,CHEMBL626367,,A,10116.0,1,,,10070
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,7768,,50597,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",N,,CHEMBL626368,,A,10116.0,1,,,10071
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,7768,,50597,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",N,,CHEMBL626369,,A,10116.0,1,,,10072
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,7768,,50597,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",N,,CHEMBL626370,,A,10116.0,1,,,10073
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4498,,50597,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",N,,CHEMBL626371,,A,10116.0,1,,,10074
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4498,,50597,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",N,,CHEMBL626372,,A,10116.0,1,,,10075
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3603,,50597,,Bioavailability after a dose of 10 mg/kg p.o.,N,,CHEMBL626373,,A,10116.0,1,,,10076
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6215,,50597,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,N,,CHEMBL626374,,A,10116.0,1,,,10077
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5710,,50597,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,N,,CHEMBL626375,,A,10116.0,1,,,10078
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5710,,50597,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),N,,CHEMBL626376,,A,10116.0,1,,,10079
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5676,,50597,,Bioavailability in rat po was determined,N,,CHEMBL626377,,A,10116.0,1,,,10080
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17667,,50597,,Bioavailability of compound at 10 mg/kg in rat after oral administration,N,,CHEMBL626378,,A,10116.0,1,,,10081
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17667,,50597,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,N,,CHEMBL626379,,A,10116.0,1,,,10082
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6848,,50597,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,,CHEMBL626380,,A,10116.0,1,,,10083
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6848,,50597,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,,CHEMBL626381,,A,10116.0,1,,,10084
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17267,,50597,,Bioavailability in rat,N,,CHEMBL626382,,A,10116.0,1,,,10085
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6362,,50597,,Bioavailability in rat (Sprague-Dawley) (female),N,,CHEMBL626383,,A,10116.0,1,,,10086
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17671,,50597,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,CHEMBL874652,,A,10116.0,1,,,10087
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17671,,50597,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),N,,CHEMBL626384,,A,10116.0,1,,,10088
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4333,,50597,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,N,,CHEMBL626385,,A,10116.0,1,,,10089
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6077,,50597,,Bioavailability in rat at an oral dose of 2 mg/kg,N,,CHEMBL626386,,A,10116.0,1,,,10090
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3278,,50597,,Bioavailability in rat,N,,CHEMBL626387,,A,10116.0,1,,,10091
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5964,,50597,,Bioavailability in rat,N,,CHEMBL626388,,A,10116.0,1,,,10092
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4884,,50597,,Bioavailability in rat,N,,CHEMBL626389,,A,10116.0,1,,,10093
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4905,,50597,,Bioavailability in rat,N,,CHEMBL626390,,A,10116.0,1,,,10094
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4884,,50597,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,N,,CHEMBL626391,,A,10116.0,1,,,10095
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6850,,50597,,Bioavailability in rat,N,,CHEMBL626392,,A,10116.0,1,,,10096
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2864,,50597,,Oral bioavailability in rat,N,,CHEMBL626393,,A,10116.0,1,,,10097
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5780,,50597,,Bioavailability was determined in rat,N,,CHEMBL623026,,A,10116.0,1,,,10098
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1465,,50597,,Bioavailability,N,,CHEMBL623027,,A,10116.0,1,,,10099
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5199,,50597,,Bioavailability,N,,CHEMBL623028,,A,10116.0,1,,,10100
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5765,,50597,,Bioavailability in rat after 1 day dosing,N,,CHEMBL623029,,A,10116.0,1,,,10101
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5765,,50597,,Bioavailability in rat after 4 day dosing,N,,CHEMBL623030,,A,10116.0,1,,,10102
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,N,,CHEMBL623031,,A,10116.0,1,,,10103
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,N,,CHEMBL623032,,A,10116.0,1,,,10104
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,N,,CHEMBL623033,,A,10116.0,1,,,10105
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6518,,50597,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,N,,CHEMBL623034,,A,10116.0,1,,,10106
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2083,,50597,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,N,,CHEMBL623035,,A,10116.0,1,,,10107
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17260,,50597,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,CHEMBL623036,,A,10116.0,1,,,10108
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4956,,50597,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,,CHEMBL623037,,A,10116.0,1,,,10109
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4368,,50597,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,N,,CHEMBL623038,,A,10116.0,1,,,10110
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17752,,50597,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,N,,CHEMBL874385,,A,10116.0,1,,,10111
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1446,,50597,,Bioavailability in rat (Fisher) (fasted),N,,CHEMBL623039,,A,10116.0,1,,,10112
,0,BAO_0000218,In vivo,Primates,,,Intermediate,2891,,22224,,Bioavailability in monkey after po administration of 10 mg/kg dose,U,,CHEMBL623040,,A,9443.0,1,,,10113
,0,BAO_0000218,In vivo,Primates,,,Intermediate,2891,,22224,,Oral bioavailability in monkey (dose 10 mg/kg),U,,CHEMBL623041,,A,9443.0,1,,,10114
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6672,,50597,,Bioavailability in rat,N,,CHEMBL623741,,A,10116.0,1,,,10115
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6673,,50597,,Bioavailability in rat,N,,CHEMBL623742,,A,10116.0,1,,,10116
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17655,,50597,,Bioavailability in rat,N,,CHEMBL623743,,A,10116.0,1,,,10117
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17796,,50597,,Bioavailability in rat,N,,CHEMBL623744,,A,10116.0,1,,,10118
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17853,,50597,,Bioavailability in rat (dose 2.0 mg/kg p.o.),N,,CHEMBL623745,,A,10116.0,1,,,10119
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4521,,50597,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),N,,CHEMBL623746,,A,10116.0,1,,,10120
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4940,,50597,,Oral bioavailability in rat (dose 5 mg/kg p.o.),N,,CHEMBL623747,,A,10116.0,1,,,10121
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2891,,22224,,Bioavailability in rat after po administration of 30 mg/kg dose,U,,CHEMBL623748,,A,10116.0,1,,,10122
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2891,,22224,,Bioavailability in rat after po administration of 30 mg/kg dose,U,,CHEMBL623916,,A,10116.0,1,,,10123
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4521,,50597,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,CHEMBL623917,,A,10116.0,1,,,10124
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17686,,50597,,Bioavailability in rat (dose 2 mg/kg i.v.),N,,CHEMBL623918,,A,10116.0,1,,,10125
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17796,,50597,,Bioavailability in rat,N,,CHEMBL874386,,A,10116.0,1,,,10126
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17796,,50597,,Bioavailability in rat; Only traces detected in rat plasma,N,,CHEMBL623919,,A,10116.0,1,,,10127
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5064,,50597,,Bioavailability in rat,N,,CHEMBL623920,,A,10116.0,1,,,10128
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5147,,50597,,Bioavailability upon oral administration of compound,N,,CHEMBL623148,,A,10116.0,1,,,10129
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1916,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),N,,CHEMBL623149,,A,10116.0,1,,,10130
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6049,,50597,,Bioavailability in rat,N,,CHEMBL623150,,A,10116.0,1,,,10131
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1445,,50597,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",N,,CHEMBL623151,,A,10116.0,1,,,10132
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1445,,50597,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",N,,CHEMBL623152,,A,10116.0,1,,,10133
,1,BAO_0000218,,Rattus norvegicus,,,Expert,2862,,50597,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,N,,CHEMBL623153,,F,10116.0,1,,,10134
,1,BAO_0000218,,Rattus norvegicus,,,Expert,2862,,50597,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,N,,CHEMBL623154,,F,10116.0,1,,,10135
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4194,,50597,,In vitro and metabolic stability was determined,N,,CHEMBL623155,,A,10116.0,1,,,10136
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4194,,50597,,In vitro metabolic stability in rat hepatocytes,N,,CHEMBL623156,,A,10116.0,1,,,10137
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5486,,50597,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,N,,CHEMBL623157,,A,10116.0,1,,,10138
,1,BAO_0000218,In vitro,Rattus norvegicus,Liver,2107.0,Intermediate,17582,,50597,,Metabolic rate for compound was observed in rat hepatocytes,N,,CHEMBL623158,,A,10116.0,1,Hepatocyte,401.0,10139
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5600,,50597,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,N,,CHEMBL623159,,A,10116.0,1,,,10140
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14294,,50597,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),N,,CHEMBL874390,,A,10116.0,1,,,10141
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14294,,50597,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),N,,CHEMBL623160,,A,10116.0,1,,,10142
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14294,,50597,,Metabolism of compound in rat S9 microsomes; Trace,N,,CHEMBL623161,,A,10116.0,1,,,10143
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17847,,50597,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,N,,CHEMBL623162,,A,10116.0,1,,,10144
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,N,,CHEMBL623163,,A,10116.0,1,,,10145
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,N,,CHEMBL623164,,A,10116.0,1,,,10146
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,N,,CHEMBL623165,,A,10116.0,1,,,10147
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,N,,CHEMBL623166,,A,10116.0,1,,,10148
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,N,,CHEMBL624983,,A,10116.0,1,,,10149
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,N,,CHEMBL624984,,A,10116.0,1,,,10150
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,N,,CHEMBL624985,,A,10116.0,1,,,10151
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,N,,CHEMBL622970,,A,10116.0,1,,,10152
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,N,,CHEMBL622971,,A,10116.0,1,,,10153
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,N,,CHEMBL622972,,A,10116.0,1,,,10154
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,N,,CHEMBL622973,,A,10116.0,1,,,10155
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,N,,CHEMBL622974,,A,10116.0,1,,,10156
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,N,,CHEMBL622975,,A,10116.0,1,,,10157
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,N,,CHEMBL622976,,A,10116.0,1,,,10158
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,N,,CHEMBL622977,,A,10116.0,1,,,10159
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,,CHEMBL624351,,A,10116.0,1,,,10160
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,N,,CHEMBL624352,,A,10116.0,1,,,10161
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,,CHEMBL624353,,A,10116.0,1,,,10162
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,N,,CHEMBL622397,,A,10116.0,1,,,10163
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,N,,CHEMBL622398,,A,10116.0,1,,,10164
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,N,,CHEMBL622399,,A,10116.0,1,,,10165
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,,CHEMBL622400,,A,10116.0,1,,,10166
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,,CHEMBL628428,,A,10116.0,1,,,10167
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,N,,CHEMBL628590,,A,10116.0,1,,,10168
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,,CHEMBL628591,,A,10116.0,1,,,10169
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,N,,CHEMBL628592,,A,10116.0,1,,,10170
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,,CHEMBL628593,,A,10116.0,1,,,10171
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,N,,CHEMBL875333,,A,10116.0,1,,,10172
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,,CHEMBL628594,,A,10116.0,1,,,10173
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,4969,,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,N,,CHEMBL628595,,A,10116.0,1,,,10174
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6737,,50597,,Stability in rat plasma was determined,N,,CHEMBL628596,,A,10116.0,1,,,10175
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,6737,,50597,,Stability in rat plasma was determined; ND= no data,N,,CHEMBL628597,,A,10116.0,1,,,10176
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,5089,,50597,,Tested for plasma half life period in rat (0-8 hr),N,,CHEMBL628598,,A,10116.0,1,,,10177
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,5089,,50597,,Tested for plasma half life period in rat (0-8 hr); Not determined,N,,CHEMBL628599,,A,10116.0,1,,,10178
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1466,,50597,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,N,,CHEMBL628600,,A,10116.0,1,,,10179
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1466,,50597,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,N,,CHEMBL628601,,A,10116.0,1,,,10180
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4950,,50597,,Tested for the half life in rat,N,,CHEMBL628602,,A,10116.0,1,,,10181
,1,BAO_0000218,In vitro,Rattus norvegicus,,,Intermediate,2412,,50597,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,N,,CHEMBL628603,,A,10116.0,1,,,10182
,1,BAO_0000218,In vitro,Rattus norvegicus,,,Intermediate,2412,,50597,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,N,,CHEMBL628604,,A,10116.0,1,,,10183
,1,BAO_0000218,In vitro,Rattus norvegicus,,,Intermediate,2412,,50597,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,N,,CHEMBL628605,,A,10116.0,1,,,10184
,1,BAO_0000218,In vitro,Rattus norvegicus,,,Intermediate,2412,,50597,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,N,,CHEMBL628606,,A,10116.0,1,,,10185
,1,BAO_0000218,In vitro,Rattus norvegicus,,,Intermediate,2412,,50597,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,N,,CHEMBL628607,,A,10116.0,1,,,10186
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15022,,50597,,The biological half life the compound was measured at the dose of 100 umol/kg,N,,CHEMBL628608,,A,10116.0,1,,,10187
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15022,,50597,,The biological half life the compound was measured at the dose of 30 umol/kg,N,,CHEMBL628609,,A,10116.0,1,,,10188
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,406,,50597,,The compound was evaluated for plasma half life period in rat,N,,CHEMBL628610,,A,10116.0,1,,,10189
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15078,,50597,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL873819,,A,10116.0,1,,,10190
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15078,,50597,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL628611,,A,10116.0,1,,,10191
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5247,,50597,,The pharmacokinetic parameter half-life period in vivo in rats,N,,CHEMBL628612,,A,10116.0,1,,,10192
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5041,,50597,,"The pharmacokinetic property, Half-life was determined",N,,CHEMBL628613,,A,10116.0,1,,,10193
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5041,,50597,,"The pharmacokinetic property, Half-life in rat in vivo",N,,CHEMBL628614,,A,10116.0,1,,,10194
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5041,,50597,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",N,,CHEMBL628615,,A,10116.0,1,,,10195
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5041,,50597,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",N,,CHEMBL628616,,A,10116.0,1,,,10196
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,3918,,50597,,The plasma half life period in rats,N,,CHEMBL627924,,A,10116.0,1,,,10197
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,2906,,50597,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,N,,CHEMBL627925,,A,10116.0,1,,,10198
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6467,,50597,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,,CHEMBL627926,,A,10116.0,1,,,10199
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5510,,50597,,t1/2 (apparent elimination)of the compound was determined,N,,CHEMBL627927,,A,10116.0,1,,,10200
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,3788,,50597,,t1/2 value in rat,N,,CHEMBL627928,,A,10116.0,1,,,10201
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17796,,50597,,Half life in rat,N,,CHEMBL627539,,A,10116.0,1,,,10202
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12873,,50597,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,,CHEMBL876790,,A,10116.0,1,,,10203
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5983,,50597,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,N,,CHEMBL858186,,A,10116.0,1,,,10204
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15765,,50597,,Half-life period in fasted rats,N,,CHEMBL627540,,A,10116.0,1,,,10205
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,N,,CHEMBL627541,,A,10116.0,1,,,10206
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,N,,CHEMBL627715,,A,10116.0,1,,,10207
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,429,,50597,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,,CHEMBL627716,,A,10116.0,1,,,10208
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17655,,50597,,Maximum time required to achieve Cmax was determined in rat,N,,CHEMBL627717,,A,10116.0,1,,,10209
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17717,,50597,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,CHEMBL627718,,A,10116.0,1,,,10210
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17717,,50597,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,CHEMBL627719,,A,10116.0,1,,,10211
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17717,,50597,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,N,,CHEMBL627720,,A,10116.0,1,,,10212
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6570,,50597,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,N,,CHEMBL627721,,A,10116.0,1,,,10213
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6570,,50597,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,N,,CHEMBL627722,,A,10116.0,1,,,10214
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL627723,,A,10116.0,1,,,10215
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL626058,,A,10116.0,1,,,10216
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL626059,,A,10116.0,1,,,10217
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL626060,,A,10116.0,1,,,10218
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17720,,50597,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,CHEMBL626061,,A,10116.0,1,,,10219
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4723,,50597,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL876791,,A,10116.0,1,,,10220
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4723,,50597,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,CHEMBL626062,,A,10116.0,1,,,10221
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4756,,50597,,Tmax at the dose of 2 mg/Kg administered perorally in rats,N,,CHEMBL626063,,A,10116.0,1,,,10222
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4756,,50597,,Tmax at the dose of 5 mg/Kg administered perorally in rats,N,,CHEMBL626064,,A,10116.0,1,,,10223
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17720,,50597,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,N,,CHEMBL626065,,A,10116.0,1,,,10224
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17720,,50597,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,N,,CHEMBL626066,,A,10116.0,1,,,10225
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1466,,50597,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,N,,CHEMBL626067,,A,10116.0,1,,,10226
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7449,,50597,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,N,,CHEMBL626068,,F,10116.0,1,,,10227
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7449,,50597,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,N,,CHEMBL626069,,F,10116.0,1,,,10228
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7449,,50597,,Percent total excretion of 3-methoxyacetaminophen glucuronide,N,,CHEMBL626070,,F,10116.0,1,,,10229
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7449,,50597,,Percent total excretion of N-methoxyacetaminophen glucuronide,N,,CHEMBL626071,,F,10116.0,1,,,10230
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7449,,50597,,Percent total excretion of N-methoxyacetaminophen sulfate,N,,CHEMBL626072,,F,10116.0,1,,,10231
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7449,,50597,,Percent total excretion of acetaminophen,N,,CHEMBL626073,,F,10116.0,1,,,10232
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,7768,,50597,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",N,,CHEMBL626741,,A,10116.0,1,,,10233
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17655,,50597,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",N,,CHEMBL626742,,A,10116.0,1,,,10234
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17735,,50597,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,N,,CHEMBL626743,,A,10116.0,1,,,10235
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5960,,50597,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,N,,CHEMBL876792,,A,10116.0,1,,,10236
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17735,,50597,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,,CHEMBL626744,,A,10116.0,1,,,10237
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7116,,50597,,Compound was tested for antidiuretic activity in rats,N,,CHEMBL626745,,A,10116.0,1,,,10238
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,4878,,50597,,AUC in rat after 3mg/kg oral dose,N,,CHEMBL626746,,A,10116.0,1,,,10239
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5939,,50597,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,N,,CHEMBL626747,,A,10116.0,1,,,10240
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5939,,50597,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,N,,CHEMBL626748,,A,10116.0,1,,,10241
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16367,,50597,,Bioavailability administered orally at a dose of 10 mg/kg to rats,N,,CHEMBL626749,,A,10116.0,1,,,10242
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16366,,50597,,Oral Bioavailability was determined,N,,CHEMBL626750,,A,10116.0,1,,,10243
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4426,,50597,,Oral bioavailability in rat,N,,CHEMBL626751,,A,10116.0,1,,,10244
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4426,,50597,,Oral bioavailability in rat; Not performed.,N,,CHEMBL626913,,A,10116.0,1,,,10245
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5041,,50597,,Bioavailability,N,,CHEMBL626914,,A,10116.0,1,,,10246
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5041,,50597,,Bioavailability was determined; ND denotes no data,N,,CHEMBL626915,,A,10116.0,1,,,10247
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1500,,50597,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,N,,CHEMBL626916,,A,10116.0,1,,,10248
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1500,,50597,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,N,,CHEMBL626917,,A,10116.0,1,,,10249
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17409,,50597,,Binding towards rat plasma protein at 10 uM,N,,CHEMBL626918,,A,10116.0,1,,,10250
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17409,,50597,,Binding towards rat plasma protein at 100 uM,N,,CHEMBL626919,,A,10116.0,1,,,10251
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2959,,50597,,Bioavailability in rat (dose 20 mg/kg p.o.),N,,CHEMBL626920,,A,10116.0,1,,,10252
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13501,,50597,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,,CHEMBL621976,,A,10116.0,1,,,10253
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6567,,50597,,Bioavailability in rat after 5 mg/kg oral gavage,N,,CHEMBL877599,,A,10116.0,1,,,10254
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6571,,50597,,Bioavailability in rat,N,,CHEMBL621977,,A,10116.0,1,,,10255
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6715,,50597,,Bioavailability in rat (dose 1 mg/kg i.v.),N,,CHEMBL621978,,A,10116.0,1,,,10256
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6715,,50597,,Bioavailability in rat (dose 3 mg/kg p.o.),N,,CHEMBL621979,,A,10116.0,1,,,10257
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2932,,50597,,Oral bioavailability in rat,N,,CHEMBL621980,,A,10116.0,1,,,10258
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4171,,50597,,Bioavailability of the compound in rats after administration of 30 mg/kg,N,,CHEMBL621981,,A,10116.0,1,,,10259
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17509,,50597,,Bioavailability after administration of 10 mg/kg in rats,N,,CHEMBL621982,,A,10116.0,1,,,10260
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17509,,50597,,Bioavailability after administration of 2 mg/kg in rats,N,,CHEMBL882953,,A,10116.0,1,,,10261
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4527,,50597,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,N,,CHEMBL621983,,A,10116.0,1,,,10262
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4026,,50597,,Bioavailability in dogs was determined; high,N,,CHEMBL621984,,A,10116.0,1,,,10263
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6659,,50597,,Bioavailability in monkey after intravenous administration at 1 mpk,N,,CHEMBL621985,,A,10116.0,1,,,10264
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6659,,50597,,Bioavailability in monkey after peroral administration at 10 mpk,N,,CHEMBL621986,,A,10116.0,1,,,10265
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6659,,50597,,Bioavailability in rat after intravenous administration at 1 mpk,N,,CHEMBL621987,,A,10116.0,1,,,10266
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6659,,50597,,Bioavailability in rat after intravenous administration at 2 mpk,N,,CHEMBL877600,,F,10116.0,1,,,10267
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6659,,50597,,Bioavailability in rat after peroral administration at 30 mpk,N,,CHEMBL621988,,A,10116.0,1,,,10268
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6659,,50597,,Bioavailability in rat after peroral administration at at 100 mpk,N,,CHEMBL621989,,F,10116.0,1,,,10269
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6597,,50597,,Bioavailability in rats was evaluated,N,,CHEMBL621990,,A,10116.0,1,,,10270
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1202,,50597,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,N,,CHEMBL621991,,A,10116.0,1,,,10271
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1202,,50597,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,N,,CHEMBL621992,,A,10116.0,1,,,10272
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1202,,50597,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,N,,CHEMBL621993,,A,10116.0,1,,,10273
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1202,,50597,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,N,,CHEMBL621994,,A,10116.0,1,,,10274
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5207,,50597,,Bioavailability in rat,N,,CHEMBL621995,,A,10116.0,1,,,10275
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5970,,50597,,Bioavailability in rat,N,,CHEMBL621996,,A,10116.0,1,,,10276
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17538,,50597,,Oral bioavailability in rat (dose 10 mg/kg),N,,CHEMBL621997,,A,10116.0,1,,,10277
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17538,,50597,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,,CHEMBL621998,,A,10116.0,1,,,10278
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1466,,50597,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,N,,CHEMBL621999,,A,10116.0,1,,,10279
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2879,,50597,,Oral bioavailability in rat,N,,CHEMBL622000,,A,10116.0,1,,,10280
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2879,,50597,,Bioavailability was measured in rat after oral administration; 2-4,N,,CHEMBL622001,,A,10116.0,1,,,10281
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2879,,50597,,Bioavailability was measured in rat after oral administration; 3-7,N,,CHEMBL622002,,A,10116.0,1,,,10282
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3777,,50597,,Bioavailability in rat (intraduodenal administration),N,,CHEMBL622003,,A,10116.0,1,,,10283
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3777,,50597,,Bioavailability in rat (intraduodenal administration),N,,CHEMBL877601,,A,10116.0,1,,,10284
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3777,,50597,,Oral bioavailability in rat,N,,CHEMBL624871,,A,10116.0,1,,,10285
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3777,,50597,,Oral bioavailability in rat,N,,CHEMBL622004,,A,10116.0,1,,,10286
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5423,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),N,,CHEMBL882954,,A,10116.0,1,,,10287
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,N,,CHEMBL622005,,A,10116.0,1,,,10288
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16365,,50597,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,N,,CHEMBL622006,,A,10116.0,1,,,10289
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4239,,50597,,Bioavailability was measured in rat,N,,CHEMBL622007,,A,10116.0,1,,,10290
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5438,,50597,,Bioavailability was reported,N,,CHEMBL622008,,A,10116.0,1,,,10291
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5334,,50597,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,CHEMBL622009,,A,10116.0,1,,,10292
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5334,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,CHEMBL622010,,A,10116.0,1,,,10293
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4199,,50597,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,,CHEMBL622011,,A,10116.0,1,,,10294
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4199,,50597,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),N,,CHEMBL622012,,A,10116.0,1,,,10295
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4199,,50597,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),N,,CHEMBL622013,,A,10116.0,1,,,10296
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4890,,50597,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,CHEMBL622014,,A,10116.0,1,,,10297
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2792,,50597,,Bioavailability was determined at 3 mg/kg po dose in rats,N,,CHEMBL624749,,A,10116.0,1,,,10298
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5529,,50597,,Oral bioavailability in rat (dose 2 mg/kg),N,,CHEMBL624750,,A,10116.0,1,,,10299
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",N,,CHEMBL624751,,A,10116.0,1,,,10300
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,,CHEMBL624752,,A,10116.0,1,,,10301
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6685,,50597,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,,CHEMBL624753,,A,10116.0,1,,,10302
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6005,,50597,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,N,,CHEMBL624754,,A,10116.0,1,,,10303
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6410,,50597,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,,CHEMBL624755,,A,10116.0,1,,,10304
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6410,,50597,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,,CHEMBL624756,,A,10116.0,1,,,10305
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6103,,50597,,Bioavailability in rat,N,,CHEMBL624757,,A,10116.0,1,,,10306
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6410,,50597,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,,CHEMBL624758,,A,10116.0,1,,,10307
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6410,,50597,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,,CHEMBL622270,,A,10116.0,1,,,10308
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5353,,50597,,Bioavailability in rat (Sprague-Dawley),N,,CHEMBL622271,,A,10116.0,1,,,10309
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4727,,50597,,Bioavailability in rat at the dose of 2 mg/kg,N,,CHEMBL622272,,A,10116.0,1,,,10310
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17804,,50597,,Oral bioavailability in rat,N,,CHEMBL622273,,A,10116.0,1,,,10311
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5809,,50597,,Bioavailability in rat (cannulated) (dose 2 mg/kg),N,,CHEMBL622274,,A,10116.0,1,,,10312
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17804,,50597,,Bioavailability value of compound in rats was determined after peroral administration,N,,CHEMBL622275,,A,10116.0,1,,,10313
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3634,,50597,,Oral bioavailability in rat (dose 20 mg/kg),N,,CHEMBL622276,,A,10116.0,1,,,10314
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3341,,50597,,Oral bioavailability in rat,N,,CHEMBL622277,,A,10116.0,1,,,10315
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2690,,50597,,Oral bioavailability in rat (dose 5 mg/kg),N,,CHEMBL622278,,A,10116.0,1,,,10316
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3184,,50597,,Oral bioavailability in rat,N,,CHEMBL622279,,A,10116.0,1,,,10317
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,740,,50597,,Oral bioavailability in rat,N,,CHEMBL622280,,A,10116.0,1,,,10318
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1806,,50597,,Compound was evaluated for oral bioavailability in rats; 15-27 %,N,,CHEMBL624083,,A,10116.0,1,,,10319
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4891,,50597,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,N,,CHEMBL624084,,A,10116.0,1,,,10320
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3634,,50597,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),N,,CHEMBL624085,,A,10116.0,1,,,10321
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,64,,50597,,Compound was tested for bioavailability in rats,N,,CHEMBL624086,,A,10116.0,1,,,10322
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4839,,50597,,Bioavailability in rat,N,,CHEMBL624087,,A,10116.0,1,,,10323
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1094,,50597,,Oral bioavailability in rat,N,,CHEMBL624088,,A,10116.0,1,,,10324
,0,BAO_0000218,In vivo,Macaca mulatta,,,Intermediate,5005,,22224,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,U,,CHEMBL624089,,A,9544.0,1,,,10325
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5005,,22224,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),U,,CHEMBL624090,,A,10116.0,1,,,10326
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4687,,50597,,Evaluated for the bioavailability in rat (in vivo),N,,CHEMBL624091,,A,10116.0,1,,,10327
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17804,,50597,,F value of compound in rats was determined after peroral administration,N,,CHEMBL624092,,A,10116.0,1,,,10328
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL624093,,A,10116.0,1,,,10329
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL624094,,A,10116.0,1,,,10330
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL624095,,A,10116.0,1,,,10331
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5974,,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,CHEMBL624096,,A,10116.0,1,,,10332
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1088,,50597,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",N,,CHEMBL624097,,A,10116.0,1,,,10333
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1742,,50597,,Maximum fall in carotid flow in rat,N,,CHEMBL624098,,A,10116.0,1,,,10334
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4689,,50597,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,N,,CHEMBL874392,,A,10116.0,1,,,10335
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2463,,50597,,Oral bioavailability in rat (dose 5 mg/kg),N,,CHEMBL624099,,A,10116.0,1,,,10336
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5654,,50597,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,CHEMBL624100,,A,10116.0,1,,,10337
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5654,,50597,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,CHEMBL624101,,A,10116.0,1,,,10338
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6874,,50597,,Oral bioavailability in rat (male Wistar),N,,CHEMBL624102,,A,10116.0,1,,,10339
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5633,,50597,,Oral bioavailability after administration (30 mg/kg) in rat; good,N,,CHEMBL624103,,A,10116.0,1,,,10340
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5496,,50597,,Oral bioavailability at the dose of 2 mg/kg in rat,N,,CHEMBL624104,,A,10116.0,1,,,10341
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2358,,50597,,Oral bioavailability determined in rats,N,,CHEMBL624105,,A,10116.0,1,,,10342
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16456,,50597,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),N,,CHEMBL624106,,A,10116.0,1,,,10343
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5302,,50597,,Oral bioavailability in rat (dose single 10 mg/kg),N,,CHEMBL624107,,A,10116.0,1,,,10344
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5302,,50597,,Oral bioavailability in rat (dose single 10 mg/kg),N,,CHEMBL623943,,A,10116.0,1,,,10345
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5302,,50597,,Oral bioavailability in rat (dose 5 mg/kg,N,,CHEMBL623944,,A,10116.0,1,,,10346
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,N,,CHEMBL623945,,A,10116.0,1,,,10347
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,N,,CHEMBL623946,,A,10116.0,1,,,10348
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,N,,CHEMBL623947,,A,10116.0,1,,,10349
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,N,,CHEMBL623948,,A,10116.0,1,,,10350
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,N,,CHEMBL623949,,A,10116.0,1,,,10351
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,N,,CHEMBL623950,,A,10116.0,1,,,10352
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,N,,CHEMBL874398,,A,10116.0,1,,,10353
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,N,,CHEMBL623951,,A,10116.0,1,,,10354
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,N,,CHEMBL623952,,A,10116.0,1,,,10355
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,N,,CHEMBL623953,,A,10116.0,1,,,10356
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,N,,CHEMBL623954,,A,10116.0,1,,,10357
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,N,,CHEMBL623955,,A,10116.0,1,,,10358
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,N,,CHEMBL623956,,A,10116.0,1,,,10359
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,N,,CHEMBL627807,,A,10116.0,1,,,10360
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,N,,CHEMBL627808,,A,10116.0,1,,,10361
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,N,,CHEMBL627809,,A,10116.0,1,,,10362
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,N,,CHEMBL627810,,A,10116.0,1,,,10363
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",N,,CHEMBL627811,,A,10116.0,1,,,10364
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",N,,CHEMBL627812,,A,10116.0,1,,,10365
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",N,,CHEMBL627813,,A,10116.0,1,,,10366
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",N,,CHEMBL627814,,A,10116.0,1,,,10367
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",N,,CHEMBL875336,,A,10116.0,1,,,10368
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",N,,CHEMBL627815,,A,10116.0,1,,,10369
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",N,,CHEMBL627816,,A,10116.0,1,,,10370
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",N,,CHEMBL627817,,A,10116.0,1,,,10371
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",N,,CHEMBL627818,,A,10116.0,1,,,10372
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",N,,CHEMBL627819,,A,10116.0,1,,,10373
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",N,,CHEMBL627820,,A,10116.0,1,,,10374
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",N,,CHEMBL627821,,A,10116.0,1,,,10375
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,,CHEMBL628464,,A,10116.0,1,,,10376
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,N,,CHEMBL626239,,A,10116.0,1,,,10377
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,N,,CHEMBL626240,,A,10116.0,1,,,10378
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,N,,CHEMBL626241,,A,10116.0,1,,,10379
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,N,,CHEMBL626242,,A,10116.0,1,,,10380
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,N,,CHEMBL626243,,A,10116.0,1,,,10381
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,,CHEMBL626244,,A,10116.0,1,,,10382
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,N,,CHEMBL626907,,A,10116.0,1,,,10383
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,,CHEMBL626908,,A,10116.0,1,,,10384
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,,CHEMBL626909,,A,10116.0,1,,,10385
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,,CHEMBL626910,,A,10116.0,1,,,10386
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7449,,50597,,Percent total excretion of acetaminophen cysteine conjugate,N,,CHEMBL875342,,F,10116.0,1,,,10387
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7449,,50597,,Percent total excretion of acetaminophen glucuronide,N,,CHEMBL626911,,F,10116.0,1,,,10388
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7449,,50597,,Percent total excretion of acetaminophen sulfate,N,,CHEMBL626912,,F,10116.0,1,,,10389
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7449,,50597,,Percent total excretion of acetaminophen-mercapturic acid,N,,CHEMBL627065,,F,10116.0,1,,,10390
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,3172,,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,N,,CHEMBL627066,,A,10116.0,1,,,10391
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16456,,50597,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,CHEMBL627067,,A,10116.0,1,,,10392
,0,BAO_0000218,In vivo,ratrat,Muscle tissue,2385.0,Autocuration,10839,,22224,,Biodistribution of compound in rat muscle after 5 min of administration,U,,CHEMBL627068,,A,8656.0,1,,,10393
,0,BAO_0000218,In vivo,ratrat,Muscle tissue,2385.0,Autocuration,10839,,22224,,Biodistribution of compound in rat muscle after 5 min of administration.,U,,CHEMBL627069,,A,8656.0,1,,,10394
,0,BAO_0000218,In vivo,Ovis aries,,,Autocuration,5334,,22224,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,CHEMBL627070,,A,9940.0,1,,,10395
,0,BAO_0000218,In vivo,Ovis aries,,,Autocuration,5334,,22224,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,CHEMBL627071,,A,9940.0,1,,,10396
,0,BAO_0000218,In vivo,Ovis aries,,,Autocuration,5334,,22224,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,CHEMBL627072,,A,9940.0,1,,,10397
,0,BAO_0000218,In vivo,Ovis aries,,,Autocuration,5334,,22224,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,CHEMBL627073,,A,9940.0,1,,,10398
,0,BAO_0000218,In vivo,Ovis aries,,,Autocuration,5334,,22224,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,CHEMBL625387,,A,9940.0,1,,,10399
,0,BAO_0000218,In vivo,Ovis aries,,,Autocuration,5334,,22224,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,CHEMBL625388,,A,9940.0,1,,,10400
,0,BAO_0000218,In vivo,Ovis aries,Plasma,1969.0,Autocuration,5334,,22224,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,CHEMBL625389,,A,9940.0,1,,,10401
,0,BAO_0000218,In vivo,Ovis aries,Plasma,1969.0,Autocuration,5334,,22224,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,CHEMBL875343,,A,9940.0,1,,,10402
,1,BAO_0000218,,Serpentes,,,Intermediate,1735,,50497,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),N,,CHEMBL876795,,A,8570.0,1,,,10403
,1,BAO_0000218,,Serpentes,,,Intermediate,1469,,50497,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,N,,CHEMBL626552,,A,8570.0,1,,,10404
,1,BAO_0000218,,Serpentes,,,Intermediate,1336,,50497,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,N,,CHEMBL626553,,A,8570.0,1,,,10405
,0,BAO_0000366,,Homo sapiens,Plasma,1969.0,Autocuration,12403,,22224,,The human biological plasma half life of the compound,U,,CHEMBL626554,,A,9606.0,1,,,10406
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8151,,50597,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,,CHEMBL626555,,A,10116.0,1,,,10407
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,N,,CHEMBL626556,,A,10116.0,1,,,10408
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,N,,CHEMBL626557,,A,10116.0,1,,,10409
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,N,,CHEMBL626558,,A,10116.0,1,,,10410
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,N,,CHEMBL626559,,A,10116.0,1,,,10411
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,N,,CHEMBL626560,,A,10116.0,1,,,10412
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,N,,CHEMBL876803,,A,10116.0,1,,,10413
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,N,,CHEMBL627964,,A,10116.0,1,,,10414
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,N,,CHEMBL627965,,A,10116.0,1,,,10415
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,N,,CHEMBL627966,,A,10116.0,1,,,10416
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,N,,CHEMBL627967,,A,10116.0,1,,,10417
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,N,,CHEMBL627968,,A,10116.0,1,,,10418
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,N,,CHEMBL627969,,A,10116.0,1,,,10419
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8004,,50597,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,N,,CHEMBL627970,,A,10116.0,1,,,10420
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8004,,50597,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,N,,CHEMBL627971,,A,10116.0,1,,,10421
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8004,,50597,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,N,,CHEMBL627972,,A,10116.0,1,,,10422
,9,BAO_0000357,,Homo sapiens,,,Expert,15917,,180,,Dissociation constant against binding to human cyclophilin A,D,,CHEMBL856029,,B,9606.0,1,,,10423
,8,BAO_0000019,,Bos taurus,,,Expert,12396,,11591,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,H,,CHEMBL627973,,B,9913.0,1,,,10424
,0,BAO_0000019,,,,,Autocuration,7065,,22224,,-Log C was determined by performing the electroshock minimum test,U,,CHEMBL627974,,A,,1,,,10425
,0,BAO_0000019,,,,,Autocuration,7065,,22224,,-Log C was determined by performing the foot shock test,U,,CHEMBL627975,,A,,1,,,10426
,0,BAO_0000019,,,,,Autocuration,7065,,22224,,-Log C was determined by performing the incl screen test,U,,CHEMBL627976,,A,,1,,,10427
,0,BAO_0000019,,,,,Autocuration,7065,,22224,,-Log C was determined by performing the maximum electroshock test,U,,CHEMBL627977,,A,,1,,,10428
,0,BAO_0000019,,,,,Autocuration,7065,,22224,,-Log C was determined by performing the pentylenetetrazole test,U,,CHEMBL627978,,A,,1,,,10429
,0,BAO_0000019,,,,,Autocuration,12415,,22224,,Tested for experimental arotinoid inhibitory dose,U,,CHEMBL627979,,A,,1,,,10430
,0,BAO_0000019,,,,,Autocuration,10256,,22224,,Negative log transformed activity,U,,CHEMBL876804,,A,,1,,,10431
,0,BAO_0000019,,,,,Autocuration,7991,,22224,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",U,,CHEMBL627980,,A,,1,,,10432
,1,BAO_0000218,,Cavia porcellus,,,Intermediate,14342,,50512,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,N,,CHEMBL627981,,A,10141.0,1,,,10433
,1,BAO_0000218,,Cavia porcellus,,,Intermediate,14342,,50512,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,N,,CHEMBL627982,,A,10141.0,1,,,10434
,1,BAO_0000218,,Cavia porcellus,,,Intermediate,14342,,50512,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,N,,CHEMBL627983,,A,10141.0,1,,,10435
,1,BAO_0000218,,Cavia porcellus,Ileum,2116.0,Intermediate,14342,,50512,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,N,,CHEMBL627984,,A,10141.0,1,,,10436
,0,BAO_0000100,,,,,Autocuration,6047,,22229,,Solubility in water was determined; values expressed as -log,U,,CHEMBL627985,,P,,1,,,10437
,0,BAO_0000019,,,,,Autocuration,17269,,22224,,Ratio of Kcat to that of Km was determined,U,,CHEMBL627986,,A,,1,,,10438
,0,BAO_0000019,,,,,Autocuration,10026,,22224,,Observed first order rate constant,U,,CHEMBL627987,,A,,1,,,10439
,0,BAO_0000019,,,,,Autocuration,14583,,22224,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,U,,CHEMBL627988,,A,,1,,,10440
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,N,,CHEMBL627989,,A,10116.0,1,,,10441
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2661,,50597,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,N,,CHEMBL627990,,A,10116.0,1,,,10442
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4029,,50597,,Oral Bioavailability after administration of 10 mg/kg in male rat,N,,CHEMBL876805,,A,10116.0,1,,,10443
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17735,,50597,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),N,,CHEMBL627991,,A,10116.0,1,,,10444
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4576,,50597,,Oral bioavailability in rat,N,,CHEMBL627992,,A,10116.0,1,,,10445
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17582,,50597,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,,CHEMBL627993,,A,10116.0,1,,,10446
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17651,,50597,,Oral bioavailability at 1 mg/kg was determined in rat,N,,CHEMBL622817,,A,10116.0,1,,,10447
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17651,,50597,,Oral bioavailability at 10 mg/kg was determined in rat,N,,CHEMBL622818,,A,10116.0,1,,,10448
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17670,,50597,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",N,,CHEMBL622819,,A,10116.0,1,,,10449
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5045,,50597,,Oral bioavailability in rat,N,,CHEMBL872267,,A,10116.0,1,,,10450
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1696,,50597,,Oral bioavailability in rat,N,,CHEMBL622820,,A,10116.0,1,,,10451
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17764,,50597,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,N,,CHEMBL622821,,A,10116.0,1,,,10452
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6448,,50597,,Oral bioavailability in rat,N,,CHEMBL622822,,A,10116.0,1,,,10453
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6596,,50597,,Oral bioavailability in rat,N,,CHEMBL622823,,A,10116.0,1,,,10454
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17547,,50597,,Oral bioavailability in rat,N,,CHEMBL622824,,A,10116.0,1,,,10455
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17771,,50597,,Oral bioavailability in rat at a dose of 3 mg/kg,N,,CHEMBL622825,,A,10116.0,1,,,10456
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6495,,50597,,Oral bioavailability in rat after oral administration at 10 mg/kg,N,,CHEMBL622901,,A,10116.0,1,,,10457
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4558,,50597,,Oral bioavailability in rat,N,,CHEMBL622902,,A,10116.0,1,,,10458
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17596,,50597,,Oral bioavailability in rat,N,,CHEMBL621844,,A,10116.0,1,,,10459
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6827,,50597,,Oral bioavailability in Dawley rats,N,,CHEMBL621845,,A,10116.0,1,,,10460
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4026,,50597,,Oral bioavailability,N,,CHEMBL621846,,A,10116.0,1,,,10461
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,10,,50597,,Oral bioavailability in rat (dose 30 mg/kg),N,,CHEMBL621847,,A,10116.0,1,,,10462
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17717,,50597,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,,CHEMBL877609,,A,10116.0,1,,,10463
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17717,,50597,,Bioavailability in rat (dose 3 mg/kg i.v.),N,,CHEMBL621848,,A,10116.0,1,,,10464
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17717,,50597,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,,CHEMBL621849,,A,10116.0,1,,,10465
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17717,,50597,,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,,CHEMBL622030,,A,10116.0,1,,,10466
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4796,,50597,,Percent oral bioavailability determined in rats,N,,CHEMBL622031,,A,10116.0,1,,,10467
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4883,,50597,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,,CHEMBL622032,,A,10116.0,1,,,10468
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2137,,50597,,The compound was evaluated for bioavailability in rats; 32-51,N,,CHEMBL622033,,A,10116.0,1,,,10469
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2959,,50597,,Bioavailability in rat (dose 20 mg/kg p.o.),N,,CHEMBL622034,,A,10116.0,1,,,10470
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1361,,50597,,Oral bioavailability in rat,N,,CHEMBL622035,,A,10116.0,1,,,10471
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4727,,50597,,Bioavailability percent in rat at the dose of 2 mg/kg,N,,CHEMBL882966,,A,10116.0,1,,,10472
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16423,,50597,,Bioavailability was evaluated after 20 uM/kg of peroral administration,N,,CHEMBL622036,,A,10116.0,1,,,10473
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5206,,50597,,Oral bioavailability in rat,N,,CHEMBL622037,,A,10116.0,1,,,10474
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6448,,50597,,Oral bioavailability in rat,N,,CHEMBL622038,,A,10116.0,1,,,10475
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17723,,50597,,Bioavailability in rats,N,,CHEMBL622039,,A,10116.0,1,,,10476
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,N,,CHEMBL622040,,A,10116.0,1,,,10477
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,N,,CHEMBL622041,,A,10116.0,1,,,10478
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,N,,CHEMBL622042,,A,10116.0,1,,,10479
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,N,,CHEMBL622043,,A,10116.0,1,,,10480
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,N,,CHEMBL622044,,A,10116.0,1,,,10481
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,N,,CHEMBL622045,,A,10116.0,1,,,10482
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,N,,CHEMBL622046,,A,10116.0,1,,,10483
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,N,,CHEMBL622047,,A,10116.0,1,,,10484
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,N,,CHEMBL877610,,A,10116.0,1,,,10485
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,N,,CHEMBL622048,,A,10116.0,1,,,10486
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,N,,CHEMBL622049,,A,10116.0,1,,,10487
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,N,,CHEMBL622050,,A,10116.0,1,,,10488
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,N,,CHEMBL622051,,A,10116.0,1,,,10489
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,N,,CHEMBL622052,,A,10116.0,1,,,10490
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,N,,CHEMBL622053,,A,10116.0,1,,,10491
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,N,,CHEMBL622054,,A,10116.0,1,,,10492
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,N,,CHEMBL622055,,A,10116.0,1,,,10493
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5237,,50597,,Oral bioavailability in rats was determined; High,N,,CHEMBL622056,,A,10116.0,1,,,10494
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5503,,50597,,Oral bioavailability in the rat was determined,N,,CHEMBL622057,,A,10116.0,1,,,10495
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15765,,50597,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,N,,CHEMBL628008,,A,10116.0,1,,,10496
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15660,,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),N,,CHEMBL622058,,A,10116.0,1,,,10497
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL622059,,A,10116.0,1,,,10498
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL622060,,A,10116.0,1,,,10499
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL622061,,A,10116.0,1,,,10500
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5978,,50597,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,CHEMBL622062,,A,10116.0,1,,,10501
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5656,,50597,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,N,,CHEMBL622063,,A,10116.0,1,,,10502
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Expert,3598,,50597,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,CHEMBL877611,,A,10116.0,1,,,10503
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4216,,50597,,Oral bioavailability of compound in Sprague Dawley rats,N,,CHEMBL622064,,A,10116.0,1,,,10504
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17839,,50597,,Oral bioavailability of compound in rat,N,,CHEMBL622065,,A,10116.0,1,,,10505
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6570,,50597,,Oral bioavailability in rat (dose 2 mg/kg),N,,CHEMBL622066,,A,10116.0,1,,,10506
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5334,,50597,,Oral bioavailability of compound in rat was determined,N,,CHEMBL622067,,A,10116.0,1,,,10507
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6886,,50597,,Oral bioavailability of compound in rats,N,,CHEMBL622068,,A,10116.0,1,,,10508
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5210,,50597,,Oral bioavailability of compound was determined in rats,N,,CHEMBL622069,,A,10116.0,1,,,10509
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4170,,50597,,Oral bioavailability at a dose of 30 mg/kg in rats,N,,CHEMBL624796,,A,10116.0,1,,,10510
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6028,,50597,,Oral bioavailability in rat (dose 10 mg/kg),N,,CHEMBL624797,,A,10116.0,1,,,10511
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6028,,50597,,Oral bioavailability in rat (dose 10 mg/kg),N,,CHEMBL623053,,A,10116.0,1,,,10512
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6078,,50597,,Oral bioavailability evaluated in rat,N,,CHEMBL623054,,A,10116.0,1,,,10513
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6168,,50597,,Oral bioavailability in fasted rat,N,,CHEMBL623055,,A,10116.0,1,,,10514
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6168,,50597,,Oral bioavailability in fed rat,N,,CHEMBL623056,,A,10116.0,1,,,10515
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5160,,50597,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),N,,CHEMBL623057,,A,10116.0,1,,,10516
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6057,,50597,,Oral bioavailability in rat,N,,CHEMBL623058,,A,10116.0,1,,,10517
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6535,,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,,CHEMBL623059,,A,10116.0,1,,,10518
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6535,,50597,,Oral bioavailability in rat after administration of 10 mg/kg po,N,,CHEMBL623060,,A,10116.0,1,,,10519
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4194,,50597,,Oral bioavailability in rat,N,,CHEMBL623061,,A,10116.0,1,,,10520
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6230,,50597,,Oral bioavailability in rat,N,,CHEMBL623062,,A,10116.0,1,,,10521
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6619,,50597,,Oral bioavailability in rat,N,,CHEMBL623063,,A,10116.0,1,,,10522
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17607,,50597,,Oral bioavailability in rat,N,,CHEMBL623064,,A,10116.0,1,,,10523
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4942,,50597,,Oral bioavailability in ratrs,N,,CHEMBL623065,,A,10116.0,1,,,10524
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4942,,50597,,Oral bioavailability in rat,N,,CHEMBL623066,,A,10116.0,1,,,10525
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6646,,50597,,Oral bioavailability in rat,N,,CHEMBL623067,,A,10116.0,1,,,10526
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5237,,50597,,Oral bioavailability in rats was determined; High,N,,CHEMBL623068,,A,10116.0,1,,,10527
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6646,,50597,,Oral bioavailability in rat,N,,CHEMBL623069,,A,10116.0,1,,,10528
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4449,,50597,,Oral bioavailability in rat,N,,CHEMBL623070,,A,10116.0,1,,,10529
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6057,,50597,,Oral bioavailability was calculated in rat,N,,CHEMBL623071,,A,10116.0,1,,,10530
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2552,,50597,,Oral bioavailability,N,,CHEMBL623072,,A,10116.0,1,,,10531
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5496,,50597,,Oral bioavailability,N,,CHEMBL623073,,A,10116.0,1,,,10532
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6484,,50597,,Oral bioavailability,N,,CHEMBL623074,,A,10116.0,1,,,10533
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6485,,50597,,Oral bioavailability,N,,CHEMBL623075,,A,10116.0,1,,,10534
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6616,,50597,,Oral bioavailability after i.v. administration,N,,CHEMBL623076,,A,10116.0,1,,,10535
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4969,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,CHEMBL623077,,A,10116.0,1,,,10536
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5862,,50597,,Oral bioavailability in rat (Sprague-Dawley),N,,CHEMBL623078,,A,10116.0,1,,,10537
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4514,,50597,,Oral bioavailability in Sprague-Dawley rats,N,,CHEMBL623079,,A,10116.0,1,,,10538
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4514,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,CHEMBL623080,,A,10116.0,1,,,10539
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4514,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,CHEMBL623081,,A,10116.0,1,,,10540
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5546,,50597,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,N,,CHEMBL623082,,A,10116.0,1,,,10541
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6168,,50597,,Oral bioavailability in fasted rat,N,,CHEMBL874400,,A,10116.0,1,,,10542
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6168,,50597,,Oral bioavailability in fed rat,N,,CHEMBL623083,,A,10116.0,1,,,10543
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3624,,50597,,Oral bioavailability in rat,N,,CHEMBL623084,,A,10116.0,1,,,10544
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5213,,50597,,Oral bioavailability in rat,N,,CHEMBL623085,,A,10116.0,1,,,10545
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5496,,50597,,Oral bioavailability in rat,N,,CHEMBL623086,,A,10116.0,1,,,10546
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5553,,50597,,Oral bioavailability in rat,N,,CHEMBL623087,,A,10116.0,1,,,10547
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5833,,50597,,Oral bioavailability in rat,N,,CHEMBL623088,,A,10116.0,1,,,10548
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5836,,50597,,Oral bioavailability in rat,N,,CHEMBL623089,,A,10116.0,1,,,10549
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5865,,50597,,Oral bioavailability in rat,N,,CHEMBL623090,,A,10116.0,1,,,10550
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5960,,50597,,Oral bioavailability in rat,N,,CHEMBL623091,,A,10116.0,1,,,10551
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6249,,50597,,Oral bioavailability in rat,N,,CHEMBL623092,,A,10116.0,1,,,10552
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6448,,50597,,Oral bioavailability in rat,N,,CHEMBL623093,,A,10116.0,1,,,10553
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6453,,50597,,Oral bioavailability in rat,N,,CHEMBL874401,,A,10116.0,1,,,10554
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6640,,50597,,Oral bioavailability in rat,N,,CHEMBL623094,,A,10116.0,1,,,10555
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17607,,50597,,Oral bioavailability in rat,N,,CHEMBL623095,,A,10116.0,1,,,10556
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5939,,50597,,Oral bioavailability in rat after peroral administration at 10 mg/kg,N,,CHEMBL623096,,A,10116.0,1,,,10557
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5939,,50597,,Oral bioavailability in rat after peroral administration at 5 mg/kg,N,,CHEMBL624913,,A,10116.0,1,,,10558
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6281,,50597,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),N,,CHEMBL624914,,A,10116.0,1,,,10559
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5874,,50597,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,N,,CHEMBL624915,,A,10116.0,1,,,10560
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5213,,50597,,Oral bioavailability in rat; Not measured,N,,CHEMBL624916,,A,10116.0,1,,,10561
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4964,,50597,,Oral bioavailability in rat,N,,CHEMBL624917,,A,10116.0,1,,,10562
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11020,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,N,,CHEMBL625157,,A,10116.0,1,,,10563
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,6251,,50597,,In vitro metabolic potential in rat liver microsomes,N,,CHEMBL625158,,A,10116.0,1,,,10564
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1568,,50597,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",N,,CHEMBL625159,,A,10116.0,1,,,10565
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3032,,50597,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",N,,CHEMBL625160,,A,10116.0,1,,,10566
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3748,,50597,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,N,,CHEMBL625161,,A,10116.0,1,,,10567
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,401,,50597,,Oral bioavailability in rat,N,,CHEMBL625162,,A,10116.0,1,,,10568
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6512,,50597,,Oral bioavailability in rat,N,,CHEMBL625163,,A,10116.0,1,,,10569
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17617,,50597,,Oral bioavailability in rats at 10 mg/kg,N,,CHEMBL625164,,A,10116.0,1,,,10570
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6679,,50597,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,CHEMBL625165,,A,10116.0,1,,,10571
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6742,,50597,,Oral bioavailability in rat,N,,CHEMBL625166,,A,10116.0,1,,,10572
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,589,,50597,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,N,,CHEMBL625167,,A,10116.0,1,,,10573
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,589,,50597,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,N,,CHEMBL625168,,A,10116.0,1,,,10574
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3185,,50597,,Plasma clearance of the compound,N,,CHEMBL625169,,A,10116.0,1,,,10575
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17596,,50597,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,N,,CHEMBL626264,,A,10116.0,1,,,10576
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2713,,50597,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,N,,CHEMBL626265,,A,10116.0,1,,,10577
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12500,,50597,,The compound was tested for plasma clearance in rat,N,,CHEMBL626266,,A,10116.0,1,,,10578
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12500,,50597,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,N,,CHEMBL626267,,A,10116.0,1,,,10579
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2713,,50597,,Plasma concentration upon oral administration of 1 mg/Kg in rats,N,,CHEMBL626268,,A,10116.0,1,,,10580
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,1446,,50597,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,N,,CHEMBL626269,,A,10116.0,1,,,10581
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6227,,50597,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,N,,CHEMBL626270,,A,10116.0,1,,,10582
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4709,,50597,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,N,,CHEMBL626271,,A,10116.0,1,,,10583
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5510,,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",N,,CHEMBL626272,,A,10116.0,1,,,10584
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5510,,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,,CHEMBL626273,,A,10116.0,1,,,10585
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5510,,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,,CHEMBL875346,,A,10116.0,1,,,10586
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5510,,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",N,,CHEMBL626274,,A,10116.0,1,,,10587
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4514,,50597,,Compound was tested for protein binding in rat plasma,N,,CHEMBL626275,,A,10116.0,1,,,10588
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2713,,50597,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,N,,CHEMBL624646,,A,10116.0,1,,,10589
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2713,,50597,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,N,,CHEMBL624647,,A,10116.0,1,,,10590
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,5340,,50597,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,N,,CHEMBL624648,,A,10116.0,1,,,10591
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12058,,50597,,Area under curve ratio was determined (po/iv) in rat,N,,CHEMBL624649,,A,10116.0,1,,,10592
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11195,,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,N,,CHEMBL624650,,A,10116.0,1,,,10593
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11195,,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,N,,CHEMBL624651,,A,10116.0,1,,,10594
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11195,,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,N,,CHEMBL624652,,A,10116.0,1,,,10595
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6495,,50597,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,N,,CHEMBL624653,,A,10116.0,1,,,10596
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6078,,50597,,Ratio of AUCbrain to AUCplasma,N,,CHEMBL624654,,A,10116.0,1,,,10597
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5656,,50597,,Ratio of brain to plasma,N,,CHEMBL624655,,A,10116.0,1,,,10598
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4910,,50597,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,N,,CHEMBL624656,,A,10116.0,1,,,10599
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4910,,50597,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,,CHEMBL624657,,A,10116.0,1,,,10600
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4910,,50597,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,,CHEMBL624658,,A,10116.0,1,,,10601
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10130,,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,N,,CHEMBL624659,,A,10116.0,1,,,10602
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10130,,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,N,,CHEMBL624660,,A,10116.0,1,,,10603
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10130,,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,N,,CHEMBL624661,,A,10116.0,1,,,10604
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5213,,50597,,Steady state brain :blood ratio was determined,N,,CHEMBL624662,,A,10116.0,1,,,10605
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4910,,50597,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,CHEMBL625199,,A,10116.0,1,,,10606
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4910,,50597,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,,CHEMBL625200,,A,10116.0,1,,,10607
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4910,,50597,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,CHEMBL625201,,A,10116.0,1,,,10608
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,4910,,50597,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,,CHEMBL625202,,A,10116.0,1,,,10609
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2083,,50597,,Percentage recovery after 3h incubation with rat hapatocytes was determined,N,,CHEMBL625203,,A,10116.0,1,,,10610
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2082,,50597,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,N,,CHEMBL625204,,A,10116.0,1,,,10611
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2082,,50597,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,N,,CHEMBL625205,,A,10116.0,1,,,10612
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6351,,50597,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,N,,CHEMBL625206,,A,10116.0,1,,,10613
,0,BAO_0000019,,,,,Autocuration,14583,,22224,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",U,,CHEMBL625207,,A,,1,,,10614
,0,BAO_0000019,,,,,Autocuration,14583,,22224,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,U,,CHEMBL625208,,A,,1,,,10615
,1,BAO_0000218,,Homo sapiens,,,Intermediate,4608,,50587,,In vivo absorption in Caco-2 cell line monolayers was determined,N,,CHEMBL625209,,A,9606.0,1,Caco-2,495.0,10616
,0,BAO_0000100,,,,,Autocuration,13668,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625210,,P,,1,,,10617
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5669,,50597,,Area under curve was determine after peroral administration at 10 mpk in Rat,N,,CHEMBL625211,,A,10116.0,1,,,10618
,1,BAO_0000218,,Macaca mulatta,,,Intermediate,5669,,50797,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,N,,CHEMBL625212,,A,9544.0,1,,,10619
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5669,,50597,,Area under curve was determine after peroral administration at 160 mpk in Rat,N,,CHEMBL625213,,A,10116.0,1,,,10620
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5669,,50597,,Area under curve was determine after peroral administration at 20 mpk in Rat,N,,CHEMBL625214,,A,10116.0,1,,,10621
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,5669,,50597,,Area under curve was determine after peroral administration at 50 mpk in Rat,N,,CHEMBL874542,,A,10116.0,1,,,10622
,0,BAO_0000100,,,,,Autocuration,6472,,22229,,Calculated partition coefficient (clogP) (AlogP),U,,CHEMBL625215,,P,,1,,,10623
,0,BAO_0000019,,,,,Autocuration,15106,,22224,,Activated partial thromboplastin time measured,U,,CHEMBL625216,,A,,1,,,10624
,0,BAO_0000100,,,,,Autocuration,15207,,22224,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),U,,CHEMBL625217,,P,,1,,,10625
,0,BAO_0000100,,,,,Autocuration,15207,,22224,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),U,,CHEMBL625218,,P,,1,,,10626
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,13941,,50588,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,N,,CHEMBL622864,,A,9615.0,1,,,10627
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,13941,,50597,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,N,,CHEMBL622865,,A,10116.0,1,,,10628
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,13941,,50597,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,N,,CHEMBL622866,,A,10116.0,1,,,10629
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,13941,,50588,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,N,,CHEMBL622867,,A,9615.0,1,,,10630
,1,BAO_0000218,,Cavia porcellus,Plasma,1969.0,Intermediate,15240,,50512,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,N,,CHEMBL876808,,A,10141.0,1,,,10631
,0,BAO_0000019,,,Brain,955.0,Autocuration,10655,,22224,,AUC in brain,U,,CHEMBL627725,,A,,1,,,10632
,0,BAO_0000019,,,Serum,1977.0,Autocuration,10655,,22224,,AUC in serum,U,,CHEMBL627726,,A,,1,,,10633
,0,BAO_0000019,,,Plasma,1969.0,Autocuration,6504,,22224,,AUC was determined,U,,CHEMBL627727,,A,,1,,,10634
,0,BAO_0000019,,,Plasma,1969.0,Autocuration,10615,,22224,,AUC of the compound.,U,,CHEMBL627728,,A,,1,,,10635
,0,BAO_0000019,,,Plasma,1969.0,Autocuration,10353,,22224,,AUC value (0-4 hr),U,,CHEMBL627729,,A,,1,,,10636
,0,BAO_0000019,,,Plasma,1969.0,Autocuration,14907,,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",U,,CHEMBL627730,,A,,1,,,10637
,0,BAO_0000019,,,Plasma,1969.0,Autocuration,14907,,22224,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,U,,CHEMBL627731,,A,,1,,,10638
,0,BAO_0000019,,,Plasma,1969.0,Autocuration,14907,,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",U,,CHEMBL627732,,A,,1,,,10639
,0,BAO_0000019,,,Plasma,1969.0,Autocuration,14907,,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",U,,CHEMBL627733,,A,,1,,,10640
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,16359,,50597,,AUC(area under curve) was determined after intravenous administration in rats,N,,CHEMBL627734,,A,10116.0,1,,,10641
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,16359,,50597,,AUC(area under curve) was determined after oral administration in rats,N,,CHEMBL627735,,A,10116.0,1,,,10642
,1,BAO_0000218,,Cavia porcellus,Plasma,1969.0,Intermediate,15240,,50512,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,N,,CHEMBL627736,,A,10141.0,1,,,10643
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,15240,,50597,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,N,,CHEMBL876809,,A,10116.0,1,,,10644
,0,BAO_0000019,,,,,Autocuration,15469,,22224,,Area Under Curve after oral dosing of 100 uM/Kg,U,,CHEMBL627737,,A,,1,,,10645
,0,BAO_0000019,,,,,Autocuration,15469,,22224,,Area Under Curve after oral dosing of 30 uM/Kg,U,,CHEMBL627738,,A,,1,,,10646
,0,BAO_0000019,,,,,Autocuration,13520,,22224,,Area Under Curve was measured by ploting the graph between concentration verses time,U,,CHEMBL627739,,A,,1,,,10647
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,17025,,50588,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,N,,CHEMBL626143,,A,9615.0,1,,,10648
,0,BAO_0000218,,Simiiformes,,,Autocuration,17025,,22224,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,U,,CHEMBL626144,,A,314293.0,1,,,10649
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,17025,,50592,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,N,,CHEMBL626145,,A,9986.0,1,,,10650
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17025,,50597,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,N,,CHEMBL626146,,A,10116.0,1,,,10651
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,12032,,50597,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,N,,CHEMBL626147,,A,10116.0,1,,,10652
,0,BAO_0000019,,,,,Autocuration,10291,,22224,,Area under curve (AUC) was determined,U,,CHEMBL626148,,A,,1,,,10653
,0,BAO_0000218,,,,,Autocuration,5767,,22224,,Area under curve (AUC) following ip administration at 1 mg/kg,U,,CHEMBL626149,,A,,1,,,10654
,0,BAO_0000019,,,,,Autocuration,1434,,22224,,Area under curve (AUC) was determined; ND is Not determined,U,,CHEMBL626150,,A,,1,,,10655
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14925,,50588,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,N,,CHEMBL626151,,A,9615.0,1,,,10656
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14925,,50588,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,N,,CHEMBL626152,,A,9615.0,1,,,10657
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14925,,50588,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,N,,CHEMBL626153,,A,9615.0,1,,,10658
,0,BAO_0000019,,,,,Autocuration,1434,,22224,,Area under curve (AUR) was determined,U,,CHEMBL626154,,A,,1,,,10659
,0,BAO_0000019,,,,,Autocuration,11883,,22224,,Area under curve at 1 uM/dg administered intravenously,U,,CHEMBL626155,,A,,1,,,10660
,0,BAO_0000019,,,,,Autocuration,11883,,22224,,Area under curve at 10 uM/dg administered perorally,U,,CHEMBL626156,,A,,1,,,10661
,0,BAO_0000019,,,,,Autocuration,11883,,22224,,Area under curve at 2 uM/dg administered intravenously,U,,CHEMBL626157,,A,,1,,,10662
,0,BAO_0000019,,,,,Autocuration,11883,,22224,,Area under curve at 20 uM/dg administered perorally,U,,CHEMBL626158,,A,,1,,,10663
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,15233,,50588,,Area under curve at a peroral dose of 3 mg/kg in dog,N,,CHEMBL626159,,A,9615.0,1,,,10664
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15233,,50597,,Area under curve at a peroral dose of 3 mg/kg in rat,N,,CHEMBL626160,,A,10116.0,1,,,10665
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,15233,,50588,,Area under curve at an iv dose of 1 mg/kg in dog,N,,CHEMBL626161,,A,9615.0,1,,,10666
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15233,,50597,,Area under curve at an iv dose of 1 mg/kg in rat,N,,CHEMBL626162,,A,10116.0,1,,,10667
,0,BAO_0000019,,,,,Autocuration,12978,,22224,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,U,,CHEMBL626163,,A,,1,,,10668
,0,BAO_0000019,,,,,Autocuration,12978,,22224,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,U,,CHEMBL626164,,A,,1,,,10669
,1,BAO_0000218,,Mus musculus,,,Intermediate,11355,,50594,,Area under curve measured as conc vs time after intravenous administration to mice.,N,,CHEMBL626165,,A,10090.0,1,,,10670
,1,BAO_0000218,,Mus musculus,,,Intermediate,11355,,50594,,Area under curve measured as conc vs time after peroral administration to mice.,N,,CHEMBL626166,,A,10090.0,1,,,10671
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,12923,,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,,CHEMBL626167,,A,9615.0,1,,,10672
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,12923,,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,N,,CHEMBL626168,,A,9615.0,1,,,10673
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,12923,,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,N,,CHEMBL877463,,A,9615.0,1,,,10674
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,12923,,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,N,,CHEMBL626169,,A,9615.0,1,,,10675
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,N,,CHEMBL626170,,A,10116.0,1,,,10676
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,N,,CHEMBL626171,,A,10116.0,1,,,10677
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,N,,CHEMBL626172,,A,10116.0,1,,,10678
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,N,,CHEMBL626173,,A,10116.0,1,,,10679
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,N,,CHEMBL626174,,A,10116.0,1,,,10680
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,N,,CHEMBL626175,,A,10116.0,1,,,10681
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,N,,CHEMBL626176,,A,10116.0,1,,,10682
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,N,,CHEMBL626177,,A,10116.0,1,,,10683
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,N,,CHEMBL622499,,A,10116.0,1,,,10684
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,N,,CHEMBL622500,,A,10116.0,1,,,10685
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,N,,CHEMBL622501,,A,10116.0,1,,,10686
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,N,,CHEMBL622502,,A,10116.0,1,,,10687
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,N,,CHEMBL622503,,A,10116.0,1,,,10688
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,N,,CHEMBL877614,,A,10116.0,1,,,10689
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,N,,CHEMBL624839,,A,10116.0,1,,,10690
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,N,,CHEMBL624840,,A,10116.0,1,,,10691
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,N,,CHEMBL624841,,A,10116.0,1,,,10692
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,N,,CHEMBL624842,,A,10116.0,1,,,10693
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,N,,CHEMBL624843,,A,10116.0,1,,,10694
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,N,,CHEMBL624844,,A,10116.0,1,,,10695
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,N,,CHEMBL624845,,A,10116.0,1,,,10696
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,17738,,50597,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,N,,CHEMBL621904,,A,10116.0,1,,,10697
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,N,,CHEMBL621905,,A,10116.0,1,,,10698
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,N,,CHEMBL874382,,A,10116.0,1,,,10699
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,N,,CHEMBL621906,,A,10116.0,1,,,10700
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,N,,CHEMBL621907,,A,10116.0,1,,,10701
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,N,,CHEMBL622096,,A,10116.0,1,,,10702
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,N,,CHEMBL622097,,A,10116.0,1,,,10703
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,N,,CHEMBL622098,,A,10116.0,1,,,10704
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,N,,CHEMBL622099,,A,10116.0,1,,,10705
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,N,,CHEMBL622100,,A,10116.0,1,,,10706
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,N,,CHEMBL622101,,A,10116.0,1,,,10707
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,N,,CHEMBL622102,,A,10116.0,1,,,10708
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,N,,CHEMBL622103,,A,10116.0,1,,,10709
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,N,,CHEMBL622104,,A,10116.0,1,,,10710
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,N,,CHEMBL622105,,A,10116.0,1,,,10711
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,N,,CHEMBL622106,,A,10116.0,1,,,10712
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,N,,CHEMBL622107,,A,10116.0,1,,,10713
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,N,,CHEMBL622108,,A,10116.0,1,,,10714
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,N,,CHEMBL622109,,A,10116.0,1,,,10715
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,N,,CHEMBL622110,,A,10116.0,1,,,10716
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,N,,CHEMBL622111,,A,10116.0,1,,,10717
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,N,,CHEMBL874383,,A,10116.0,1,,,10718
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,N,,CHEMBL622112,,A,10116.0,1,,,10719
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,N,,CHEMBL622113,,A,10116.0,1,,,10720
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,N,,CHEMBL622114,,A,10116.0,1,,,10721
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,N,,CHEMBL622115,,A,10116.0,1,,,10722
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,11195,,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,N,,CHEMBL622116,,A,10116.0,1,,,10723
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6193,,50597,,Oral bioavailability in rat,N,,CHEMBL622117,,A,10116.0,1,,,10724
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6803,,50597,,Oral bioavailability in rat,N,,CHEMBL622118,,A,10116.0,1,,,10725
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6647,,50597,,Oral bioavailability in rats at 6 mg/kg,N,,CHEMBL622119,,A,10116.0,1,,,10726
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6647,,50597,,Oral bioavailability in rat (dose 6 mg/kg),N,,CHEMBL622120,,A,10116.0,1,,,10727
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6647,,50597,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,N,,CHEMBL622121,,A,10116.0,1,,,10728
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6640,,50597,,Oral bioavailability in rat,N,,CHEMBL622122,,A,10116.0,1,,,10729
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6641,,50597,,Oral bioavailability in rat,N,,CHEMBL622123,,A,10116.0,1,,,10730
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6641,,50597,,Oral bioavailability in rat,N,,CHEMBL622124,,A,10116.0,1,,,10731
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6642,,50597,,Bioavailability in rat,N,,CHEMBL622125,,A,10116.0,1,,,10732
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5472,,50597,,Oral bioavailability,N,,CHEMBL622126,,A,10116.0,1,,,10733
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6141,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,CHEMBL620455,,A,10116.0,1,,,10734
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4390,,50597,,Oral bioavailability in rat,N,,CHEMBL620456,,A,10116.0,1,,,10735
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5472,,50597,,Oral bioavailability in rat,N,,CHEMBL620457,,A,10116.0,1,,,10736
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5472,,50597,,Oral bioavailability was evaluated; Not tested,N,,CHEMBL620458,,A,10116.0,1,,,10737
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5438,,50597,,Oral bioavailability,N,,CHEMBL620459,,A,10116.0,1,,,10738
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4883,,50597,,Oral bioavailability in rat by oral dosing,N,,CHEMBL620460,,A,10116.0,1,,,10739
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1908,,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,,CHEMBL620461,,A,10116.0,1,,,10740
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4853,,50597,,Oral bioavailability in rat (Sprague-Dawley),N,,CHEMBL620462,,A,10116.0,1,,,10741
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4853,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,CHEMBL620463,,A,10116.0,1,,,10742
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4853,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,CHEMBL620464,,A,10116.0,1,,,10743
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4853,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,CHEMBL620465,,A,10116.0,1,,,10744
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4853,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),N,,CHEMBL620466,,A,10116.0,1,,,10745
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4853,,50597,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,N,,CHEMBL620467,,A,10116.0,1,,,10746
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4853,,50597,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,N,,CHEMBL620468,,A,10116.0,1,,,10747
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12873,,50597,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,N,,CHEMBL620469,,A,10116.0,1,,,10748
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12873,,50597,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,N,,CHEMBL620470,,A,10116.0,1,,,10749
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3169,,50597,,Oral bioavailability in rat,N,,CHEMBL620471,,A,10116.0,1,,,10750
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6305,,50597,,Oral bioavailability in rat,N,,CHEMBL620472,,A,10116.0,1,,,10751
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4762,,50597,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,N,,CHEMBL620473,,A,10116.0,1,,,10752
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17847,,50597,,Oral bioavailability in rat,N,,CHEMBL620474,,A,10116.0,1,,,10753
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6211,,50597,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),N,,CHEMBL620475,,A,10116.0,1,,,10754
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6011,,50597,,Oral bioavailability in rat,N,,CHEMBL620476,,A,10116.0,1,,,10755
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6317,,50597,,Oral bioavailability in rat,N,,CHEMBL620477,,A,10116.0,1,,,10756
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6644,,50597,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,N,,CHEMBL620478,,A,10116.0,1,,,10757
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6644,,50597,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,N,,CHEMBL618768,,A,10116.0,1,,,10758
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6644,,50597,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,N,,CHEMBL618769,,A,10116.0,1,,,10759
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6644,,50597,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,N,,CHEMBL618770,,A,10116.0,1,,,10760
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6113,,50597,,Oral bioavailability (dose 20 mg/kg p.o.),N,,CHEMBL618771,,A,10116.0,1,,,10761
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5937,,50597,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,N,,CHEMBL618772,,A,10116.0,1,,,10762
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5711,,50597,,Oral bioavailability in rat at 10 mg/kg of the compound,N,,CHEMBL618773,,A,10116.0,1,,,10763
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17717,,50597,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,,CHEMBL875842,,A,10116.0,1,,,10764
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17717,,50597,,Bioavailability in rat (dose 3 mg/kg i.v.),N,,CHEMBL618774,,A,10116.0,1,,,10765
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17717,,50597,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,,CHEMBL618775,,A,10116.0,1,,,10766
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17717,,50597,,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,,CHEMBL618776,,A,10116.0,1,,,10767
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4722,,50597,,Percent bioavailability (F) in rats after iv administration,N,,CHEMBL618777,,A,10116.0,1,,,10768
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4722,,50597,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,N,,CHEMBL618778,,A,10116.0,1,,,10769
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4353,,50597,,Bioavailability in rat (dose 5 uM/kg p.o.),N,,CHEMBL618779,,A,10116.0,1,,,10770
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15662,,50597,,Oral bioavailability,N,,CHEMBL618780,,A,10116.0,1,,,10771
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4756,,50597,,Bioavailability in rat (dose 2 mg/kg p.o.),N,,CHEMBL618781,,A,10116.0,1,,,10772
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,4756,,50597,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,N,,CHEMBL618782,,A,10116.0,1,,,10773
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3436,,50597,,Oral bioavailability in rat (dose 20 mg/kg),N,,CHEMBL618783,,A,10116.0,1,,,10774
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17800,,50597,,Oral bioavailability in rat,N,,CHEMBL618784,,A,10116.0,1,,,10775
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15762,,50597,,Percent oral bioavailability evaluated in rat,N,,CHEMBL618785,,A,10116.0,1,,,10776
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5089,,50597,,Oral bioavailability in rat,N,,CHEMBL618786,,A,10116.0,1,,,10777
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5089,,50597,,Percent oral bioavailability in rat; Not determined,N,,CHEMBL618787,,A,10116.0,1,,,10778
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3185,,50597,,Oral bioavailability in rat,N,,CHEMBL618788,,A,10116.0,1,,,10779
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5145,,50597,,Bioavailability in rat,N,,CHEMBL618789,,A,10116.0,1,,,10780
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3457,,50597,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),N,,CHEMBL618790,,A,10116.0,1,,,10781
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3457,,50597,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),N,,CHEMBL618791,,A,10116.0,1,,,10782
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5983,,50597,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,N,,CHEMBL875843,,A,10116.0,1,,,10783
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5739,,50597,,Oral bioavailability in rat (dose 20 mg/kg p.o.),N,,CHEMBL618792,,A,10116.0,1,,,10784
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,3579,,50597,,Cmax at a dose of 30 mg/kg in rat,N,,CHEMBL623395,,A,10116.0,1,,,10785
,0,BAO_0000218,In vivo,Simiiformes,,,Autocuration,17788,,22224,,Cmax in monkeys at a dose of 1 mg/kg,U,,CHEMBL623396,,A,314293.0,1,,,10786
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14956,,50597,,Cmax in rat,N,,CHEMBL623397,,A,10116.0,1,,,10787
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17788,,50597,,Cmax in rats at a dose of 1 mg/kg,N,,CHEMBL623398,,A,10116.0,1,,,10788
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,9750,,50594,,Cmax was measured in mice after an oral dose of 50 mg/kg.,N,,CHEMBL623399,,A,10090.0,1,,,10789
,0,BAO_0000218,In vivo,,,,Autocuration,12767,,22224,,"Cmax value at a dose of 12.7 uM/kg, po",U,,CHEMBL623400,,A,,1,,,10790
,0,BAO_0000218,In vivo,,,,Autocuration,12767,,22224,,"Cmax value at a dose of 6.3 uM/kg, iv",U,,CHEMBL623401,,A,,1,,,10791
,0,BAO_0000218,In vivo,,,,Autocuration,12767,,22224,,"Cmax value at a dose of 7.1 uM/kg, iv",U,,CHEMBL623402,,A,,1,,,10792
,0,BAO_0000218,In vivo,,,,Autocuration,12703,,22224,,Cmax value of compound was determined after 1 hr,U,,CHEMBL623403,,A,,1,,,10793
,0,BAO_0000218,In vivo,,,,Autocuration,15778,,22224,,Cmax value of the compound,U,,CHEMBL623404,,A,,1,,,10794
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12818,,50597,,Cmax value administered intraintestinal in rats.,N,,CHEMBL625997,,A,10116.0,1,,,10795
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14964,,50597,,Cmax value administered perorally was determined in rat; Not determined,N,,CHEMBL625998,,A,10116.0,1,,,10796
,0,BAO_0000218,In vivo,,,,Autocuration,15808,,22224,,Cmax value at the dose of 2.3 mg/kg,U,,CHEMBL625999,,A,,1,,,10797
,0,BAO_0000218,In vivo,,,,Autocuration,15808,,22224,,Cmax value at the dose of 5 mg/kg,U,,CHEMBL626000,,A,,1,,,10798
,0,BAO_0000218,In vivo,,,,Autocuration,15778,,22224,,Cmax value in the period of 8 hr after dosing. ,U,,CHEMBL626001,,A,,1,,,10799
,0,BAO_0000218,In vivo,,,,Autocuration,3715,,22224,,Cmax value at a oral dose of 20 mg/kg; Not tested,U,,CHEMBL626002,,A,,1,,,10800
,0,BAO_0000218,In vivo,,,,Autocuration,3715,,22224,,Cmax value at a oral dose of 20 mg/kg,U,,CHEMBL626003,,A,,1,,,10801
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,1446,,50597,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,,CHEMBL626004,,A,10116.0,1,,,10802
,1,BAO_0000218,In vivo,Cavia porcellus,,,Intermediate,15240,,50512,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,N,,CHEMBL626005,,A,10141.0,1,,,10803
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15240,,50597,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,N,,CHEMBL626006,,A,10116.0,1,,,10804
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14810,,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,N,,CHEMBL626007,,A,10116.0,1,,,10805
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,14239,,50594,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,N,,CHEMBL626008,,A,10090.0,1,,,10806
,1,BAO_0000218,In vivo,Canis lupus familiaris,Liver,2107.0,Intermediate,12555,,50588,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,N,,CHEMBL626009,,A,9615.0,1,,,10807
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,10754,,50588,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,N,,CHEMBL626010,,A,9615.0,1,,,10808
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,10754,,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,N,,CHEMBL626011,,A,10090.0,1,,,10809
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,10754,,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,N,,CHEMBL626012,,A,10090.0,1,,,10810
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,10754,,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,N,,CHEMBL626013,,A,10090.0,1,,,10811
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,10754,,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,N,,CHEMBL626014,,A,10090.0,1,,,10812
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,10754,,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,N,,CHEMBL877496,,A,10090.0,1,,,10813
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14600,,50588,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,N,,CHEMBL626015,,F,9615.0,1,,,10814
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14600,,50588,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,N,,CHEMBL626016,,F,9615.0,1,,,10815
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14600,,50588,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,N,,CHEMBL626017,,F,9615.0,1,,,10816
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,13543,,50588,,Bioavailability as maximal plasma concentration in dogs,N,,CHEMBL626018,,A,9615.0,1,,,10817
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,13543,,50588,,Bioavailability as maximal plasma concentration in dogs,N,,CHEMBL626692,,A,9615.0,1,,,10818
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,13543,,50597,,Bioavailability as maximal plasma concentration in rats,N,,CHEMBL626693,,A,10116.0,1,,,10819
,0,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Autocuration,13543,,22224,,Bioavailability as maximal plasma concentration in rats,U,,CHEMBL626694,,A,10116.0,1,,,10820
,1,BAO_0000218,In vivo,Canis lupus familiaris,Blood,178.0,Intermediate,14600,,50588,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,CHEMBL626695,,A,9615.0,1,,,10821
,1,BAO_0000218,In vivo,Canis lupus familiaris,Blood,178.0,Intermediate,14600,,50588,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,CHEMBL626696,,A,9615.0,1,,,10822
,1,BAO_0000218,In vivo,Canis lupus familiaris,Blood,178.0,Intermediate,14600,,50588,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,CHEMBL626697,,A,9615.0,1,,,10823
,1,BAO_0000218,In vivo,Canis lupus familiaris,Blood,178.0,Intermediate,14600,,50588,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,N,,CHEMBL626859,,A,9615.0,1,,,10824
,1,BAO_0000218,In vivo,Canis lupus familiaris,Blood,178.0,Intermediate,14600,,50588,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,CHEMBL626860,,A,9615.0,1,,,10825
,1,BAO_0000218,In vivo,Canis lupus familiaris,Blood,178.0,Intermediate,14600,,50588,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,CHEMBL626861,,A,9615.0,1,,,10826
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14681,,50597,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,,CHEMBL626296,,A,10116.0,1,,,10827
,0,BAO_0000218,In vivo,,,,Autocuration,15905,,22224,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,U,,CHEMBL626297,,A,,1,,,10828
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,15905,,22224,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,U,,CHEMBL626298,,A,,1,,,10829
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,13304,,50597,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",N,,CHEMBL626299,,A,10116.0,1,,,10830
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15137,,50597,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,N,,CHEMBL626300,,A,10116.0,1,,,10831
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15137,,50597,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,N,,CHEMBL626301,,A,10116.0,1,,,10832
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15137,,50597,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,N,,CHEMBL626962,,A,10116.0,1,,,10833
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15137,,50597,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,N,,CHEMBL626963,,A,10116.0,1,,,10834
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15137,,50597,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,N,,CHEMBL626964,,A,10116.0,1,,,10835
,1,BAO_0000218,In vivo,Macaca fascicularis,Plasma,1969.0,Intermediate,14839,,100710,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,N,,CHEMBL626965,,A,9541.0,1,,,10836
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,14839,,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,CHEMBL626966,,A,10090.0,1,,,10837
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,14839,,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,CHEMBL626967,,A,10090.0,1,,,10838
,1,BAO_0000218,In vivo,Macaca fascicularis,Plasma,1969.0,Intermediate,14839,,100710,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,N,,CHEMBL626968,,A,9541.0,1,,,10839
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,N,,CHEMBL626969,,A,10116.0,1,,,10840
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,N,,CHEMBL627126,,A,10116.0,1,,,10841
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,N,,CHEMBL631276,,A,10116.0,1,,,10842
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,N,,CHEMBL631277,,A,10116.0,1,,,10843
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,N,,CHEMBL631278,,A,10116.0,1,,,10844
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,N,,CHEMBL874457,,A,10116.0,1,,,10845
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,N,,CHEMBL631279,,A,10116.0,1,,,10846
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,N,,CHEMBL631280,,A,10116.0,1,,,10847
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,N,,CHEMBL631281,,A,10116.0,1,,,10848
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,N,,CHEMBL631968,,A,10116.0,1,,,10849
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,N,,CHEMBL631969,,A,10116.0,1,,,10850
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,N,,CHEMBL631970,,A,10116.0,1,,,10851
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,N,,CHEMBL631971,,A,10116.0,1,,,10852
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,N,,CHEMBL631972,,A,10116.0,1,,,10853
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,N,,CHEMBL630435,,A,10116.0,1,,,10854
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,N,,CHEMBL630436,,A,10116.0,1,,,10855
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,N,,CHEMBL630437,,A,10116.0,1,,,10856
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,N,,CHEMBL630438,,A,10116.0,1,,,10857
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8418,,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,N,,CHEMBL630439,,A,10116.0,1,,,10858
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,N,,CHEMBL630440,,A,10116.0,1,,,10859
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,N,,CHEMBL630441,,A,10116.0,1,,,10860
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,N,,CHEMBL630442,,A,10116.0,1,,,10861
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,N,,CHEMBL625234,,A,10116.0,1,,,10862
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,N,,CHEMBL625235,,A,10116.0,1,,,10863
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,N,,CHEMBL625236,,A,10116.0,1,,,10864
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,N,,CHEMBL625237,,A,10116.0,1,,,10865
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,N,,CHEMBL626125,,A,10116.0,1,,,10866
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,N,,CHEMBL626126,,A,10116.0,1,,,10867
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,N,,CHEMBL626127,,A,10116.0,1,,,10868
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,N,,CHEMBL626128,,A,10116.0,1,,,10869
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,N,,CHEMBL626129,,A,10116.0,1,,,10870
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,N,,CHEMBL626130,,A,10116.0,1,,,10871
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,N,,CHEMBL626131,,A,10116.0,1,,,10872
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,N,,CHEMBL626132,,A,10116.0,1,,,10873
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,N,,CHEMBL626752,,A,10116.0,1,,,10874
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,N,,CHEMBL626753,,A,10116.0,1,,,10875
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,N,,CHEMBL626754,,A,10116.0,1,,,10876
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8418,,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,N,,CHEMBL626755,,A,10116.0,1,,,10877
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,N,,CHEMBL626756,,A,10116.0,1,,,10878
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,N,,CHEMBL626757,,A,10116.0,1,,,10879
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,N,,CHEMBL626758,,A,10116.0,1,,,10880
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,N,,CHEMBL626759,,A,10116.0,1,,,10881
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,N,,CHEMBL626760,,A,10116.0,1,,,10882
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL626394,,A,9615.0,1,,,10883
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,N,,CHEMBL626395,,A,9615.0,1,,,10884
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,,CHEMBL626396,,A,9615.0,1,,,10885
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,,CHEMBL626397,,A,9615.0,1,,,10886
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,,CHEMBL626398,,A,9615.0,1,,,10887
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL626399,,A,9615.0,1,,,10888
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,N,,CHEMBL874653,,A,10116.0,1,,,10889
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL626400,,A,10116.0,1,,,10890
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,,CHEMBL626401,,A,10116.0,1,,,10891
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,,CHEMBL626402,,A,10116.0,1,,,10892
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL626403,,A,10116.0,1,,,10893
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL626404,,A,10116.0,1,,,10894
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,N,,CHEMBL626405,,A,10116.0,1,,,10895
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL625529,,A,10116.0,1,,,10896
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,,CHEMBL625530,,A,10116.0,1,,,10897
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,,CHEMBL625531,,A,10116.0,1,,,10898
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL625532,,A,10116.0,1,,,10899
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL625533,,A,10116.0,1,,,10900
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,N,,CHEMBL875474,,A,10116.0,1,,,10901
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL625534,,A,10116.0,1,,,10902
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,,CHEMBL625535,,A,10116.0,1,,,10903
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,,CHEMBL625536,,A,10116.0,1,,,10904
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL625537,,A,10116.0,1,,,10905
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL625538,,A,10116.0,1,,,10906
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,N,,CHEMBL625539,,A,10116.0,1,,,10907
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL625540,,A,10116.0,1,,,10908
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,CHEMBL625541,,A,10116.0,1,,,10909
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,,CHEMBL625542,,A,10116.0,1,,,10910
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL625543,,A,10116.0,1,,,10911
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL625544,,A,10116.0,1,,,10912
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,N,,CHEMBL625545,,A,9615.0,1,,,10913
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,,CHEMBL625546,,A,9615.0,1,,,10914
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,N,,CHEMBL625547,,A,9615.0,1,,,10915
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL625548,,A,9615.0,1,,,10916
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL625549,,A,9615.0,1,,,10917
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,,CHEMBL625550,,A,9615.0,1,,,10918
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL625551,,A,9615.0,1,,,10919
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL875475,,A,9615.0,1,,,10920
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL625552,,A,9615.0,1,,,10921
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,,CHEMBL625553,,A,9615.0,1,,,10922
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,,CHEMBL625554,,A,9615.0,1,,,10923
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,,CHEMBL625555,,A,9615.0,1,,,10924
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL625556,,A,9615.0,1,,,10925
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,N,,CHEMBL624986,,A,9615.0,1,,,10926
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,,CHEMBL624987,,A,9615.0,1,,,10927
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,,CHEMBL624988,,A,9615.0,1,,,10928
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,N,,CHEMBL624989,,A,9615.0,1,,,10929
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,N,,CHEMBL624990,,A,9615.0,1,,,10930
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,N,,CHEMBL874391,,A,9615.0,1,,,10931
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,N,,CHEMBL624991,,A,9615.0,1,,,10932
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,N,,CHEMBL624992,,A,9615.0,1,,,10933
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,N,,CHEMBL624993,,A,9615.0,1,,,10934
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,N,,CHEMBL624994,,A,9615.0,1,,,10935
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,N,,CHEMBL624995,,A,9615.0,1,,,10936
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,N,,CHEMBL624996,,A,9615.0,1,,,10937
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,N,,CHEMBL624997,,A,9615.0,1,,,10938
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,N,,CHEMBL624998,,A,9615.0,1,,,10939
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,N,,CHEMBL624999,,A,9615.0,1,,,10940
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,N,,CHEMBL882955,,A,9615.0,1,,,10941
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,N,,CHEMBL625000,,A,9615.0,1,,,10942
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,N,,CHEMBL625001,,A,9615.0,1,,,10943
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,N,,CHEMBL625089,,A,9615.0,1,,,10944
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,N,,CHEMBL625090,,A,9615.0,1,,,10945
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,N,,CHEMBL625091,,A,9615.0,1,,,10946
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,N,,CHEMBL625092,,A,9615.0,1,,,10947
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,N,,CHEMBL625093,,A,9615.0,1,,,10948
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,N,,CHEMBL625094,,A,9615.0,1,,,10949
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,N,,CHEMBL625095,,A,9615.0,1,,,10950
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,2249,,50588,,Compound was evaluated for its bioavailability in the dogs,N,,CHEMBL625096,,A,9615.0,1,,,10951
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2249,,50597,,Compound was evaluated for its bioavailability in the rats,N,,CHEMBL625097,,A,10116.0,1,,,10952
,0,BAO_0000218,In vivo,,,,Autocuration,17515,,22224,,Compound was evaluated for oral bioavailability,U,,CHEMBL882956,,A,,1,,,10953
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14541,,50597,,Compound was evaluated for percentage of Oral bioavailability in rats,N,,CHEMBL625098,,A,10116.0,1,,,10954
,0,BAO_0000218,In vivo,Cavia porcellus,,,Autocuration,12797,,22224,,Bioavailability in guinea pig,U,,CHEMBL625099,,A,10141.0,1,,,10955
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12797,,50597,,Compound was evaluated for the oral bioavailability in rat,N,,CHEMBL625100,,A,10116.0,1,,,10956
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,12797,,50588,,Compound was evaluated for the oral bioavailability in dog,N,,CHEMBL625101,,A,9615.0,1,,,10957
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12797,,50597,,Compound was evaluated for the oral bioavailability in rat,N,,CHEMBL874396,,A,10116.0,1,,,10958
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,11727,,22224,,Bioavailability in dog (dosed i.v.),U,,CHEMBL625102,,F,9615.0,1,,,10959
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13249,,50588,,Compound was tested for in vivo bioavailability in dog,N,,CHEMBL625103,,A,9615.0,1,,,10960
,1,BAO_0000218,In vivo,Cricetinae,,,Intermediate,13249,,100712,,Compound was tested for in vivo bioavailability in hamsters,N,,CHEMBL625104,,A,10026.0,1,,,10961
,0,BAO_0000218,In vivo,Simiiformes,,,Autocuration,13249,,22224,,Compound was tested for in vivo bioavailability in monkey,U,,CHEMBL625105,,A,314293.0,1,,,10962
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13249,,50597,,Compound was tested for in vivo bioavailability in rat,N,,CHEMBL625106,,A,10116.0,1,,,10963
,0,BAO_0000218,In vivo,Mus musculus,,,Autocuration,9552,,22224,,Oral bioavailability in mouse,U,,CHEMBL625107,,A,10090.0,1,,,10964
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,9552,,50594,,Compound was tested for percent of oral bioavailability in mice; 56-74,N,,CHEMBL625108,,A,10090.0,1,,,10965
,0,BAO_0000218,In vivo,Mus musculus,,,Autocuration,14839,,22224,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),U,,CHEMBL625109,,A,10090.0,1,,,10966
,0,BAO_0000218,In vivo,Macaca fascicularis,,,Autocuration,14839,,22224,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),U,,CHEMBL625110,,A,9541.0,1,,,10967
,0,BAO_0000218,In vivo,Macaca fascicularis,,,Autocuration,14839,,22224,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),U,,CHEMBL625111,,A,9541.0,1,,,10968
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14839,,50594,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),N,,CHEMBL625112,,A,10090.0,1,,,10969
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14839,,50594,,Oral bioavailability in nude mice,N,,CHEMBL875334,,A,10090.0,1,,,10970
,0,BAO_0000218,In vivo,Primates,,,Autocuration,11219,,22224,,Bioavailability in monkey (i.d. dosing),U,,CHEMBL628617,,A,9443.0,1,,,10971
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,9552,,22224,,Bioavailability in rat,U,,CHEMBL628618,,A,10116.0,1,,,10972
,0,BAO_0000218,In vivo,,,,Autocuration,11732,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,U,,CHEMBL628619,,A,,1,,,10973
,0,BAO_0000218,In vivo,,,,Autocuration,11732,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,U,,CHEMBL628620,,A,,1,,,10974
,1,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,14839,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,,CHEMBL628621,,A,9541.0,1,,,10975
,1,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,14839,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,,CHEMBL628622,,A,9541.0,1,,,10976
,1,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,14839,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,,CHEMBL628623,,A,9541.0,1,,,10977
,1,BAO_0000218,In vivo,Macaca fascicularis,Plasma,1969.0,Intermediate,14839,,100710,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,N,,CHEMBL628624,,A,9541.0,1,,,10978
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,14839,,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,CHEMBL628625,,A,10090.0,1,,,10979
,1,BAO_0000218,In vivo,Macaca fascicularis,Plasma,1969.0,Intermediate,14839,,100710,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,N,,CHEMBL628626,,A,9541.0,1,,,10980
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,14839,,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,CHEMBL627041,,A,10090.0,1,,,10981
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,14839,,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,CHEMBL627042,,A,10090.0,1,,,10982
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,14839,,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,CHEMBL627043,,A,10090.0,1,,,10983
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,13932,,22224,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,U,,CHEMBL627044,,A,,1,,,10984
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,11637,,50594,,Cmax in mouse plasma,N,,CHEMBL627045,,A,10090.0,1,,,10985
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,11637,,22224,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,U,,CHEMBL627046,,A,,1,,,10986
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,13960,,50597,,Maximal plasma concentration in rat,N,,CHEMBL627047,,A,10116.0,1,,,10987
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15905,,50597,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,N,,CHEMBL627048,,A,10116.0,1,,,10988
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14062,,50597,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,N,,CHEMBL627049,,A,10116.0,1,,,10989
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14062,,50597,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,N,,CHEMBL627050,,A,10116.0,1,,,10990
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14062,,50597,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,N,,CHEMBL627051,,A,10116.0,1,,,10991
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14062,,50597,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,N,,CHEMBL627052,,A,10116.0,1,,,10992
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14062,,50597,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,N,,CHEMBL627053,,A,10116.0,1,,,10993
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14062,,50597,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,N,,CHEMBL627054,,A,10116.0,1,,,10994
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,15011,,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,CHEMBL627055,,A,10090.0,1,,,10995
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,15011,,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,,CHEMBL627056,,A,10090.0,1,,,10996
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,15011,,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,,CHEMBL627057,,A,10090.0,1,,,10997
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,15011,,50594,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,CHEMBL627058,,A,10090.0,1,,,10998
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,15011,,50594,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,,CHEMBL626211,,A,10090.0,1,,,10999
,0,BAO_0000218,In vivo,,,,Autocuration,10291,,22224,,Maximum Concentration of the compound.,U,,CHEMBL626212,,A,,1,,,11000
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14599,,50588,,Maximum Concentration was measured after iv administration into Beagle dog,N,,CHEMBL626213,,A,9615.0,1,,,11001
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14599,,50588,,Maximum Concentration was measured after iv administration into Beagle dog.,N,,CHEMBL626214,,A,9615.0,1,,,11002
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14599,,50588,,Maximum Concentration was measured after po administration into Beagle dog,N,,CHEMBL626215,,A,9615.0,1,,,11003
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14599,,50588,,Maximum Concentration was measured after po administration into Beagle dog.,N,,CHEMBL626216,,A,9615.0,1,,,11004
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,12767,,22224,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,U,,CHEMBL626217,,A,,1,,,11005
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,12767,,22224,,Maximum blood level reached after an iv dose of 12.2 uM/kg,U,,CHEMBL626218,,A,,1,,,11006
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,12767,,22224,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,U,,CHEMBL626219,,A,,1,,,11007
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,12767,,22224,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,U,,CHEMBL626220,,A,,1,,,11008
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,12767,,22224,,Maximum blood level reached after an oral dose of 5.0 mg/kg,U,,CHEMBL626221,,A,,1,,,11009
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,12767,,22224,,Maximum blood level reached at dose of 10.6 uM/kg orally,U,,CHEMBL626222,,A,,1,,,11010
,1,BAO_0000218,In vivo,Cavia porcellus,,,Intermediate,14706,,50512,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,N,,CHEMBL626223,,A,10141.0,1,,,11011
,1,BAO_0000218,In vivo,Cavia porcellus,,,Intermediate,14706,,50512,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,N,,CHEMBL626224,,A,10141.0,1,,,11012
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,14793,,50597,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,N,,CHEMBL626225,,A,10116.0,1,,,11013
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,14793,,50597,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,N,,CHEMBL626226,,A,10116.0,1,,,11014
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,14793,,50597,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,N,,CHEMBL626227,,A,10116.0,1,,,11015
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,14793,,50597,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,N,,CHEMBL626228,,A,10116.0,1,,,11016
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14793,,50597,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,,CHEMBL626229,,A,10116.0,1,,,11017
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14793,,50597,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,N,,CHEMBL626921,,A,10116.0,1,,,11018
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14793,,50597,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,N,,CHEMBL876793,,A,10116.0,1,,,11019
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14793,,50597,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,N,,CHEMBL625309,,A,10116.0,1,,,11020
,1,BAO_0000218,In vivo,Bacillus subtilis,,,Intermediate,10524,,50278,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,,CHEMBL625310,,A,1423.0,1,,,11021
,0,BAO_0000218,In vivo,Simiiformes,,,Autocuration,11871,,22224,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,U,,CHEMBL625311,,A,314293.0,1,,,11022
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,11871,,50597,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,N,,CHEMBL625312,,A,10116.0,1,,,11023
,0,BAO_0000218,In vivo,,,,Autocuration,3437,,22224,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,U,,CHEMBL625313,,A,,1,,,11024
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,12038,,50594,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,N,,CHEMBL625314,,A,10090.0,1,,,11025
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12038,,50597,,Maximum concentration in male rats after iv administration of 20 mg/kg,N,,CHEMBL625315,,A,10116.0,1,,,11026
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,N,,CHEMBL625316,,A,10116.0,1,,,11027
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,N,,CHEMBL625317,,A,10116.0,1,,,11028
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,N,,CHEMBL625318,,A,10116.0,1,,,11029
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,N,,CHEMBL625319,,A,10116.0,1,,,11030
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,N,,CHEMBL625320,,A,10116.0,1,,,11031
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,N,,CHEMBL625321,,A,10116.0,1,,,11032
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,N,,CHEMBL625322,,A,10116.0,1,,,11033
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,N,,CHEMBL876801,,A,10116.0,1,,,11034
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,N,,CHEMBL625323,,A,10116.0,1,,,11035
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,N,,CHEMBL625324,,A,10116.0,1,,,11036
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,N,,CHEMBL625325,,A,10116.0,1,,,11037
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,N,,CHEMBL625326,,A,10116.0,1,,,11038
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,N,,CHEMBL625327,,A,10116.0,1,,,11039
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8418,,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,N,,CHEMBL625328,,A,10116.0,1,,,11040
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,N,,CHEMBL625329,,A,10116.0,1,,,11041
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,N,,CHEMBL625330,,A,10116.0,1,,,11042
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,N,,CHEMBL627774,,A,10116.0,1,,,11043
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,N,,CHEMBL627775,,A,10116.0,1,,,11044
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,N,,CHEMBL627949,,A,10116.0,1,,,11045
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,N,,CHEMBL627950,,A,10116.0,1,,,11046
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,N,,CHEMBL627951,,A,10116.0,1,,,11047
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,N,,CHEMBL627952,,A,10116.0,1,,,11048
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,N,,CHEMBL627953,,A,10116.0,1,,,11049
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,N,,CHEMBL627954,,A,10116.0,1,,,11050
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,N,,CHEMBL627955,,A,10116.0,1,,,11051
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,N,,CHEMBL627956,,A,10116.0,1,,,11052
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,N,,CHEMBL876802,,A,10116.0,1,,,11053
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,N,,CHEMBL627957,,A,10116.0,1,,,11054
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,N,,CHEMBL627958,,A,10116.0,1,,,11055
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,N,,CHEMBL627959,,A,10116.0,1,,,11056
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,N,,CHEMBL627960,,A,10116.0,1,,,11057
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,N,,CHEMBL627961,,A,10116.0,1,,,11058
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8418,,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,N,,CHEMBL627962,,A,10116.0,1,,,11059
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9796,,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,CHEMBL627963,,A,10116.0,1,,,11060
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9796,,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,,CHEMBL624759,,A,10116.0,1,,,11061
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9796,,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,CHEMBL624760,,A,10116.0,1,,,11062
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9796,,50597,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,CHEMBL624761,,A,10116.0,1,,,11063
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9796,,50597,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,CHEMBL877607,,A,10116.0,1,,,11064
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,CHEMBL624762,,A,10116.0,1,,,11065
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,,CHEMBL624763,,A,10116.0,1,,,11066
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,CHEMBL624764,,A,10116.0,1,,,11067
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,CHEMBL624765,,A,10116.0,1,,,11068
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,CHEMBL624766,,A,10116.0,1,,,11069
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL624767,,A,9615.0,1,,,11070
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,N,,CHEMBL624768,,A,9615.0,1,,,11071
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,,CHEMBL624769,,A,9615.0,1,,,11072
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,,CHEMBL624770,,A,9615.0,1,,,11073
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,,CHEMBL624771,,A,9615.0,1,,,11074
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL624772,,A,9615.0,1,,,11075
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,N,,CHEMBL624773,,A,10116.0,1,,,11076
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL624774,,A,10116.0,1,,,11077
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,,CHEMBL624775,,A,10116.0,1,,,11078
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,,CHEMBL624776,,A,10116.0,1,,,11079
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL624777,,A,10116.0,1,,,11080
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL624778,,A,10116.0,1,,,11081
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,N,,CHEMBL624779,,A,10116.0,1,,,11082
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,,CHEMBL624780,,A,10116.0,1,,,11083
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL624781,,A,10116.0,1,,,11084
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL877608,,A,10116.0,1,,,11085
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,,CHEMBL624782,,A,10116.0,1,,,11086
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL624783,,A,10116.0,1,,,11087
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,N,,CHEMBL624784,,A,10116.0,1,,,11088
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL624785,,A,10116.0,1,,,11089
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,,CHEMBL624786,,A,10116.0,1,,,11090
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL624787,,A,10116.0,1,,,11091
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL628676,,A,10116.0,1,,,11092
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,N,,CHEMBL621842,,A,10116.0,1,,,11093
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL621843,,A,10116.0,1,,,11094
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,CHEMBL623873,,A,10116.0,1,,,11095
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,,CHEMBL623874,,A,10116.0,1,,,11096
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL623875,,A,10116.0,1,,,11097
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL623876,,A,10116.0,1,,,11098
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,N,,CHEMBL623877,,A,9615.0,1,,,11099
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,,CHEMBL623878,,A,9615.0,1,,,11100
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,N,,CHEMBL623879,,A,9615.0,1,,,11101
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL623880,,A,9615.0,1,,,11102
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL623881,,A,9615.0,1,,,11103
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,,CHEMBL623957,,A,9615.0,1,,,11104
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL623958,,A,9615.0,1,,,11105
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL623959,,A,9615.0,1,,,11106
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL623960,,A,9615.0,1,,,11107
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,,CHEMBL623961,,A,9615.0,1,,,11108
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,,CHEMBL623962,,A,9615.0,1,,,11109
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,,CHEMBL624676,,A,9615.0,1,,,11110
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL624677,,A,9615.0,1,,,11111
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,N,,CHEMBL624678,,A,9615.0,1,,,11112
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,,CHEMBL624679,,A,9615.0,1,,,11113
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,,CHEMBL624680,,A,9615.0,1,,,11114
,0,BAO_0000218,In vivo,,,,Autocuration,11732,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,U,,CHEMBL624849,,A,,1,,,11115
,0,BAO_0000218,In vivo,,,,Autocuration,11732,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,U,,CHEMBL624850,,A,,1,,,11116
,0,BAO_0000218,In vivo,,,,Autocuration,11732,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,U,,CHEMBL874399,,A,,1,,,11117
,0,BAO_0000218,In vivo,,,,Autocuration,11732,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,U,,CHEMBL624851,,A,,1,,,11118
,0,BAO_0000218,In vivo,,,,Autocuration,11732,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,U,,CHEMBL624852,,A,,1,,,11119
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,13359,,22224,,Oral bioavailability in rat (dose 10 mg/kg),U,,CHEMBL624853,,A,10116.0,1,,,11120
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,16618,,22224,,Oral bioavailability in rat (Sprague-Dawley),U,,CHEMBL624854,,A,10116.0,1,,,11121
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,13960,,22224,,Oral bioavailability in rat,U,,CHEMBL624855,,A,10116.0,1,,,11122
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,13917,,22224,,Oral bioavailability in rats was determined in vivo,U,,CHEMBL624856,,A,10116.0,1,,,11123
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,14266,,22224,,Oral bioavailability in dog,U,,CHEMBL882957,,A,9615.0,1,,,11124
,0,BAO_0000218,In vivo,Simiiformes,,,Autocuration,12359,,22224,,Oral bioavailability of compound in monkey,U,,CHEMBL624857,,A,314293.0,1,,,11125
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12359,,50597,,Oral bioavailability of compound in rat,N,,CHEMBL622202,,A,10116.0,1,,,11126
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,12359,,22224,,Bioavailability in rat of PMEA prodrug,U,,CHEMBL622203,,A,10116.0,1,,,11127
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12359,,50597,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,N,,CHEMBL625522,,A,10116.0,1,,,11128
,0,BAO_0000218,In vivo,Macaca mulatta,,,Autocuration,10791,,22224,,Serum conc at 3 hours following 25 mg/kg dose,U,,CHEMBL622868,,A,9544.0,1,,,11129
,0,BAO_0000218,In vivo,Macaca mulatta,Urine,1088.0,Autocuration,10791,,22224,,Urine conc 0-5 hours following 25 mg/kg dose,U,,CHEMBL622869,,A,9544.0,1,,,11130
,0,BAO_0000218,In vivo,Macaca mulatta,Urine,1088.0,Autocuration,10791,,22224,,Urine conc 0-24 hours following 25 mg/kg dose,U,,CHEMBL622870,,A,9544.0,1,,,11131
,0,BAO_0000218,In vivo,Chlorocebus aethiops,,,Autocuration,138,,22224,,Oral bioavailability in African green monkeys; 20-25,U,,CHEMBL622871,,A,9534.0,1,,,11132
,1,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,14521,,100710,,Oral bioavailability in cynomolgus monkey.,N,,CHEMBL620560,,A,9541.0,1,,,11133
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,13953,,22224,,Oral bioavailability in dog,U,,CHEMBL620561,,A,9615.0,1,,,11134
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,12836,,50588,,Oral bioavailability in dog at 10 mg/kg oral dose,N,,CHEMBL620562,,A,9615.0,1,,,11135
,1,BAO_0000218,In vivo,Cricetinae,,,Intermediate,12836,,100712,,Oral bioavailability in hamster at 10 mg/kg oral dose,N,,CHEMBL620563,,A,10026.0,1,,,11136
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12836,,50597,,Oral bioavailability in rat at 10 mg/kg oral dose,N,,CHEMBL620564,,A,10116.0,1,,,11137
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,14521,,22224,,Oral bioavailability in rat,U,,CHEMBL872265,,A,10116.0,1,,,11138
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,13953,,22224,,Oral bioavailability in rat,U,,CHEMBL620565,,A,10116.0,1,,,11139
,0,BAO_0000218,In vivo,Eutheria,,,Autocuration,6799,,22224,,Oral bioavailability,U,,CHEMBL620566,,A,9347.0,1,,,11140
,0,BAO_0000218,In vivo,,,,Autocuration,11311,,22224,,Oral bioavailability was determined; range 49-102%,U,,CHEMBL620567,,A,,1,,,11141
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,4013,,50588,,Oral bioavailability was determined in dogs,N,,CHEMBL620568,,A,9615.0,1,,,11142
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,4013,,22224,,Oral bioavailability in rat,U,,CHEMBL620569,,A,10116.0,1,,,11143
,0,BAO_0000218,In vivo,Eutheria,,,Autocuration,17591,,22224,,Oral bioavailability,U,,CHEMBL620570,,A,9347.0,1,,,11144
,0,BAO_0000218,In vivo,,,,Autocuration,17591,,22224,,Oral bioavailability was determined; Not orally available,U,,CHEMBL620571,,A,,1,,,11145
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,15011,,50594,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),N,,CHEMBL620572,,A,10090.0,1,,,11146
,0,BAO_0000218,In vivo,Mus musculus,,,Autocuration,15011,,22224,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),U,,CHEMBL620573,,A,10090.0,1,,,11147
,0,BAO_0000218,In vivo,Mus musculus,,,Autocuration,15011,,22224,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,U,,CHEMBL620574,,A,10090.0,1,,,11148
,0,BAO_0000218,In vivo,Macaca mulatta,,,Autocuration,9552,,22224,,Oral bioavailability in Rhesus monkey,U,,CHEMBL620575,,A,9544.0,1,,,11149
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,9552,,22224,,Oral bioavailability in dog (female mongrel),U,,CHEMBL620576,,A,9615.0,1,,,11150
,0,BAO_0000218,In vivo,,,,Autocuration,3639,,22224,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,U,,CHEMBL875846,,A,,1,,,11151
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,13397,,22224,,Oral bioavailability in dog,U,,CHEMBL620577,,A,9615.0,1,,,11152
,0,BAO_0000218,In vivo,,,,Autocuration,3031,,22224,,Percentage Bioavailability was evaluated.,U,,CHEMBL620578,,A,,1,,,11153
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,12818,,22224,,Bioavailability in rat administered i.d.,U,,CHEMBL620579,,A,10116.0,1,,,11154
,0,BAO_0000218,In vivo,Eutheria,,,Autocuration,4847,,22224,,Bioavailability,U,,CHEMBL621248,,A,9347.0,1,,,11155
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,12421,,22224,,Bioavailability in dog (male Beagle) i.v. administration,U,,CHEMBL625390,,A,9615.0,1,,,11156
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,11966,,22224,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",U,,CHEMBL625391,,A,10116.0,1,,,11157
,0,BAO_0000218,In vivo,Primates,,,Autocuration,11218,,22224,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),U,,CHEMBL872266,,A,9443.0,1,,,11158
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,13129,,22224,,Oral bioavailability in rat (Sprague-Dawley) (male),U,,CHEMBL625392,,A,10116.0,1,,,11159
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12350,,50597,,The oral bioavailability was measured on rats after oral administration,N,,CHEMBL625393,,A,10116.0,1,,,11160
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,2231,,50597,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,,CHEMBL625394,,A,10116.0,1,,,11161
,1,BAO_0000218,In vivo,Macaca mulatta,,,Intermediate,2231,,50797,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,,CHEMBL625395,,A,9544.0,1,,,11162
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,12187,,22224,,Bioavailability in rat (dose 10 mg/kg i.d.),U,,CHEMBL625396,,A,10116.0,1,,,11163
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,12421,,22224,,Bioavailability in dog (male Beagle) i.v. administration,U,,CHEMBL625397,,A,9615.0,1,,,11164
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL625398,,A,10090.0,1,,,11165
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL625399,,A,10090.0,1,,,11166
,1,BAO_0000218,In vivo,Mus musculus,Cerebellum,2037.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL626074,,A,10090.0,1,,,11167
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL626075,,A,10090.0,1,,,11168
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2231,,50597,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,,CHEMBL626076,,A,10116.0,1,,,11169
,1,BAO_0000218,In vivo,Macaca mulatta,Plasma,1969.0,Intermediate,2231,,50797,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,,CHEMBL626077,,A,9544.0,1,,,11170
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12178,,50597,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),N,,CHEMBL626078,,A,10116.0,1,,,11171
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,12178,,22224,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),U,,CHEMBL625846,,A,,1,,,11172
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,12178,,22224,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),U,,CHEMBL625847,,A,,1,,,11173
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Expert,15633,,50597,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,N,,CHEMBL625848,,A,10116.0,1,,,11174
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14258,,50597,,Maximum concentration of compound in plasma administered orally to rats,N,,CHEMBL625849,,A,10116.0,1,,,11175
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14224,,50588,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",N,,CHEMBL626023,,A,9615.0,1,,,11176
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14224,,50588,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",N,,CHEMBL626024,,A,9615.0,1,,,11177
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14224,,50588,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",N,,CHEMBL626025,,A,9615.0,1,,,11178
,0,BAO_0000218,In vivo,,,,Autocuration,5566,,22224,,Maximum concentration after 10 mg/kg by oral administration,U,,CHEMBL626026,,A,,1,,,11179
,0,BAO_0000218,In vivo,,,,Autocuration,16935,,22224,,Maximum concentration at a dose of 1.5 mg/kg,U,,CHEMBL626027,,A,,1,,,11180
,0,BAO_0000218,In vivo,,,,Autocuration,16935,,22224,,Maximum concentration at a dose of 2.0 mg/kg,U,,CHEMBL626028,,A,,1,,,11181
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14224,,50588,,Maximum concentration in dog plasma,N,,CHEMBL626029,,A,9615.0,1,,,11182
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,12536,,22224,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,U,,CHEMBL626030,,A,,1,,,11183
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,12536,,22224,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,U,,CHEMBL626031,,A,,1,,,11184
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,12536,,22224,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,U,,CHEMBL626032,,A,,1,,,11185
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,12536,,22224,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,U,,CHEMBL626033,,A,,1,,,11186
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,12536,,22224,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,U,,CHEMBL626034,,A,,1,,,11187
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,9994,,50588,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),N,,CHEMBL626035,,A,9615.0,1,,,11188
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,1434,,22224,,Maximum concentration in plasma at Tmax,U,,CHEMBL626036,,A,,1,,,11189
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Expert,12836,,50588,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,N,,CHEMBL626037,,A,9615.0,1,,,11190
,1,BAO_0000218,In vivo,Cricetinae,Plasma,1969.0,Intermediate,12836,,100712,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,N,,CHEMBL626038,,A,10026.0,1,,,11191
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12836,,50597,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,N,,CHEMBL626039,,A,10116.0,1,,,11192
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12545,,50597,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,N,,CHEMBL626040,,A,10116.0,1,,,11193
,1,BAO_0000218,In vivo,Oryctolagus cuniculus,Plasma,1969.0,Intermediate,13856,,50592,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,N,,CHEMBL626041,,A,9986.0,1,,,11194
,0,BAO_0000218,In vivo,,,,Autocuration,3550,,22224,,Maximum concentration was calculated,U,,CHEMBL626042,,A,,1,,,11195
,0,BAO_0000218,In vivo,,,,Autocuration,2632,,22224,,Maximum concentration was calculated.,U,,CHEMBL626043,,A,,1,,,11196
,0,BAO_0000218,In vivo,,,,Autocuration,5566,,22224,,Maximum concentration at a peroral dose of 10 mg/kg,U,,CHEMBL626044,,A,,1,,,11197
,0,BAO_0000218,In vivo,,,,Autocuration,11883,,22224,,Maximum concentration of the drug at 10 uM/dg administered perorally,U,,CHEMBL626045,,A,,1,,,11198
,0,BAO_0000218,In vivo,,,,Autocuration,11883,,22224,,Maximum concentration of the drug at 2 uM/dg administered intravenously,U,,CHEMBL626046,,A,,1,,,11199
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14122,,50588,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",N,,CHEMBL626047,,A,9615.0,1,,,11200
,1,BAO_0000218,In vivo,Cricetinae,Plasma,1969.0,Intermediate,14122,,100712,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",N,,CHEMBL626048,,A,10026.0,1,,,11201
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14122,,50597,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",N,,CHEMBL626049,,A,10116.0,1,,,11202
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12542,,50597,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,N,,CHEMBL626050,,A,10116.0,1,,,11203
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,12542,,50588,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,N,,CHEMBL874541,,A,9615.0,1,,,11204
,1,BAO_0000218,In vivo,Cricetinae,Plasma,1969.0,Intermediate,12542,,100712,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,N,,CHEMBL622826,,A,10026.0,1,,,11205
,1,BAO_0000218,In vivo,Cricetinae,Plasma,1969.0,Intermediate,12542,,100712,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,N,,CHEMBL622827,,A,10026.0,1,,,11206
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12542,,50597,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,N,,CHEMBL622828,,A,10116.0,1,,,11207
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14080,,50597,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,N,,CHEMBL622829,,A,10116.0,1,,,11208
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,11911,,50597,,Maximum concentration reached following intravenous administration in male rat,N,,CHEMBL876806,,A,10116.0,1,,,11209
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13204,,50588,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,N,,CHEMBL622830,,A,9615.0,1,,,11210
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13204,,50597,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,N,,CHEMBL622831,,A,10116.0,1,,,11211
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14346,,50588,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,N,,CHEMBL626794,,A,9615.0,1,,,11212
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14346,,50597,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,N,,CHEMBL626795,,A,10116.0,1,,,11213
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14346,,50597,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,N,,CHEMBL626796,,A,10116.0,1,,,11214
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14346,,50597,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,N,,CHEMBL626797,,A,10116.0,1,,,11215
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14127,,50597,,Maximum drug concentration is determined after oral dosing in rats.,N,,CHEMBL626798,,A,10116.0,1,,,11216
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14339,,50588,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,N,,CHEMBL626799,,A,9615.0,1,,,11217
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14339,,50588,,Maximum observed concentration in oral (5 mg/kg) fed dogs,N,,CHEMBL626800,,A,9615.0,1,,,11218
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,13494,,22224,,Maximum plasma concentration,U,,CHEMBL626801,,A,,1,,,11219
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14925,,50597,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,N,,CHEMBL876816,,A,10116.0,1,,,11220
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14474,,50597,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,N,,CHEMBL626802,,A,10116.0,1,,,11221
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14474,,50588,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,N,,CHEMBL626803,,A,9615.0,1,,,11222
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,13917,,22224,,Maximum plasma concentration following oral administration of 30 umol/kg,U,,CHEMBL626804,,A,,1,,,11223
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,N,,CHEMBL626805,,A,10116.0,1,,,11224
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,CHEMBL626309,,A,10116.0,1,,,11225
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,CHEMBL626310,,A,10116.0,1,,,11226
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,CHEMBL626311,,A,10116.0,1,,,11227
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,CHEMBL626312,,A,10116.0,1,,,11228
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,,CHEMBL626313,,A,10116.0,1,,,11229
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,CHEMBL626314,,A,10116.0,1,,,11230
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,CHEMBL626315,,A,10116.0,1,,,11231
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,CHEMBL626316,,A,10116.0,1,,,11232
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,9796,,50597,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,CHEMBL626317,,A,10116.0,1,,,11233
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),N,,CHEMBL626318,,A,10116.0,1,,,11234
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),N,,CHEMBL626319,,A,10116.0,1,,,11235
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),N,,CHEMBL626320,,A,10116.0,1,,,11236
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),N,,CHEMBL875053,,A,10116.0,1,,,11237
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),N,,CHEMBL626321,,A,10116.0,1,,,11238
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),N,,CHEMBL626322,,A,10116.0,1,,,11239
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),N,,CHEMBL626323,,A,10116.0,1,,,11240
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),N,,CHEMBL626324,,A,10116.0,1,,,11241
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),N,,CHEMBL626325,,A,10116.0,1,,,11242
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),N,,CHEMBL626326,,A,10116.0,1,,,11243
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),N,,CHEMBL626327,,A,10116.0,1,,,11244
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8363,,50597,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),N,,CHEMBL626328,,A,10116.0,1,,,11245
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8684,,50597,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",N,,CHEMBL626329,,A,10116.0,1,,,11246
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8684,,50597,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",N,,CHEMBL626330,,A,10116.0,1,,,11247
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8684,,50597,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL626331,,A,10116.0,1,,,11248
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8684,,50597,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL626332,,A,10116.0,1,,,11249
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8684,,50597,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",N,,CHEMBL626333,,A,10116.0,1,,,11250
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8684,,50597,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL626334,,A,10116.0,1,,,11251
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8684,,50597,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL626335,,A,10116.0,1,,,11252
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8684,,50597,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL624798,,A,10116.0,1,,,11253
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,8684,,50597,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",N,,CHEMBL624799,,A,10116.0,1,,,11254
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,8684,,50597,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",N,,CHEMBL624800,,A,10116.0,1,,,11255
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,8684,,50597,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",N,,CHEMBL624801,,A,10116.0,1,,,11256
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,8684,,50597,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",N,,CHEMBL624802,,A,10116.0,1,,,11257
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,8684,,50597,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",N,,CHEMBL624803,,A,10116.0,1,,,11258
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,8684,,50597,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",N,,CHEMBL624804,,A,10116.0,1,,,11259
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,8684,,50597,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",N,,CHEMBL624805,,A,10116.0,1,,,11260
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,8684,,50597,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",N,,CHEMBL624806,,A,10116.0,1,,,11261
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",N,,CHEMBL624807,,A,10116.0,1,,,11262
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL624808,,A,10116.0,1,,,11263
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL624809,,A,10116.0,1,,,11264
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",N,,CHEMBL624810,,A,10116.0,1,,,11265
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL877618,,A,10116.0,1,,,11266
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",N,,CHEMBL624811,,A,10116.0,1,,,11267
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL624812,,A,10116.0,1,,,11268
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL624813,,A,10116.0,1,,,11269
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",N,,CHEMBL624814,,A,10116.0,1,,,11270
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL624815,,A,10116.0,1,,,11271
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL624816,,A,10116.0,1,,,11272
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",N,,CHEMBL624817,,A,10116.0,1,,,11273
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL624818,,A,9615.0,1,,,11274
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,N,,CHEMBL624819,,A,9615.0,1,,,11275
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,,CHEMBL624820,,A,9615.0,1,,,11276
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,,CHEMBL624821,,A,9615.0,1,,,11277
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,,CHEMBL624822,,A,9615.0,1,,,11278
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL624823,,A,9615.0,1,,,11279
,1,BAO_0000218,,Escherichia coli,,,Intermediate,15599,,50212,,Observed diffusion coefficient in organic solvent for Escherichia coli,N,,CHEMBL624824,,A,562.0,1,,,11280
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,9614,,50597,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,CHEMBL624825,,A,10116.0,1,,,11281
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,9614,,50597,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,CHEMBL624826,,A,10116.0,1,,,11282
,1,BAO_0000218,,Rattus norvegicus,Cardiac atrium,2081.0,Intermediate,9614,,50597,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,CHEMBL876817,,A,10116.0,1,,,11283
,1,BAO_0000218,,Rattus norvegicus,Cardiac atrium,2081.0,Intermediate,9614,,50597,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,CHEMBL624827,,A,10116.0,1,,,11284
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9614,,50597,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,CHEMBL624828,,A,10116.0,1,,,11285
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9614,,50597,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,CHEMBL624829,,A,10116.0,1,,,11286
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,9614,,50597,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,CHEMBL624830,,A,10116.0,1,,,11287
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,9614,,50597,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,CHEMBL624831,,A,10116.0,1,,,11288
,1,BAO_0000218,,Rattus norvegicus,Cardiac atrium,2081.0,Intermediate,9614,,50597,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,CHEMBL624832,,A,10116.0,1,,,11289
,1,BAO_0000218,,Rattus norvegicus,Cardiac atrium,2081.0,Intermediate,9614,,50597,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,CHEMBL624833,,A,10116.0,1,,,11290
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9614,,50597,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,CHEMBL624834,,A,10116.0,1,,,11291
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9614,,50597,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,CHEMBL624835,,A,10116.0,1,,,11292
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,9614,,50597,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,CHEMBL624836,,A,10116.0,1,,,11293
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,9614,,50597,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,CHEMBL624837,,A,10116.0,1,,,11294
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,N,,CHEMBL624838,,A,10116.0,1,,,11295
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,N,,CHEMBL622188,,A,10116.0,1,,,11296
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,N,,CHEMBL622189,,A,10116.0,1,,,11297
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,N,,CHEMBL622190,,A,10116.0,1,,,11298
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,N,,CHEMBL625170,,A,10116.0,1,,,11299
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,,CHEMBL625171,,A,10116.0,1,,,11300
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,,CHEMBL625172,,A,10116.0,1,,,11301
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,N,,CHEMBL625173,,A,10116.0,1,,,11302
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,N,,CHEMBL625174,,A,10116.0,1,,,11303
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,N,,CHEMBL625175,,A,10116.0,1,,,11304
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,N,,CHEMBL625176,,A,10116.0,1,,,11305
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,,CHEMBL625177,,A,10116.0,1,,,11306
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,N,,CHEMBL625178,,A,10116.0,1,,,11307
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,N,,CHEMBL625179,,A,10116.0,1,,,11308
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,9071,,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,,CHEMBL625180,,A,10116.0,1,,,11309
,0,BAO_0000218,,,,,Autocuration,10677,,22224,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",U,,CHEMBL625181,,A,,1,,,11310
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,9750,,50594,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,N,,CHEMBL625182,,A,10090.0,1,,,11311
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,CHEMBL625183,,A,10116.0,1,,,11312
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,CHEMBL875848,,A,10116.0,1,,,11313
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,CHEMBL622260,,A,10116.0,1,,,11314
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,CHEMBL622261,,A,10116.0,1,,,11315
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,CHEMBL622262,,A,10116.0,1,,,11316
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,CHEMBL622263,,A,10116.0,1,,,11317
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,CHEMBL622418,,A,10116.0,1,,,11318
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,CHEMBL622419,,A,10116.0,1,,,11319
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL623388,,A,10090.0,1,,,11320
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL623389,,A,10090.0,1,,,11321
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL623390,,A,10090.0,1,,,11322
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL623391,,A,10090.0,1,,,11323
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL623392,,A,10090.0,1,,,11324
,1,BAO_0000218,In vivo,Mus musculus,Cerebellum,2037.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL623393,,A,10090.0,1,,,11325
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL623394,,A,10090.0,1,,,11326
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL618885,,A,10090.0,1,,,11327
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL618886,,A,10090.0,1,,,11328
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL618887,,A,10090.0,1,,,11329
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL619535,,A,10090.0,1,,,11330
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL619536,,A,10090.0,1,,,11331
,1,BAO_0000218,In vivo,Mus musculus,Cerebellum,2037.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL619537,,A,10090.0,1,,,11332
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL619705,,A,10090.0,1,,,11333
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL619706,,A,10090.0,1,,,11334
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL619707,,A,10090.0,1,,,11335
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL619708,,A,10090.0,1,,,11336
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL625219,,A,10090.0,1,,,11337
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL625220,,A,10090.0,1,,,11338
,1,BAO_0000218,In vivo,Mus musculus,Cerebellum,2037.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL625221,,A,10090.0,1,,,11339
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL625222,,A,10090.0,1,,,11340
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL625223,,A,10090.0,1,,,11341
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL625224,,A,10090.0,1,,,11342
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13256,,50594,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,CHEMBL625225,,A,10090.0,1,,,11343
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,8829,,50597,,Biodistribution in Rat blood after 24 hours of iv administration,N,,CHEMBL625226,,A,10116.0,1,,,11344
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,8829,,50597,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,N,,CHEMBL625227,,A,10116.0,1,,,11345
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,8829,,50597,,Biodistribution in Rat blood after 30 minutes of iv administration,N,,CHEMBL625228,,A,10116.0,1,,,11346
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,8829,,50597,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,N,,CHEMBL875354,,A,10116.0,1,,,11347
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,8829,,50597,,Biodistribution in Rat blood after 5 minutes of iv administration,N,,CHEMBL625229,,A,10116.0,1,,,11348
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,8829,,50597,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,N,,CHEMBL625230,,A,10116.0,1,,,11349
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,8829,,50597,,Biodistribution in Rat heart after 24 hours of iv administration,N,,CHEMBL625231,,A,10116.0,1,,,11350
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,8829,,50597,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,N,,CHEMBL625900,,A,10116.0,1,,,11351
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,8829,,50597,,Biodistribution in Rat heart after 30 minutes of iv administration,N,,CHEMBL625901,,A,10116.0,1,,,11352
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,8829,,50597,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,N,,CHEMBL625902,,A,10116.0,1,,,11353
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,8829,,50597,,Biodistribution in Rat heart after 5 minutes of iv administration,N,,CHEMBL625903,,A,10116.0,1,,,11354
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,8829,,50597,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,N,,CHEMBL625904,,A,10116.0,1,,,11355
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8829,,50597,,Biodistribution in Rat liver after 24 hours of iv administration,N,,CHEMBL625905,,A,10116.0,1,,,11356
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8829,,50597,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,N,,CHEMBL627861,,A,10116.0,1,,,11357
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8829,,50597,,Biodistribution in Rat liver after 30 minutes of iv administration,N,,CHEMBL627862,,A,10116.0,1,,,11358
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8829,,50597,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,,CHEMBL627863,,A,10116.0,1,,,11359
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8829,,50597,,Biodistribution in Rat liver after 30 minutes of iv administration,N,,CHEMBL627769,,A,10116.0,1,,,11360
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,13249,,50588,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,,CHEMBL627770,,A,9615.0,1,,,11361
,1,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,13622,,100710,,Cmax in cynomolgus monkey (PO dose),N,,CHEMBL627771,,A,9541.0,1,,,11362
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13622,,50597,,Cmax in rat (PO dose),N,,CHEMBL627772,,A,10116.0,1,,,11363
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13622,,50597,,Cmax in rat (PO dose),N,,CHEMBL627773,,A,10116.0,1,,,11364
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,13494,,50597,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,N,,CHEMBL621922,,A,10116.0,1,,,11365
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12170,,50597,,Cmax in rat plasma after oral dose (10 mg/kg),N,,CHEMBL621923,,A,10116.0,1,,,11366
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,12170,,22224,,Cmax in plasma after oral dose (10 mg/kg),U,,CHEMBL621924,,A,,1,,,11367
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,17025,,50588,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,N,,CHEMBL621925,,A,9615.0,1,,,11368
,0,BAO_0000218,In vivo,Simiiformes,Plasma,1969.0,Autocuration,17025,,22224,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,U,,CHEMBL621926,,A,314293.0,1,,,11369
,1,BAO_0000218,In vivo,Oryctolagus cuniculus,Plasma,1969.0,Intermediate,17025,,50592,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,N,,CHEMBL621927,,A,9986.0,1,,,11370
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17025,,50597,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,N,,CHEMBL621928,,A,10116.0,1,,,11371
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14187,,50597,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,N,,CHEMBL621929,,A,10116.0,1,,,11372
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,14816,,50594,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,N,,CHEMBL621930,,A,10090.0,1,,,11373
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17820,,50597,,Maximum plasma concentration after oral dosing in rat,N,,CHEMBL621931,,A,10116.0,1,,,11374
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14380,,22224,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,,CHEMBL621932,,A,,1,,,11375
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14380,,22224,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,CHEMBL621933,,A,,1,,,11376
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14691,,50588,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,N,,CHEMBL621934,,A,9615.0,1,,,11377
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14691,,50588,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,N,,CHEMBL621935,,A,9615.0,1,,,11378
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,13375,,50597,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,N,,CHEMBL621936,,A,10116.0,1,,,11379
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,6236,,22224,,Maximum plasma concentration was determined,U,,CHEMBL621937,,A,,1,,,11380
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14380,,22224,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,CHEMBL621938,,A,,1,,,11381
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14380,,22224,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,CHEMBL621939,,A,,1,,,11382
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14380,,22224,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,U,,CHEMBL621940,,A,,1,,,11383
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14380,,22224,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,U,,CHEMBL621941,,A,,1,,,11384
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14380,,22224,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,,CHEMBL621942,,A,,1,,,11385
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14380,,22224,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,CHEMBL626178,,A,,1,,,11386
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14380,,22224,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,U,,CHEMBL626179,,A,,1,,,11387
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14380,,22224,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,U,,CHEMBL626180,,A,,1,,,11388
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,13622,,50597,,Plasma Cmax in rat (PO dose),N,,CHEMBL626181,,A,10116.0,1,,,11389
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15372,,50597,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,N,,CHEMBL626182,,A,10116.0,1,,,11390
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15372,,50597,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,N,,CHEMBL626183,,A,10116.0,1,,,11391
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15372,,50597,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,N,,CHEMBL626184,,A,10116.0,1,,,11392
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15372,,50597,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,N,,CHEMBL626185,,A,10116.0,1,,,11393
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14925,,50588,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,N,,CHEMBL626186,,A,9615.0,1,,,11394
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14925,,50588,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,N,,CHEMBL877589,,A,9615.0,1,,,11395
,0,BAO_0000218,In vivo,,,,Autocuration,11883,,22224,,Maximum concentration of the drug at 1 uM/dg administered intravenously,U,,CHEMBL626187,,A,,1,,,11396
,0,BAO_0000218,In vivo,,,,Autocuration,11883,,22224,,Maximum concentration of the drug at 20 uM/dg administered perorally,U,,CHEMBL626188,,A,,1,,,11397
,0,BAO_0000218,In vivo,,,,Autocuration,13391,,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,U,,CHEMBL626189,,A,,1,,,11398
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,13391,,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,,CHEMBL626855,,A,,1,,,11399
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,13391,,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,,CHEMBL623781,,A,,1,,,11400
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,13391,,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,,CHEMBL623782,,A,,1,,,11401
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,16360,,50597,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,N,,CHEMBL623783,,A,10116.0,1,,,11402
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,3673,,50588,,Cmax in dog plasma after 1mg/kg oral dose,N,,CHEMBL623784,,A,9615.0,1,,,11403
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14431,,50588,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,N,,CHEMBL623785,,A,9615.0,1,,,11404
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14431,,50597,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,N,,CHEMBL623786,,A,10116.0,1,,,11405
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14964,,50597,,Oral maximum concentration in rat,N,,CHEMBL623787,,A,10116.0,1,,,11406
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14964,,50597,,Oral maximum concentration in rat,N,,CHEMBL623788,,A,10116.0,1,,,11407
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,14209,,50594,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,N,,CHEMBL623789,,A,10090.0,1,,,11408
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,11355,,50594,,Peak concentration in blood after intravenous administration to mice,N,,CHEMBL623790,,A,10090.0,1,,,11409
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,11355,,50594,,Peak concentration in blood after peroral administration to mice,N,,CHEMBL623791,,A,10090.0,1,,,11410
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,11966,,50597,,Peak concentration in rat plasma was determined,N,,CHEMBL623792,,A,10116.0,1,,,11411
,0,BAO_0000218,In vivo,Simiiformes,Plasma,1969.0,Autocuration,8918,,22224,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,U,,CHEMBL623793,,A,314293.0,1,,,11412
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,8918,,50594,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,N,,CHEMBL623794,,A,10090.0,1,,,11413
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,8918,,50597,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,N,,CHEMBL623795,,A,10116.0,1,,,11414
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL623796,,A,10116.0,1,,,11415
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",N,,CHEMBL623797,,A,10116.0,1,,,11416
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL623798,,A,10116.0,1,,,11417
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL623799,,A,10116.0,1,,,11418
,1,BAO_0000218,,Rattus norvegicus,Intestine,160.0,Intermediate,8684,,50597,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",N,,CHEMBL624490,,A,10116.0,1,,,11419
,1,BAO_0000218,,Rattus norvegicus,Intestine,160.0,Intermediate,8684,,50597,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL624491,,A,10116.0,1,,,11420
,1,BAO_0000218,,Rattus norvegicus,Intestine,160.0,Intermediate,8684,,50597,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL624492,,A,10116.0,1,,,11421
,1,BAO_0000218,,Rattus norvegicus,Intestine,160.0,Intermediate,8684,,50597,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",N,,CHEMBL624493,,A,10116.0,1,,,11422
,1,BAO_0000218,,Rattus norvegicus,Intestine,160.0,Intermediate,8684,,50597,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL877595,,A,10116.0,1,,,11423
,1,BAO_0000218,,Rattus norvegicus,Intestine,160.0,Intermediate,8684,,50597,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",N,,CHEMBL624494,,A,10116.0,1,,,11424
,1,BAO_0000218,,Rattus norvegicus,Intestine,160.0,Intermediate,8684,,50597,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL624495,,A,10116.0,1,,,11425
,1,BAO_0000218,,Rattus norvegicus,Intestine,160.0,Intermediate,8684,,50597,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL624681,,A,10116.0,1,,,11426
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",N,,CHEMBL624682,,A,10116.0,1,,,11427
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL624683,,A,10116.0,1,,,11428
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL624684,,A,10116.0,1,,,11429
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",N,,CHEMBL624685,,A,10116.0,1,,,11430
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL624686,,A,10116.0,1,,,11431
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",N,,CHEMBL624687,,A,10116.0,1,,,11432
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL624688,,A,10116.0,1,,,11433
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL627161,,A,10116.0,1,,,11434
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",N,,CHEMBL622127,,A,10116.0,1,,,11435
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL622128,,A,10116.0,1,,,11436
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL874384,,A,10116.0,1,,,11437
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",N,,CHEMBL624898,,A,10116.0,1,,,11438
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL624899,,A,10116.0,1,,,11439
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",N,,CHEMBL624900,,A,10116.0,1,,,11440
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL624901,,A,10116.0,1,,,11441
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL624902,,A,10116.0,1,,,11442
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",N,,CHEMBL624903,,A,10116.0,1,,,11443
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL624904,,A,10116.0,1,,,11444
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL624905,,A,10116.0,1,,,11445
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",N,,CHEMBL624906,,A,10116.0,1,,,11446
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL624907,,A,10116.0,1,,,11447
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",N,,CHEMBL624908,,A,10116.0,1,,,11448
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL624909,,A,10116.0,1,,,11449
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL624910,,A,10116.0,1,,,11450
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8684,,50597,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",N,,CHEMBL624911,,A,10116.0,1,,,11451
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8684,,50597,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL874388,,A,10116.0,1,,,11452
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8684,,50597,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL624912,,A,10116.0,1,,,11453
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8684,,50597,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",N,,CHEMBL622930,,A,10116.0,1,,,11454
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8684,,50597,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL623121,,A,10116.0,1,,,11455
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8684,,50597,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",N,,CHEMBL623122,,A,10116.0,1,,,11456
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8684,,50597,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL623123,,A,10116.0,1,,,11457
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,8684,,50597,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL623124,,A,10116.0,1,,,11458
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",N,,CHEMBL623125,,A,10116.0,1,,,11459
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL623126,,A,10116.0,1,,,11460
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL623127,,A,10116.0,1,,,11461
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",N,,CHEMBL623128,,A,10116.0,1,,,11462
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL623129,,A,10116.0,1,,,11463
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",N,,CHEMBL623130,,A,10116.0,1,,,11464
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL623131,,A,10116.0,1,,,11465
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL623132,,A,10116.0,1,,,11466
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,CHEMBL623133,,A,10116.0,1,,,11467
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,CHEMBL623134,,A,10116.0,1,,,11468
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,CHEMBL874389,,A,10116.0,1,,,11469
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,CHEMBL623135,,A,10116.0,1,,,11470
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,CHEMBL623136,,A,10116.0,1,,,11471
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,CHEMBL623137,,A,10116.0,1,,,11472
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,CHEMBL623138,,A,10116.0,1,,,11473
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,CHEMBL623139,,A,10116.0,1,,,11474
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,CHEMBL623140,,A,10116.0,1,,,11475
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,CHEMBL623141,,A,10116.0,1,,,11476
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,CHEMBL623142,,A,10116.0,1,,,11477
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,CHEMBL623143,,A,10116.0,1,,,11478
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,14571,,50594,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,N,,CHEMBL623144,,A,10090.0,1,,,11479
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,14571,,50597,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,N,,CHEMBL623405,,A,10116.0,1,,,11480
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,CHEMBL624074,,A,10116.0,1,,,11481
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,CHEMBL624075,,A,10116.0,1,,,11482
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,CHEMBL624076,,A,10116.0,1,,,11483
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,CHEMBL624077,,A,10116.0,1,,,11484
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,CHEMBL624078,,A,10116.0,1,,,11485
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,CHEMBL624079,,A,10116.0,1,,,11486
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,CHEMBL624261,,A,10116.0,1,,,11487
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,CHEMBL624262,,A,10116.0,1,,,11488
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,CHEMBL624263,,A,10116.0,1,,,11489
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,CHEMBL624264,,A,10116.0,1,,,11490
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,CHEMBL624265,,A,10116.0,1,,,11491
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,CHEMBL624266,,A,10116.0,1,,,11492
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,CHEMBL624267,,A,10116.0,1,,,11493
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,CHEMBL624268,,A,10116.0,1,,,11494
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,CHEMBL875227,,A,10116.0,1,,,11495
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,CHEMBL624269,,A,10116.0,1,,,11496
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,CHEMBL624270,,A,10116.0,1,,,11497
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,CHEMBL624271,,A,10116.0,1,,,11498
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,CHEMBL624272,,A,10116.0,1,,,11499
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8319,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,CHEMBL624273,,A,10116.0,1,,,11500
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12064,,50597,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,N,,CHEMBL624274,,A,10116.0,1,,,11501
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12064,,50597,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,N,,CHEMBL624275,,A,10116.0,1,,,11502
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12064,,50597,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,N,,CHEMBL624276,,A,10116.0,1,,,11503
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12038,,50597,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,N,,CHEMBL624277,,A,10116.0,1,,,11504
,0,BAO_0000019,,,,,Autocuration,14314,,22224,,% dose converted to 2-amino-5-chlorophenyl sulfate,U,,CHEMBL624278,,A,,1,,,11505
,0,BAO_0000019,,,,,Autocuration,14314,,22224,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),U,,CHEMBL624279,,A,,1,,,11506
,1,BAO_0000218,,Rattus norvegicus,Feces,1988.0,Intermediate,11488,,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,,CHEMBL624280,,A,10116.0,1,,,11507
,1,BAO_0000218,,Rattus norvegicus,Feces,1988.0,Intermediate,11488,,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,,CHEMBL624281,,A,10116.0,1,,,11508
,1,BAO_0000218,,Rattus norvegicus,Feces,1988.0,Intermediate,11488,,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,,CHEMBL622933,,A,10116.0,1,,,11509
,1,BAO_0000218,,Rattus norvegicus,Feces,1988.0,Intermediate,11488,,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,,CHEMBL622934,,A,10116.0,1,,,11510
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8829,,50597,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,,CHEMBL622935,,A,10116.0,1,,,11511
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8829,,50597,,Biodistribution in Rat liver after 5 minutes of iv administration,N,,CHEMBL622936,,A,10116.0,1,,,11512
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,8829,,50597,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,N,,CHEMBL875228,,A,10116.0,1,,,11513
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,8829,,50597,,Biodistribution in Rat lung after 24 hours of iv administration,N,,CHEMBL622937,,A,10116.0,1,,,11514
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,8829,,50597,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,N,,CHEMBL622938,,A,10116.0,1,,,11515
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,8829,,50597,,Biodistribution in Rat lung after 30 minutes of iv administration,N,,CHEMBL619736,,A,10116.0,1,,,11516
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,8829,,50597,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,N,,CHEMBL625117,,A,10116.0,1,,,11517
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,8829,,50597,,Biodistribution in Rat lung after 5 minutes of iv administration,N,,CHEMBL625118,,A,10116.0,1,,,11518
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,8829,,50597,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,N,,CHEMBL625119,,A,10116.0,1,,,11519
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,14972,,50597,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",N,,CHEMBL625120,,A,10116.0,1,,,11520
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14972,,50597,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",N,,CHEMBL625121,,A,10116.0,1,,,11521
,1,BAO_0000218,In vivo,Rattus norvegicus,Thalamus,10000006.0,Intermediate,14972,,50597,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",N,,CHEMBL625122,,A,10116.0,1,,,11522
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,14608,,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL622204,,A,10116.0,1,,,11523
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,14608,,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL877503,,A,10116.0,1,,,11524
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,14608,,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL627127,,A,10116.0,1,,,11525
,0,BAO_0000218,In vivo,,Hippocampus,10000000.0,Autocuration,14608,,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,U,,CHEMBL627128,,A,,1,,,11526
,0,BAO_0000218,In vivo,,Hippocampus,10000000.0,Autocuration,14608,,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,U,,CHEMBL627129,,A,,1,,,11527
,0,BAO_0000218,In vivo,,Hippocampus,10000000.0,Autocuration,14608,,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,U,,CHEMBL627130,,A,,1,,,11528
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,14608,,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL627131,,A,10116.0,1,,,11529
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,14608,,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL627132,,A,10116.0,1,,,11530
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,14608,,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL627133,,A,10116.0,1,,,11531
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,14608,,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL627134,,A,10116.0,1,,,11532
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,14608,,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL627135,,A,10116.0,1,,,11533
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,14608,,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL627136,,A,10116.0,1,,,11534
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14608,,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL628435,,A,10116.0,1,,,11535
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14608,,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL628436,,A,10116.0,1,,,11536
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14608,,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL628437,,A,10116.0,1,,,11537
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,14608,,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL628438,,A,10116.0,1,,,11538
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,14608,,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL628439,,A,10116.0,1,,,11539
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,14608,,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL628440,,A,10116.0,1,,,11540
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,14608,,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL628441,,A,10116.0,1,,,11541
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,14608,,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL628442,,A,10116.0,1,,,11542
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,14608,,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL628443,,A,10116.0,1,,,11543
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,14608,,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL628444,,A,10116.0,1,,,11544
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,14608,,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL628445,,A,10116.0,1,,,11545
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,14608,,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL877504,,A,10116.0,1,,,11546
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,14608,,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL628446,,A,10116.0,1,,,11547
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,14608,,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL626874,,A,10116.0,1,,,11548
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,14608,,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL626875,,A,10116.0,1,,,11549
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,14608,,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL626876,,A,10116.0,1,,,11550
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,14608,,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL626877,,A,10116.0,1,,,11551
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,14608,,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL626878,,A,10116.0,1,,,11552
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,14608,,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL626879,,A,10116.0,1,,,11553
,0,BAO_0000218,In vivo,Simiiformes,Plasma,1969.0,Autocuration,8918,,22224,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,U,,CHEMBL626880,,A,314293.0,1,,,11554
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,8918,,50594,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,N,,CHEMBL626881,,A,10090.0,1,,,11555
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,8918,,50597,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,N,,CHEMBL626882,,A,10116.0,1,,,11556
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14470,,50588,,Peak plasma concentration was measured in dogs,N,,CHEMBL626883,,A,9615.0,1,,,11557
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14393,,50597,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,CHEMBL626884,,A,10116.0,1,,,11558
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14886,,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,,CHEMBL626885,,A,10116.0,1,,,11559
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14886,,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,,CHEMBL626886,,A,10116.0,1,,,11560
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14886,,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,,CHEMBL626887,,A,10116.0,1,,,11561
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14393,,50597,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,CHEMBL626888,,A,10116.0,1,,,11562
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13465,,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,N,,CHEMBL626889,,A,9615.0,1,,,11563
,0,BAO_0000218,In vivo,Simiiformes,,,Autocuration,13465,,22224,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,U,,CHEMBL626761,,A,314293.0,1,,,11564
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13465,,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,N,,CHEMBL626762,,A,9615.0,1,,,11565
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13465,,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,N,,CHEMBL626763,,A,9615.0,1,,,11566
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13465,,50597,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,N,,CHEMBL626764,,A,10116.0,1,,,11567
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13465,,50597,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,N,,CHEMBL626765,,A,10116.0,1,,,11568
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13465,,50588,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,N,,CHEMBL626766,,A,9615.0,1,,,11569
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13465,,50597,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,N,,CHEMBL626767,,A,10116.0,1,,,11570
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13465,,50597,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,N,,CHEMBL626768,,A,10116.0,1,,,11571
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13465,,50588,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,N,,CHEMBL626769,,A,9615.0,1,,,11572
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13465,,50588,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,N,,CHEMBL874463,,A,9615.0,1,,,11573
,0,BAO_0000218,In vivo,Simiiformes,,,Autocuration,13465,,22224,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,U,,CHEMBL626770,,A,314293.0,1,,,11574
,0,BAO_0000218,In vivo,Simiiformes,,,Autocuration,13465,,22224,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,U,,CHEMBL626771,,A,314293.0,1,,,11575
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13465,,50597,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,N,,CHEMBL626772,,A,10116.0,1,,,11576
,1,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,14731,,100710,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,,CHEMBL626773,,A,9541.0,1,,,11577
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14731,,50594,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,N,,CHEMBL626774,,A,10090.0,1,,,11578
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13376,,50588,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,,CHEMBL626775,,A,9615.0,1,,,11579
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13376,,50588,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,,CHEMBL626776,,A,9615.0,1,,,11580
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14443,,50597,,Maximum concentration (Cmax) in rat when administered orally,N,,CHEMBL626777,,A,10116.0,1,,,11581
,0,BAO_0000218,In vivo,Simiiformes,Plasma,1969.0,Autocuration,13465,,22224,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,U,,CHEMBL626778,,A,314293.0,1,,,11582
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,16359,,22224,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",U,,CHEMBL626779,,A,10116.0,1,,,11583
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,16359,,22224,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",U,,CHEMBL626780,,A,10116.0,1,,,11584
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,15618,,22224,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,U,,CHEMBL626781,,A,,1,,,11585
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14554,,50597,,Pharmacokinetic profile Cmax was evaluated in rats,N,,CHEMBL632164,,A,10116.0,1,,,11586
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,11537,,50588,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),N,,CHEMBL632165,,A,9615.0,1,,,11587
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,11537,,50594,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),N,,CHEMBL632166,,A,10090.0,1,,,11588
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,11537,,50588,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),N,,CHEMBL632167,,A,9615.0,1,,,11589
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,11537,,50594,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),N,,CHEMBL632168,,A,10090.0,1,,,11590
,0,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Autocuration,2021,,22224,,Cmax in rat plasma,U,,CHEMBL632169,,A,10116.0,1,,,11591
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,5932,,50588,,Cmax in dog plasma after 30mg/kg oral dose,N,,CHEMBL632170,,A,9615.0,1,,,11592
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5932,,50597,,Cmax in rat plasma after 30mg/kg oral dose,N,,CHEMBL632171,,A,10116.0,1,,,11593
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,17320,,50597,,Plasma level in rats at 30 mg/kg,N,,CHEMBL632172,,A,10116.0,1,,,11594
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,15831,,50594,,Tested for maximum plasma concentration in mice,N,,CHEMBL632173,,A,10090.0,1,,,11595
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15078,,50597,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL632174,,A,10116.0,1,,,11596
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14941,,50597,,The Cmax values in female wistar rats.,N,,CHEMBL632175,,A,10116.0,1,,,11597
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,15343,,50588,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,N,,CHEMBL632176,,A,9615.0,1,,,11598
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15343,,50597,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,N,,CHEMBL632177,,A,10116.0,1,,,11599
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14856,,50597,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,N,,CHEMBL632178,,A,10116.0,1,,,11600
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13129,,50597,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,N,,CHEMBL632179,,A,10116.0,1,,,11601
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13098,,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,N,,CHEMBL632180,,A,10116.0,1,,,11602
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13098,,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,N,,CHEMBL632181,,A,10116.0,1,,,11603
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13098,,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,N,,CHEMBL632182,,A,10116.0,1,,,11604
,0,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Autocuration,15478,,22224,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,U,,CHEMBL632183,,A,10090.0,1,,,11605
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,15341,,50588,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,N,,CHEMBL632184,,A,9615.0,1,,,11606
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15341,,50597,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,N,,CHEMBL874470,,A,10116.0,1,,,11607
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",N,,CHEMBL631302,,A,10116.0,1,,,11608
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL631303,,A,10116.0,1,,,11609
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL631304,,A,10116.0,1,,,11610
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",N,,CHEMBL631305,,A,10116.0,1,,,11611
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL631306,,A,10116.0,1,,,11612
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",N,,CHEMBL631307,,A,10116.0,1,,,11613
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL631308,,A,10116.0,1,,,11614
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8684,,50597,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL625557,,A,10116.0,1,,,11615
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,8684,,50597,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",N,,CHEMBL625558,,A,10116.0,1,,,11616
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,8684,,50597,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL625559,,A,10116.0,1,,,11617
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,8684,,50597,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL625560,,A,10116.0,1,,,11618
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,8684,,50597,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",N,,CHEMBL625561,,A,10116.0,1,,,11619
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,8684,,50597,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL625562,,A,10116.0,1,,,11620
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,8684,,50597,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",N,,CHEMBL875320,,A,10116.0,1,,,11621
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,8684,,50597,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL625563,,A,10116.0,1,,,11622
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,8684,,50597,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL625564,,A,10116.0,1,,,11623
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8684,,50597,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",N,,CHEMBL625565,,A,10116.0,1,,,11624
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8684,,50597,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",N,,CHEMBL625566,,A,10116.0,1,,,11625
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8684,,50597,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",N,,CHEMBL625567,,A,10116.0,1,,,11626
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8684,,50597,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",N,,CHEMBL625568,,A,10116.0,1,,,11627
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8684,,50597,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",N,,CHEMBL628217,,A,10116.0,1,,,11628
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8684,,50597,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",N,,CHEMBL628218,,A,10116.0,1,,,11629
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8684,,50597,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",N,,CHEMBL628219,,A,10116.0,1,,,11630
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8684,,50597,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",N,,CHEMBL628220,,A,10116.0,1,,,11631
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the blood after 120 min of intravenous administration,U,,CHEMBL628221,,A,,1,,,11632
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the blood after 15 min of intravenous administration,U,,CHEMBL628222,,A,,1,,,11633
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the blood after 30 min of intravenous administration,U,,CHEMBL628223,,A,,1,,,11634
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the blood after 5 min of intravenous administration,U,,CHEMBL628224,,A,,1,,,11635
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the blood after 60 min of intravenous administration,U,,CHEMBL628225,,A,,1,,,11636
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the blood after 90 min of intravenous administration,U,,CHEMBL628226,,A,,1,,,11637
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the bone after 120 min of intravenous administration,U,,CHEMBL628227,,A,,1,,,11638
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the bone after 15 min of intravenous administration,U,,CHEMBL875481,,A,,1,,,11639
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the bone after 30 min of intravenous administration,U,,CHEMBL628228,,A,,1,,,11640
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the bone after 5 min of intravenous administration,U,,CHEMBL628229,,A,,1,,,11641
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the bone after 60 min of intravenous administration,U,,CHEMBL628230,,A,,1,,,11642
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the bone after 90 min of intravenous administration,U,,CHEMBL628231,,A,,1,,,11643
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the heart after 120 min of intravenous administration,U,,CHEMBL628232,,A,,1,,,11644
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the heart after 15 min of intravenous administration,U,,CHEMBL628233,,A,,1,,,11645
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the heart after 30 min of intravenous administration,U,,CHEMBL628234,,A,,1,,,11646
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the heart after 5 min of intravenous administration,U,,CHEMBL628235,,A,,1,,,11647
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the heart after 60 min of intravenous administration,U,,CHEMBL628236,,A,,1,,,11648
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the heart after 90 min of intravenous administration,U,,CHEMBL628237,,A,,1,,,11649
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the kidneys after 120 min of intravenous administration,U,,CHEMBL628238,,A,,1,,,11650
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the kidneys after 15 min of intravenous administration,U,,CHEMBL628239,,A,,1,,,11651
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the kidneys after 30 min of intravenous administration,U,,CHEMBL628240,,A,,1,,,11652
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the kidneys after 5 min of intravenous administration,U,,CHEMBL628241,,A,,1,,,11653
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the kidneys after 60 min of intravenous administration,U,,CHEMBL628242,,A,,1,,,11654
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the kidneys after 90 min of intravenous administration,U,,CHEMBL875482,,A,,1,,,11655
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the liver after 120 min of intravenous administration,U,,CHEMBL628243,,A,,1,,,11656
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the liver after 15 min of intravenous administration,U,,CHEMBL628244,,A,,1,,,11657
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the liver after 30 min of intravenous administration,U,,CHEMBL628245,,A,,1,,,11658
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the liver after 5 min of intravenous administration,U,,CHEMBL628246,,A,,1,,,11659
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the liver after 60 min of intravenous administration,U,,CHEMBL628247,,A,,1,,,11660
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the liver after 90 min of intravenous administration,U,,CHEMBL628248,,A,,1,,,11661
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the lung after 120 min of intravenous administration,U,,CHEMBL628249,,A,,1,,,11662
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",N,,CHEMBL625452,,A,10090.0,1,,,11663
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",N,,CHEMBL625453,,A,10090.0,1,,,11664
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",N,,CHEMBL625454,,A,10090.0,1,,,11665
,1,BAO_0000218,,Mus musculus,,,Intermediate,14839,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",N,,CHEMBL623844,,A,10090.0,1,,,11666
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12178,,50597,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,N,,CHEMBL623845,,A,10116.0,1,,,11667
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12178,,50597,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,N,,CHEMBL623846,,A,10116.0,1,,,11668
,0,BAO_0000218,,,,,Autocuration,12178,,22224,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,U,,CHEMBL623847,,A,,1,,,11669
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,12186,,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,CHEMBL623848,,A,9541.0,1,,,11670
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,12186,,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,,CHEMBL623849,,A,9541.0,1,,,11671
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,12186,,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,CHEMBL623850,,A,9541.0,1,,,11672
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,12186,,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,,CHEMBL623851,,A,9541.0,1,,,11673
,0,BAO_0000218,,Simiiformes,,,Autocuration,12187,,22224,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,,CHEMBL623852,,A,314293.0,1,,,11674
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,12187,,50506,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,,CHEMBL624551,,A,9669.0,1,,,11675
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,12187,,50506,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,,CHEMBL624552,,A,9669.0,1,,,11676
,0,BAO_0000218,,Simiiformes,,,Autocuration,12187,,22224,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,,CHEMBL624553,,A,314293.0,1,,,11677
,0,BAO_0000218,,Simiiformes,,,Autocuration,12187,,22224,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,U,,CHEMBL624554,,A,314293.0,1,,,11678
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12187,,50597,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,,CHEMBL624555,,A,10116.0,1,,,11679
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12187,,50597,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,,CHEMBL624741,,A,10116.0,1,,,11680
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14122,,50588,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",N,,CHEMBL624742,,A,9615.0,1,,,11681
,1,BAO_0000218,,Cricetinae,,,Intermediate,14122,,100712,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",N,,CHEMBL624743,,A,10026.0,1,,,11682
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14122,,50597,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",N,,CHEMBL877606,,A,10116.0,1,,,11683
,0,BAO_0000218,,,,,Autocuration,13391,,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,U,,CHEMBL624744,,A,,1,,,11684
,0,BAO_0000218,,,Blood,178.0,Autocuration,13391,,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,,CHEMBL624745,,A,,1,,,11685
,0,BAO_0000218,,,Blood,178.0,Autocuration,13391,,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,,CHEMBL624746,,A,,1,,,11686
,0,BAO_0000218,,,Blood,178.0,Autocuration,13391,,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,,CHEMBL624747,,A,,1,,,11687
,0,BAO_0000019,,,,,Autocuration,16360,,22224,,Oral absorption expressed as Area under curve was determined,U,,CHEMBL624748,,A,,1,,,11688
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,3673,,50588,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,N,,CHEMBL622504,,A,9615.0,1,,,11689
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14122,,50588,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",N,,CHEMBL622505,,A,9615.0,1,,,11690
,1,BAO_0000218,,Cricetinae,,,Intermediate,14122,,100712,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,,CHEMBL622506,,A,10026.0,1,,,11691
,1,BAO_0000218,,Cricetinae,,,Intermediate,14122,,100712,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,,CHEMBL622507,,A,10026.0,1,,,11692
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14122,,50597,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",N,,CHEMBL622508,,A,10116.0,1,,,11693
,0,BAO_0000019,,,,,Autocuration,13889,,22224,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,U,,CHEMBL622509,,A,,1,,,11694
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14393,,50597,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,CHEMBL622510,,A,10116.0,1,,,11695
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17279,,50597,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),N,,CHEMBL622511,,A,10116.0,1,,,11696
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14548,,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,,CHEMBL622512,,A,9541.0,1,,,11697
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14548,,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,,CHEMBL622513,,A,9541.0,1,,,11698
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14548,,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,N,,CHEMBL622514,,A,9541.0,1,,,11699
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14548,,50588,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,,CHEMBL622515,,A,9615.0,1,,,11700
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14548,,50588,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,N,,CHEMBL622516,,A,9615.0,1,,,11701
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14548,,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,,CHEMBL622517,,A,10116.0,1,,,11702
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14548,,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,N,,CHEMBL622518,,A,10116.0,1,,,11703
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14548,,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,N,,CHEMBL622519,,A,10116.0,1,,,11704
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,14608,,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL622520,,A,10116.0,1,,,11705
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,14608,,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL622521,,A,10116.0,1,,,11706
,1,BAO_0000218,In vivo,Mus musculus,Zone of skin,14.0,Intermediate,14608,,50594,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL625113,,A,10090.0,1,,,11707
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,14608,,50597,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL625114,,A,10116.0,1,,,11708
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,14608,,50597,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL874397,,A,10116.0,1,,,11709
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,14608,,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL625115,,A,10116.0,1,,,11710
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,14608,,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL625116,,A,10116.0,1,,,11711
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,14608,,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL623932,,A,10116.0,1,,,11712
,1,BAO_0000218,In vivo,Rattus norvegicus,Striatum,2435.0,Intermediate,14608,,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL623933,,A,10116.0,1,,,11713
,1,BAO_0000218,In vivo,Rattus norvegicus,Striatum,2435.0,Intermediate,14608,,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL623934,,A,10116.0,1,,,11714
,1,BAO_0000218,In vivo,Rattus norvegicus,Striatum,2435.0,Intermediate,14608,,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL623935,,A,10116.0,1,,,11715
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,14608,,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,CHEMBL623936,,A,10116.0,1,,,11716
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,14608,,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,CHEMBL623937,,A,10116.0,1,,,11717
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,14608,,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,CHEMBL623938,,A,10116.0,1,,,11718
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,CHEMBL623939,,A,10090.0,1,,,11719
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,CHEMBL623940,,A,10090.0,1,,,11720
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,CHEMBL623941,,A,10090.0,1,,,11721
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,CHEMBL627216,,A,10090.0,1,,,11722
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,CHEMBL623942,,A,10090.0,1,,,11723
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,15383,,50594,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,CHEMBL618793,,A,10090.0,1,,,11724
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,15383,,50594,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,CHEMBL618794,,A,10090.0,1,,,11725
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,15383,,50594,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,CHEMBL618795,,A,10090.0,1,,,11726
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,CHEMBL618796,,A,10090.0,1,,,11727
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,CHEMBL618797,,A,10090.0,1,,,11728
,1,BAO_0000218,,Mus musculus,Kidney,2113.0,Intermediate,15383,,50594,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,,CHEMBL618798,,A,10090.0,1,,,11729
,1,BAO_0000218,,Mus musculus,Kidney,2113.0,Intermediate,15383,,50594,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,CHEMBL618799,,A,10090.0,1,,,11730
,1,BAO_0000218,,Mus musculus,Kidney,2113.0,Intermediate,15383,,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,CHEMBL618800,,A,10090.0,1,,,11731
,1,BAO_0000218,,Mus musculus,Kidney,2113.0,Intermediate,15383,,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,CHEMBL618801,,A,10090.0,1,,,11732
,1,BAO_0000218,,Mus musculus,Kidney,2113.0,Intermediate,15383,,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,CHEMBL618802,,A,10090.0,1,,,11733
,1,BAO_0000218,,Mus musculus,Kidney,2113.0,Intermediate,15383,,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,CHEMBL618803,,A,10090.0,1,,,11734
,1,BAO_0000218,,Mus musculus,Liver,2107.0,Intermediate,15383,,50594,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,,CHEMBL618804,,A,10090.0,1,,,11735
,1,BAO_0000218,,Mus musculus,Liver,2107.0,Intermediate,15383,,50594,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,CHEMBL618805,,A,10090.0,1,,,11736
,1,BAO_0000218,,Mus musculus,Liver,2107.0,Intermediate,15383,,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,CHEMBL618806,,A,10090.0,1,,,11737
,1,BAO_0000218,,Mus musculus,Liver,2107.0,Intermediate,15383,,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,CHEMBL618807,,A,10090.0,1,,,11738
,1,BAO_0000218,,Mus musculus,Liver,2107.0,Intermediate,15383,,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,CHEMBL618808,,A,10090.0,1,,,11739
,1,BAO_0000218,,Mus musculus,Liver,2107.0,Intermediate,15383,,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,CHEMBL618809,,A,10090.0,1,,,11740
,1,BAO_0000218,,Mus musculus,Muscle tissue,2385.0,Intermediate,15383,,50594,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,CHEMBL618810,,A,10090.0,1,,,11741
,1,BAO_0000218,,Mus musculus,Muscle tissue,2385.0,Intermediate,15383,,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,CHEMBL618811,,A,10090.0,1,,,11742
,1,BAO_0000218,,Mus musculus,Muscle tissue,2385.0,Intermediate,15383,,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,CHEMBL875844,,A,10090.0,1,,,11743
,1,BAO_0000218,,Mus musculus,Muscle tissue,2385.0,Intermediate,15383,,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,CHEMBL618812,,A,10090.0,1,,,11744
,1,BAO_0000218,,Mus musculus,Muscle tissue,2385.0,Intermediate,15383,,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,CHEMBL618813,,A,10090.0,1,,,11745
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,CHEMBL618814,,A,10090.0,1,,,11746
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,CHEMBL618815,,A,10090.0,1,,,11747
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,CHEMBL618816,,A,10090.0,1,,,11748
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,CHEMBL618817,,A,10090.0,1,,,11749
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,CHEMBL620544,,A,10090.0,1,,,11750
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15341,,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,N,,CHEMBL626230,,A,10116.0,1,,,11751
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15341,,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,N,,CHEMBL626231,,A,10116.0,1,,,11752
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15341,,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,N,,CHEMBL626232,,A,10116.0,1,,,11753
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14906,,50588,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,N,,CHEMBL626233,,A,9615.0,1,,,11754
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14906,,50597,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,N,,CHEMBL626234,,A,10116.0,1,,,11755
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14906,,50597,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,N,,CHEMBL875341,,A,10116.0,1,,,11756
,1,BAO_0000218,In vivo,Homo sapiens,Plasma,1969.0,Intermediate,14215,,50587,,The maximum plasma concentration (100 mg/kg) administered orally in human,N,,CHEMBL626235,,A,9606.0,1,,,11757
,0,BAO_0000218,In vivo,Callithrix,Plasma,1969.0,Autocuration,14215,,22224,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,U,,CHEMBL626236,,A,9481.0,1,,,11758
,0,BAO_0000218,In vivo,Simiiformes,Plasma,1969.0,Autocuration,14215,,22224,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,U,,CHEMBL626237,,A,314293.0,1,,,11759
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14215,,50588,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,N,,CHEMBL626238,,A,9615.0,1,,,11760
,1,BAO_0000218,In vivo,Homo sapiens,Plasma,1969.0,Intermediate,14215,,50587,,The maximum plasma concentration (200 mg/kg) administered orally in human,N,,CHEMBL622412,,A,9606.0,1,,,11761
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14215,,50597,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,N,,CHEMBL623114,,A,10116.0,1,,,11762
,0,BAO_0000218,In vivo,Callithrix,Plasma,1969.0,Autocuration,14215,,22224,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,U,,CHEMBL623115,,A,9481.0,1,,,11763
,0,BAO_0000218,In vivo,Simiiformes,Plasma,1969.0,Autocuration,14215,,22224,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,U,,CHEMBL623116,,A,314293.0,1,,,11764
,0,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Autocuration,14215,,22224,,The maximum plasma concentration (30 mg/kg) administered orally in dog,U,,CHEMBL623117,,A,9615.0,1,,,11765
,1,BAO_0000218,In vivo,Homo sapiens,Plasma,1969.0,Intermediate,14215,,50587,,The maximum plasma concentration (400 mg/kg) administered orally in human,N,,CHEMBL623118,,A,9606.0,1,,,11766
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14215,,50597,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,N,,CHEMBL623119,,A,10116.0,1,,,11767
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14215,,50597,,The maximum plasma concentration (50 mg/kg) administered orally in rat,N,,CHEMBL623120,,A,10116.0,1,,,11768
,1,BAO_0000218,In vivo,Homo sapiens,Plasma,1969.0,Intermediate,14215,,50587,,The maximum plasma concentration (800 mg/kg) administered orally in human,N,,CHEMBL623286,,A,9606.0,1,,,11769
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14067,,50597,,The maximum plasma concentration was measured on rats,N,,CHEMBL623287,,A,10116.0,1,,,11770
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12350,,50597,,The maximum plasma concentration was measured on rats after oral administration,N,,CHEMBL623288,,A,10116.0,1,,,11771
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14813,,50597,,Plasma drug Cmax in rat (PO dose),N,,CHEMBL623289,,A,10116.0,1,,,11772
,0,BAO_0000218,In vivo,,,,Autocuration,12536,,22224,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,U,,CHEMBL623290,,A,,1,,,11773
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14169,,50588,,maximum Plasma concentration in Dog was determined after Peroral administration,N,,CHEMBL623291,,A,9615.0,1,,,11774
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14169,,50597,,maximum Plasma concentration in Rats was determined after Peroral administration,N,,CHEMBL623292,,A,10116.0,1,,,11775
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,15604,,50588,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,,CHEMBL623293,,A,9615.0,1,,,11776
,0,BAO_0000218,In vivo,Simiiformes,Plasma,1969.0,Autocuration,15604,,22224,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,,CHEMBL623294,,A,314293.0,1,,,11777
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15604,,50597,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,,CHEMBL623295,,A,10116.0,1,,,11778
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14387,,50594,,maximum concentration was measured when administered through oral route in mice,N,,CHEMBL623296,,A,10090.0,1,,,11779
,1,BAO_0000218,,Mus musculus,,,Intermediate,15115,,50594,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,N,,CHEMBL875349,,A,10090.0,1,,,11780
,0,BAO_0000019,,Simiiformes,,,Autocuration,15115,,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,U,,CHEMBL623297,,A,314293.0,1,,,11781
,0,BAO_0000019,,Simiiformes,,,Autocuration,15115,,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,U,,CHEMBL623298,,A,314293.0,1,,,11782
,0,BAO_0000019,,Simiiformes,,,Autocuration,15115,,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,U,,CHEMBL623299,,A,314293.0,1,,,11783
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,16359,,50597,,Pharmacokinetic parameter was evaluated in rats,N,,CHEMBL623300,,A,10116.0,1,,,11784
,1,BAO_0000218,,Mus musculus,,,Intermediate,12829,,50594,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,,CHEMBL623301,,A,10090.0,1,,,11785
,1,BAO_0000218,,Mus musculus,,,Intermediate,12829,,50594,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,N,,CHEMBL623302,,A,10090.0,1,,,11786
,1,BAO_0000218,,Mus musculus,,,Intermediate,12829,,50594,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,,CHEMBL623303,,A,10090.0,1,,,11787
,1,BAO_0000218,,Mus musculus,,,Intermediate,12829,,50594,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,N,,CHEMBL623304,,A,10090.0,1,,,11788
,1,BAO_0000218,,Mus musculus,,,Intermediate,12829,,50594,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,N,,CHEMBL623305,,A,10090.0,1,,,11789
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,15137,,50597,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,N,,CHEMBL623306,,A,10116.0,1,,,11790
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,15137,,50597,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,N,,CHEMBL623307,,A,10116.0,1,,,11791
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,15137,,50597,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,N,,CHEMBL623308,,A,10116.0,1,,,11792
,1,BAO_0000218,,Mus musculus,Plasma,1969.0,Intermediate,15137,,50594,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,N,,CHEMBL623309,,A,10090.0,1,,,11793
,1,BAO_0000218,,Mus musculus,,,Intermediate,13509,,50594,,Plasma Concentration after 120 min of oral administration to mice,N,,CHEMBL623310,,A,10090.0,1,,,11794
,1,BAO_0000218,,Mus musculus,,,Intermediate,13509,,50594,,Plasma Concentration after 30 min of oral administration to mice,N,,CHEMBL623311,,A,10090.0,1,,,11795
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,13509,,100710,,Plasma Concentration after 60 min of oral administration to mice,N,,CHEMBL623312,,A,9541.0,1,,,11796
,1,BAO_0000218,,Mus musculus,,,Intermediate,13509,,50594,,Plasma Concentration after 60 min of oral administration to mice; Not determined,N,,CHEMBL875350,,A,10090.0,1,,,11797
,1,BAO_0000218,,Mus musculus,,,Intermediate,13509,,50594,,Plasma Concentration after 90 min of oral administration to mice,N,,CHEMBL628635,,A,10090.0,1,,,11798
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12064,,50597,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,N,,CHEMBL628636,,A,10116.0,1,,,11799
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12064,,50597,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,N,,CHEMBL628637,,A,10116.0,1,,,11800
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12064,,50597,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,N,,CHEMBL628058,,A,10116.0,1,,,11801
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10677,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,N,,CHEMBL628059,,A,10116.0,1,,,11802
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10677,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,N,,CHEMBL628060,,A,10116.0,1,,,11803
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the lung after 15 min of intravenous administration,U,,CHEMBL628061,,A,,1,,,11804
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the lung after 30 min of intravenous administration,U,,CHEMBL628062,,A,,1,,,11805
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the lung after 5 min of intravenous administration,U,,CHEMBL628063,,A,,1,,,11806
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the lung after 60 min of intravenous administration,U,,CHEMBL628064,,A,,1,,,11807
,0,BAO_0000019,,,,,Autocuration,8926,,22224,,Distribution in the lung after 90 min of intravenous administration,U,,CHEMBL628065,,A,,1,,,11808
,0,BAO_0000019,,,Muscle tissue,2385.0,Autocuration,8926,,22224,,Distribution in the muscle after 120 min of intravenous administration,U,,CHEMBL628066,,A,,1,,,11809
,0,BAO_0000019,,,Muscle tissue,2385.0,Autocuration,8926,,22224,,Distribution in the muscle after 15 min of intravenous administration,U,,CHEMBL628067,,A,,1,,,11810
,1,BAO_0000218,,Mus musculus,Muscle tissue,2385.0,Intermediate,8926,,50594,,Distribution in the muscle after 30 min of intravenous administration,N,,CHEMBL874646,,A,10090.0,1,,,11811
,0,BAO_0000019,,,Muscle tissue,2385.0,Autocuration,8926,,22224,,Distribution in the muscle after 5 min of intravenous administration,U,,CHEMBL628068,,A,,1,,,11812
,0,BAO_0000019,,,Muscle tissue,2385.0,Autocuration,8926,,22224,,Distribution in the muscle after 60 min of intravenous administration,U,,CHEMBL628069,,A,,1,,,11813
,0,BAO_0000019,,,Muscle tissue,2385.0,Autocuration,8926,,22224,,Distribution in the muscle after 90 min of intravenous administration,U,,CHEMBL628070,,A,,1,,,11814
,0,BAO_0000019,,,Spleen,2106.0,Autocuration,8926,,22224,,Distribution in the spleen after 120 min of intravenous administration,U,,CHEMBL628071,,A,,1,,,11815
,0,BAO_0000019,,,Spleen,2106.0,Autocuration,8926,,22224,,Distribution in the spleen after 15 min of intravenous administration,U,,CHEMBL628072,,A,,1,,,11816
,0,BAO_0000019,,,Spleen,2106.0,Autocuration,8926,,22224,,Distribution in the spleen after 30 min of intravenous administration,U,,CHEMBL628073,,A,,1,,,11817
,0,BAO_0000019,,,Spleen,2106.0,Autocuration,8926,,22224,,Distribution in the spleen after 5 min of intravenous administration,U,,CHEMBL628074,,A,,1,,,11818
,0,BAO_0000019,,,Spleen,2106.0,Autocuration,8926,,22224,,Distribution in the spleen after 60 min of intravenous administration,U,,CHEMBL628075,,A,,1,,,11819
,0,BAO_0000019,,,Spleen,2106.0,Autocuration,8926,,22224,,Distribution in the spleen after 90 min of intravenous administration,U,,CHEMBL628076,,A,,1,,,11820
,1,BAO_0000218,,Rattus norvegicus,Adrenal cortex,1235.0,Intermediate,7570,,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,,CHEMBL628077,,A,10116.0,1,,,11821
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,7570,,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,N,,CHEMBL628078,,A,10116.0,1,,,11822
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,7570,,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,N,,CHEMBL628079,,A,10116.0,1,,,11823
,1,BAO_0000218,,Rattus norvegicus,Female gonad,992.0,Intermediate,7570,,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,N,,CHEMBL628080,,A,10116.0,1,,,11824
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,7570,,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,N,,CHEMBL628081,,A,10116.0,1,,,11825
,1,BAO_0000218,,Rattus norvegicus,Adrenal cortex,1235.0,Intermediate,7570,,50597,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,,CHEMBL628082,,A,10116.0,1,,,11826
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,7570,,50597,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,N,,CHEMBL874647,,A,10116.0,1,,,11827
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,7570,,50597,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,N,,CHEMBL626406,,A,10116.0,1,,,11828
,1,BAO_0000218,,Rattus norvegicus,Female gonad,992.0,Intermediate,7570,,50597,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,N,,CHEMBL626407,,A,10116.0,1,,,11829
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,7570,,50597,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,N,,CHEMBL626408,,A,10116.0,1,,,11830
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",N,,CHEMBL626409,,A,10116.0,1,,,11831
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",N,,CHEMBL626410,,A,10116.0,1,,,11832
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",N,,CHEMBL626411,,A,10116.0,1,,,11833
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",N,,CHEMBL626412,,A,10116.0,1,,,11834
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",N,,CHEMBL626413,,A,10116.0,1,,,11835
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",N,,CHEMBL626414,,A,10116.0,1,,,11836
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",N,,CHEMBL626415,,A,10116.0,1,,,11837
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",N,,CHEMBL626416,,A,10116.0,1,,,11838
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",N,,CHEMBL627062,,A,10116.0,1,,,11839
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",N,,CHEMBL627063,,A,10116.0,1,,,11840
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",N,,CHEMBL627064,,A,10116.0,1,,,11841
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",N,,CHEMBL627227,,A,10116.0,1,,,11842
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",N,,CHEMBL627228,,A,10116.0,1,,,11843
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",N,,CHEMBL627229,,A,10116.0,1,,,11844
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",N,,CHEMBL625792,,A,10116.0,1,,,11845
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",N,,CHEMBL625793,,A,10116.0,1,,,11846
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",N,,CHEMBL625794,,A,10116.0,1,,,11847
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",N,,CHEMBL625795,,A,10116.0,1,,,11848
,1,BAO_0000218,,Mus musculus,,,Intermediate,13792,,50594,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,N,,CHEMBL625796,,A,10090.0,1,,,11849
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,13376,,50588,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,,CHEMBL625797,,A,9615.0,1,,,11850
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,13376,,50588,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,,CHEMBL625798,,A,9615.0,1,,,11851
,0,BAO_0000218,,,,,Autocuration,14380,,22224,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,CHEMBL875613,,A,,1,,,11852
,0,BAO_0000218,,,,,Autocuration,14380,,22224,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,CHEMBL625799,,A,,1,,,11853
,0,BAO_0000218,,,,,Autocuration,14380,,22224,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,U,,CHEMBL625800,,A,,1,,,11854
,0,BAO_0000218,,,,,Autocuration,14380,,22224,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,,CHEMBL625801,,A,,1,,,11855
,0,BAO_0000218,,,,,Autocuration,14380,,22224,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,,CHEMBL625802,,A,,1,,,11856
,0,BAO_0000218,,,,,Autocuration,14380,,22224,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,CHEMBL625803,,A,,1,,,11857
,0,BAO_0000019,,,,,Autocuration,14380,,22224,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,U,,CHEMBL625804,,A,,1,,,11858
,0,BAO_0000218,,,,,Autocuration,14380,,22224,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,U,,CHEMBL622530,,A,,1,,,11859
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,N,,CHEMBL622531,,A,10090.0,1,,,11860
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,,CHEMBL622532,,A,10090.0,1,,,11861
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,,CHEMBL623176,,A,10090.0,1,,,11862
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,,CHEMBL623177,,A,10090.0,1,,,11863
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,,CHEMBL623178,,A,10090.0,1,,,11864
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,N,,CHEMBL623179,,A,10090.0,1,,,11865
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,,CHEMBL623180,,A,10090.0,1,,,11866
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,,CHEMBL623181,,A,10090.0,1,,,11867
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,,CHEMBL624131,,A,10090.0,1,,,11868
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),N,,CHEMBL624132,,A,10090.0,1,,,11869
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,,CHEMBL624133,,A,10090.0,1,,,11870
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,N,,CHEMBL624846,,A,10090.0,1,,,11871
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,,CHEMBL624847,,A,10090.0,1,,,11872
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,,CHEMBL624848,,A,10090.0,1,,,11873
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,,CHEMBL625012,,A,10090.0,1,,,11874
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,,CHEMBL625013,,A,10090.0,1,,,11875
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,N,,CHEMBL625014,,A,10090.0,1,,,11876
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),N,,CHEMBL625015,,A,10090.0,1,,,11877
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,,CHEMBL625016,,A,10090.0,1,,,11878
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,N,,CHEMBL625017,,A,10090.0,1,,,11879
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,,CHEMBL625018,,A,10090.0,1,,,11880
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),N,,CHEMBL625019,,A,10090.0,1,,,11881
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),N,,CHEMBL625020,,A,10090.0,1,,,11882
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,N,,CHEMBL625021,,A,10090.0,1,,,11883
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14393,,50597,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,CHEMBL625022,,A,10116.0,1,,,11884
,1,BAO_0000218,,Mus musculus,,,Intermediate,14731,,50594,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,N,,CHEMBL625023,,A,10090.0,1,,,11885
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14731,,100710,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,N,,CHEMBL625024,,A,9541.0,1,,,11886
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,14731,,100710,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,,CHEMBL627626,,A,9541.0,1,,,11887
,0,BAO_0000218,,,Brain,955.0,Autocuration,13758,,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,,CHEMBL627627,,A,,1,,,11888
,0,BAO_0000218,,,Serum,1977.0,Autocuration,13758,,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,U,,CHEMBL627628,,A,,1,,,11889
,0,BAO_0000218,,,Brain,955.0,Autocuration,13758,,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,,CHEMBL627629,,A,,1,,,11890
,0,BAO_0000218,,,Serum,1977.0,Autocuration,13758,,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,U,,CHEMBL627630,,A,,1,,,11891
,0,BAO_0000019,,,,,Autocuration,16359,,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),U,,CHEMBL627631,,A,,1,,,11892
,0,BAO_0000218,,,,,Autocuration,16359,,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),U,,CHEMBL629515,,A,,1,,,11893
,1,BAO_0000218,,Mus musculus,Spleen,2106.0,Intermediate,15383,,50594,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,CHEMBL629516,,A,10090.0,1,,,11894
,1,BAO_0000218,,Mus musculus,Spleen,2106.0,Intermediate,15383,,50594,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,CHEMBL629517,,A,10090.0,1,,,11895
,1,BAO_0000218,,Mus musculus,Spleen,2106.0,Intermediate,15383,,50594,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,CHEMBL629518,,A,10090.0,1,,,11896
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,CHEMBL877499,,A,10090.0,1,,,11897
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,CHEMBL629519,,A,10090.0,1,,,11898
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,CHEMBL629520,,A,10090.0,1,,,11899
,1,BAO_0000218,,Mus musculus,,,Intermediate,15383,,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,CHEMBL629521,,A,10090.0,1,,,11900
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),N,,CHEMBL629522,,A,10090.0,1,,,11901
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),N,,CHEMBL629523,,A,10090.0,1,,,11902
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),N,,CHEMBL629524,,A,10090.0,1,,,11903
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),N,,CHEMBL629525,,A,10090.0,1,,,11904
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),N,,CHEMBL629526,,A,10090.0,1,,,11905
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),N,,CHEMBL629527,,A,10090.0,1,,,11906
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),N,,CHEMBL629528,,A,10090.0,1,,,11907
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),N,,CHEMBL629529,,A,10090.0,1,,,11908
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),N,,CHEMBL629530,,A,10090.0,1,,,11909
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),N,,CHEMBL629531,,A,10090.0,1,,,11910
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),N,,CHEMBL628656,,A,10090.0,1,,,11911
,1,BAO_0000218,,Mus musculus,,,Intermediate,14439,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),N,,CHEMBL628657,,A,10090.0,1,,,11912
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL628658,,A,10116.0,1,,,11913
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,CHEMBL628659,,A,10116.0,1,,,11914
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,CHEMBL877500,,A,10116.0,1,,,11915
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,CHEMBL628660,,A,10116.0,1,,,11916
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,CHEMBL628661,,A,10116.0,1,,,11917
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL628662,,A,10116.0,1,,,11918
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,CHEMBL628663,,A,10116.0,1,,,11919
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,CHEMBL628664,,A,10116.0,1,,,11920
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13751,,50597,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,CHEMBL628665,,A,10116.0,1,,,11921
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13751,,50597,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,CHEMBL628666,,A,10116.0,1,,,11922
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13751,,50597,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,CHEMBL628667,,A,10116.0,1,,,11923
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13751,,50597,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,CHEMBL628668,,A,10116.0,1,,,11924
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13751,,50597,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL628669,,A,10116.0,1,,,11925
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13751,,50597,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,CHEMBL628670,,A,10116.0,1,,,11926
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13751,,50597,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,CHEMBL628671,,A,10116.0,1,,,11927
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,13751,,50597,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,CHEMBL628672,,A,10116.0,1,,,11928
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,13751,,50597,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,CHEMBL630300,,A,10116.0,1,,,11929
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,13751,,50597,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,CHEMBL629787,,A,10116.0,1,,,11930
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,13751,,50597,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL629788,,A,10116.0,1,,,11931
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13751,,50597,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,CHEMBL629789,,A,10116.0,1,,,11932
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13751,,50597,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,CHEMBL629790,,A,10116.0,1,,,11933
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13751,,50597,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,CHEMBL629791,,A,10116.0,1,,,11934
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13751,,50597,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,CHEMBL629792,,A,10116.0,1,,,11935
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13751,,50597,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL629793,,A,10116.0,1,,,11936
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13751,,50597,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,CHEMBL629794,,A,10116.0,1,,,11937
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10677,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,N,,CHEMBL874459,,A,10116.0,1,,,11938
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10677,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,N,,CHEMBL629795,,A,10116.0,1,,,11939
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10677,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,N,,CHEMBL629796,,A,10116.0,1,,,11940
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10677,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,N,,CHEMBL629797,,A,10116.0,1,,,11941
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10677,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,N,,CHEMBL629798,,A,10116.0,1,,,11942
,1,BAO_0000218,In vivo,Rattus norvegicus,Adrenal gland,2369.0,Intermediate,10911,,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL629799,,A,10116.0,1,,,11943
,1,BAO_0000218,In vivo,Rattus norvegicus,Adrenal gland,2369.0,Intermediate,10911,,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL629800,,A,10116.0,1,,,11944
,1,BAO_0000218,In vivo,Rattus norvegicus,Adrenal gland,2369.0,Intermediate,10911,,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL629801,,A,10116.0,1,,,11945
,1,BAO_0000218,In vivo,Rattus norvegicus,Adrenal gland,2369.0,Intermediate,10911,,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,N,,CHEMBL629802,,A,10116.0,1,,,11946
,1,BAO_0000218,In vivo,Rattus norvegicus,Adrenal gland,2369.0,Intermediate,10911,,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL629803,,A,10116.0,1,,,11947
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,10911,,50597,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL629804,,A,10116.0,1,,,11948
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,10911,,50597,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL629805,,A,10116.0,1,,,11949
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,10911,,50597,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,,CHEMBL629806,,A,10116.0,1,,,11950
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,10911,,50597,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL629807,,A,10116.0,1,,,11951
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,10911,,50597,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL629808,,A,10116.0,1,,,11952
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,10911,,50597,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL629809,,A,10116.0,1,,,11953
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,10911,,50597,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL629810,,A,10116.0,1,,,11954
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,10911,,50597,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,,CHEMBL629811,,A,10116.0,1,,,11955
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,10911,,50597,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL629812,,A,10116.0,1,,,11956
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,10911,,50597,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,N,,CHEMBL629813,,A,10116.0,1,,,11957
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,10911,,50597,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL874460,,A,10116.0,1,,,11958
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,10911,,50597,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL629814,,A,10116.0,1,,,11959
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,10911,,50597,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL629815,,A,10116.0,1,,,11960
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,10911,,50597,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL629816,,A,10116.0,1,,,11961
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,10911,,50597,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL629817,,A,10116.0,1,,,11962
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,10911,,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL626643,,A,10116.0,1,,,11963
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,10911,,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL626644,,A,10116.0,1,,,11964
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,10911,,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL626806,,A,10116.0,1,,,11965
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,10911,,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL626807,,A,10116.0,1,,,11966
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,10911,,50597,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL627261,,A,10116.0,1,,,11967
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,10911,,50597,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627262,,A,10116.0,1,,,11968
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,10911,,50597,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627263,,A,10116.0,1,,,11969
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,10911,,50597,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627264,,A,10116.0,1,,,11970
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,10911,,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL627265,,A,10116.0,1,,,11971
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,10911,,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627266,,A,10116.0,1,,,11972
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,10911,,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627267,,A,10116.0,1,,,11973
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,10911,,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627268,,A,10116.0,1,,,11974
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10911,,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL627269,,A,10116.0,1,,,11975
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10911,,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627270,,A,10116.0,1,,,11976
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",N,,CHEMBL627271,,A,10116.0,1,,,11977
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",N,,CHEMBL627946,,A,10116.0,1,,,11978
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",N,,CHEMBL875472,,A,10116.0,1,,,11979
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",N,,CHEMBL627947,,A,10116.0,1,,,11980
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",N,,CHEMBL627948,,A,10116.0,1,,,11981
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",N,,CHEMBL628113,,A,10116.0,1,,,11982
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",N,,CHEMBL628114,,A,10116.0,1,,,11983
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",N,,CHEMBL628115,,A,10116.0,1,,,11984
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",N,,CHEMBL628116,,A,10116.0,1,,,11985
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",N,,CHEMBL628117,,A,10116.0,1,,,11986
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",N,,CHEMBL628118,,A,10116.0,1,,,11987
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",N,,CHEMBL628119,,A,10116.0,1,,,11988
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",N,,CHEMBL628120,,A,10116.0,1,,,11989
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",N,,CHEMBL628121,,A,10116.0,1,,,11990
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",N,,CHEMBL628122,,A,10116.0,1,,,11991
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",N,,CHEMBL627297,,A,10116.0,1,,,11992
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",N,,CHEMBL627298,,A,10116.0,1,,,11993
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",N,,CHEMBL627299,,A,10116.0,1,,,11994
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",N,,CHEMBL627300,,A,10116.0,1,,,11995
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",N,,CHEMBL627301,,A,10116.0,1,,,11996
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",N,,CHEMBL627302,,A,10116.0,1,,,11997
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",N,,CHEMBL627303,,A,10116.0,1,,,11998
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",N,,CHEMBL627304,,A,10116.0,1,,,11999
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",N,,CHEMBL627305,,A,10116.0,1,,,12000
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,,CHEMBL627306,,A,10116.0,1,,,12001
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",N,,CHEMBL623982,,A,10116.0,1,,,12002
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",N,,CHEMBL623983,,A,10116.0,1,,,12003
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",N,,CHEMBL623984,,A,10116.0,1,,,12004
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",N,,CHEMBL623985,,A,10116.0,1,,,12005
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",N,,CHEMBL623986,,A,10116.0,1,,,12006
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",N,,CHEMBL623987,,A,10116.0,1,,,12007
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",N,,CHEMBL623988,,A,10116.0,1,,,12008
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",N,,CHEMBL623989,,A,10116.0,1,,,12009
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",N,,CHEMBL622215,,A,10116.0,1,,,12010
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",N,,CHEMBL622216,,A,10116.0,1,,,12011
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",N,,CHEMBL877481,,A,10116.0,1,,,12012
,0,BAO_0000218,,,,,Autocuration,16359,,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),U,,CHEMBL622217,,A,,1,,,12013
,1,BAO_0000218,,Mus musculus,,,Intermediate,13701,,50594,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,,CHEMBL622218,,A,10090.0,1,,,12014
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14554,,50597,,Pharmacokinetic profile AUC was evaluated in rats,N,,CHEMBL622219,,A,10116.0,1,,,12015
,0,BAO_0000019,,,,,Autocuration,6241,,22224,,Pharmacokinetic property (Area under curve),U,,CHEMBL622220,,A,,1,,,12016
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,11537,,50588,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",N,,CHEMBL622221,,A,9615.0,1,,,12017
,1,BAO_0000218,,Mus musculus,,,Intermediate,11537,,50594,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",N,,CHEMBL622222,,A,10090.0,1,,,12018
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,11537,,50588,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",N,,CHEMBL622223,,A,9615.0,1,,,12019
,1,BAO_0000218,,Mus musculus,,,Intermediate,11537,,50594,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",N,,CHEMBL622224,,A,10090.0,1,,,12020
,0,BAO_0000019,,,,,Autocuration,13118,,22224,,Plasma concentration (AUC) was determined,U,,CHEMBL622225,,A,,1,,,12021
,0,BAO_0000019,,,,,Autocuration,13118,,22224,,Plasma concentration (AUC) was determined; Not detectable,U,,CHEMBL622226,,A,,1,,,12022
,1,BAO_0000218,,Cavia porcellus,,,Intermediate,9562,,50512,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),N,,CHEMBL624154,,A,10141.0,1,,,12023
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10363,,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,N,,CHEMBL624155,,A,10116.0,1,,,12024
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10363,,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,,CHEMBL624156,,A,10116.0,1,,,12025
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10363,,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,N,,CHEMBL624157,,A,10116.0,1,,,12026
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10363,,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,N,,CHEMBL624158,,A,10116.0,1,,,12027
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12504,,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,N,,CHEMBL624159,,A,10116.0,1,,,12028
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12504,,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,N,,CHEMBL624160,,A,10116.0,1,,,12029
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12504,,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,N,,CHEMBL624161,,A,10116.0,1,,,12030
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12504,,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,N,,CHEMBL624162,,A,10116.0,1,,,12031
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,13317,,50588,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,N,,CHEMBL624163,,A,9615.0,1,,,12032
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15078,,50597,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL624164,,A,10116.0,1,,,12033
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14941,,50597,,The AUC(0-infinity) values in female wistar rats.,N,,CHEMBL624165,,A,10116.0,1,,,12034
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15078,,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL624166,,A,10116.0,1,,,12035
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15078,,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",N,,CHEMBL624167,,A,10116.0,1,,,12036
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14941,,50597,,The AUC(0-t)values in female wistar rats.,N,,CHEMBL624168,,A,10116.0,1,,,12037
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14067,,50597,,The Area under the concentration time curve of compound was measured on rats,N,,CHEMBL624169,,A,10116.0,1,,,12038
,1,BAO_0000218,,Homo sapiens,,,Intermediate,14215,,50587,,The area under curve (100 mg/kg) administered orally in humans,N,,CHEMBL624170,,A,9606.0,1,,,12039
,0,BAO_0000218,,Callithrix,,,Autocuration,14215,,22224,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,U,,CHEMBL624171,,A,9481.0,1,,,12040
,0,BAO_0000218,,Simiiformes,,,Autocuration,14215,,22224,,The area under curve (12.5 mg/kg) administered intravenously in monkey,U,,CHEMBL624172,,A,314293.0,1,,,12041
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14215,,50588,,The area under curve (15 mg/kg) administered intravenously in dog,N,,CHEMBL624173,,A,9615.0,1,,,12042
,1,BAO_0000218,,Homo sapiens,,,Intermediate,14215,,50587,,The area under curve (200 mg/kg) administered orally in humans,N,,CHEMBL877488,,A,9606.0,1,,,12043
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14215,,50597,,The area under curve (25 mg/kg) administered intravenously in rat,N,,CHEMBL624174,,A,10116.0,1,,,12044
,0,BAO_0000218,,Callithrix,,,Autocuration,14215,,22224,,The area under curve (25 mg/kg) administered orally in marmoset,U,,CHEMBL624175,,A,9481.0,1,,,12045
,0,BAO_0000218,,Simiiformes,,,Autocuration,14215,,22224,,The area under curve (25 mg/kg) administered orally in monkey,U,,CHEMBL624176,,A,314293.0,1,,,12046
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,14215,,50588,,The area under curve (30 mg/kg) administered orally in dog,N,,CHEMBL624177,,A,9615.0,1,,,12047
,1,BAO_0000218,,Homo sapiens,,,Intermediate,14215,,50587,,The area under curve (400 mg/kg) administered orally in humans,N,,CHEMBL624178,,A,9606.0,1,,,12048
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14215,,50597,,The area under curve (50 mg/kg) administered orally in fasted rat,N,,CHEMBL624179,,A,10116.0,1,,,12049
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14215,,50597,,The area under curve (50 mg/kg) administered orally in rat,N,,CHEMBL627689,,A,10116.0,1,,,12050
,1,BAO_0000218,,Homo sapiens,,,Intermediate,14215,,50587,,The area under curve (800 mg/kg) administered orally in humans,N,,CHEMBL627690,,A,9606.0,1,,,12051
,0,BAO_0000019,,,,,Autocuration,11324,,22224,,The compound was evaluated for area under the curve,U,,CHEMBL627691,,A,,1,,,12052
,0,BAO_0000019,,Callithrix,,,Autocuration,11324,,22224,,The compound was evaluated for area under the curve in marmosets,U,,CHEMBL627692,,A,9481.0,1,,,12053
,0,BAO_0000019,,Callithrix,,,Autocuration,11324,,22224,,The compound was evaluated for area under the curve in marmosets,U,,CHEMBL627693,,A,9481.0,1,,,12054
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13875,,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,,CHEMBL627694,,A,10116.0,1,,,12055
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13875,,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,N,,CHEMBL627695,,A,10116.0,1,,,12056
,0,BAO_0000218,,,,,Autocuration,13875,,22224,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),U,,CHEMBL627696,,A,,1,,,12057
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13875,,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,,CHEMBL627697,,A,10116.0,1,,,12058
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13875,,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,,CHEMBL627698,,A,10116.0,1,,,12059
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13875,,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,N,,CHEMBL627699,,A,10116.0,1,,,12060
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13807,,50597,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,N,,CHEMBL627700,,A,10116.0,1,,,12061
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14127,,50597,,Total drug exposure is determined after oral dosing in rats.,N,,CHEMBL627701,,A,10116.0,1,,,12062
,0,BAO_0000218,,,,,Autocuration,15116,,22224,,Total drug exposure (5 mg/kg) when administered intravenously,U,,CHEMBL627702,,A,,1,,,12063
,0,BAO_0000218,,,,,Autocuration,15116,,22224,,Total drug exposure (5 mg/kg) when administered orally,U,,CHEMBL627703,,A,,1,,,12064
,0,BAO_0000218,,Simiiformes,,,Autocuration,15604,,22224,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,,CHEMBL626873,,A,314293.0,1,,,12065
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15604,,50597,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,,CHEMBL629583,,A,10116.0,1,,,12066
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,15604,,50588,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,,CHEMBL629584,,A,9615.0,1,,,12067
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,15604,,50588,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,,CHEMBL629585,,A,9615.0,1,,,12068
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13751,,50597,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,CHEMBL629586,,A,10116.0,1,,,12069
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13751,,50597,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL629587,,A,10116.0,1,,,12070
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,CHEMBL629588,,A,10116.0,1,,,12071
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,CHEMBL629589,,A,10116.0,1,,,12072
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,CHEMBL629590,,A,10116.0,1,,,12073
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,CHEMBL629591,,A,10116.0,1,,,12074
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL629592,,A,10116.0,1,,,12075
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,CHEMBL629593,,A,10116.0,1,,,12076
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,CHEMBL629594,,A,10116.0,1,,,12077
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13751,,50597,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,CHEMBL629595,,A,10116.0,1,,,12078
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13751,,50597,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,CHEMBL630290,,A,10116.0,1,,,12079
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13751,,50597,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,CHEMBL627137,,A,10116.0,1,,,12080
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13751,,50597,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,CHEMBL627138,,A,10116.0,1,,,12081
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13751,,50597,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL627139,,A,10116.0,1,,,12082
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13751,,50597,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,CHEMBL627140,,A,10116.0,1,,,12083
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13751,,50597,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,CHEMBL627141,,A,10116.0,1,,,12084
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13751,,50597,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,CHEMBL627142,,A,10116.0,1,,,12085
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13751,,50597,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,CHEMBL627143,,A,10116.0,1,,,12086
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13751,,50597,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,CHEMBL874449,,A,10116.0,1,,,12087
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13751,,50597,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,CHEMBL627144,,A,10116.0,1,,,12088
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13751,,50597,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL627145,,A,10116.0,1,,,12089
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13751,,50597,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,CHEMBL627146,,A,10116.0,1,,,12090
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13751,,50597,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,CHEMBL627147,,A,10116.0,1,,,12091
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13751,,50597,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,CHEMBL627148,,A,10116.0,1,,,12092
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13751,,50597,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,CHEMBL627149,,A,10116.0,1,,,12093
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13751,,50597,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,CHEMBL632160,,A,10116.0,1,,,12094
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13751,,50597,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,CHEMBL632161,,A,10116.0,1,,,12095
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13751,,50597,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,CHEMBL632162,,A,10116.0,1,,,12096
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13751,,50597,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL632163,,A,10116.0,1,,,12097
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13751,,50597,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,CHEMBL874469,,A,10116.0,1,,,12098
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13751,,50597,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,CHEMBL627182,,A,10116.0,1,,,12099
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13751,,50597,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,CHEMBL627183,,A,10116.0,1,,,12100
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13751,,50597,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,CHEMBL627184,,A,10116.0,1,,,12101
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13751,,50597,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,CHEMBL627185,,A,10116.0,1,,,12102
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13751,,50597,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,CHEMBL627186,,A,10116.0,1,,,12103
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13751,,50597,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL627187,,A,10116.0,1,,,12104
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13751,,50597,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,CHEMBL627188,,A,10116.0,1,,,12105
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13751,,50597,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,CHEMBL627189,,A,10116.0,1,,,12106
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13751,,50597,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL627190,,A,10116.0,1,,,12107
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13751,,50597,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,CHEMBL627191,,A,10116.0,1,,,12108
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13751,,50597,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,CHEMBL627192,,A,10116.0,1,,,12109
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13751,,50597,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,CHEMBL627193,,A,10116.0,1,,,12110
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10911,,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,,CHEMBL874590,,A,10116.0,1,,,12111
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10911,,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627194,,A,10116.0,1,,,12112
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10911,,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627195,,A,10116.0,1,,,12113
,1,BAO_0000218,In vivo,Rattus norvegicus,Female gonad,992.0,Intermediate,10911,,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL627196,,A,10116.0,1,,,12114
,1,BAO_0000218,In vivo,Rattus norvegicus,Female gonad,992.0,Intermediate,10911,,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627197,,A,10116.0,1,,,12115
,1,BAO_0000218,In vivo,Rattus norvegicus,Female gonad,992.0,Intermediate,10911,,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627198,,A,10116.0,1,,,12116
,1,BAO_0000218,In vivo,Rattus norvegicus,Female gonad,992.0,Intermediate,10911,,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,N,,CHEMBL627199,,A,10116.0,1,,,12117
,1,BAO_0000218,In vivo,Rattus norvegicus,Female gonad,992.0,Intermediate,10911,,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627200,,A,10116.0,1,,,12118
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,10911,,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL627201,,A,10116.0,1,,,12119
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,10911,,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627202,,A,10116.0,1,,,12120
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,10911,,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627203,,A,10116.0,1,,,12121
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,10911,,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627204,,A,10116.0,1,,,12122
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,10911,,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL627205,,A,10116.0,1,,,12123
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,10911,,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627206,,A,10116.0,1,,,12124
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,10911,,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627207,,A,10116.0,1,,,12125
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,10911,,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627208,,A,10116.0,1,,,12126
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,10911,,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL627209,,A,10116.0,1,,,12127
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,10911,,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627210,,A,10116.0,1,,,12128
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,10911,,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627211,,A,10116.0,1,,,12129
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,10911,,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL627212,,A,10116.0,1,,,12130
,1,BAO_0000218,In vivo,Rattus norvegicus,Uterus,995.0,Intermediate,10911,,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,CHEMBL627213,,A,10116.0,1,,,12131
,1,BAO_0000218,In vivo,Rattus norvegicus,Uterus,995.0,Intermediate,10911,,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,CHEMBL626599,,A,10116.0,1,,,12132
,1,BAO_0000218,In vivo,Rattus norvegicus,Uterus,995.0,Intermediate,10911,,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,CHEMBL626600,,A,10116.0,1,,,12133
,1,BAO_0000218,In vivo,Rattus norvegicus,Uterus,995.0,Intermediate,10911,,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,CHEMBL626601,,A,10116.0,1,,,12134
,0,BAO_0000019,,,,,Autocuration,8081,,22224,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,U,,CHEMBL627484,,A,,1,,,12135
,1,BAO_0000218,,Macaca fascicularis,Plasma,1969.0,Intermediate,17248,,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),N,,CHEMBL627485,,A,9541.0,1,,,12136
,1,BAO_0000218,,Macaca fascicularis,Plasma,1969.0,Intermediate,17248,,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,N,,CHEMBL628147,,A,9541.0,1,,,12137
,1,BAO_0000218,,Macaca fascicularis,Plasma,1969.0,Intermediate,17248,,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,N,,CHEMBL628148,,A,9541.0,1,,,12138
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,17248,,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),N,,CHEMBL628149,,A,9615.0,1,,,12139
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,17248,,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,N,,CHEMBL628150,,A,9615.0,1,,,12140
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,17248,,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,N,,CHEMBL628318,,A,9615.0,1,,,12141
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,17248,,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,N,,CHEMBL628319,,A,9615.0,1,,,12142
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,15592,,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,,CHEMBL875609,,A,9615.0,1,,,12143
,0,BAO_0000019,,,,,Autocuration,7040,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,U,,CHEMBL628320,,A,,1,,,12144
,0,BAO_0000019,,,,,Autocuration,7040,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,U,,CHEMBL628321,,A,,1,,,12145
,0,BAO_0000019,,,,,Autocuration,7040,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,U,,CHEMBL628322,,A,,1,,,12146
,0,BAO_0000019,,,,,Autocuration,7040,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,U,,CHEMBL628323,,A,,1,,,12147
,0,BAO_0000019,,,,,Autocuration,7040,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,U,,CHEMBL628324,,A,,1,,,12148
,0,BAO_0000019,,,,,Autocuration,7040,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,U,,CHEMBL628325,,A,,1,,,12149
,0,BAO_0000019,,,,,Autocuration,7040,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,U,,CHEMBL628326,,A,,1,,,12150
,1,BAO_0000218,,Canis lupus familiaris,Adrenal medulla,1236.0,Intermediate,9614,,50588,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",N,,CHEMBL628327,,A,9615.0,1,,,12151
,1,BAO_0000218,,Canis lupus familiaris,Adrenal medulla,1236.0,Intermediate,9614,,50588,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",N,,CHEMBL628328,,A,9615.0,1,,,12152
,1,BAO_0000218,,Canis lupus familiaris,Blood,178.0,Intermediate,9614,,50588,,"Concentration of compound in blood of dog 1, after administering intravenously",N,,CHEMBL628329,,A,9615.0,1,,,12153
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",N,,CHEMBL628330,,A,10116.0,1,,,12154
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",N,,CHEMBL628331,,A,10116.0,1,,,12155
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",N,,CHEMBL628332,,A,10116.0,1,,,12156
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",N,,CHEMBL628333,,A,10116.0,1,,,12157
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",N,,CHEMBL628334,,A,10116.0,1,,,12158
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",N,,CHEMBL628335,,A,10116.0,1,,,12159
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",N,,CHEMBL628336,,A,10116.0,1,,,12160
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,,CHEMBL628337,,A,10116.0,1,,,12161
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",N,,CHEMBL628338,,A,10116.0,1,,,12162
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",N,,CHEMBL875610,,A,10116.0,1,,,12163
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",N,,CHEMBL628339,,A,10116.0,1,,,12164
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",N,,CHEMBL628340,,A,10116.0,1,,,12165
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",N,,CHEMBL628341,,A,10116.0,1,,,12166
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",N,,CHEMBL622214,,A,10116.0,1,,,12167
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",N,,CHEMBL623167,,A,10116.0,1,,,12168
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",N,,CHEMBL623168,,A,10116.0,1,,,12169
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",N,,CHEMBL623169,,A,10116.0,1,,,12170
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",N,,CHEMBL623170,,A,10116.0,1,,,12171
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",N,,CHEMBL627224,,A,10116.0,1,,,12172
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",N,,CHEMBL875634,,A,10116.0,1,,,12173
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",N,,CHEMBL627225,,A,10116.0,1,,,12174
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",N,,CHEMBL627226,,A,10116.0,1,,,12175
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",N,,CHEMBL626083,,A,10116.0,1,,,12176
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",N,,CHEMBL626084,,A,10116.0,1,,,12177
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",N,,CHEMBL626085,,A,10116.0,1,,,12178
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",N,,CHEMBL626086,,A,10116.0,1,,,12179
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",N,,CHEMBL626087,,A,10116.0,1,,,12180
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",N,,CHEMBL626088,,A,10116.0,1,,,12181
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",N,,CHEMBL626089,,A,10116.0,1,,,12182
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",N,,CHEMBL626090,,A,10116.0,1,,,12183
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",N,,CHEMBL626091,,A,10116.0,1,,,12184
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",N,,CHEMBL626092,,A,10116.0,1,,,12185
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",N,,CHEMBL626093,,A,10116.0,1,,,12186
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",N,,CHEMBL626094,,A,10116.0,1,,,12187
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",N,,CHEMBL626095,,A,10116.0,1,,,12188
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",N,,CHEMBL626096,,A,10116.0,1,,,12189
,0,BAO_0000218,,Simiiformes,,,Autocuration,15604,,22224,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,,CHEMBL626097,,A,314293.0,1,,,12190
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15604,,50597,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,,CHEMBL626098,,A,10116.0,1,,,12191
,0,BAO_0000218,,,Plasma,1969.0,Autocuration,1806,,22224,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,U,,CHEMBL626099,,A,,1,,,12192
,0,BAO_0000218,,,Plasma,1969.0,Autocuration,1806,,22224,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,U,,CHEMBL626100,,A,,1,,,12193
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,17237,,50588,,AUC 0-inf in dog,N,,CHEMBL626101,,A,9615.0,1,,,12194
,1,BAO_0000218,,Cavia porcellus,Plasma,1969.0,Intermediate,17237,,50512,,AUC 0-inf in guinea pig,N,,CHEMBL626102,,A,10141.0,1,,,12195
,1,BAO_0000218,,Canis lupus familiaris,Plasma,1969.0,Intermediate,17237,,50588,,AUC 0-t in dog,N,,CHEMBL626103,,A,9615.0,1,,,12196
,1,BAO_0000218,,Cavia porcellus,Plasma,1969.0,Intermediate,17237,,50512,,AUC 0-t in guinea pig,N,,CHEMBL628391,,A,10141.0,1,,,12197
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15194,,50597,,The compound was tested for brain to plasma partition in rat,N,,CHEMBL628392,,A,10116.0,1,,,12198
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15194,,50597,,The compound was tested for brain to plasma partition in rat.,N,,CHEMBL628393,,A,10116.0,1,,,12199
,0,BAO_0000019,,,Blood,178.0,Autocuration,8787,,22224,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,U,,CHEMBL628394,,A,,1,,,12200
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,17025,,50588,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,N,,CHEMBL628395,,A,9615.0,1,,,12201
,0,BAO_0000218,,Simiiformes,,,Autocuration,17025,,22224,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,U,,CHEMBL628396,,A,314293.0,1,,,12202
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,17025,,50592,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,,CHEMBL628397,,A,9986.0,1,,,12203
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17025,,50597,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,N,,CHEMBL628398,,A,10116.0,1,,,12204
,1,BAO_0000218,,Macaca mulatta,,,Intermediate,4236,,50797,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,N,,CHEMBL628399,,A,9544.0,1,,,12205
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,15343,,50588,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,N,,CHEMBL628400,,A,9615.0,1,,,12206
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15343,,50597,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,N,,CHEMBL874907,,A,10116.0,1,,,12207
,0,BAO_0000019,,,,,Autocuration,17720,,22224,,Area under curve of the compound was determined,U,,CHEMBL628401,,A,,1,,,12208
,0,BAO_0000218,,Simiiformes,Plasma,1969.0,Autocuration,17788,,22224,,AUC in monkeys at a dose of 1 mg/kg,U,,CHEMBL628402,,A,314293.0,1,,,12209
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,17788,,50597,,AUC in rats at a dose of 1 mg/kg,N,,CHEMBL628403,,A,10116.0,1,,,12210
,0,BAO_0000019,,,,,Autocuration,8778,,22224,,Compound was evaluated for the overall absorbance loss at pH of 2,U,,CHEMBL628404,,A,,1,,,12211
,0,BAO_0000019,,,,,Autocuration,8778,,22224,,Compound was evaluated for the overall absorbance loss at pH of 4,U,,CHEMBL628405,,A,,1,,,12212
,0,BAO_0000019,,,,,Autocuration,8778,,22224,,Compound was evaluated for the overall absorbance loss at pH of 7,U,,CHEMBL628406,,A,,1,,,12213
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,2249,,50597,,Compound was evaluated for its absorption in the rats,N,,CHEMBL628407,,A,10116.0,1,,,12214
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8881,,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,,CHEMBL628408,,A,10116.0,1,,,12215
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8881,,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,N,,CHEMBL629171,,A,10116.0,1,,,12216
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8881,,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,,CHEMBL629172,,A,10116.0,1,,,12217
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8881,,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,N,,CHEMBL629173,,A,10116.0,1,,,12218
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum,N,,CHEMBL629174,,A,10116.0,1,,,12219
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 10-17,N,,CHEMBL629175,,A,10116.0,1,,,12220
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 10-18,N,,CHEMBL629176,,A,10116.0,1,,,12221
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 10-19,N,,CHEMBL629177,,A,10116.0,1,,,12222
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 12-15,N,,CHEMBL629178,,A,10116.0,1,,,12223
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 13-19,N,,CHEMBL631869,,A,10116.0,1,,,12224
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 14-17,N,,CHEMBL631870,,A,10116.0,1,,,12225
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 15-18,N,,CHEMBL631871,,A,10116.0,1,,,12226
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 2-5,N,,CHEMBL631872,,A,10116.0,1,,,12227
,0,BAO_0000221,,,Ileum,2116.0,Autocuration,15286,,22224,,In vitro percent permeability into rat ileum; Range is 23-42,U,,CHEMBL875775,,A,,1,,,12228
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 28-36,N,,CHEMBL631873,,A,10116.0,1,,,12229
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 29-35,N,,CHEMBL631874,,A,10116.0,1,,,12230
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 46-66,N,,CHEMBL631875,,A,10116.0,1,,,12231
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 50-68,N,,CHEMBL631876,,A,10116.0,1,,,12232
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; Range is 78-81,N,,CHEMBL631877,,A,10116.0,1,,,12233
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,N,,CHEMBL631878,,A,10116.0,1,,,12234
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; nd indicates not detected,N,,CHEMBL631879,,A,10116.0,1,,,12235
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; nt indicates not detected,N,,CHEMBL631880,,A,10116.0,1,,,12236
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15286,,50597,,In vitro percent permeability into rat ileum; nt indicates not tested,N,,CHEMBL631881,,A,10116.0,1,,,12237
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13770,,50597,,Compound was tested for oral absorption in bile-duct cannulated rats,N,,CHEMBL631882,,A,10116.0,1,,,12238
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13770,,50597,,Compound was tested for oral absorption in bile-duct cannulated rats.,N,,CHEMBL630749,,A,10116.0,1,,,12239
,1,BAO_0000218,,Homo sapiens,,,Intermediate,5202,,50587,,Oral absorption using Caco-2 cell monolayers.,N,,CHEMBL630750,,A,9606.0,1,,,12240
,1,BAO_0000218,,Homo sapiens,,,Intermediate,14920,,50587,,Percent of the drug absorbed after administration to humans was determined,N,,CHEMBL630253,,A,9606.0,1,,,12241
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,,CHEMBL630254,,A,10116.0,1,,,12242
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,,CHEMBL630255,,A,10116.0,1,,,12243
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,,CHEMBL630256,,A,10116.0,1,,,12244
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13751,,50597,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,CHEMBL875781,,A,10116.0,1,,,12245
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13751,,50597,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,CHEMBL630257,,A,10116.0,1,,,12246
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13751,,50597,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,CHEMBL630258,,A,10116.0,1,,,12247
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15807,,50597,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",N,,CHEMBL630259,,A,10116.0,1,,,12248
,1,BAO_0000218,,Rattus norvegicus,Striatum,2435.0,Intermediate,15807,,50597,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",N,,CHEMBL630260,,A,10116.0,1,,,12249
,1,BAO_0000218,,Rattus norvegicus,Striatum,2435.0,Intermediate,15807,,50597,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",N,,CHEMBL630261,,A,10116.0,1,,,12250
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,N,,CHEMBL630262,,A,10116.0,1,,,12251
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,N,,CHEMBL630263,,A,10116.0,1,,,12252
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,N,,CHEMBL630264,,A,10116.0,1,,,12253
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,N,,CHEMBL630265,,A,10116.0,1,,,12254
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,N,,CHEMBL630266,,A,10116.0,1,,,12255
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,N,,CHEMBL630267,,A,10116.0,1,,,12256
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,N,,CHEMBL630268,,A,10116.0,1,,,12257
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,N,,CHEMBL630269,,A,10116.0,1,,,12258
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,N,,CHEMBL630270,,A,10116.0,1,,,12259
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,N,,CHEMBL630141,,A,10116.0,1,,,12260
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,N,,CHEMBL630142,,A,10116.0,1,,,12261
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,N,,CHEMBL630143,,A,10116.0,1,,,12262
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,N,,CHEMBL630144,,A,10116.0,1,,,12263
,1,BAO_0000218,,Rattus norvegicus,Prostate gland,2367.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,N,,CHEMBL630145,,A,10116.0,1,,,12264
,1,BAO_0000218,,Rattus norvegicus,Prostate gland,2367.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,N,,CHEMBL630146,,A,10116.0,1,,,12265
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,N,,CHEMBL630147,,A,10116.0,1,,,12266
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,N,,CHEMBL630148,,A,10116.0,1,,,12267
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,N,,CHEMBL630149,,A,10116.0,1,,,12268
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,N,,CHEMBL630150,,A,10116.0,1,,,12269
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,N,,CHEMBL630151,,A,10116.0,1,,,12270
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,N,,CHEMBL632031,,A,10116.0,1,,,12271
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,N,,CHEMBL632032,,A,10116.0,1,,,12272
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,N,,CHEMBL632033,,A,10116.0,1,,,12273
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,N,,CHEMBL632034,,A,10116.0,1,,,12274
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,N,,CHEMBL632035,,A,10116.0,1,,,12275
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,N,,CHEMBL632036,,A,10116.0,1,,,12276
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,14950,,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,N,,CHEMBL632037,,A,10116.0,1,,,12277
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,,CHEMBL632038,,A,10116.0,1,,,12278
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,,CHEMBL632039,,A,10116.0,1,,,12279
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,,CHEMBL632040,,A,10116.0,1,,,12280
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,,CHEMBL632041,,A,10116.0,1,,,12281
,1,BAO_0000218,,Canis lupus familiaris,Blood,178.0,Intermediate,9614,,50588,,"Concentration of compound in blood of dog 2, after administering intravenously",N,,CHEMBL632042,,A,9615.0,1,,,12282
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,9614,,50588,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",N,,CHEMBL632043,,A,9615.0,1,,,12283
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,9614,,50588,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",N,,CHEMBL632044,,A,9615.0,1,,,12284
,1,BAO_0000218,,Canis lupus familiaris,Liver,2107.0,Intermediate,9614,,50588,,"Concentration of compound in liver of dog 1, after administering intravenously",N,,CHEMBL632045,,A,9615.0,1,,,12285
,1,BAO_0000218,,Canis lupus familiaris,Liver,2107.0,Intermediate,9614,,50588,,"Concentration of compound in liver of dog 2, after administering intravenously",N,,CHEMBL632046,,A,9615.0,1,,,12286
,1,BAO_0000218,,Canis lupus familiaris,Lung,2048.0,Intermediate,9614,,50588,,"Concentration of compound in lung of dog 1, after administering intravenously",N,,CHEMBL632047,,A,9615.0,1,,,12287
,1,BAO_0000218,,Canis lupus familiaris,Lung,2048.0,Intermediate,9614,,50588,,"Concentration of compound in lung of dog 2, after administering intravenously",N,,CHEMBL632048,,A,9615.0,1,,,12288
,1,BAO_0000218,,Canis lupus familiaris,Muscle tissue,2385.0,Intermediate,9614,,50588,,"Concentration of compound in muscle of dog 1, after administering intravenously",N,,CHEMBL632049,,A,9615.0,1,,,12289
,1,BAO_0000218,,Canis lupus familiaris,Muscle tissue,2385.0,Intermediate,9614,,50588,,"Concentration of compound in muscle of dog 2, after administering intravenously",N,,CHEMBL876418,,A,9615.0,1,,,12290
,1,BAO_0000218,,Canis lupus familiaris,Spleen,2106.0,Intermediate,9614,,50588,,"Concentration of compound in spleen of dog 1,after administering intravenously",N,,CHEMBL632050,,A,9615.0,1,,,12291
,1,BAO_0000218,,Canis lupus familiaris,Spleen,2106.0,Intermediate,9614,,50588,,"Concentration of compound in spleen of dog 2, after administering intravenously",N,,CHEMBL632051,,A,9615.0,1,,,12292
,0,BAO_0000218,,,,,Autocuration,10353,,22224,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,U,,CHEMBL632052,,F,,1,,,12293
,0,BAO_0000218,,,,,Autocuration,10353,,22224,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,U,,CHEMBL632053,,F,,1,,,12294
,0,BAO_0000218,,,,,Autocuration,10353,,22224,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,,CHEMBL632054,,A,,1,,,12295
,0,BAO_0000218,,,,,Autocuration,10353,,22224,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,,CHEMBL632055,,F,,1,,,12296
,0,BAO_0000218,,,,,Autocuration,10353,,22224,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,U,,CHEMBL631181,,F,,1,,,12297
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,U,,CHEMBL631182,,A,,1,,,12298
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,CHEMBL631183,,A,,1,,,12299
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,CHEMBL631184,,A,,1,,,12300
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,CHEMBL629774,,A,,1,,,12301
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,CHEMBL629775,,A,,1,,,12302
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,CHEMBL876549,,A,,1,,,12303
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,CHEMBL628172,,A,,1,,,12304
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,CHEMBL628173,,A,,1,,,12305
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,U,,CHEMBL628174,,A,,1,,,12306
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,U,,CHEMBL628175,,A,,1,,,12307
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,CHEMBL628176,,A,,1,,,12308
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,CHEMBL628177,,A,,1,,,12309
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,CHEMBL628178,,A,,1,,,12310
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,CHEMBL628179,,A,,1,,,12311
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,,CHEMBL628180,,A,,1,,,12312
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,U,,CHEMBL628181,,A,,1,,,12313
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,CHEMBL628182,,A,,1,,,12314
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,CHEMBL628183,,A,,1,,,12315
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,U,,CHEMBL628184,,A,,1,,,12316
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,CHEMBL628185,,A,,1,,,12317
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,CHEMBL875617,,A,,1,,,12318
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,,CHEMBL628186,,A,,1,,,12319
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,CHEMBL628187,,A,,1,,,12320
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,CHEMBL628188,,A,,1,,,12321
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,,CHEMBL628189,,A,,1,,,12322
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,U,,CHEMBL628190,,A,,1,,,12323
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,CHEMBL628191,,A,,1,,,12324
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,U,,CHEMBL626513,,A,,1,,,12325
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",N,,CHEMBL626514,,A,10116.0,1,,,12326
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",N,,CHEMBL626515,,A,10116.0,1,,,12327
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",N,,CHEMBL626516,,A,10116.0,1,,,12328
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",N,,CHEMBL626517,,A,10116.0,1,,,12329
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",N,,CHEMBL626518,,A,10116.0,1,,,12330
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",N,,CHEMBL626519,,A,10116.0,1,,,12331
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",N,,CHEMBL626520,,A,10116.0,1,,,12332
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",N,,CHEMBL626521,,A,10116.0,1,,,12333
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",N,,CHEMBL626522,,A,10116.0,1,,,12334
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",N,,CHEMBL626523,,A,10116.0,1,,,12335
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",N,,CHEMBL626524,,A,10116.0,1,,,12336
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",N,,CHEMBL626688,,A,10116.0,1,,,12337
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",N,,CHEMBL626689,,A,10116.0,1,,,12338
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",N,,CHEMBL626690,,A,10116.0,1,,,12339
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",N,,CHEMBL626691,,A,10116.0,1,,,12340
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",N,,CHEMBL627319,,A,10116.0,1,,,12341
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",N,,CHEMBL624052,,A,10116.0,1,,,12342
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8608,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",N,,CHEMBL624053,,A,10116.0,1,,,12343
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8085,,50597,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,CHEMBL624054,,A,10116.0,1,,,12344
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8085,,50597,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,CHEMBL624055,,A,10116.0,1,,,12345
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8085,,50597,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,CHEMBL624056,,A,10116.0,1,,,12346
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8085,,50597,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,CHEMBL624057,,A,10116.0,1,,,12347
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8085,,50597,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,CHEMBL622281,,A,10116.0,1,,,12348
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8085,,50597,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,CHEMBL622282,,A,10116.0,1,,,12349
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8085,,50597,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,CHEMBL622283,,A,10116.0,1,,,12350
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8085,,50597,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,CHEMBL622284,,A,10116.0,1,,,12351
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8085,,50597,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,CHEMBL622285,,A,10116.0,1,,,12352
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,8085,,50597,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,CHEMBL622286,,A,10116.0,1,,,12353
,0,BAO_0000100,,,,,Autocuration,7657,,22224,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,U,,CHEMBL622287,,P,,1,,,12354
,1,BAO_0000218,,Mus musculus,,,Intermediate,8935,,50594,,Partition coefficient (logD7.4),N,,CHEMBL622288,,A,10090.0,1,,,12355
,1,BAO_0000218,,Mus musculus,,,Intermediate,13792,,50594,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,,CHEMBL622289,,A,10090.0,1,,,12356
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,13792,,50594,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,,CHEMBL622290,,A,10090.0,1,,,12357
,1,BAO_0000218,,Mus musculus,,,Intermediate,13792,,50594,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,,CHEMBL622291,,A,10090.0,1,,,12358
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,13792,,50594,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,,CHEMBL622292,,A,10090.0,1,,,12359
,1,BAO_0000218,,Mus musculus,,,Intermediate,13792,,50594,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,,CHEMBL622293,,A,10090.0,1,,,12360
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,13792,,50594,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,,CHEMBL622294,,A,10090.0,1,,,12361
,1,BAO_0000218,,Mus musculus,,,Intermediate,13792,,50594,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,,CHEMBL622295,,A,10090.0,1,,,12362
,1,BAO_0000218,,Rattus norvegicus,Brain,955.0,Intermediate,13792,,50597,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,,CHEMBL622296,,A,10116.0,1,,,12363
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,N,,CHEMBL874409,,A,10116.0,1,,,12364
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,,CHEMBL622297,,A,10116.0,1,,,12365
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,,CHEMBL622298,,A,10116.0,1,,,12366
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,,CHEMBL622299,,A,10116.0,1,,,12367
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,,CHEMBL622300,,A,10116.0,1,,,12368
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,,CHEMBL622301,,A,10116.0,1,,,12369
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,,CHEMBL622302,,A,10116.0,1,,,12370
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,,CHEMBL622303,,A,10116.0,1,,,12371
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,,CHEMBL622304,,A,10116.0,1,,,12372
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,N,,CHEMBL622305,,A,10116.0,1,,,12373
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,,CHEMBL622306,,A,10116.0,1,,,12374
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,N,,CHEMBL626864,,A,10116.0,1,,,12375
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,,CHEMBL626865,,A,10116.0,1,,,12376
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,N,,CHEMBL626866,,A,10116.0,1,,,12377
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,,CHEMBL626867,,A,10116.0,1,,,12378
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,,CHEMBL626868,,A,10116.0,1,,,12379
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,N,,CHEMBL626869,,A,10116.0,1,,,12380
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,,CHEMBL626870,,A,10116.0,1,,,12381
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,N,,CHEMBL626871,,A,10116.0,1,,,12382
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,,CHEMBL626872,,A,10116.0,1,,,12383
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,,CHEMBL632185,,A,10116.0,1,,,12384
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,14103,,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,N,,CHEMBL632186,,A,10116.0,1,,,12385
,0,BAO_0000019,,,,,Autocuration,12904,,22224,,Amount of acetic acid produced by the compound,U,,CHEMBL629310,,A,,1,,,12386
,0,BAO_0000019,,,,,Autocuration,12904,,22224,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,U,,CHEMBL629311,,A,,1,,,12387
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9663,,50597,,Log of (Cbrain/Cblood) in rats,N,,CHEMBL629312,,A,10116.0,1,,,12388
,0,BAO_0000221,,,,,Autocuration,7652,,22224,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,,CHEMBL629313,,A,,1,,,12389
,0,BAO_0000221,,,,,Autocuration,7652,,22224,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,CHEMBL629314,,A,,1,,,12390
,0,BAO_0000221,,,,,Autocuration,7652,,22224,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,,CHEMBL629315,,A,,1,,,12391
,0,BAO_0000219,,,,,Autocuration,7652,,22224,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),U,,CHEMBL629316,,B,,1,,,12392
,0,BAO_0000221,,,,,Autocuration,7652,,22224,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,CHEMBL629317,,A,,1,,,12393
,0,BAO_0000019,,,,,Autocuration,7652,,22224,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,,CHEMBL629318,,A,,1,,,12394
,0,BAO_0000019,,,,,Autocuration,7652,,22224,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),U,,CHEMBL877497,,A,,1,,,12395
,0,BAO_0000019,,,,,Autocuration,7652,,22224,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),U,,CHEMBL629319,,A,,1,,,12396
,0,BAO_0000019,,,,,Autocuration,7652,,22224,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,CHEMBL629320,,A,,1,,,12397
,0,BAO_0000019,,,,,Autocuration,7652,,22224,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),U,,CHEMBL629496,,A,,1,,,12398
,0,BAO_0000019,,,,,Autocuration,7652,,22224,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),U,,CHEMBL629497,,A,,1,,,12399
,0,BAO_0000019,,,,,Autocuration,7652,,22224,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),U,,CHEMBL629498,,A,,1,,,12400
,0,BAO_0000019,,,,,Autocuration,7652,,22224,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),U,,CHEMBL629499,,A,,1,,,12401
,0,BAO_0000019,,,,,Autocuration,7652,,22224,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,,CHEMBL629500,,A,,1,,,12402
,0,BAO_0000019,,,,,Autocuration,7652,,22224,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),U,,CHEMBL629501,,A,,1,,,12403
,0,BAO_0000019,,,,,Autocuration,7652,,22224,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),U,,CHEMBL629502,,A,,1,,,12404
,0,BAO_0000218,In vivo,,,,Autocuration,8267,,22224,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,U,,CHEMBL629503,,F,,1,,,12405
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8267,,50588,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,N,,CHEMBL629504,,A,9615.0,1,,,12406
,0,BAO_0000019,,,,,Autocuration,14479,,22224,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,U,,CHEMBL629505,,A,,1,,,12407
,0,BAO_0000019,,,,,Autocuration,17515,,22224,,Compound was evaluated for total body clearance,U,,CHEMBL629506,,A,,1,,,12408
,0,BAO_0000019,,,,,Autocuration,17515,,22224,,Compound was evaluated for volume of distribution at steady state,U,,CHEMBL629507,,A,,1,,,12409
,0,BAO_0000019,,,,,Autocuration,8142,,22224,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,U,,CHEMBL877498,,A,,1,,,12410
,0,BAO_0000019,,,,,Autocuration,14849,,22224,,Percentage of the diamine which is monoprotonated at pH 7.4,U,,CHEMBL629508,,A,,1,,,12411
,0,BAO_0000019,,,,,Autocuration,7653,,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,U,,CHEMBL629509,,A,,1,,,12412
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,,CHEMBL629510,,A,10116.0,1,,,12413
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,,CHEMBL629511,,A,10116.0,1,,,12414
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,CHEMBL629512,,A,10116.0,1,,,12415
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,CHEMBL629513,,A,10116.0,1,,,12416
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,,CHEMBL629514,,A,10116.0,1,,,12417
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,CHEMBL628447,,A,10116.0,1,,,12418
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,,CHEMBL628448,,A,10116.0,1,,,12419
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,,CHEMBL628449,,A,10116.0,1,,,12420
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,,CHEMBL631119,,A,10116.0,1,,,12421
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,,CHEMBL631120,,A,10116.0,1,,,12422
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,,CHEMBL631121,,A,10116.0,1,,,12423
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,N,,CHEMBL874458,,A,10116.0,1,,,12424
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,CHEMBL631122,,A,10116.0,1,,,12425
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,CHEMBL631123,,A,10116.0,1,,,12426
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,CHEMBL631124,,A,10116.0,1,,,12427
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,,CHEMBL631125,,A,10116.0,1,,,12428
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,CHEMBL631290,,A,10116.0,1,,,12429
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,CHEMBL631291,,A,10116.0,1,,,12430
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,CHEMBL631292,,A,10116.0,1,,,12431
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,,CHEMBL631293,,A,10116.0,1,,,12432
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,CHEMBL631294,,A,10116.0,1,,,12433
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,CHEMBL631295,,A,10116.0,1,,,12434
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,,CHEMBL631296,,A,10116.0,1,,,12435
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8631,,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,CHEMBL631297,,A,10116.0,1,,,12436
,0,BAO_0000218,,,,,Autocuration,10263,,22224,,Maximum biodistribution (Bmax) was determined.,U,,CHEMBL631298,,A,,1,,,12437
,1,BAO_0000218,,Mus musculus,,,Intermediate,12364,,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,N,,CHEMBL631299,,A,10090.0,1,,,12438
,1,BAO_0000218,,Mus musculus,,,Intermediate,12364,,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,N,,CHEMBL631300,,A,10090.0,1,,,12439
,1,BAO_0000218,,Mus musculus,,,Intermediate,12364,,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,N,,CHEMBL631301,,A,10090.0,1,,,12440
,1,BAO_0000218,,Mus musculus,,,Intermediate,12364,,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,N,,CHEMBL630291,,A,10090.0,1,,,12441
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,CHEMBL630292,,A,,1,,,12442
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,U,,CHEMBL630293,,A,,1,,,12443
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,U,,CHEMBL630294,,A,,1,,,12444
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,U,,CHEMBL630295,,A,,1,,,12445
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,U,,CHEMBL630296,,A,,1,,,12446
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,U,,CHEMBL626782,,A,,1,,,12447
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,U,,CHEMBL626783,,A,,1,,,12448
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,CHEMBL626784,,A,,1,,,12449
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,U,,CHEMBL626785,,A,,1,,,12450
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,U,,CHEMBL626786,,A,,1,,,12451
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,CHEMBL626787,,A,,1,,,12452
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,,CHEMBL626788,,A,,1,,,12453
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,CHEMBL625927,,A,,1,,,12454
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL625928,,A,10116.0,1,,,12455
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,CHEMBL625929,,A,10116.0,1,,,12456
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,,CHEMBL625930,,A,10116.0,1,,,12457
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",N,,CHEMBL625931,,A,10116.0,1,,,12458
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,N,,CHEMBL627230,,A,10116.0,1,,,12459
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627231,,A,10116.0,1,,,12460
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,CHEMBL627232,,A,10116.0,1,,,12461
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,,CHEMBL627233,,A,10116.0,1,,,12462
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL875470,,A,10116.0,1,,,12463
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627234,,A,10116.0,1,,,12464
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627235,,A,10116.0,1,,,12465
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627236,,A,10116.0,1,,,12466
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627237,,A,10116.0,1,,,12467
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627238,,A,10116.0,1,,,12468
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627239,,A,10116.0,1,,,12469
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627240,,A,10116.0,1,,,12470
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627241,,A,10116.0,1,,,12471
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627242,,A,10116.0,1,,,12472
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,N,,CHEMBL627243,,A,10116.0,1,,,12473
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,CHEMBL627244,,A,10116.0,1,,,12474
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627245,,A,10116.0,1,,,12475
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627246,,A,10116.0,1,,,12476
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627247,,A,10116.0,1,,,12477
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627248,,A,10116.0,1,,,12478
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627249,,A,10116.0,1,,,12479
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL625569,,A,10116.0,1,,,12480
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL625570,,A,10116.0,1,,,12481
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL625571,,A,10116.0,1,,,12482
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,CHEMBL625572,,A,10116.0,1,,,12483
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,CHEMBL625573,,A,10116.0,1,,,12484
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,N,,CHEMBL625574,,A,10116.0,1,,,12485
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,CHEMBL626245,,A,10116.0,1,,,12486
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL626246,,A,10116.0,1,,,12487
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,CHEMBL626247,,A,,1,,,12488
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,CHEMBL626248,,A,,1,,,12489
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,,CHEMBL626249,,A,,1,,,12490
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,CHEMBL626420,,A,,1,,,12491
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,CHEMBL626421,,A,,1,,,12492
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,CHEMBL626422,,A,,1,,,12493
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,CHEMBL626423,,A,,1,,,12494
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,CHEMBL626424,,A,,1,,,12495
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,12023,,50588,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,N,,CHEMBL626425,,A,9615.0,1,,,12496
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12023,,50597,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,N,,CHEMBL875476,,A,10116.0,1,,,12497
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,12023,,100710,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,N,,CHEMBL626426,,A,9541.0,1,,,12498
,0,BAO_0000100,,,,,Autocuration,10580,,22224,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,U,,CHEMBL626427,,P,,1,,,12499
,0,BAO_0000100,,,,,Autocuration,10580,,22224,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,U,,CHEMBL626428,,P,,1,,,12500
,0,BAO_0000019,,,,,Autocuration,16032,,22224,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,U,,CHEMBL626429,,A,,1,,,12501
,0,BAO_0000019,,,Urine,1088.0,Autocuration,16032,,22224,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,U,,CHEMBL625025,,A,,1,,,12502
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,CHEMBL625026,,A,10116.0,1,,,12503
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,CHEMBL625027,,A,10116.0,1,,,12504
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,CHEMBL874410,,A,10116.0,1,,,12505
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,CHEMBL625028,,A,10116.0,1,,,12506
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,CHEMBL625029,,A,10116.0,1,,,12507
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,CHEMBL625030,,A,10116.0,1,,,12508
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,CHEMBL625031,,A,10116.0,1,,,12509
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,CHEMBL625032,,A,10116.0,1,,,12510
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,CHEMBL625033,,A,10116.0,1,,,12511
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,CHEMBL625034,,A,10116.0,1,,,12512
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,CHEMBL624872,,A,10116.0,1,,,12513
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,CHEMBL624873,,A,10116.0,1,,,12514
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,CHEMBL624874,,A,10116.0,1,,,12515
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,CHEMBL624875,,A,10116.0,1,,,12516
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,CHEMBL624876,,A,10116.0,1,,,12517
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,CHEMBL624877,,A,10116.0,1,,,12518
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,CHEMBL624878,,A,10116.0,1,,,12519
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,CHEMBL624879,,A,10116.0,1,,,12520
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,CHEMBL624880,,A,10116.0,1,,,12521
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,N,,CHEMBL624881,,A,10116.0,1,,,12522
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",N,,CHEMBL624882,,A,10116.0,1,,,12523
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,CHEMBL624883,,A,10116.0,1,,,12524
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,CHEMBL624884,,A,10116.0,1,,,12525
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,CHEMBL624885,,A,10116.0,1,,,12526
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,CHEMBL624886,,A,10116.0,1,,,12527
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,CHEMBL624887,,A,10116.0,1,,,12528
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,CHEMBL624888,,A,10116.0,1,,,12529
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,CHEMBL624889,,A,10116.0,1,,,12530
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,CHEMBL624890,,A,10116.0,1,,,12531
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,CHEMBL621964,,A,10116.0,1,,,12532
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,CHEMBL621965,,A,10116.0,1,,,12533
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,CHEMBL621966,,A,10116.0,1,,,12534
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,CHEMBL621967,,A,10116.0,1,,,12535
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,CHEMBL622164,,A,10116.0,1,,,12536
,0,BAO_0000019,,,,,Autocuration,7653,,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),U,,CHEMBL623097,,A,,1,,,12537
,0,BAO_0000019,,,,,Autocuration,7653,,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),U,,CHEMBL623098,,A,,1,,,12538
,0,BAO_0000019,,,,,Autocuration,7653,,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,U,,CHEMBL623099,,A,,1,,,12539
,0,BAO_0000019,,,,,Autocuration,7653,,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,U,,CHEMBL623100,,A,,1,,,12540
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9104,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",N,,CHEMBL628673,,A,10116.0,1,,,12541
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9104,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",N,,CHEMBL628674,,A,10116.0,1,,,12542
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9104,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",N,,CHEMBL628675,,A,10116.0,1,,,12543
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9104,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",N,,CHEMBL627644,,A,10116.0,1,,,12544
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9104,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",N,,CHEMBL627645,,A,10116.0,1,,,12545
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9104,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",N,,CHEMBL627646,,A,10116.0,1,,,12546
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9104,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",N,,CHEMBL627647,,A,10116.0,1,,,12547
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9104,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",N,,CHEMBL627648,,A,10116.0,1,,,12548
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12902,,50597,,Free level in rat plasma,N,,CHEMBL627649,,A,10116.0,1,,,12549
,0,BAO_0000019,,,,,Autocuration,6614,,22224,,Level reaching in blood plasma of rat or human was determined,U,,CHEMBL628313,,A,,1,,,12550
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9663,,50597,,Log (Cbrain/Cblood) in rats,N,,CHEMBL628314,,A,10116.0,1,,,12551
,0,BAO_0000019,,,,,Autocuration,17658,,22224,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,U,,CHEMBL628315,,A,,1,,,12552
,0,BAO_0000019,,,,,Autocuration,17658,,22224,,Mean percentage of compound transport through membrane; expressed as membrane transport,U,,CHEMBL628316,,A,,1,,,12553
,0,BAO_0000218,,,,,Autocuration,14314,,22224,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,U,,CHEMBL628317,,A,,1,,,12554
,0,BAO_0000019,,,,,Autocuration,7385,,22224,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,U,,CHEMBL628473,,A,,1,,,12555
,0,BAO_0000019,,,,,Autocuration,7385,,22224,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",U,,CHEMBL628474,,A,,1,,,12556
,0,BAO_0000019,,,,,Autocuration,7385,,22224,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,U,,CHEMBL628475,,A,,1,,,12557
,0,BAO_0000019,,,,,Autocuration,1329,,22224,,Net water uptake by a carrier mediated transport (%cm) mechanism,U,,CHEMBL628476,,A,,1,,,12558
,0,BAO_0000218,,Simiiformes,,,Autocuration,12187,,22224,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,,CHEMBL628477,,A,314293.0,1,,,12559
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,12187,,50506,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,,CHEMBL628478,,A,9669.0,1,,,12560
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,12187,,50506,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,,CHEMBL628479,,A,9669.0,1,,,12561
,0,BAO_0000218,,Simiiformes,,,Autocuration,12187,,22224,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,,CHEMBL628480,,A,314293.0,1,,,12562
,0,BAO_0000218,,Simiiformes,,,Autocuration,12187,,22224,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",U,,CHEMBL628481,,A,314293.0,1,,,12563
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12187,,50597,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,,CHEMBL628482,,A,10116.0,1,,,12564
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12187,,50597,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,,CHEMBL628483,,A,10116.0,1,,,12565
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,9278,,50597,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,,CHEMBL628484,,A,10116.0,1,,,12566
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,9278,,50597,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,,CHEMBL628485,,A,10116.0,1,,,12567
,1,BAO_0000218,,Macaca fascicularis,Plasma,1969.0,Intermediate,9278,,100710,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",N,,CHEMBL628486,,A,9541.0,1,,,12568
,1,BAO_0000218,,Homo sapiens,Plasma,1969.0,Intermediate,9278,,50587,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",N,,CHEMBL628487,,A,9606.0,1,,,12569
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,9278,,50597,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,,CHEMBL628488,,A,10116.0,1,,,12570
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,9278,,50597,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,,CHEMBL628489,,A,10116.0,1,,,12571
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,9278,,50597,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,,CHEMBL628490,,A,10116.0,1,,,12572
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,12186,,100710,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,CHEMBL628491,,A,9541.0,1,,,12573
,1,BAO_0000218,,Macaca fascicularis,,,Intermediate,12186,,100710,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,CHEMBL877507,,A,9541.0,1,,,12574
,0,BAO_0000218,,,,,Autocuration,12186,,22224,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,U,,CHEMBL628492,,A,,1,,,12575
,0,BAO_0000019,,Simiiformes,,,Autocuration,12041,,22224,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),U,,CHEMBL628493,,A,314293.0,1,,,12576
,0,BAO_0000019,,Simiiformes,,,Autocuration,12041,,22224,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),U,,CHEMBL628494,,A,314293.0,1,,,12577
,0,BAO_0000019,,Simiiformes,,,Autocuration,12041,,22224,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),U,,CHEMBL628495,,A,314293.0,1,,,12578
,1,BAO_0000218,,Homo sapiens,,,Intermediate,6737,,50587,,Permeability in Caco-2 assay at 10E-6,N,,CHEMBL628496,,A,9606.0,1,,,12579
,0,BAO_0000218,,,Brain,955.0,Autocuration,13758,,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,,CHEMBL628497,,A,,1,,,12580
,0,BAO_0000218,,,Brain,955.0,Autocuration,13758,,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,,CHEMBL628498,,A,,1,,,12581
,0,BAO_0000019,,,,,Autocuration,5676,,22224,,Plasma protein binding was determined,U,,CHEMBL628499,,A,,1,,,12582
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,U,,CHEMBL627656,,A,,1,,,12583
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,CHEMBL627657,,A,,1,,,12584
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,U,,CHEMBL626808,,A,,1,,,12585
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,U,,CHEMBL626809,,A,,1,,,12586
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,U,,CHEMBL626810,,A,,1,,,12587
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,CHEMBL626811,,A,,1,,,12588
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,U,,CHEMBL874465,,A,,1,,,12589
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,U,,CHEMBL626812,,A,,1,,,12590
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,U,,CHEMBL626813,,A,,1,,,12591
,0,BAO_0000218,,,,,Autocuration,14793,,22224,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,U,,CHEMBL626814,,A,,1,,,12592
,0,BAO_0000019,,,,,Autocuration,14000,,22224,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,U,,CHEMBL626815,,A,,1,,,12593
,0,BAO_0000019,,,,,Autocuration,5948,,22224,,Partition coefficient (logP),U,,CHEMBL628566,,A,,1,,,12594
,0,BAO_0000100,,,,,Autocuration,13824,,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,CHEMBL628567,,P,,1,,,12595
,0,BAO_0000100,,,,,Autocuration,10778,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL628568,,P,,1,,,12596
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,17237,,50588,,C max in dog,N,,CHEMBL628569,,A,9615.0,1,,,12597
,1,BAO_0000218,In vivo,Cavia porcellus,,,Intermediate,17237,,50512,,C max in guinea pig,N,,CHEMBL628570,,A,10141.0,1,,,12598
,0,BAO_0000218,In vivo,,,,Autocuration,2809,,22224,,C max value was evaluated,U,,CHEMBL628571,,A,,1,,,12599
,0,BAO_0000218,In vivo,,,,Autocuration,11954,,22224,,Cmax value after oral dose of 0.1 mg//kg,U,,CHEMBL628572,,A,,1,,,12600
,0,BAO_0000218,In vivo,,,,Autocuration,11954,,22224,,Cmax value after oral dose of 0.3 mg/kg,U,,CHEMBL628573,,A,,1,,,12601
,0,BAO_0000218,In vivo,,,,Autocuration,11954,,22224,,Cmax value after oral dose of 1 mg/kg,U,,CHEMBL628574,,A,,1,,,12602
,0,BAO_0000218,In vivo,,,,Autocuration,11954,,22224,,Cmax value after oral dose of 10 mg/kg,U,,CHEMBL628575,,A,,1,,,12603
,0,BAO_0000218,In vivo,,,,Autocuration,11954,,22224,,Cmax value after oral dose of 23.4 mg/kg,U,,CHEMBL628576,,A,,1,,,12604
,0,BAO_0000218,In vivo,,,,Autocuration,11954,,22224,,Cmax value after oral dose of 3 mg/kg,U,,CHEMBL628577,,A,,1,,,12605
,0,BAO_0000218,In vivo,,,,Autocuration,11954,,22224,,Cmax value after oral dose of 3.87 mg/kg,U,,CHEMBL628578,,A,,1,,,12606
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,12768,,50588,,Cmax value in female Beagle dogs,N,,CHEMBL874466,,A,9615.0,1,,,12607
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12768,,50597,,Cmax value in male rats,N,,CHEMBL628579,,A,10116.0,1,,,12608
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,12780,,50597,,Cmax value in rat plasma when administered 20 mg/kg perorally,N,,CHEMBL628580,,A,10116.0,1,,,12609
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,15592,,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,,CHEMBL628581,,A,9615.0,1,,,12610
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,15592,,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,,CHEMBL628582,,A,9615.0,1,,,12611
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,17025,,50588,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,N,,CHEMBL628583,,A,9615.0,1,,,12612
,0,BAO_0000218,,Simiiformes,,,Autocuration,17025,,22224,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,U,,CHEMBL625782,,A,314293.0,1,,,12613
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,17025,,50592,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,N,,CHEMBL625783,,A,9986.0,1,,,12614
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,17025,,50597,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,N,,CHEMBL625784,,A,10116.0,1,,,12615
,1,BAO_0000218,,Macaca mulatta,Plasma,1969.0,Intermediate,4236,,50797,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,N,,CHEMBL625785,,A,9544.0,1,,,12616
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15791,,50597,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,N,,CHEMBL625786,,A,10116.0,1,,,12617
,0,BAO_0000019,,,,,Autocuration,11149,,22224,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,U,,CHEMBL874467,,A,,1,,,12618
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,15592,,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,,CHEMBL625787,,A,9615.0,1,,,12619
,1,BAO_0000218,,Human immunodeficiency virus,,,Intermediate,15778,,50677,,cytotoxicity against HIV protease enzyme.,N,,CHEMBL625964,,A,12721.0,1,,,12620
,1,BAO_0000218,,Mus musculus,,,Intermediate,12745,,50594,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,N,,CHEMBL625965,,A,10090.0,1,,,12621
,1,BAO_0000218,,Mus musculus,,,Intermediate,12745,,50594,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,N,,CHEMBL625966,,A,10090.0,1,,,12622
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,13941,,50588,,The plasma clearance in dog.,N,,CHEMBL625967,,A,9615.0,1,,,12623
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,13941,,50597,,The plasma clearance in rat.,N,,CHEMBL625968,,A,10116.0,1,,,12624
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,16449,,50597,,Clearance from plasma in male Sprague-Dawley rats,N,,CHEMBL625969,,A,10116.0,1,,,12625
,1,BAO_0000218,In vivo,Macaca fascicularis,Plasma,1969.0,Intermediate,16449,,100710,,Clearance from plasma in male cynomolgus monkeys,N,,CHEMBL625970,,A,9541.0,1,,,12626
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14224,,50588,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",N,,CHEMBL625971,,A,9615.0,1,,,12627
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14224,,50588,,Clearance of compound in dog plasma,N,,CHEMBL625972,,A,9615.0,1,,,12628
,1,BAO_0000218,In vivo,Homo sapiens,Plasma,1969.0,Intermediate,14224,,50587,,Clearance of compound in human plasma,N,,CHEMBL625973,,A,9606.0,1,,,12629
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14317,,50588,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,N,,CHEMBL625974,,A,9615.0,1,,,12630
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14317,,50588,,Clearance of compound when administered intravenously as an individual dose to a single dog.,N,,CHEMBL625975,,A,9615.0,1,,,12631
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14224,,50588,,"Clearance (10 mg/kg, intravenously) in dog plasma",N,,CHEMBL625976,,A,9615.0,1,,,12632
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,17237,,50588,,Clearance value in dog,N,,CHEMBL625977,,A,9615.0,1,,,12633
,1,BAO_0000218,In vivo,Cavia porcellus,,,Intermediate,17237,,50512,,Clearance value in guinea pig,N,,CHEMBL625978,,A,10141.0,1,,,12634
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14187,,50597,,Clearance values in rats after iv administration.,N,,CHEMBL874468,,A,10116.0,1,,,12635
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,4806,,22224,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,U,,CHEMBL625421,,A,,1,,,12636
,1,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Intermediate,15025,,50592,,In vivo clearance (5 mg/kg) was determined in rabbits,N,,CHEMBL625422,,A,9986.0,1,,,12637
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13197,,50597,,Plasma Clearance rate was determined for the compound in rats,N,,CHEMBL625423,,A,10116.0,1,,,12638
,0,BAO_0000218,In vivo,Saimiri,,,Autocuration,13197,,22224,,Plasma Clearance rate was determined for the compound in squirrel monkeys,U,,CHEMBL625424,,A,9520.0,1,,,12639
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13960,,50597,,Plasma clearance in rat,N,,CHEMBL625425,,A,10116.0,1,,,12640
,0,BAO_0000218,In vivo,,,,Autocuration,17820,,22224,,Plasma clearance of the compound,U,,CHEMBL625426,,A,,1,,,12641
,1,BAO_0000218,In vivo,Cavia porcellus,,,Intermediate,14706,,50512,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,N,,CHEMBL625427,,A,10141.0,1,,,12642
,1,BAO_0000218,In vivo,Cavia porcellus,,,Intermediate,14706,,50512,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,N,,CHEMBL625428,,A,10141.0,1,,,12643
,0,BAO_0000218,In vivo,,,,Autocuration,6504,,22224,,Plasma clearance was determined,U,,CHEMBL625429,,A,,1,,,12644
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14925,,50588,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,N,,CHEMBL625430,,A,9615.0,1,,,12645
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13197,,50597,,Plasma clearance rate was determined for the compound in rats,N,,CHEMBL625431,,A,10116.0,1,,,12646
,0,BAO_0000218,In vivo,Saimiri,,,Autocuration,13197,,22224,,Plasma clearance rate was determined for the compound in squirrel monkeys,U,,CHEMBL627307,,A,9520.0,1,,,12647
,0,BAO_0000218,In vivo,,,,Autocuration,3437,,22224,,Slow clearance (CL) was determined,U,,CHEMBL627308,,A,,1,,,12648
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,CHEMBL627309,,A,,1,,,12649
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,,CHEMBL627310,,A,,1,,,12650
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,,CHEMBL627311,,A,,1,,,12651
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,CHEMBL627312,,A,,1,,,12652
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,,CHEMBL627313,,A,,1,,,12653
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,CHEMBL627314,,A,,1,,,12654
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,CHEMBL627315,,A,,1,,,12655
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,CHEMBL627316,,A,,1,,,12656
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,CHEMBL627317,,A,,1,,,12657
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,CHEMBL627318,,A,,1,,,12658
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,,CHEMBL627999,,A,,1,,,12659
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,CHEMBL628000,,A,,1,,,12660
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,CHEMBL628001,,A,,1,,,12661
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,CHEMBL628002,,A,,1,,,12662
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,CHEMBL625610,,A,,1,,,12663
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,CHEMBL625611,,A,,1,,,12664
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,,CHEMBL625612,,A,,1,,,12665
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,,CHEMBL625613,,A,,1,,,12666
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,CHEMBL875479,,A,,1,,,12667
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,CHEMBL625614,,A,,1,,,12668
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,CHEMBL625615,,A,,1,,,12669
,0,BAO_0000218,,,,,Autocuration,9196,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,,CHEMBL626302,,A,,1,,,12670
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL626303,,A,10116.0,1,,,12671
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8374,,50597,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,CHEMBL627420,,A,10116.0,1,,,12672
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,N,,CHEMBL627421,,A,10116.0,1,,,12673
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,N,,CHEMBL625695,,A,10116.0,1,,,12674
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,N,,CHEMBL625696,,A,10116.0,1,,,12675
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,10009,,50594,,Distribution of compound in mice brain was measured after 1 hr,N,,CHEMBL875606,,A,10090.0,1,,,12676
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,10009,,50594,,Distribution of compound in mice brain was measured after 24 hr r,N,,CHEMBL625697,,A,10090.0,1,,,12677
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,10009,,50594,,Distribution of compound in mice brain was measured after 2 hr,N,,CHEMBL625698,,A,10090.0,1,,,12678
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,10009,,50594,,Distribution of compound in mice brain was measured after 3 hr,N,,CHEMBL625699,,A,10090.0,1,,,12679
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,10009,,50594,,Distribution of compound in mice brain was measured after 6 hr,N,,CHEMBL625700,,A,10090.0,1,,,12680
,1,BAO_0000218,,Mus musculus,,,Intermediate,10009,,50594,,Distribution of compound in mice liver was measured after 1 hr,N,,CHEMBL625701,,A,10090.0,1,,,12681
,1,BAO_0000218,,Mus musculus,,,Intermediate,10009,,50594,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,N,,CHEMBL625702,,A,10090.0,1,,,12682
,1,BAO_0000218,,Mus musculus,,,Intermediate,10009,,50594,,Distribution of compound in mice liver was measured after 2 hr,N,,CHEMBL625703,,A,10090.0,1,,,12683
,1,BAO_0000218,,Mus musculus,,,Intermediate,10009,,50594,,Distribution of compound in mice liver was measured after 3 hr,N,,CHEMBL625704,,A,10090.0,1,,,12684
,1,BAO_0000218,,Mus musculus,,,Intermediate,10009,,50594,,Distribution of compound in mice liver was measured after 6 hr,N,,CHEMBL625705,,A,10090.0,1,,,12685
,1,BAO_0000218,,Canis lupus familiaris,Adrenal medulla,1236.0,Intermediate,8170,,50588,,Distribution in dog adrenal medulla 30 min after administration.,N,,CHEMBL625706,,A,9615.0,1,,,12686
,1,BAO_0000218,,Canis lupus familiaris,Adrenal medulla,1236.0,Intermediate,8170,,50588,,Distribution in dog adrenal medulla 72 hours after administration.,N,,CHEMBL625707,,A,9615.0,1,,,12687
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog Ovary 24 hours after administration.,N,,CHEMBL625708,,A,9615.0,1,,,12688
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog Ovary 72 hours after administration.,N,,CHEMBL625709,,A,9615.0,1,,,12689
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog adipose 24 hours after administration.,N,,CHEMBL624180,,A,9615.0,1,,,12690
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog adipose 72 hours after administration.,N,,CHEMBL624181,,A,9615.0,1,,,12691
,1,BAO_0000218,,Canis lupus familiaris,Adrenal cortex,1235.0,Intermediate,8170,,50588,,Distribution in female dog adrenal cortex 72 hours after administration.,N,,CHEMBL624182,,A,9615.0,1,,,12692
,1,BAO_0000218,,Canis lupus familiaris,Adrenal cortex,1235.0,Intermediate,8170,,50588,,Distribution in female dog adrenal cortex 72 hours after administration.,N,,CHEMBL624183,,A,9615.0,1,,,12693
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,CHEMBL624184,,A,10116.0,1,,,12694
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,CHEMBL877489,,A,10116.0,1,,,12695
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,CHEMBL624185,,A,10116.0,1,,,12696
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,CHEMBL624186,,A,10116.0,1,,,12697
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,CHEMBL624187,,A,10116.0,1,,,12698
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,CHEMBL624188,,A,10116.0,1,,,12699
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,CHEMBL624189,,A,10116.0,1,,,12700
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,CHEMBL624190,,A,10116.0,1,,,12701
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,CHEMBL624191,,A,10116.0,1,,,12702
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,CHEMBL624192,,A,10116.0,1,,,12703
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,CHEMBL624193,,A,10116.0,1,,,12704
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,CHEMBL624194,,A,10116.0,1,,,12705
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,CHEMBL624891,,A,10116.0,1,,,12706
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,CHEMBL624892,,A,10116.0,1,,,12707
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,CHEMBL624893,,A,10116.0,1,,,12708
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,CHEMBL627632,,A,10116.0,1,,,12709
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,CHEMBL627633,,A,10116.0,1,,,12710
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,CHEMBL627634,,A,10116.0,1,,,12711
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,CHEMBL627635,,A,10116.0,1,,,12712
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,CHEMBL627636,,A,10116.0,1,,,12713
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,CHEMBL626816,,A,10116.0,1,,,12714
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,CHEMBL626817,,A,10116.0,1,,,12715
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,CHEMBL626818,,A,10116.0,1,,,12716
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,CHEMBL626819,,A,10116.0,1,,,12717
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,CHEMBL626820,,A,10116.0,1,,,12718
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,CHEMBL626821,,A,10116.0,1,,,12719
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,CHEMBL626822,,A,10116.0,1,,,12720
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,CHEMBL626823,,A,10116.0,1,,,12721
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,CHEMBL626824,,A,10116.0,1,,,12722
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,CHEMBL626825,,A,10116.0,1,,,12723
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,CHEMBL626826,,A,10116.0,1,,,12724
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,CHEMBL626827,,A,10116.0,1,,,12725
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,CHEMBL626828,,A,10116.0,1,,,12726
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,CHEMBL626829,,A,10116.0,1,,,12727
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,CHEMBL626830,,A,10116.0,1,,,12728
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,CHEMBL627150,,A,10116.0,1,,,12729
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,CHEMBL627151,,A,10116.0,1,,,12730
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,CHEMBL627152,,A,10116.0,1,,,12731
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,CHEMBL627153,,A,10116.0,1,,,12732
,0,BAO_0000019,,,,,Autocuration,12904,,22224,,Rate of acetate production by the compound was determined,U,,CHEMBL627154,,A,,1,,,12733
,0,BAO_0000019,,,,,Autocuration,12904,,22224,,Rate of acetate production by the compound was determined; Not determined,U,,CHEMBL627155,,A,,1,,,12734
,0,BAO_0000019,,,,,Autocuration,3730,,22224,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,U,,CHEMBL627156,,A,,1,,,12735
,0,BAO_0000019,,,,,Autocuration,3627,,22224,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,U,,CHEMBL627157,,A,,1,,,12736
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,13799,,50592,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,,CHEMBL627158,,A,9986.0,1,,,12737
,1,BAO_0000218,,Oryctolagus cuniculus,Plasma,1969.0,Intermediate,13799,,50592,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,,CHEMBL627159,,A,9986.0,1,,,12738
,1,BAO_0000218,,Mus musculus,,,Intermediate,13799,,50594,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,,CHEMBL627160,,A,10090.0,1,,,12739
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13799,,50597,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,,CHEMBL628540,,A,10116.0,1,,,12740
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,13799,,50597,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,,CHEMBL628541,,A,10116.0,1,,,12741
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,13799,,50597,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,,CHEMBL628542,,A,10116.0,1,,,12742
,0,BAO_0000100,,,,,Autocuration,6629,,22229,,Solubility after at a pH 1.2,U,,CHEMBL628543,,P,,1,,,12743
,0,BAO_0000100,,,,,Autocuration,6629,,22229,,Solubility after at pH 1.2,U,,CHEMBL628544,,P,,1,,,12744
,0,BAO_0000100,,,,,Autocuration,6629,,22229,,Solubility after injection of water,U,,CHEMBL628545,,P,,1,,,12745
,0,BAO_0000019,,,,,Autocuration,14000,,22224,,Statistical significance of IC 50 values; Expressed as R value,U,,CHEMBL628546,,A,,1,,,12746
,0,BAO_0000019,,,,,Autocuration,8267,,22224,,Systemic availability with respect to methyldopa was determined,U,,CHEMBL874455,,A,,1,,,12747
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13799,,50597,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,N,,CHEMBL628547,,A,10116.0,1,,,12748
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,13799,,50597,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,N,,CHEMBL628548,,A,10116.0,1,,,12749
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",N,,CHEMBL628549,,A,9986.0,1,,,12750
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",N,,CHEMBL628550,,A,9986.0,1,,,12751
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",N,,CHEMBL628551,,A,9986.0,1,,,12752
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",N,,CHEMBL628552,,A,9986.0,1,,,12753
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",N,,CHEMBL628553,,A,9986.0,1,,,12754
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",N,,CHEMBL628554,,A,9986.0,1,,,12755
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",N,,CHEMBL628555,,A,9986.0,1,,,12756
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",N,,CHEMBL628556,,A,9986.0,1,,,12757
,1,BAO_0000218,,Oryctolagus cuniculus,Kidney,2113.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",N,,CHEMBL628557,,A,9986.0,1,,,12758
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",N,,CHEMBL628558,,A,9986.0,1,,,12759
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",N,,CHEMBL628559,,A,9986.0,1,,,12760
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",N,,CHEMBL628560,,A,9986.0,1,,,12761
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",N,,CHEMBL874456,,A,9986.0,1,,,12762
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",N,,CHEMBL628561,,A,9986.0,1,,,12763
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",N,,CHEMBL628562,,A,9986.0,1,,,12764
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",N,,CHEMBL628563,,A,9986.0,1,,,12765
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",N,,CHEMBL628564,,A,9986.0,1,,,12766
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",N,,CHEMBL628565,,A,9986.0,1,,,12767
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",N,,CHEMBL631248,,A,9986.0,1,,,12768
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",N,,CHEMBL631249,,A,9986.0,1,,,12769
,1,BAO_0000218,,Oryctolagus cuniculus,Kidney,2113.0,Intermediate,7132,,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",N,,CHEMBL627214,,A,9986.0,1,,,12770
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",N,,CHEMBL874591,,A,9986.0,1,,,12771
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",N,,CHEMBL627215,,A,9986.0,1,,,12772
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,N,,CHEMBL625471,,A,9986.0,1,,,12773
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,7132,,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,N,,CHEMBL625472,,A,9986.0,1,,,12774
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,7132,,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,N,,CHEMBL625473,,A,9986.0,1,,,12775
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13317,,50588,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,N,,CHEMBL625474,,A,9615.0,1,,,12776
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,15341,,50588,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,N,,CHEMBL625475,,A,9615.0,1,,,12777
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15341,,50597,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,N,,CHEMBL625476,,A,10116.0,1,,,12778
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15341,,50597,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,N,,CHEMBL625477,,A,10116.0,1,,,12779
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15341,,50597,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,N,,CHEMBL625478,,A,10116.0,1,,,12780
,1,BAO_0000218,In vitro,Rattus norvegicus,esophageal tunica muscularis mucosae,,Intermediate,12801,,50597,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,N,,CHEMBL625479,,A,10116.0,1,,,12781
,1,BAO_0000218,In vitro,Rattus norvegicus,esophageal tunica muscularis mucosae,,Intermediate,12801,,50597,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,N,,CHEMBL625480,,A,10116.0,1,,,12782
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14856,,50597,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,N,,CHEMBL625481,,A,10116.0,1,,,12783
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14062,,50597,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,N,,CHEMBL625482,,A,10116.0,1,,,12784
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14062,,50597,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,N,,CHEMBL625483,,A,10116.0,1,,,12785
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14062,,50597,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,N,,CHEMBL625484,,A,10116.0,1,,,12786
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14062,,50597,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,N,,CHEMBL625485,,A,10116.0,1,,,12787
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14346,,50588,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,N,,CHEMBL625486,,A,9615.0,1,,,12788
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14346,,50597,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,N,,CHEMBL625487,,A,10116.0,1,,,12789
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14346,,50597,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,N,,CHEMBL625488,,A,10116.0,1,,,12790
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14346,,50597,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,N,,CHEMBL625489,,A,10116.0,1,,,12791
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14346,,50597,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,N,,CHEMBL625490,,A,10116.0,1,,,12792
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14346,,50588,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,N,,CHEMBL625491,,A,9615.0,1,,,12793
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14346,,50597,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,N,,CHEMBL625492,,A,10116.0,1,,,12794
,1,BAO_0000218,In vivo,Homo sapiens,Plasma,1969.0,Intermediate,15711,,50587,,plasma clearance in human,N,,CHEMBL625493,,A,9606.0,1,,,12795
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14886,,50597,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,,CHEMBL625494,,A,10116.0,1,,,12796
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14886,,50597,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,,CHEMBL625495,,A,10116.0,1,,,12797
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14886,,50597,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,,CHEMBL625496,,A,10116.0,1,,,12798
,0,BAO_0000100,,,,,Autocuration,4115,,22229,,1-Octanol/water partition coefficient measured at 7.4,U,,CHEMBL625497,,P,,1,,,12799
,0,BAO_0000100,,,,,Autocuration,13733,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625498,,P,,1,,,12800
,0,BAO_0000019,,,,,Autocuration,12102,,22224,,Partition coefficient (logP),U,,CHEMBL625499,,A,,1,,,12801
,0,BAO_0000100,,,,,Autocuration,12676,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625500,,P,,1,,,12802
,0,BAO_0000100,,,,,Autocuration,13733,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625501,,P,,1,,,12803
,0,BAO_0000100,,,,,Autocuration,13740,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625502,,P,,1,,,12804
,0,BAO_0000100,,,,,Autocuration,12766,,22229,,Calculated partition coefficient (clogP) (relative to BAY K 8644),U,,CHEMBL625503,,P,,1,,,12805
,0,BAO_0000100,,,,,Autocuration,2764,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625504,,P,,1,,,12806
,0,BAO_0000100,,,,,Autocuration,12355,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625505,,P,,1,,,12807
,0,BAO_0000100,,,,,Autocuration,11314,,22229,,Calculated partition coefficient of the compound,U,,CHEMBL625506,,P,,1,,,12808
,0,BAO_0000019,,,,,Autocuration,12706,,22224,,Partition coefficient (logP),U,,CHEMBL625507,,A,,1,,,12809
,0,BAO_0000100,,,,,Autocuration,12645,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625508,,P,,1,,,12810
,0,BAO_0000100,,,,,Autocuration,13668,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625509,,P,,1,,,12811
,0,BAO_0000100,,,,,Autocuration,12819,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625510,,P,,1,,,12812
,0,BAO_0000100,,,,,Autocuration,13668,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL883125,,P,,1,,,12813
,0,BAO_0000100,,,,,Autocuration,13017,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625511,,P,,1,,,12814
,0,BAO_0000019,,,,,Autocuration,2448,,22224,,Partition coefficient of the compound,U,,CHEMBL874650,,A,,1,,,12815
,0,BAO_0000019,,,,,Autocuration,11526,,22224,,Partition coefficient of the compound,U,,CHEMBL625512,,A,,1,,,12816
,0,BAO_0000019,,,,,Autocuration,12426,,22224,,Partition coefficient of compound was determined,U,,CHEMBL625513,,A,,1,,,12817
,0,BAO_0000019,,,,,Autocuration,2448,,22224,,Partition coefficient was determined,U,,CHEMBL625514,,A,,1,,,12818
,0,BAO_0000100,,,,,Autocuration,12001,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625515,,P,,1,,,12819
,0,BAO_0000100,,,,,Autocuration,12426,,22229,,partition coefficient of compound was determined,U,,CHEMBL625516,,P,,1,,,12820
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13204,,50588,,The total body administered intravenously in dog,N,,CHEMBL625517,,A,9615.0,1,,,12821
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13204,,50597,,The total body administered intravenously in rats,N,,CHEMBL625518,,A,10116.0,1,,,12822
,1,BAO_0000218,,Mus musculus,,,Intermediate,13889,,50594,,Time taken for the administration to female NIH mice weighing 25-30 g.,N,,CHEMBL625519,,A,10090.0,1,,,12823
,0,BAO_0000019,,,,,Autocuration,13889,,22224,,Time taken for the administration,U,,CHEMBL625520,,A,,1,,,12824
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,17025,,50588,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,N,,CHEMBL874651,,A,9615.0,1,,,12825
,0,BAO_0000218,In vivo,Simiiformes,,,Autocuration,17025,,22224,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,U,,CHEMBL625521,,A,314293.0,1,,,12826
,1,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Intermediate,17025,,50592,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,,CHEMBL623171,,A,9986.0,1,,,12827
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,17025,,50597,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,N,,CHEMBL623853,,A,10116.0,1,,,12828
,0,BAO_0000019,,,,,Autocuration,15067,,22224,,Plasma clearance for the compound was determined.,U,,CHEMBL623854,,A,,1,,,12829
,0,BAO_0000100,,,,,Autocuration,3091,,22224,,CLog P value of the compound,U,,CHEMBL874405,,P,,1,,,12830
,0,BAO_0000100,,,,,Autocuration,15592,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL623855,,P,,1,,,12831
,0,BAO_0000100,,,,,Autocuration,14738,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL623856,,P,,1,,,12832
,0,BAO_0000100,,,,,Autocuration,14738,,22224,,ClogP value of the compound; nd ='no data',U,,CHEMBL623857,,P,,1,,,12833
,0,BAO_0000100,,,,,Autocuration,14738,,22224,,ClogP value of the compound; nd ='not determined',U,,CHEMBL623858,,P,,1,,,12834
,0,BAO_0000100,,,,,Autocuration,6076,,22224,,CLog P was determined,U,,CHEMBL623859,,P,,1,,,12835
,0,BAO_0000100,,,,,Autocuration,17840,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL839829,,P,,1,,,12836
,0,BAO_0000019,,,,,Autocuration,13589,,22224,,CLogP was calculated,U,,CHEMBL623860,,A,,1,,,12837
,0,BAO_0000019,,,,,Autocuration,17655,,22224,,CLogP value was determined,U,,CHEMBL623861,,A,,1,,,12838
,0,BAO_0000019,,,,,Autocuration,5867,,22224,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,U,,CHEMBL623862,,A,,1,,,12839
,0,BAO_0000100,,,,,Autocuration,5867,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL874406,,P,,1,,,12840
,0,BAO_0000100,,,,,Autocuration,10783,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL623863,,P,,1,,,12841
,0,BAO_0000100,,,,,Autocuration,14849,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624021,,P,,1,,,12842
,1,BAO_0000218,,Canis lupus familiaris,Adrenal medulla,1236.0,Intermediate,8170,,50588,,Distribution in female dog adrenal medulla 24 hours after administration.,N,,CHEMBL624022,,A,9615.0,1,,,12843
,1,BAO_0000218,,Canis lupus familiaris,Adrenal medulla,1236.0,Intermediate,8170,,50588,,Distribution in female dog adrenal medulla 72 hours after administration.,N,,CHEMBL624023,,A,9615.0,1,,,12844
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog bile 24 hours after administration.,N,,CHEMBL624024,,A,9615.0,1,,,12845
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog bile 72 hr after administration.,N,,CHEMBL624025,,A,9615.0,1,,,12846
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog blood 24 hours after administration.,N,,CHEMBL624026,,A,9615.0,1,,,12847
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog blood 72 hours after administration.,N,,CHEMBL624027,,A,9615.0,1,,,12848
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog heart 24 hours after administration.,N,,CHEMBL624028,,A,9615.0,1,,,12849
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog heart 72 hours after administration.,N,,CHEMBL624029,,A,9615.0,1,,,12850
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog kidney 24 hours after administration.,N,,CHEMBL624030,,A,9615.0,1,,,12851
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog kidney 72 hours after administration.,N,,CHEMBL624031,,A,9615.0,1,,,12852
,1,BAO_0000218,,Canis lupus familiaris,Intestine,160.0,Intermediate,8170,,50588,,Distribution in female dog large intestine 24 hours after administration.,N,,CHEMBL624032,,A,9615.0,1,,,12853
,1,BAO_0000218,,Canis lupus familiaris,Intestine,160.0,Intermediate,8170,,50588,,Distribution in female dog large intestine 72 hours after administration.,N,,CHEMBL874407,,A,9615.0,1,,,12854
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog liver 24 hours after administration.,N,,CHEMBL624033,,A,9615.0,1,,,12855
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog liver 72 hours after administration.,N,,CHEMBL624034,,A,9615.0,1,,,12856
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog lung 24 hours after administration.,N,,CHEMBL624035,,A,9615.0,1,,,12857
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog lung 72 hours after administration.,N,,CHEMBL624036,,A,9615.0,1,,,12858
,1,BAO_0000218,,Canis lupus familiaris,Muscle tissue,2385.0,Intermediate,8170,,50588,,Distribution in female dog muscle 24 hours after administration.,N,,CHEMBL624037,,A,9615.0,1,,,12859
,1,BAO_0000218,,Canis lupus familiaris,Muscle tissue,2385.0,Intermediate,8170,,50588,,Distribution in female dog muscle 72 hours after administration.,N,,CHEMBL624038,,A,9615.0,1,,,12860
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog pancreas 24 hours after administration.,N,,CHEMBL624039,,A,9615.0,1,,,12861
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8170,,50588,,Distribution in female dog pancreas 72 hours after administration.,N,,CHEMBL624040,,A,9615.0,1,,,12862
,1,BAO_0000218,,Canis lupus familiaris,Intestine,160.0,Intermediate,8170,,50588,,Distribution in female dog small intestine 24 hours after administration.,N,,CHEMBL624041,,A,9615.0,1,,,12863
,1,BAO_0000218,,Canis lupus familiaris,Intestine,160.0,Intermediate,8170,,50588,,Distribution in female dog small intestine 72 hours after administration.,N,,CHEMBL624042,,A,9615.0,1,,,12864
,1,BAO_0000218,,Canis lupus familiaris,Spleen,2106.0,Intermediate,8170,,50588,,Distribution in female dog spleen 24 hours after administration.,N,,CHEMBL624043,,A,9615.0,1,,,12865
,1,BAO_0000218,,Canis lupus familiaris,Spleen,2106.0,Intermediate,8170,,50588,,Distribution in female dog spleen 72 hours after administration.,N,,CHEMBL624044,,A,9615.0,1,,,12866
,1,BAO_0000218,,Canis lupus familiaris,Stomach,945.0,Intermediate,8170,,50588,,Distribution in female dog stomach 24 hours after administration.,N,,CHEMBL624045,,A,9615.0,1,,,12867
,1,BAO_0000218,,Canis lupus familiaris,Stomach,945.0,Intermediate,8170,,50588,,Distribution in female dog stomach 72 hours after administration.,N,,CHEMBL624046,,A,9615.0,1,,,12868
,1,BAO_0000218,,Canis lupus familiaris,Thyroid gland,2046.0,Intermediate,8170,,50588,,Distribution in female dog thyroid 24 hours after administration.,N,,CHEMBL624047,,A,9615.0,1,,,12869
,1,BAO_0000218,,Canis lupus familiaris,Thyroid gland,2046.0,Intermediate,8170,,50588,,Distribution in female dog thyroid 72 hours after administration.,N,,CHEMBL624048,,A,9615.0,1,,,12870
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8170,,50588,,Distribution in female dog urine 24 hours after administration.,N,,CHEMBL874408,,A,9615.0,1,,,12871
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8170,,50588,,Distribution in female dog urine 72 hr after administration.,N,,CHEMBL624049,,A,9615.0,1,,,12872
,0,BAO_0000218,,,Plasma,1969.0,Autocuration,14283,,22224,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,U,,CHEMBL624050,,A,,1,,,12873
,0,BAO_0000019,,,,,Autocuration,5623,,22224,,Plasma concentration at 7 hr after intravenous dosing,U,,CHEMBL624051,,A,,1,,,12874
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,N,,CHEMBL623278,,A,10116.0,1,,,12875
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,N,,CHEMBL623279,,A,10116.0,1,,,12876
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,N,,CHEMBL623280,,A,10116.0,1,,,12877
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,N,,CHEMBL623963,,A,10116.0,1,,,12878
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,N,,CHEMBL623964,,A,10116.0,1,,,12879
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,N,,CHEMBL623965,,A,10116.0,1,,,12880
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,N,,CHEMBL623966,,A,10116.0,1,,,12881
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,N,,CHEMBL874415,,A,10116.0,1,,,12882
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,N,,CHEMBL623967,,A,10116.0,1,,,12883
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,N,,CHEMBL623968,,A,10116.0,1,,,12884
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,N,,CHEMBL623969,,A,10116.0,1,,,12885
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,N,,CHEMBL628409,,A,10116.0,1,,,12886
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,N,,CHEMBL628410,,A,10116.0,1,,,12887
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,N,,CHEMBL628411,,A,10116.0,1,,,12888
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,N,,CHEMBL628412,,A,10116.0,1,,,12889
,0,BAO_0000019,,,,,Autocuration,12553,,22224,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,U,,CHEMBL628413,,A,,1,,,12890
,0,BAO_0000019,,,Plasma,1969.0,Autocuration,14548,,22224,,The concentration in plasmat; Not determined,U,,CHEMBL628414,,A,,1,,,12891
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14393,,50597,,Tissue level at 10 mg/kg/po in wistar rats in blood,N,,CHEMBL628415,,A,10116.0,1,,,12892
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14393,,50597,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,N,,CHEMBL628416,,A,10116.0,1,,,12893
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14393,,50597,,Tissue level at 10 mg/kg/po in wistar rats in heart,N,,CHEMBL628417,,A,10116.0,1,,,12894
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,14393,,50597,,Tissue level at 10 mg/kg/po in wistar rats in liver,N,,CHEMBL874908,,A,10116.0,1,,,12895
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14393,,50597,,Tissue level at 10 mg/kg/po in wistar rats in plasma,N,,CHEMBL628418,,A,10116.0,1,,,12896
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,14393,,50597,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,N,,CHEMBL628419,,A,10116.0,1,,,12897
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14393,,50597,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,N,,CHEMBL628420,,A,10116.0,1,,,12898
,0,BAO_0000019,,,,,Autocuration,1629,,22224,,Water solubility at 37 degree C.,U,,CHEMBL628421,,A,,1,,,12899
,0,BAO_0000100,,,,,Autocuration,8194,,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,,CHEMBL626726,,P,,1,,,12900
,0,BAO_0000100,,,,,Autocuration,8194,,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,CHEMBL626727,,P,,1,,,12901
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,CHEMBL626728,,A,10116.0,1,,,12902
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,CHEMBL626729,,A,10116.0,1,,,12903
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,CHEMBL626730,,A,10116.0,1,,,12904
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,CHEMBL626731,,A,10116.0,1,,,12905
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,CHEMBL626732,,A,10116.0,1,,,12906
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,CHEMBL626733,,A,10116.0,1,,,12907
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,CHEMBL626734,,A,10116.0,1,,,12908
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,CHEMBL626735,,A,10116.0,1,,,12909
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,CHEMBL874909,,A,10116.0,1,,,12910
,1,BAO_0000218,,Rattus norvegicus,Heart,948.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,CHEMBL626736,,A,10116.0,1,,,12911
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,CHEMBL626737,,A,10116.0,1,,,12912
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,CHEMBL630999,,A,10116.0,1,,,12913
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,CHEMBL631000,,A,10116.0,1,,,12914
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,CHEMBL631001,,A,10116.0,1,,,12915
,1,BAO_0000218,,Rattus norvegicus,Kidney,2113.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,CHEMBL631002,,A,10116.0,1,,,12916
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,CHEMBL631003,,A,10116.0,1,,,12917
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,CHEMBL631004,,A,10116.0,1,,,12918
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,CHEMBL631005,,A,10116.0,1,,,12919
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,CHEMBL631006,,A,10116.0,1,,,12920
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,CHEMBL631007,,A,10116.0,1,,,12921
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,CHEMBL631008,,A,10116.0,1,,,12922
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,CHEMBL631009,,A,10116.0,1,,,12923
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,CHEMBL631010,,A,10116.0,1,,,12924
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,CHEMBL631011,,A,10116.0,1,,,12925
,1,BAO_0000218,,Rattus norvegicus,Lung,2048.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,CHEMBL631012,,A,10116.0,1,,,12926
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,CHEMBL630271,,A,10116.0,1,,,12927
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,CHEMBL630272,,A,10116.0,1,,,12928
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,CHEMBL630273,,A,10116.0,1,,,12929
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,CHEMBL630274,,A,10116.0,1,,,12930
,1,BAO_0000218,,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,8594,,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,CHEMBL630275,,A,10116.0,1,,,12931
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,N,,CHEMBL875782,,A,10116.0,1,,,12932
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,N,,CHEMBL630276,,A,10116.0,1,,,12933
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,N,,CHEMBL630277,,A,10116.0,1,,,12934
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,N,,CHEMBL630278,,A,10116.0,1,,,12935
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8594,,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,N,,CHEMBL630279,,A,10116.0,1,,,12936
,0,BAO_0000019,,,,,Autocuration,8151,,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,U,,CHEMBL630280,,A,,1,,,12937
,0,BAO_0000019,,,,,Autocuration,8151,,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,,CHEMBL630281,,A,,1,,,12938
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,7132,,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,N,,CHEMBL630282,,A,9986.0,1,,,12939
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,7132,,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,N,,CHEMBL630283,,A,9986.0,1,,,12940
,0,BAO_0000019,,,,,Autocuration,5797,,22224,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),U,,CHEMBL630284,,A,,1,,,12941
,0,BAO_0000019,,,,,Autocuration,7849,,22224,,Alkylating activity was determined,U,,CHEMBL630285,,A,,1,,,12942
,0,BAO_0000251,,,,,Autocuration,14220,Microsomes,22224,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),U,,CHEMBL630286,,A,,1,,,12943
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,8650,,50592,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",N,,CHEMBL630069,,A,9986.0,1,,,12944
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,8650,,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",N,,CHEMBL630070,,A,9986.0,1,,,12945
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,8650,,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",N,,CHEMBL630071,,A,9986.0,1,,,12946
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,8650,,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",N,,CHEMBL630072,,A,9986.0,1,,,12947
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,8650,,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",N,,CHEMBL875110,,A,9986.0,1,,,12948
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7116,,50597,,Compound was tested for antidiuretic activity in rats,N,,CHEMBL630073,,A,10116.0,1,,,12949
,0,BAO_0000019,,,,,Autocuration,14131,,22224,,Compound was tested for inactivation kinetic values,U,,CHEMBL630074,,A,,1,,,12950
,0,BAO_0000218,In vivo,,,,Autocuration,7415,,22224,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,U,,CHEMBL630075,,A,,1,,,12951
,0,BAO_0000019,,,,,Autocuration,13178,,22224,,Dissociation rate calculated from the first-order equation using the t1/2 value,U,,CHEMBL630076,,A,,1,,,12952
,0,BAO_0000100,,,,,Autocuration,8815,,22229,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,U,,CHEMBL630077,,P,,1,,,12953
,0,BAO_0000100,,,,,Autocuration,1450,,22229,,Aqueous solubility was measured,U,,CHEMBL630078,,P,,1,,,12954
,0,BAO_0000100,,,,,Autocuration,1450,,22229,,Aqueous solubility was measured at a pH 4,U,,CHEMBL630079,,P,,1,,,12955
,0,BAO_0000100,,,,,Autocuration,1450,,22229,,Aqueous solubility (pH 7),U,,CHEMBL630080,,P,,1,,,12956
,0,BAO_0000100,,,,,Autocuration,1450,,22229,,Aqueous solubility was measured at a pH 9,U,,CHEMBL630081,,P,,1,,,12957
,0,BAO_0000019,,,,,Autocuration,12711,,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",U,,CHEMBL630082,,A,,1,,,12958
,0,BAO_0000019,,,,,Autocuration,12711,,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,,CHEMBL630083,,A,,1,,,12959
,0,BAO_0000019,,,,,Autocuration,12711,,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,,CHEMBL630084,,A,,1,,,12960
,0,BAO_0000100,,,,,Autocuration,15032,,22229,,Aqueous solubility of the compound,U,,CHEMBL629198,,P,,1,,,12961
,0,BAO_0000100,,,,,Autocuration,9964,,22229,,Aqueous solubility at 37 degree Celsius at pH 7.38,U,,CHEMBL629199,,P,,1,,,12962
,0,BAO_0000100,,,,,Autocuration,14962,,22229,,Aqueous solubility in pH 7.4 phosphate buffer,U,,CHEMBL629200,,P,,1,,,12963
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,12487,,50588,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,N,,CHEMBL629201,,A,9615.0,1,,,12964
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,12487,,50588,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,N,,CHEMBL629202,,A,9615.0,1,,,12965
,1,BAO_0000218,,Homo sapiens,,,Intermediate,10026,,50587,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,N,,CHEMBL875111,,A,9606.0,1,,,12966
,1,BAO_0000218,,Homo sapiens,,,Intermediate,10026,,50587,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,N,,CHEMBL629203,,A,9606.0,1,,,12967
,1,BAO_0000218,,Homo sapiens,,,Intermediate,10026,,50587,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,N,,CHEMBL629204,,A,9606.0,1,,,12968
,1,BAO_0000218,,Homo sapiens,,,Intermediate,10026,,50587,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,N,,CHEMBL629205,,A,9606.0,1,,,12969
,1,BAO_0000218,,Homo sapiens,,,Intermediate,10026,,50587,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,N,,CHEMBL629206,,A,9606.0,1,,,12970
,0,BAO_0000019,,,,,Autocuration,10026,,22224,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,U,,CHEMBL631185,,A,,1,,,12971
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7415,,50597,,Compound was evaluated for the average bile flow rat in rats,N,,CHEMBL631186,,A,10116.0,1,,,12972
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,17025,,50592,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,,CHEMBL631187,,A,9986.0,1,,,12973
,1,BAO_0000218,,Oryctolagus cuniculus,,,Intermediate,17025,,50592,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,,CHEMBL631188,,A,9986.0,1,,,12974
,0,BAO_0000019,,,,,Autocuration,10184,,22224,,Average half life period was determined,U,,CHEMBL876419,,A,,1,,,12975
,0,BAO_0000019,,,,,Autocuration,10184,,22224,,Average half life period was determined,U,,CHEMBL631189,,A,,1,,,12976
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,,CHEMBL631190,,A,10298.0,1,,,12977
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,,CHEMBL631191,,A,10298.0,1,,,12978
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,N,,CHEMBL631192,,A,10298.0,1,,,12979
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,N,,CHEMBL632400,,A,10298.0,1,,,12980
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,,CHEMBL630564,,A,10298.0,1,,,12981
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,,CHEMBL630565,,A,10298.0,1,,,12982
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,N,,CHEMBL630566,,A,10298.0,1,,,12983
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,N,,CHEMBL631229,,A,10298.0,1,,,12984
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,N,,CHEMBL631230,,A,10298.0,1,,,12985
,0,BAO_0000100,,,,,Autocuration,6030,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL876428,,P,,1,,,12986
,0,BAO_0000100,,,,,Autocuration,6147,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL631231,,P,,1,,,12987
,0,BAO_0000100,,,,,Autocuration,14556,,22229,,Calculated partition coefficient (clogP) (MacLogP),U,,CHEMBL631232,,P,,1,,,12988
,0,BAO_0000019,,,,,Autocuration,768,,22224,,Hydrophilicity was determined,U,,CHEMBL631233,,A,,1,,,12989
,0,BAO_0000100,,,,,Autocuration,14452,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL631234,,P,,1,,,12990
,0,BAO_0000019,,,,,Autocuration,5237,,22224,,Increased absorption was determined,U,,CHEMBL883126,,A,,1,,,12991
,0,BAO_0000100,,,,,Autocuration,14378,,22224,,Lipophilicity value was evaluated,U,,CHEMBL631235,,P,,1,,,12992
,0,BAO_0000100,,,,,Autocuration,14418,,22224,,Log P value of the compound.,U,,CHEMBL631236,,P,,1,,,12993
,0,BAO_0000019,,,,,Autocuration,5249,,22224,,Partition coefficient of compound was determined,U,,CHEMBL631237,,A,,1,,,12994
,0,BAO_0000100,,,,,Autocuration,14621,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL631238,,P,,1,,,12995
,0,BAO_0000100,,,,,Autocuration,12542,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL876429,,P,,1,,,12996
,0,BAO_0000019,,,,,Autocuration,12542,,22224,,Partition coefficient was measured by medchem software; Not calculated,U,,CHEMBL631414,,A,,1,,,12997
,0,BAO_0000100,,,,,Autocuration,12542,,22224,,Partition coefficient was measured by octanol-water using standard shake-flask method,U,,CHEMBL631415,,P,,1,,,12998
,0,BAO_0000100,,,,,Autocuration,15462,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL631416,,P,,1,,,12999
,0,BAO_0000019,,,,,Autocuration,14884,,22224,,Partition coefficient (logP),U,,CHEMBL631417,,A,,1,,,13000
,0,BAO_0000100,,,,,Autocuration,16526,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL631418,,P,,1,,,13001
,0,BAO_0000100,,,,,Autocuration,13693,,22229,,The Octanol/Water partition coefficient CLogP,U,,CHEMBL631419,,P,,1,,,13002
,0,BAO_0000019,,,,,Autocuration,13693,,22224,,The pharmacokinetic parameter C Log p was reported,U,,CHEMBL631420,,A,,1,,,13003
,0,BAO_0000100,,,,,Autocuration,13779,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL631421,,P,,1,,,13004
,0,BAO_0000100,,,,,Autocuration,14772,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL631422,,P,,1,,,13005
,0,BAO_0000100,,,,,Autocuration,14393,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL631423,,P,,1,,,13006
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,,CHEMBL876430,,A,10116.0,1,,,13007
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,N,,CHEMBL631424,,A,10116.0,1,,,13008
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,13744,,50588,,Compound was administered intravenously in dog to evaluate plasma clearance values,N,,CHEMBL631425,,A,9615.0,1,,,13009
,0,BAO_0000218,In vivo,Simiiformes,Plasma,1969.0,Autocuration,13744,,22224,,Compound was administered intravenously in monkey to evaluate plasma clearance values,U,,CHEMBL631426,,A,314293.0,1,,,13010
,1,BAO_0000218,In vivo,Mus musculus,Plasma,1969.0,Intermediate,13744,,50594,,Compound was administered intravenously in mouse to evaluate plasma clearance values,N,,CHEMBL631427,,A,10090.0,1,,,13011
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,13207,,50588,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,N,,CHEMBL631428,,A,9615.0,1,,,13012
,1,BAO_0000218,In vitro,Macaca mulatta,Liver,2107.0,Intermediate,5669,Microsomes,50797,,Intrinsic clearance in Rhesus liver microsome,N,,CHEMBL631429,,A,9544.0,1,,,13013
,1,BAO_0000218,In vitro,Canis lupus familiaris,Liver,2107.0,Intermediate,5669,Microsomes,50588,,Intrinsic clearance in dog liver microsome,N,,CHEMBL631430,,A,9615.0,1,,,13014
,1,BAO_0000218,In vitro,Rattus norvegicus,Liver,2107.0,Intermediate,5669,Microsomes,50597,,Intrinsic clearance in rat liver microsome,N,,CHEMBL631431,,A,10116.0,1,,,13015
,1,BAO_0000218,In vivo,Macaca mulatta,Plasma,1969.0,Intermediate,4853,,50797,,Low plasma clearance was calculated in rhesus monkey,N,,CHEMBL631432,,A,9544.0,1,,,13016
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,16452,,50588,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,N,,CHEMBL631433,,A,9615.0,1,,,13017
,0,BAO_0000218,In vivo,,,,Autocuration,11954,,22224,,Plasma clearance after intravenous dose of 0.3 mg/kg,U,,CHEMBL631434,,A,,1,,,13018
,0,BAO_0000218,In vivo,,,,Autocuration,11954,,22224,,Plasma clearance after intravenous dose of 1 mg/kg,U,,CHEMBL631435,,A,,1,,,13019
,0,BAO_0000218,In vivo,,,,Autocuration,11954,,22224,,Plasma clearance after intravenous dose of 3 mg/kg,U,,CHEMBL631436,,A,,1,,,13020
,0,BAO_0000218,In vivo,,,,Autocuration,11954,,22224,,Plasma clearance after intravenous dose of 3.87 mg/kg,U,,CHEMBL631437,,A,,1,,,13021
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5669,,50597,,Plasma clearance after peroral administration at 10 mpk in Rat,N,,CHEMBL631438,,A,10116.0,1,,,13022
,1,BAO_0000218,In vivo,Macaca mulatta,,,Intermediate,5669,,50797,,Plasma clearance after peroral administration at 10 mpk in Rhesus,N,,CHEMBL876431,,A,9544.0,1,,,13023
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,5669,,50588,,Plasma clearance after peroral administration at 10 mpk in dog,N,,CHEMBL631439,,A,9615.0,1,,,13024
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13662,,50597,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,N,,CHEMBL631440,,A,10116.0,1,,,13025
,0,BAO_0000019,,,,,Autocuration,8272,,22224,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),U,,CHEMBL631441,,A,,1,,,13026
,0,BAO_0000019,,,,,Autocuration,13410,,22224,,Critical Micellar concentration was determined,U,,CHEMBL631442,,A,,1,,,13027
,0,BAO_0000019,,,,,Autocuration,13410,,22224,,Critical Micellar concentration of the compound. was determined,U,,CHEMBL626525,,A,,1,,,13028
,0,BAO_0000019,,,,,Autocuration,12628,,22224,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,U,,CHEMBL627168,,A,,1,,,13029
,0,BAO_0000019,,,,,Autocuration,9675,,22224,,Critical micellar concentration was measured in water by the dye solubilization method,U,,CHEMBL875618,,A,,1,,,13030
,0,BAO_0000019,,,,,Autocuration,12628,,22224,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,U,,CHEMBL626612,,B,,1,,,13031
,0,BAO_0000019,,,,,Autocuration,12766,,22224,,CMR value (relative to BAY K 8644),U,,CHEMBL626613,,A,,1,,,13032
,0,BAO_0000019,,,,,Autocuration,7849,,22224,,Carbamoylating activity was determined,U,,CHEMBL626614,,A,,1,,,13033
,0,BAO_0000218,,Simiiformes,,,Autocuration,12187,,22224,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,U,,CHEMBL626615,,A,314293.0,1,,,13034
,0,BAO_0000019,,,,,Autocuration,2040,,22224,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,U,,CHEMBL626616,,A,,1,,,13035
,0,BAO_0000019,,,,,Autocuration,2040,,22224,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,U,,CHEMBL626617,,A,,1,,,13036
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,14180,,50588,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,N,,CHEMBL626618,,A,9615.0,1,,,13037
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14180,,50597,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,N,,CHEMBL626619,,A,10116.0,1,,,13038
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14474,,50588,,"Clearance rate at 0.46 mg/kg, iv, in dogs",N,,CHEMBL626620,,A,9615.0,1,,,13039
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14474,,50597,,"Clearance rate at 5.5 mg/kg, iv, in rat",N,,CHEMBL626621,,A,10116.0,1,,,13040
,1,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,14548,,100710,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,,CHEMBL626622,,A,9541.0,1,,,13041
,1,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,14548,,100710,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,,CHEMBL626623,,A,9541.0,1,,,13042
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,14548,,50588,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,,CHEMBL626624,,A,9615.0,1,,,13043
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14548,,50597,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,,CHEMBL626625,,A,10116.0,1,,,13044
,1,BAO_0000218,Ex vivo,Rattus norvegicus,Liver,2107.0,Intermediate,6125,,50597,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,,CHEMBL626626,,A,10116.0,1,,,13045
,0,BAO_0000218,In vivo,,,,Autocuration,6874,,22224,,Tested for the total clearance of the compound,U,,CHEMBL626627,,A,,1,,,13046
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,15343,,50588,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,N,,CHEMBL626628,,A,9615.0,1,,,13047
,0,BAO_0000218,In vivo,,,,Autocuration,6236,,22224,,Total body clearance was determined,U,,CHEMBL626629,,A,,1,,,13048
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,,CHEMBL626630,,A,10116.0,1,,,13049
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,,CHEMBL626631,,A,10116.0,1,,,13050
,0,BAO_0000100,,,,,Autocuration,8194,,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,,CHEMBL626632,,P,,1,,,13051
,0,BAO_0000100,,,,,Autocuration,8194,,22229,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,CHEMBL626633,,P,,1,,,13052
,0,BAO_0000100,,,,,Autocuration,8194,,22229,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,U,,CHEMBL626634,,P,,1,,,13053
,0,BAO_0000100,,,,,Autocuration,8194,,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,,CHEMBL626635,,P,,1,,,13054
,0,BAO_0000100,,,,,Autocuration,8194,,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,CHEMBL626636,,P,,1,,,13055
,0,BAO_0000100,,,,,Autocuration,8194,,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,,CHEMBL626637,,P,,1,,,13056
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),N,,CHEMBL626638,,A,4754.0,1,,,13057
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,N,,CHEMBL626639,,A,4754.0,1,,,13058
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,N,,CHEMBL626640,,A,4754.0,1,,,13059
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,N,,CHEMBL626641,,A,4754.0,1,,,13060
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,N,,CHEMBL627272,,A,4754.0,1,,,13061
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,N,,CHEMBL627273,,A,4754.0,1,,,13062
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),N,,CHEMBL627441,,A,4754.0,1,,,13063
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),N,,CHEMBL628355,,A,4754.0,1,,,13064
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),N,,CHEMBL628356,,A,4754.0,1,,,13065
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),N,,CHEMBL628357,,A,4754.0,1,,,13066
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),N,,CHEMBL628358,,A,4754.0,1,,,13067
,1,BAO_0000218,,Pneumocystis carinii,,,Intermediate,13273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),N,,CHEMBL622307,,A,4754.0,1,,,13068
,0,BAO_0000019,,,,,Autocuration,13118,,22224,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,U,,CHEMBL622527,,A,,1,,,13069
,0,BAO_0000019,,,,,Autocuration,13118,,22224,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,U,,CHEMBL622528,,A,,1,,,13070
,0,BAO_0000019,,,,,Autocuration,13118,,22224,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,U,,CHEMBL622529,,A,,1,,,13071
,0,BAO_0000019,,,,,Autocuration,13118,,22224,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,U,,CHEMBL622992,,A,,1,,,13072
,0,BAO_0000019,,,,,Autocuration,13118,,22224,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,U,,CHEMBL622993,,A,,1,,,13073
,0,BAO_0000019,,,,,Autocuration,13118,,22224,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,U,,CHEMBL622994,,A,,1,,,13074
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10633,,50597,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",N,,CHEMBL622995,,A,10116.0,1,,,13075
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10633,,50597,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",N,,CHEMBL622996,,A,10116.0,1,,,13076
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10633,,50597,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",N,,CHEMBL622997,,A,10116.0,1,,,13077
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10633,,50597,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",N,,CHEMBL622998,,A,10116.0,1,,,13078
,0,BAO_0000218,,,,,Autocuration,5767,,22224,,Cp max following ip administration at 1 mg/kg,U,,CHEMBL622999,,A,,1,,,13079
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,3302,,22224,,Maximum concentration in plasma was reported at 0.5 hour,U,,CHEMBL623000,,A,,1,,,13080
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,3302,,22224,,Maximum concentration in plasma was reported at 2 hour,U,,CHEMBL623001,,A,,1,,,13081
,1,BAO_0000218,,Mus musculus,,,Intermediate,12467,,50594,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,N,,CHEMBL623002,,A,10090.0,1,,,13082
,0,BAO_0000100,,,,,Autocuration,11778,,22229,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),U,,CHEMBL623003,,P,,1,,,13083
,0,BAO_0000019,,,,,Autocuration,4321,,22224,,Steady state concentration was evaluated,U,,CHEMBL623004,,A,,1,,,13084
,0,BAO_0000019,,,,,Autocuration,14884,,22224,,Partition coefficient (logP),U,,CHEMBL623005,,A,,1,,,13085
,0,BAO_0000019,,,,,Autocuration,15234,,22224,,Partition coefficient (logD7.4),U,,CHEMBL623006,,A,,1,,,13086
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,14198,,50597,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,N,,CHEMBL623007,,A,10116.0,1,,,13087
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,N,,CHEMBL623008,,A,10116.0,1,,,13088
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,,CHEMBL876654,,A,10116.0,1,,,13089
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,N,,CHEMBL623009,,A,10116.0,1,,,13090
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,N,,CHEMBL623010,,A,10116.0,1,,,13091
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,N,,CHEMBL623011,,A,10116.0,1,,,13092
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,N,,CHEMBL623012,,A,10116.0,1,,,13093
,0,BAO_0000019,,,,,Autocuration,8151,,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,U,,CHEMBL623013,,A,,1,,,13094
,0,BAO_0000019,,,,,Autocuration,8151,,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,,CHEMBL623014,,A,,1,,,13095
,0,BAO_0000019,,,Urine,1088.0,Autocuration,8151,,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,U,,CHEMBL623015,,A,,1,,,13096
,0,BAO_0000019,,,Urine,1088.0,Autocuration,8151,,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,U,,CHEMBL623016,,A,,1,,,13097
,0,BAO_0000019,,,Urine,1088.0,Autocuration,8151,,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,U,,CHEMBL624858,,A,,1,,,13098
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8151,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,N,,CHEMBL624859,,A,10116.0,1,,,13099
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8151,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,,CHEMBL624860,,A,10116.0,1,,,13100
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8151,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,,CHEMBL624861,,A,10116.0,1,,,13101
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8151,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,N,,CHEMBL624862,,A,10116.0,1,,,13102
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8151,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,N,,CHEMBL624863,,A,10116.0,1,,,13103
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8151,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,,CHEMBL876655,,A,10116.0,1,,,13104
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,,CHEMBL624864,,A,9615.0,1,,,13105
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,,CHEMBL624865,,A,9615.0,1,,,13106
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,,CHEMBL624866,,A,9615.0,1,,,13107
,1,BAO_0000218,,Canis lupus familiaris,,,Expert,6996,,50588,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,N,,CHEMBL624867,,F,9615.0,1,,,13108
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,,CHEMBL624868,,A,9615.0,1,,,13109
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,N,,CHEMBL628450,,A,9615.0,1,,,13110
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,,CHEMBL628451,,A,9615.0,1,,,13111
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,,CHEMBL628452,,A,9615.0,1,,,13112
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,,CHEMBL628453,,A,9615.0,1,,,13113
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,N,,CHEMBL628454,,A,9615.0,1,,,13114
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,,CHEMBL628455,,A,9615.0,1,,,13115
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,,CHEMBL628456,,A,9615.0,1,,,13116
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,,CHEMBL628457,,A,9615.0,1,,,13117
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,N,,CHEMBL877505,,A,9615.0,1,,,13118
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,N,,CHEMBL628458,,A,9615.0,1,,,13119
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,,CHEMBL628459,,A,9615.0,1,,,13120
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,,CHEMBL628460,,A,9615.0,1,,,13121
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,,CHEMBL628461,,A,9615.0,1,,,13122
,0,BAO_0000218,,,,,Autocuration,6996,,22224,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",U,,CHEMBL628462,,B,,1,,,13123
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,,CHEMBL628463,,A,9615.0,1,,,13124
,1,BAO_0000218,,Rattus norvegicus,,,Expert,6996,,50597,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",N,,CHEMBL625666,,F,10116.0,1,,,13125
,0,BAO_0000218,,,,,Autocuration,6996,,22224,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,U,,CHEMBL625667,,B,,1,,,13126
,1,BAO_0000218,,Rattus norvegicus,,,Expert,6996,,50597,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,,CHEMBL625668,,A,10116.0,1,,,13127
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,,CHEMBL625669,,A,10116.0,1,,,13128
,0,BAO_0000019,,,,,Autocuration,7114,,22224,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,U,,CHEMBL625670,,A,,1,,,13129
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7114,,50597,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,N,,CHEMBL625671,,A,10116.0,1,,,13130
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,N,,CHEMBL625672,,A,10298.0,1,,,13131
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,N,,CHEMBL625673,,A,10298.0,1,,,13132
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,N,,CHEMBL625674,,A,10298.0,1,,,13133
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,N,,CHEMBL625675,,A,10298.0,1,,,13134
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,,CHEMBL627637,,A,10298.0,1,,,13135
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,N,,CHEMBL627638,,A,10298.0,1,,,13136
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,N,,CHEMBL627639,,A,10298.0,1,,,13137
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,N,,CHEMBL627640,,A,10298.0,1,,,13138
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,N,,CHEMBL627641,,A,10298.0,1,,,13139
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,,CHEMBL627642,,A,10298.0,1,,,13140
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,,CHEMBL877506,,A,10298.0,1,,,13141
,1,BAO_0000218,,Mus musculus,,,Intermediate,8613,,50594,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,,CHEMBL627275,,A,10090.0,1,,,13142
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,11219,,50506,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",N,,CHEMBL627643,,A,9669.0,1,,,13143
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,11219,,50506,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,,CHEMBL631246,,A,9669.0,1,,,13144
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,11219,,50506,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,,CHEMBL631247,,A,9669.0,1,,,13145
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,11219,,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,,CHEMBL629532,,A,9669.0,1,,,13146
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,11219,,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,N,,CHEMBL629533,,A,9669.0,1,,,13147
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,11219,,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,,CHEMBL629534,,A,9669.0,1,,,13148
,1,BAO_0000218,,Mustela putorius furo,,,Intermediate,11219,,50506,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,N,,CHEMBL629535,,A,9669.0,1,,,13149
,0,BAO_0000019,,,,,Autocuration,14837,,22224,,Pharmacokinetic parameter :drug bound to plasma was reported,U,,CHEMBL625932,,A,,1,,,13150
,0,BAO_0000019,,,,,Autocuration,14837,,22224,,compound was evaluated for drug bound in plasma,U,,CHEMBL625933,,A,,1,,,13151
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15343,,50597,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,N,,CHEMBL625934,,A,10116.0,1,,,13152
,0,BAO_0000218,,Eutheria,,,Autocuration,13761,,22224,,Bioavailability,U,,CHEMBL625935,,A,9347.0,1,,,13153
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14810,,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,N,,CHEMBL625936,,A,10116.0,1,,,13154
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14810,,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,N,,CHEMBL625937,,A,10116.0,1,,,13155
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,13249,,50588,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,,CHEMBL625938,,A,9615.0,1,,,13156
,1,BAO_0000218,,Rattus norvegicus,Bile,1970.0,Intermediate,9267,,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,N,,CHEMBL625939,,A,10116.0,1,,,13157
,1,BAO_0000218,,Rattus norvegicus,Bile,1970.0,Intermediate,9267,,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,N,,CHEMBL625940,,A,10116.0,1,,,13158
,1,BAO_0000218,,Rattus norvegicus,Bile,1970.0,Intermediate,9267,,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,N,,CHEMBL874464,,A,10116.0,1,,,13159
,1,BAO_0000218,,Rattus norvegicus,Bile,1970.0,Intermediate,9267,,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,N,,CHEMBL625941,,A,10116.0,1,,,13160
,1,BAO_0000218,,Rattus norvegicus,Bile,1970.0,Intermediate,9267,,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,N,,CHEMBL625942,,A,10116.0,1,,,13161
,1,BAO_0000218,,Rattus norvegicus,Bile,1970.0,Intermediate,9267,,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,N,,CHEMBL625943,,A,10116.0,1,,,13162
,1,BAO_0000218,,Homo sapiens,Serum,1977.0,Intermediate,15549,,50587,,In vitro protein binding in human serum at 5 ug/ml,N,,CHEMBL625944,,A,9606.0,1,,,13163
,0,BAO_0000019,,,,,Autocuration,10929,,22224,,Serum protein binding ability was measured,U,,CHEMBL625945,,A,,1,,,13164
,0,BAO_0000019,,,,,Autocuration,15444,,22224,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),U,,CHEMBL625946,,A,,1,,,13165
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,12860,,22224,,Oral bioavailability in dog,U,,CHEMBL625947,,A,9615.0,1,,,13166
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12170,,50597,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,N,,CHEMBL625948,,A,10116.0,1,,,13167
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,Absolute oral bioavailability at an iv dose of 14 mg/kg,U,,CHEMBL625949,,A,,1,,,13168
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,U,,CHEMBL625950,,A,,1,,,13169
,0,BAO_0000218,In vivo,Eutheria,,,Autocuration,15173,,22224,,Oral bioavailability (dose 15 mg/kg i.v.),U,,CHEMBL625951,,A,9347.0,1,,,13170
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,U,,CHEMBL625952,,A,,1,,,13171
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,U,,CHEMBL625953,,A,,1,,,13172
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,U,,CHEMBL625954,,A,,1,,,13173
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,U,,CHEMBL882959,,A,,1,,,13174
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,11767,,50588,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,N,,CHEMBL625955,,A,9615.0,1,,,13175
,0,BAO_0000218,In vivo,Mustela putorius furo,,,Autocuration,11219,,22224,,Bioavailability in ferret,U,,CHEMBL625956,,A,9669.0,1,,,13176
,1,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,12186,,100710,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,N,,CHEMBL625957,,A,9541.0,1,,,13177
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,,CHEMBL625958,,A,10116.0,1,,,13178
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,,CHEMBL625959,,A,10116.0,1,,,13179
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,,CHEMBL626642,,A,10116.0,1,,,13180
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,,CHEMBL631330,,A,10116.0,1,,,13181
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,,CHEMBL631331,,A,10116.0,1,,,13182
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,,CHEMBL631332,,A,10116.0,1,,,13183
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,,CHEMBL631333,,A,10116.0,1,,,13184
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,,CHEMBL632018,,A,10116.0,1,,,13185
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,,CHEMBL632019,,A,10116.0,1,,,13186
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,,CHEMBL632020,,A,10116.0,1,,,13187
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,,CHEMBL632021,,A,10116.0,1,,,13188
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,,CHEMBL632022,,A,10116.0,1,,,13189
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,,CHEMBL632023,,A,10116.0,1,,,13190
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,,CHEMBL632024,,A,10116.0,1,,,13191
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,,CHEMBL874472,,A,10116.0,1,,,13192
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,,CHEMBL632025,,A,10116.0,1,,,13193
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,,CHEMBL632026,,A,10116.0,1,,,13194
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,,CHEMBL632027,,A,10116.0,1,,,13195
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,,CHEMBL632028,,A,10116.0,1,,,13196
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,,CHEMBL626430,,A,10116.0,1,,,13197
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,,CHEMBL626431,,A,10116.0,1,,,13198
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,,CHEMBL626432,,A,10116.0,1,,,13199
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,,CHEMBL626433,,A,10116.0,1,,,13200
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,,CHEMBL626434,,A,10116.0,1,,,13201
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,,CHEMBL627280,,A,10116.0,1,,,13202
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,,CHEMBL627281,,A,10116.0,1,,,13203
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,,CHEMBL627282,,A,10116.0,1,,,13204
,0,BAO_0000019,,,,,Autocuration,7199,,22224,,Total body clearance was measured at given dose,U,,CHEMBL627283,,A,,1,,,13205
,0,BAO_0000218,,,,,Autocuration,7199,,22224,,Total body clearance was measured at given dose.,U,,CHEMBL627284,,A,,1,,,13206
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7095,,50597,,Metabolic clearance from the body in rat,N,,CHEMBL627285,,A,10116.0,1,,,13207
,0,BAO_0000218,In vivo,,,,Autocuration,7095,,22224,,Renal clearance from the body,U,,CHEMBL627286,,A,,1,,,13208
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,7095,,50597,,Renal clearance from the body in rat,N,,CHEMBL875477,,A,10116.0,1,,,13209
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12528,,50597,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,N,,CHEMBL627287,,A,10116.0,1,,,13210
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,12528,,50588,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,N,,CHEMBL627288,,A,9615.0,1,,,13211
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7095,,50597,,Total clearance from the body in rat,N,,CHEMBL627289,,A,10116.0,1,,,13212
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14223,,50597,,Clearance into cortex from rat plasma or PBS,N,,CHEMBL627290,,A,10116.0,1,,,13213
,0,BAO_0000218,In vivo,,,,Autocuration,13569,,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,U,,CHEMBL627291,,A,,1,,,13214
,0,BAO_0000218,In vivo,,,,Autocuration,13569,,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,U,,CHEMBL627292,,A,,1,,,13215
,0,BAO_0000218,In vivo,,,,Autocuration,13569,,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,U,,CHEMBL627293,,A,,1,,,13216
,0,BAO_0000218,In vivo,,,,Autocuration,13569,,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,U,,CHEMBL627294,,A,,1,,,13217
,0,BAO_0000218,In vivo,,,,Autocuration,13569,,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,U,,CHEMBL875478,,A,,1,,,13218
,0,BAO_0000218,In vivo,,,,Autocuration,13979,,22224,,Clearance was determined,U,,CHEMBL627295,,A,,1,,,13219
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14315,,50594,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,N,,CHEMBL627296,,A,10090.0,1,,,13220
,1,BAO_0000218,In vivo,Oryctolagus cuniculus,,,Intermediate,14315,,50592,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,N,,CHEMBL626119,,A,9986.0,1,,,13221
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14315,,50597,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,N,,CHEMBL626120,,A,10116.0,1,,,13222
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12174,,50597,,Clearance in rat after iv dose (100 ug/kg),N,,CHEMBL626121,,A,10116.0,1,,,13223
,0,BAO_0000218,In vivo,Cavia porcellus,,,Autocuration,12797,,22224,,Clearance in guinea pig,U,,CHEMBL626122,,A,10141.0,1,,,13224
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12797,,50597,,Compound was evaluated for clearance in rat,N,,CHEMBL626123,,A,10116.0,1,,,13225
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,12797,,50588,,Compound was evaluated for the clearance in dog,N,,CHEMBL623456,,A,9615.0,1,,,13226
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12797,,50597,,Compound was evaluated for the clearance in rat,N,,CHEMBL623457,,A,10116.0,1,,,13227
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,11500,,50597,,Compound was tested in vivo for clearance after iv administration in the rat,N,,CHEMBL623458,,A,10116.0,1,,,13228
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,IV clearance determined at an iv dose of 14 mg/kg,U,,CHEMBL623459,,A,,1,,,13229
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,IV clearance determined at an iv dose of 15.2 mg/kg,U,,CHEMBL875484,,A,,1,,,13230
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,IV clearance determined at an iv dose of 15 mg/kg,U,,CHEMBL623460,,A,,1,,,13231
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,IV clearance determined at an peroral dose of 30 mg/kg.,U,,CHEMBL623461,,A,,1,,,13232
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,IV clearance determined at an peroral dose of 30.2 mg/kg.,U,,CHEMBL623462,,A,,1,,,13233
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,IV clearance determined at an peroral dose of 30.3 mg/kg.,U,,CHEMBL627386,,A,,1,,,13234
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,N,,CHEMBL627387,,A,10116.0,1,,,13235
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,N,,CHEMBL627388,,A,10116.0,1,,,13236
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,N,,CHEMBL627389,,A,10116.0,1,,,13237
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,N,,CHEMBL627390,,A,10116.0,1,,,13238
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,N,,CHEMBL627391,,A,10116.0,1,,,13239
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,,CHEMBL627392,,A,10116.0,1,,,13240
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,N,,CHEMBL627393,,A,10116.0,1,,,13241
,1,BAO_0000218,In vivo,Rattus norvegicus,Trachea,3126.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,N,,CHEMBL627394,,A,10116.0,1,,,13242
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,N,,CHEMBL627395,,A,10116.0,1,,,13243
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,,CHEMBL875485,,A,10116.0,1,,,13244
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,N,,CHEMBL627396,,A,10116.0,1,,,13245
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,N,,CHEMBL627397,,A,10116.0,1,,,13246
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,N,,CHEMBL627398,,A,10116.0,1,,,13247
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,N,,CHEMBL627399,,A,10116.0,1,,,13248
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,N,,CHEMBL627400,,A,10116.0,1,,,13249
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,N,,CHEMBL627401,,A,10116.0,1,,,13250
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,N,,CHEMBL627402,,A,10116.0,1,,,13251
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,N,,CHEMBL627403,,A,10116.0,1,,,13252
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,N,,CHEMBL627404,,A,10116.0,1,,,13253
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,,CHEMBL623101,,A,10116.0,1,,,13254
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,N,,CHEMBL877480,,A,10116.0,1,,,13255
,1,BAO_0000218,In vivo,Rattus norvegicus,Trachea,3126.0,Intermediate,14198,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,N,,CHEMBL623102,,A,10116.0,1,,,13256
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,N,,CHEMBL623103,,A,10116.0,1,,,13257
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,,CHEMBL623104,,A,10116.0,1,,,13258
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,N,,CHEMBL623105,,A,10116.0,1,,,13259
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,N,,CHEMBL623106,,A,10116.0,1,,,13260
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,N,,CHEMBL623107,,A,10116.0,1,,,13261
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,N,,CHEMBL623108,,A,10116.0,1,,,13262
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,N,,CHEMBL623109,,A,10116.0,1,,,13263
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,N,,CHEMBL623110,,A,10116.0,1,,,13264
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,N,,CHEMBL623111,,A,10116.0,1,,,13265
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,N,,CHEMBL625060,,A,10116.0,1,,,13266
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,N,,CHEMBL625061,,A,10116.0,1,,,13267
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,,CHEMBL625062,,A,10116.0,1,,,13268
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,N,,CHEMBL625063,,A,10116.0,1,,,13269
,1,BAO_0000218,In vivo,Rattus norvegicus,Trachea,3126.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,N,,CHEMBL625064,,A,10116.0,1,,,13270
,1,BAO_0000218,In vivo,Rattus norvegicus,Bone,10000001.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,N,,CHEMBL625065,,A,10116.0,1,,,13271
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,,CHEMBL625066,,A,10116.0,1,,,13272
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,N,,CHEMBL625067,,A,10116.0,1,,,13273
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,N,,CHEMBL625068,,A,10116.0,1,,,13274
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,N,,CHEMBL622159,,A,10116.0,1,,,13275
,1,BAO_0000218,In vivo,Rattus norvegicus,Intestine,160.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,N,,CHEMBL622160,,A,10116.0,1,,,13276
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,N,,CHEMBL622161,,A,10116.0,1,,,13277
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,N,,CHEMBL622162,,A,10116.0,1,,,13278
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,N,,CHEMBL622163,,A,10116.0,1,,,13279
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,N,,CHEMBL622313,,A,10116.0,1,,,13280
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,,CHEMBL622314,,A,10116.0,1,,,13281
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,N,,CHEMBL622315,,A,10116.0,1,,,13282
,1,BAO_0000218,In vivo,Rattus norvegicus,Trachea,3126.0,Intermediate,14198,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,N,,CHEMBL622316,,A,10116.0,1,,,13283
,1,BAO_0000218,,Escherichia coli,,,Intermediate,15599,,50212,,Normal diffusion coefficient in water for Escherichia coli,N,,CHEMBL877486,,A,562.0,1,,,13284
,0,BAO_0000019,,,,,Autocuration,8204,,22224,,Average max percent decrease in RVR (renal vascular resistance) was determined,U,,CHEMBL622317,,A,,1,,,13285
,0,BAO_0000019,,,,,Autocuration,8204,,22224,,Average max percent decrease in RVR (renal vascular resistance) was determined.,U,,CHEMBL622318,,A,,1,,,13286
,0,BAO_0000019,,,,,Autocuration,6154,,22224,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,U,,CHEMBL622319,,A,,1,,,13287
,0,BAO_0000019,,,,,Autocuration,6154,,22224,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,U,,CHEMBL622320,,A,,1,,,13288
,0,BAO_0000019,,,,,Autocuration,6154,,22224,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,U,,CHEMBL622321,,A,,1,,,13289
,0,BAO_0000019,,,,,Autocuration,6154,,22224,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,U,,CHEMBL622322,,A,,1,,,13290
,0,BAO_0000019,,,,,Autocuration,7114,,22224,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,U,,CHEMBL622323,,A,,1,,,13291
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7114,,50597,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,N,,CHEMBL622324,,A,10116.0,1,,,13292
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,,CHEMBL622325,,A,9615.0,1,,,13293
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,,CHEMBL622326,,A,9615.0,1,,,13294
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",N,,CHEMBL877487,,A,9615.0,1,,,13295
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,,CHEMBL622327,,A,9615.0,1,,,13296
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",N,,CHEMBL622328,,A,9615.0,1,,,13297
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,,CHEMBL622329,,A,9615.0,1,,,13298
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,,CHEMBL622330,,A,9615.0,1,,,13299
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,,CHEMBL622331,,A,9615.0,1,,,13300
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,,CHEMBL622332,,A,9615.0,1,,,13301
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",N,,CHEMBL622333,,A,9615.0,1,,,13302
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,,CHEMBL627658,,A,314293.0,1,,,13303
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",U,,CHEMBL630428,,A,314293.0,1,,,13304
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,,CHEMBL630429,,A,314293.0,1,,,13305
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",U,,CHEMBL630430,,A,314293.0,1,,,13306
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",U,,CHEMBL630431,,A,314293.0,1,,,13307
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,,CHEMBL630432,,A,10116.0,1,,,13308
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,,CHEMBL630433,,A,10116.0,1,,,13309
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,,CHEMBL630434,,A,10116.0,1,,,13310
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,,CHEMBL629372,,A,10116.0,1,,,13311
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",N,,CHEMBL629553,,A,10116.0,1,,,13312
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,,CHEMBL629554,,A,10116.0,1,,,13313
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,,CHEMBL874447,,A,10116.0,1,,,13314
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,,CHEMBL629555,,A,10116.0,1,,,13315
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,,CHEMBL629556,,A,10116.0,1,,,13316
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",N,,CHEMBL629557,,A,10116.0,1,,,13317
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,,CHEMBL629558,,A,10116.0,1,,,13318
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,,CHEMBL629559,,A,10116.0,1,,,13319
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,,CHEMBL629560,,A,10116.0,1,,,13320
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,,CHEMBL629561,,A,9615.0,1,,,13321
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,,CHEMBL629562,,A,9615.0,1,,,13322
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,,CHEMBL629563,,A,9615.0,1,,,13323
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,,CHEMBL629564,,A,9615.0,1,,,13324
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,,CHEMBL629565,,A,9615.0,1,,,13325
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,,CHEMBL629566,,A,9615.0,1,,,13326
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,,CHEMBL629567,,A,9615.0,1,,,13327
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,,CHEMBL629568,,A,9615.0,1,,,13328
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",N,,CHEMBL629569,,A,9615.0,1,,,13329
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,,CHEMBL629570,,A,9615.0,1,,,13330
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,,CHEMBL629571,,A,314293.0,1,,,13331
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,12170,,22224,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,,CHEMBL629572,,A,10116.0,1,,,13332
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,12170,,22224,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,,CHEMBL629573,,A,10116.0,1,,,13333
,0,BAO_0000218,In vivo,Eutheria,,,Autocuration,4985,,22224,,Bioavailability (dose 20 mg/kg),U,,CHEMBL629574,,A,9347.0,1,,,13334
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,15145,,22224,,Bioavailability in dog,U,,CHEMBL629575,,A,9615.0,1,,,13335
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,14080,,22224,,Bioavailability in rat (Sprague-Dawley) (male),U,,CHEMBL874448,,A,10116.0,1,,,13336
,0,BAO_0000218,In vivo,Primates,,,Autocuration,11219,,22224,,Bioavailability in monkey (dose 10 mg/kg i.d.),U,,CHEMBL629576,,A,9443.0,1,,,13337
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,15145,,22224,,Bioavailability in rat,U,,CHEMBL629577,,A,10116.0,1,,,13338
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,15145,,22224,,Bioavailability in rat,U,,CHEMBL629578,,A,10116.0,1,,,13339
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,1202,,22224,,Bioavailability in dog (dose 3.0 mg/kg p.o.),U,,CHEMBL629579,,A,9615.0,1,,,13340
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,1202,,22224,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,U,,CHEMBL882958,,A,9615.0,1,,,13341
,1,BAO_0000218,In vivo,Pan troglodytes,,,Intermediate,1202,,50505,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,N,,CHEMBL629580,,A,9598.0,1,,,13342
,0,BAO_0000218,In vivo,Eutheria,,,Autocuration,4026,,22224,,Bioavailability,U,,CHEMBL629581,,A,9347.0,1,,,13343
,0,BAO_0000218,In vivo,Saimiri,,,Autocuration,1492,,22224,,Bioavailability in squirrel monkey,U,,CHEMBL629582,,A,9520.0,1,,,13344
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,12793,,50588,,Bioavailability was evaluated in dog,N,,CHEMBL628522,,A,9615.0,1,,,13345
,1,BAO_0000218,In vivo,Cricetinae,,,Intermediate,12793,,100712,,Bioavailability was evaluated in hamster,N,,CHEMBL625432,,A,10026.0,1,,,13346
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,12793,,22224,,Bioavailability in rat,U,,CHEMBL625433,,A,10116.0,1,,,13347
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,,CHEMBL625434,,A,10116.0,1,,,13348
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,14793,,50597,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,N,,CHEMBL625435,,A,10116.0,1,,,13349
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,14793,,22224,,Bioavailability in rat (dose 10 mg/kg p.o.),U,,CHEMBL625436,,A,10116.0,1,,,13350
,1,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,14731,,100710,,Bioavailability was measured in cynomolgus monkeys.,N,,CHEMBL874588,,A,9541.0,1,,,13351
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14731,,50594,,Bioavailability was measured in nude mice.,N,,CHEMBL625437,,A,10090.0,1,,,13352
,0,BAO_0000218,In vivo,Mustela putorius furo,,,Autocuration,12187,,22224,,Bioavailability in ferret (dose 10 mg/kg i.d.),U,,CHEMBL625438,,A,9669.0,1,,,13353
,0,BAO_0000218,In vivo,Simiiformes,,,Autocuration,12187,,22224,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),U,,CHEMBL625439,,A,314293.0,1,,,13354
,0,BAO_0000218,In vivo,Simiiformes,,,Autocuration,12187,,22224,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",U,,CHEMBL625440,,A,314293.0,1,,,13355
,0,BAO_0000218,In vivo,Simiiformes,,,Autocuration,12187,,22224,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),U,,CHEMBL625441,,A,314293.0,1,,,13356
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,12187,,22224,,Bioavailability in rat (dose 10 mg/kg i.d.),U,,CHEMBL625442,,A,10116.0,1,,,13357
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12187,,50597,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,,CHEMBL625443,,A,10116.0,1,,,13358
,0,BAO_0000218,In vivo,,,,Autocuration,17431,,22224,,Bioavailability was determined; extremely poor,U,,CHEMBL625444,,A,,1,,,13359
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,13318,,50594,,% bioavailability in mice after oral administration of prodrug,N,,CHEMBL625445,,A,10090.0,1,,,13360
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,N,,CHEMBL625446,,A,9615.0,1,,,13361
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,N,,CHEMBL882960,,A,9615.0,1,,,13362
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,N,,CHEMBL625447,,A,9615.0,1,,,13363
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,N,,CHEMBL625448,,A,9615.0,1,,,13364
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,N,,CHEMBL625449,,A,9615.0,1,,,13365
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),N,,CHEMBL874589,,A,9615.0,1,,,13366
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,N,,CHEMBL625450,,A,9615.0,1,,,13367
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,N,,CHEMBL625451,,A,9615.0,1,,,13368
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,N,,CHEMBL626584,,A,9615.0,1,,,13369
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,N,,CHEMBL626585,,A,9615.0,1,,,13370
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,N,,CHEMBL626586,,A,9615.0,1,,,13371
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,N,,CHEMBL626587,,A,9615.0,1,,,13372
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,N,,CHEMBL626588,,A,9615.0,1,,,13373
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,N,,CHEMBL626589,,A,9615.0,1,,,13374
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,N,,CHEMBL626590,,A,9615.0,1,,,13375
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,N,,CHEMBL626591,,A,9615.0,1,,,13376
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,N,,CHEMBL627181,,A,9615.0,1,,,13377
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,N,,CHEMBL628083,,A,9615.0,1,,,13378
,0,BAO_0000218,In vivo,,,,Autocuration,15173,,22224,,IV clearance determined at an peroral dose of 15 mg/kg.,U,,CHEMBL628084,,A,,1,,,13379
,1,BAO_0000218,In vivo,Hymenolepis nana,,,Expert,7732,,50064,,Mouse oral clearance was measured against Hymenolepiasis nana.,N,,CHEMBL628085,,F,102285.0,1,,,13380
,1,BAO_0000218,In vivo,Heligmosomoides polygyrus,,,Expert,7732,,50545,,Mouse oral clearance was measured against Nematospiroides dubius,N,,CHEMBL628086,,F,6339.0,1,,,13381
,0,BAO_0000218,In vivo,,,,Autocuration,7732,,22224,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,U,,CHEMBL628087,,F,,1,,,13382
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,7732,,50594,,Mouse oral clearance was measured against N. nana; NT is Not Tested,N,,CHEMBL628088,,A,10090.0,1,,,13383
,0,BAO_0000218,In vivo,,,,Autocuration,7732,,22224,,Mouse oral clearance was measured against N. nana; NT is Not Tested,U,,CHEMBL628089,,B,,1,,,13384
,0,BAO_0000218,In vivo,,,,Autocuration,8328,,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,U,,CHEMBL628090,,A,,1,,,13385
,0,BAO_0000218,In vivo,,,,Autocuration,8328,,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,U,,CHEMBL628091,,A,,1,,,13386
,0,BAO_0000218,In vivo,,,,Autocuration,8328,,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,U,,CHEMBL628092,,A,,1,,,13387
,0,BAO_0000218,In vivo,,,,Autocuration,8328,,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,U,,CHEMBL628093,,A,,1,,,13388
,0,BAO_0000218,In vivo,,,,Autocuration,8328,,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,U,,CHEMBL875607,,A,,1,,,13389
,0,BAO_0000218,In vivo,,,,Autocuration,8328,,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,U,,CHEMBL625710,,A,,1,,,13390
,0,BAO_0000218,In vivo,,,,Autocuration,8328,,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,U,,CHEMBL625711,,A,,1,,,13391
,0,BAO_0000218,In vivo,,,,Autocuration,8328,,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,U,,CHEMBL625712,,A,,1,,,13392
,0,BAO_0000218,In vivo,,,,Autocuration,8328,,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,U,,CHEMBL625713,,A,,1,,,13393
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,13376,,50588,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,N,,CHEMBL625714,,A,9615.0,1,,,13394
,1,BAO_0000218,In vivo,Macaca mulatta,,,Intermediate,13477,,50797,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,N,,CHEMBL625715,,A,9544.0,1,,,13395
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,N,,CHEMBL625716,,A,10116.0,1,,,13396
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13477,,50597,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,N,,CHEMBL625717,,A,10116.0,1,,,13397
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13313,,50597,,Plasma clearance was determined for the compound in rats,N,,CHEMBL625718,,A,10116.0,1,,,13398
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12504,,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,N,,CHEMBL625719,,A,10116.0,1,,,13399
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12504,,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,N,,CHEMBL625720,,A,10116.0,1,,,13400
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12504,,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,N,,CHEMBL625721,,A,10116.0,1,,,13401
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12504,,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,N,,CHEMBL625722,,A,10116.0,1,,,13402
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13129,,50597,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,N,,CHEMBL625723,,A,10116.0,1,,,13403
,1,BAO_0000218,In vivo,Heligmosomoides polygyrus,,,Intermediate,7732,,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,N,,CHEMBL625724,,A,6339.0,1,,,13404
,1,BAO_0000218,In vivo,Heligmosomoides polygyrus,,,Intermediate,7732,,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,N,,CHEMBL625725,,A,6339.0,1,,,13405
,1,BAO_0000218,In vivo,Heligmosomoides polygyrus,,,Intermediate,7732,,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,N,,CHEMBL625726,,A,6339.0,1,,,13406
,1,BAO_0000218,In vivo,Heligmosomoides polygyrus,,,Intermediate,7732,,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,N,,CHEMBL875608,,A,6339.0,1,,,13407
,1,BAO_0000218,In vivo,Heligmosomoides polygyrus,,,Intermediate,7732,,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,N,,CHEMBL625727,,A,6339.0,1,,,13408
,0,BAO_0000218,In vivo,Rattus norvegicus,Urine,1088.0,Autocuration,9278,,22224,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,U,,CHEMBL625728,,A,10116.0,1,,,13409
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,9278,,22224,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,,CHEMBL625729,,A,10116.0,1,,,13410
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,9278,,22224,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,U,,CHEMBL625730,,A,10116.0,1,,,13411
,0,BAO_0000218,In vivo,Rattus norvegicus,Urine,1088.0,Autocuration,9278,,22224,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,,CHEMBL625731,,A,10116.0,1,,,13412
,0,BAO_0000218,In vivo,Rattus norvegicus,Urine,1088.0,Autocuration,9278,,22224,,Urinary clearance was determined in rat at 25 mg/kg os dosage,U,,CHEMBL626417,,A,10116.0,1,,,13413
,1,BAO_0000218,In vivo,Homo sapiens,Urine,1088.0,Intermediate,9278,,50587,,Urinary clearance was determined at 100 mg/kg oral dosage in human,N,,CHEMBL626418,,A,9606.0,1,,,13414
,1,BAO_0000218,In vivo,Canis lupus familiaris,Urine,1088.0,Intermediate,9278,,50588,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,N,,CHEMBL626419,,A,9615.0,1,,,13415
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,5932,,50588,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,N,,CHEMBL626592,,A,9615.0,1,,,13416
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,5932,,50597,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,,CHEMBL626593,,A,10116.0,1,,,13417
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5182,,50597,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,,CHEMBL626594,,A,10116.0,1,,,13418
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,10499,,50588,,Clearance rate in dogs,N,,CHEMBL625035,,A,9615.0,1,,,13419
,0,BAO_0000019,In vitro,,,,Autocuration,6051,,22224,,Compound was measured for intrinsic clearance,U,,CHEMBL625036,,A,,1,,,13420
,0,BAO_0000100,,,,,Autocuration,17508,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625037,,P,,1,,,13421
,0,BAO_0000100,,,,,Autocuration,6228,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625038,,P,,1,,,13422
,0,BAO_0000100,,,,,Autocuration,6231,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625039,,P,,1,,,13423
,0,BAO_0000100,,,,,Autocuration,17740,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625040,,P,,1,,,13424
,0,BAO_0000100,,,,,Autocuration,6495,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625041,,P,,1,,,13425
,0,BAO_0000100,,,,,Autocuration,2171,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625042,,P,,1,,,13426
,0,BAO_0000019,,,,,Autocuration,3255,,22224,,Partition coefficient of the compound,U,,CHEMBL874411,,A,,1,,,13427
,0,BAO_0000019,,,,,Autocuration,6821,,22224,,Permeability,U,,CHEMBL625043,,A,,1,,,13428
,0,BAO_0000100,,,,,Autocuration,2685,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625044,,P,,1,,,13429
,0,BAO_0000019,,,,,Autocuration,17584,,22224,,Partition coefficient (logD),U,,CHEMBL625045,,A,,1,,,13430
,0,BAO_0000100,,,,,Autocuration,13824,,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,CHEMBL625046,,P,,1,,,13431
,0,BAO_0000100,,,,,Autocuration,13824,,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,CHEMBL625047,,P,,1,,,13432
,0,BAO_0000100,,,,,Autocuration,16479,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625048,,P,,1,,,13433
,0,BAO_0000100,,,,,Autocuration,11997,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625049,,P,,1,,,13434
,0,BAO_0000100,,,,,Autocuration,2988,,22229,,Calculated logarithm of partition coefficient (P) was determined,U,,CHEMBL625050,,P,,1,,,13435
,0,BAO_0000100,,,,,Autocuration,931,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625051,,P,,1,,,13436
,0,BAO_0000100,,,,,Autocuration,4381,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL874412,,P,,1,,,13437
,0,BAO_0000100,,,,,Autocuration,4397,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625052,,P,,1,,,13438
,0,BAO_0000100,,,,,Autocuration,5889,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL625053,,P,,1,,,13439
,0,BAO_0000019,,,,,Autocuration,6154,,22224,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,U,,CHEMBL623250,,A,,1,,,13440
,0,BAO_0000019,,,,,Autocuration,6154,,22224,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,U,,CHEMBL623251,,A,,1,,,13441
,0,BAO_0000019,,,,,Autocuration,6154,,22224,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,U,,CHEMBL623252,,A,,1,,,13442
,0,BAO_0000019,,,,,Autocuration,6154,,22224,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,U,,CHEMBL623253,,A,,1,,,13443
,0,BAO_0000019,,,,,Autocuration,6154,,22224,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,U,,CHEMBL623254,,A,,1,,,13444
,0,BAO_0000019,,,,,Autocuration,6154,,22224,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,U,,CHEMBL623255,,A,,1,,,13445
,0,BAO_0000019,,,,,Autocuration,6887,,22224,,Percent degradation of compound at a pH of 1 over a 18 hr period,U,,CHEMBL626831,,A,,1,,,13446
,0,BAO_0000019,,,,,Autocuration,6887,,22224,,Percent degradation of compound at pH of 1 over an 18 hr period,U,,CHEMBL877494,,A,,1,,,13447
,0,BAO_0000019,,,,,Autocuration,14116,,22224,,Delta Logarithm of Partition Coefficient value was determined.,U,,CHEMBL626832,,A,,1,,,13448
,0,BAO_0000019,,,,,Autocuration,11137,,22224,,Delta logPoct-cyc,U,,CHEMBL626833,,A,,1,,,13449
,0,BAO_0000100,,,,,Autocuration,7230,,22224,,Lipophilicity estimated on reversed phase TLC,U,,CHEMBL626834,,P,,1,,,13450
,0,BAO_0000019,,,,,Autocuration,15741,,22224,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,U,,CHEMBL626835,,A,,1,,,13451
,0,BAO_0000019,,,,,Autocuration,9663,,22224,,Delta logPoct-cyc,U,,CHEMBL626836,,A,,1,,,13452
,0,BAO_0000100,,,,,Autocuration,9663,,22229,,Change in logarithm of partition coefficient of the compound,U,,CHEMBL626837,,P,,1,,,13453
,0,BAO_0000019,,,,,Autocuration,13807,,22224,,Delta logD (pH 6.5),U,,CHEMBL626838,,A,,1,,,13454
,0,BAO_0000100,,,,,Autocuration,13807,,22224,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",U,,CHEMBL626839,,P,,1,,,13455
,0,BAO_0000019,,,,,Autocuration,17425,,22224,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,U,,CHEMBL626840,,A,,1,,,13456
,0,BAO_0000019,,,,,Autocuration,12143,,22224,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),U,,CHEMBL626841,,A,,1,,,13457
,0,BAO_0000219,,,,,Autocuration,12608,,22224,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,U,,CHEMBL626842,,A,,1,,,13458
,0,BAO_0000219,,,,,Autocuration,12608,,22224,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,U,,CHEMBL626843,,A,,1,,,13459
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8649,,50597,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,N,,CHEMBL626844,,A,10116.0,1,,,13460
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8649,,50597,,Amount of deuterium retained was reported after normal workup in rats,N,,CHEMBL877495,,A,10116.0,1,,,13461
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8649,,50597,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,N,,CHEMBL626845,,A,10116.0,1,,,13462
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8649,,50597,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,N,,CHEMBL626846,,A,10116.0,1,,,13463
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8649,,50597,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,,CHEMBL626847,,A,10116.0,1,,,13464
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8649,,50597,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,,CHEMBL628677,,A,10116.0,1,,,13465
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8649,,50597,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,N,,CHEMBL628678,,A,10116.0,1,,,13466
,0,BAO_0000019,,,,,Autocuration,9659,,22224,,Compound was subjected to electrochemical oxidation,U,,CHEMBL628679,,A,,1,,,13467
,0,BAO_0000019,,,,,Autocuration,9659,,22224,,Compound was subjected to photochemical oxidation,U,,CHEMBL628680,,A,,1,,,13468
,0,BAO_0000019,,,,,Autocuration,9659,,22224,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,U,,CHEMBL628681,,A,,1,,,13469
,0,BAO_0000019,,,,,Autocuration,9659,,22224,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,U,,CHEMBL628682,,A,,1,,,13470
,0,BAO_0000019,,,,,Autocuration,9659,,22224,,Oxidation of compound by methemoglobin in presence of hydroperoxide,U,,CHEMBL628683,,A,,1,,,13471
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,9607,,50597,,Percent diffusion through fuzzy rat skin after 48 h of incubation,N,,CHEMBL628684,,A,10116.0,1,,,13472
,0,BAO_0000100,,,,,Autocuration,7057,,22229,,Dissociation constant (pKa),U,,CHEMBL877501,,P,,1,,,13473
,0,BAO_0000100,,,,,Autocuration,7057,,22224,,Dissociation constant value of the compound; ND means not determined.,U,,CHEMBL628685,,P,,1,,,13474
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,7911,,50597,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,N,,CHEMBL628686,,A,10116.0,1,,,13475
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,7911,,50597,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,CHEMBL628687,,A,10116.0,1,,,13476
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7911,,50597,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,N,,CHEMBL628688,,A,10116.0,1,,,13477
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7911,,50597,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,CHEMBL628689,,A,10116.0,1,,,13478
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,7911,,50597,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,N,,CHEMBL628690,,A,10116.0,1,,,13479
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,7911,,50597,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,,CHEMBL629363,,A,10116.0,1,,,13480
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,7911,,50597,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,N,,CHEMBL629364,,A,10116.0,1,,,13481
,1,BAO_0000218,,Rattus norvegicus,Spleen,2106.0,Intermediate,7911,,50597,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,CHEMBL629365,,A,10116.0,1,,,13482
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7911,,50597,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,N,,CHEMBL629366,,A,10116.0,1,,,13483
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,7911,,50597,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,N,,CHEMBL629367,,A,10116.0,1,,,13484
,1,BAO_0000218,,Rattus norvegicus,Feces,1988.0,Intermediate,7911,,50597,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,CHEMBL629368,,A,10116.0,1,,,13485
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,7911,,50597,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,,CHEMBL877502,,A,10116.0,1,,,13486
,1,BAO_0000218,,Mus musculus,Cerebellum,2037.0,Intermediate,13792,,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,N,,CHEMBL629369,,A,10090.0,1,,,13487
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,13792,,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,N,,CHEMBL629370,,A,10090.0,1,,,13488
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",U,,CHEMBL629371,,A,314293.0,1,,,13489
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,,CHEMBL626276,,A,314293.0,1,,,13490
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,,CHEMBL626277,,A,314293.0,1,,,13491
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,,CHEMBL631250,,A,314293.0,1,,,13492
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,,CHEMBL631251,,A,10116.0,1,,,13493
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,,CHEMBL631252,,A,10116.0,1,,,13494
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",N,,CHEMBL631253,,A,10116.0,1,,,13495
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,,CHEMBL631254,,A,10116.0,1,,,13496
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,,CHEMBL631255,,A,10116.0,1,,,13497
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,,CHEMBL631256,,A,10116.0,1,,,13498
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,,CHEMBL631257,,A,10116.0,1,,,13499
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",N,,CHEMBL628009,,A,10116.0,1,,,13500
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,,CHEMBL628010,,A,10116.0,1,,,13501
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,,CHEMBL628011,,A,10116.0,1,,,13502
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",N,,CHEMBL628012,,A,10116.0,1,,,13503
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,,CHEMBL628013,,A,10116.0,1,,,13504
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,,CHEMBL628014,,A,10116.0,1,,,13505
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",N,,CHEMBL628015,,A,9615.0,1,,,13506
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,,CHEMBL628016,,A,9615.0,1,,,13507
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",N,,CHEMBL874461,,A,9615.0,1,,,13508
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,,CHEMBL628017,,A,9615.0,1,,,13509
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,,CHEMBL628018,,A,9615.0,1,,,13510
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,,CHEMBL628019,,A,9615.0,1,,,13511
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,,CHEMBL628020,,A,9615.0,1,,,13512
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,,CHEMBL628021,,A,9615.0,1,,,13513
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,,CHEMBL628022,,A,9615.0,1,,,13514
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,8133,,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,,CHEMBL628023,,A,9615.0,1,,,13515
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,,CHEMBL628024,,A,314293.0,1,,,13516
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",U,,CHEMBL628025,,A,314293.0,1,,,13517
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,,CHEMBL628026,,A,314293.0,1,,,13518
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,,CHEMBL628027,,A,314293.0,1,,,13519
,0,BAO_0000218,,Simiiformes,Urine,1088.0,Autocuration,8133,,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,,CHEMBL628028,,A,314293.0,1,,,13520
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,,CHEMBL628029,,A,10116.0,1,,,13521
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",N,,CHEMBL628030,,A,10116.0,1,,,13522
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,,CHEMBL628031,,A,10116.0,1,,,13523
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",N,,CHEMBL628032,,A,10116.0,1,,,13524
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,,CHEMBL628033,,A,10116.0,1,,,13525
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",N,,CHEMBL628034,,A,10116.0,1,,,13526
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,,CHEMBL628035,,A,10116.0,1,,,13527
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",N,,CHEMBL628036,,A,10116.0,1,,,13528
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,,CHEMBL874462,,A,10116.0,1,,,13529
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,N,,CHEMBL628037,,A,9615.0,1,,,13530
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,N,,CHEMBL628123,,A,9615.0,1,,,13531
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,N,,CHEMBL628124,,A,9615.0,1,,,13532
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,N,,CHEMBL628125,,A,9615.0,1,,,13533
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,N,,CHEMBL628126,,A,9615.0,1,,,13534
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),N,,CHEMBL628127,,A,9615.0,1,,,13535
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,N,,CHEMBL628128,,A,9615.0,1,,,13536
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,N,,CHEMBL628129,,A,9615.0,1,,,13537
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,N,,CHEMBL628130,,A,9615.0,1,,,13538
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,N,,CHEMBL628131,,A,9615.0,1,,,13539
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,N,,CHEMBL628132,,A,9615.0,1,,,13540
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,N,,CHEMBL628133,,A,9615.0,1,,,13541
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,N,,CHEMBL628134,,A,9615.0,1,,,13542
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,N,,CHEMBL628135,,A,9615.0,1,,,13543
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,N,,CHEMBL628136,,A,9615.0,1,,,13544
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,N,,CHEMBL628137,,A,9615.0,1,,,13545
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,N,,CHEMBL628138,,A,9615.0,1,,,13546
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,N,,CHEMBL628139,,A,9615.0,1,,,13547
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,N,,CHEMBL628140,,A,9615.0,1,,,13548
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,N,,CHEMBL628141,,A,9615.0,1,,,13549
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,N,,CHEMBL628142,,A,9615.0,1,,,13550
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,N,,CHEMBL628143,,A,9615.0,1,,,13551
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,N,,CHEMBL628144,,A,9615.0,1,,,13552
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,N,,CHEMBL628145,,A,9615.0,1,,,13553
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,N,,CHEMBL628146,,A,9615.0,1,,,13554
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,N,,CHEMBL625355,,A,9615.0,1,,,13555
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,N,,CHEMBL625356,,A,9615.0,1,,,13556
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,N,,CHEMBL625357,,A,9615.0,1,,,13557
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,N,,CHEMBL625527,,A,9615.0,1,,,13558
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),N,,CHEMBL875473,,A,9615.0,1,,,13559
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,N,,CHEMBL625528,,A,9615.0,1,,,13560
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,9025,,50597,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,N,,CHEMBL626304,,A,10116.0,1,,,13561
,1,BAO_0000218,In vivo,Canis lupus familiaris,Artery,1637.0,Intermediate,9025,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,N,,CHEMBL624138,,A,9615.0,1,,,13562
,0,BAO_0000100,,,,,Autocuration,6448,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624139,,P,,1,,,13563
,0,BAO_0000100,,,,,Autocuration,17221,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624140,,P,,1,,,13564
,0,BAO_0000100,,,,,Autocuration,6545,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624141,,P,,1,,,13565
,0,BAO_0000100,,,,,Autocuration,577,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624142,,P,,1,,,13566
,0,BAO_0000100,,,,,Autocuration,6285,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624143,,P,,1,,,13567
,0,BAO_0000100,,,,,Autocuration,6500,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624144,,P,,1,,,13568
,0,BAO_0000100,,,,,Autocuration,6716,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624145,,P,,1,,,13569
,0,BAO_0000100,,,,,Autocuration,13658,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624146,,P,,1,,,13570
,0,BAO_0000100,,,,,Autocuration,6549,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624147,,P,,1,,,13571
,0,BAO_0000100,,,,,Autocuration,14685,,22229,,Calculated partition coefficient (clogP) (MacLogP),U,,CHEMBL883123,,P,,1,,,13572
,0,BAO_0000019,,,,,Autocuration,6893,,22224,,Partition coefficient (logP),U,,CHEMBL624148,,A,,1,,,13573
,0,BAO_0000019,,,,,Autocuration,3687,,22224,,Kinetic parameter was determined,U,,CHEMBL874416,,A,,1,,,13574
,0,BAO_0000100,,,,,Autocuration,4207,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624149,,P,,1,,,13575
,0,BAO_0000100,,,,,Autocuration,4626,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL624150,,P,,1,,,13576
,0,BAO_0000100,,,,,Autocuration,1021,,22224,,Lipophilicity was determined,U,,CHEMBL624151,,P,,1,,,13577
,0,BAO_0000100,,,,,Autocuration,3777,,22224,,Lipophilicity was determined,U,,CHEMBL624152,,P,,1,,,13578
,0,BAO_0000100,,,,,Autocuration,17533,,22224,,Lipophilicity was determined,U,,CHEMBL622139,,P,,1,,,13579
,0,BAO_0000100,,,,,Autocuration,6524,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL622140,,P,,1,,,13580
,0,BAO_0000100,,,,,Autocuration,17533,,22224,,Lipophilicity was determined,U,,CHEMBL622141,,P,,1,,,13581
,0,BAO_0000100,,,,,Autocuration,6480,,22224,,Lipophilicity in octanol-water,U,,CHEMBL622142,,P,,1,,,13582
,0,BAO_0000100,,,,,Autocuration,17606,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL622143,,P,,1,,,13583
,0,BAO_0000100,,,,,Autocuration,6863,,22229,,Octanol-water partition coefficient was determined,U,,CHEMBL622144,,P,,1,,,13584
,0,BAO_0000019,,,,,Autocuration,1356,,22224,,Partition coefficient (logP),U,,CHEMBL877473,,A,,1,,,13585
,0,BAO_0000100,,,,,Autocuration,3326,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL622145,,P,,1,,,13586
,0,BAO_0000019,,,,,Autocuration,1356,,22224,,Partition coefficient was determined; ND means not determined,U,,CHEMBL622146,,A,,1,,,13587
,0,BAO_0000100,,,,,Autocuration,12984,,22229,,Calculated partition coefficient (clogP),U,,CHEMBL622147,,P,,1,,,13588
,0,BAO_0000019,,,,,Autocuration,17363,,22224,,Partition coefficient of the compound,U,,CHEMBL622148,,A,,1,,,13589
,0,BAO_0000019,,,,,Autocuration,6827,,22224,,Permeability was determined,U,,CHEMBL883124,,A,,1,,,13590
,0,BAO_0000100,,,,,Autocuration,261,,22229,,The compound was evaluated for the partition coefficient,U,,CHEMBL622149,,P,,1,,,13591
,0,BAO_0000019,,,,,Autocuration,2685,,22224,,Partition coefficient (logP),U,,CHEMBL622150,,A,,1,,,13592
,0,BAO_0000100,,,,,Autocuration,414,,22224,,The lipophilicity was reported,U,,CHEMBL622151,,P,,1,,,13593
,0,BAO_0000100,,,,,Autocuration,15769,,22229,,logarithm of the octanol-water partition coefficient for the compound,U,,CHEMBL622152,,P,,1,,,13594
,0,BAO_0000019,,,,,Autocuration,17248,,22224,,Clogp value was determined,U,,CHEMBL622153,,A,,1,,,13595
,0,BAO_0000218,In vivo,,,,Autocuration,16935,,22224,,Clp at a dose of 1.5 mg/kg,U,,CHEMBL877474,,A,,1,,,13596
,0,BAO_0000218,In vivo,,,,Autocuration,16935,,22224,,Clp at a dose of 2.0 mg/kg,U,,CHEMBL622154,,A,,1,,,13597
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14832,,22224,,"Clp, plasma clearance at a dose of 10 mg/kg",U,,CHEMBL622155,,A,,1,,,13598
,0,BAO_0000218,In vivo,,Plasma,1969.0,Autocuration,14832,,22224,,"Clp, plasma clearance at a dose of 50 mg/kg",U,,CHEMBL622156,,A,,1,,,13599
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2399,,50597,,Compound was tested for plasma clearance in rat,N,,CHEMBL622157,,A,10116.0,1,,,13600
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,2399,,50597,,Compound was tested for plasma clearance in rat; Not determined,N,,CHEMBL622158,,A,10116.0,1,,,13601
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,6227,,50597,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,N,,CHEMBL622807,,A,10116.0,1,,,13602
,1,BAO_0000218,In vivo,Macaca mulatta,,,Intermediate,6227,,50797,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,N,,CHEMBL622808,,A,9544.0,1,,,13603
,0,BAO_0000218,In vivo,,,,Autocuration,5623,,22224,,Plasma clearance by iv administration at a dose 0.003 ug/mL,U,,CHEMBL622809,,A,,1,,,13604
,0,BAO_0000218,In vivo,,,,Autocuration,4854,,22224,,Plasma clearance determined,U,,CHEMBL622810,,A,,1,,,13605
,1,BAO_0000218,In vivo,Cricetinae,,,Intermediate,4493,,100712,,Plasma clearance after iv administration at 3 mg/kg in hamster,N,,CHEMBL876653,,A,10026.0,1,,,13606
,1,BAO_0000218,In vivo,Cricetinae,,,Intermediate,4493,,100712,,Plasma clearance after iv administration at 4 mg/kg in hamster,N,,CHEMBL622811,,A,10026.0,1,,,13607
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14956,,50597,,Rate of clearance in rat was determined,N,,CHEMBL622986,,A,10116.0,1,,,13608
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15372,,50597,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,N,,CHEMBL622987,,A,10116.0,1,,,13609
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15372,,50597,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,N,,CHEMBL622988,,A,10116.0,1,,,13610
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15372,,50597,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,N,,CHEMBL622989,,A,10116.0,1,,,13611
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15372,,50597,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,N,,CHEMBL622990,,A,10116.0,1,,,13612
,0,BAO_0000218,In vivo,Simiiformes,Plasma,1969.0,Autocuration,15604,,22224,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,,CHEMBL622991,,A,314293.0,1,,,13613
,1,BAO_0000218,In vivo,Rattus norvegicus,Plasma,1969.0,Intermediate,15604,,50597,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,,CHEMBL622227,,A,10116.0,1,,,13614
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,15604,,50588,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,,CHEMBL622228,,A,9615.0,1,,,13615
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14964,,50597,,Clpl value in rat,N,,CHEMBL622229,,A,10116.0,1,,,13616
,1,BAO_0000218,In vivo,Cavia porcellus,,,Intermediate,15240,,50512,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,N,,CHEMBL622230,,A,10141.0,1,,,13617
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16449,,50597,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,N,,CHEMBL622231,,A,10116.0,1,,,13618
,1,BAO_0000218,In vivo,Macaca fascicularis,,,Intermediate,16449,,100710,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,N,,CHEMBL622232,,A,9541.0,1,,,13619
,0,BAO_0000218,In vivo,,,,Autocuration,12902,,22224,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,U,,CHEMBL622233,,A,,1,,,13620
,0,BAO_0000218,In vivo,,,,Autocuration,12902,,22224,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,U,,CHEMBL622234,,A,,1,,,13621
,0,BAO_0000218,In vivo,,,,Autocuration,12902,,22224,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,U,,CHEMBL622235,,A,,1,,,13622
,0,BAO_0000218,In vivo,,,,Autocuration,12902,,22224,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,U,,CHEMBL622236,,A,,1,,,13623
,0,BAO_0000218,In vivo,,,,Autocuration,12902,,22224,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,U,,CHEMBL622237,,A,,1,,,13624
,0,BAO_0000218,In vivo,,,,Autocuration,12902,,22224,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,U,,CHEMBL877482,,A,,1,,,13625
,0,BAO_0000218,In vivo,,,,Autocuration,12902,,22224,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,U,,CHEMBL622238,,A,,1,,,13626
,0,BAO_0000218,In vivo,,,,Autocuration,12902,,22224,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,U,,CHEMBL622239,,A,,1,,,13627
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,11149,,22224,,Cmax was calculated as maximum concentration reached in the blood,U,,CHEMBL622240,,A,,1,,,13628
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,11149,,22224,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,U,,CHEMBL622241,,A,,1,,,13629
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5669,,50597,,Cmax was determine after peroral administration at 10 mpk in Rat,N,,CHEMBL631013,,A,10116.0,1,,,13630
,1,BAO_0000218,In vivo,Macaca mulatta,,,Intermediate,5669,,50797,,Cmax was determine after peroral administration at 10 mpk in Rhesus,N,,CHEMBL631014,,A,9544.0,1,,,13631
,1,BAO_0000218,In vivo,Canis lupus familiaris,,,Intermediate,5669,,50588,,Cmax was determine after peroral administration at 10 mpk in dog,N,,CHEMBL631015,,A,9615.0,1,,,13632
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5669,,50597,,Cmax was determine after peroral administration at 160 mpk in Rat,N,,CHEMBL631016,,A,10116.0,1,,,13633
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5669,,50597,,Cmax was determine after peroral administration at 20 mpk in Rat,N,,CHEMBL631017,,A,10116.0,1,,,13634
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,5669,,50597,,Cmax was determine after peroral administration at 50 mpk in Rat,N,,CHEMBL631018,,A,10116.0,1,,,13635
,0,BAO_0000218,In vivo,,,,Autocuration,4236,,22224,,Cmax was determined,U,,CHEMBL631019,,A,,1,,,13636
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,13792,,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,N,,CHEMBL875761,,A,10090.0,1,,,13637
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,13792,,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,N,,CHEMBL631020,,A,10090.0,1,,,13638
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,13792,,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,N,,CHEMBL631669,,A,10090.0,1,,,13639
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,13792,,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,N,,CHEMBL631670,,A,10090.0,1,,,13640
,1,BAO_0000218,,Mus musculus,Striatum,2435.0,Intermediate,13792,,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,N,,CHEMBL631671,,A,10090.0,1,,,13641
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,N,,CHEMBL631672,,A,10116.0,1,,,13642
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,N,,CHEMBL631673,,A,10116.0,1,,,13643
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,N,,CHEMBL631856,,A,10116.0,1,,,13644
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,N,,CHEMBL631857,,A,10116.0,1,,,13645
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,N,,CHEMBL631858,,A,10116.0,1,,,13646
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,N,,CHEMBL631859,,A,10116.0,1,,,13647
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,N,,CHEMBL631860,,A,10116.0,1,,,13648
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,N,,CHEMBL631861,,A,10116.0,1,,,13649
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,N,,CHEMBL631862,,A,10116.0,1,,,13650
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,N,,CHEMBL631863,,A,10116.0,1,,,13651
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,N,,CHEMBL631864,,A,10116.0,1,,,13652
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,N,,CHEMBL631865,,A,10116.0,1,,,13653
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,N,,CHEMBL631866,,A,10116.0,1,,,13654
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,N,,CHEMBL629360,,A,10116.0,1,,,13655
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,N,,CHEMBL629361,,A,10116.0,1,,,13656
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,N,,CHEMBL629362,,A,10116.0,1,,,13657
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,N,,CHEMBL630740,,A,10116.0,1,,,13658
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,N,,CHEMBL630741,,A,10116.0,1,,,13659
,1,BAO_0000218,,Rattus norvegicus,Blood,178.0,Intermediate,8418,,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,N,,CHEMBL630742,,A,10116.0,1,,,13660
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,N,,CHEMBL630743,,A,10116.0,1,,,13661
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,N,,CHEMBL630744,,A,10116.0,1,,,13662
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,N,,CHEMBL630745,,A,10116.0,1,,,13663
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,N,,CHEMBL630746,,A,10116.0,1,,,13664
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,N,,CHEMBL630747,,A,10116.0,1,,,13665
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,N,,CHEMBL630748,,A,10116.0,1,,,13666
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,N,,CHEMBL632056,,A,10116.0,1,,,13667
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,N,,CHEMBL632057,,A,10116.0,1,,,13668
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,N,,CHEMBL632058,,A,10116.0,1,,,13669
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,N,,CHEMBL632059,,A,10116.0,1,,,13670
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,N,,CHEMBL632060,,A,10116.0,1,,,13671
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,N,,CHEMBL632061,,A,10116.0,1,,,13672
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,N,,CHEMBL629207,,A,10116.0,1,,,13673
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,N,,CHEMBL629208,,A,10116.0,1,,,13674
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,N,,CHEMBL629209,,A,10116.0,1,,,13675
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,N,,CHEMBL629210,,A,10116.0,1,,,13676
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,N,,CHEMBL629211,,A,10116.0,1,,,13677
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,N,,CHEMBL629212,,A,10116.0,1,,,13678
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8418,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,N,,CHEMBL629213,,A,10116.0,1,,,13679
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,,CHEMBL629214,,A,10116.0,1,,,13680
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",N,,CHEMBL629215,,A,10116.0,1,,,13681
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,8133,,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",N,,CHEMBL635154,,A,10116.0,1,,,13682
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,CHEMBL629216,,A,10116.0,1,,,13683
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,N,,CHEMBL629217,,A,10116.0,1,,,13684
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL629218,,A,10116.0,1,,,13685
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,,CHEMBL629219,,A,10116.0,1,,,13686
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,,CHEMBL629220,,A,10116.0,1,,,13687
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL629221,,A,10116.0,1,,,13688
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL631127,,A,10116.0,1,,,13689
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,N,,CHEMBL631128,,A,10116.0,1,,,13690
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL631129,,A,10116.0,1,,,13691
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,,CHEMBL631130,,A,10116.0,1,,,13692
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,,CHEMBL631131,,A,10116.0,1,,,13693
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL631132,,A,10116.0,1,,,13694
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL631133,,A,10116.0,1,,,13695
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,N,,CHEMBL631134,,A,10116.0,1,,,13696
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL875120,,A,10116.0,1,,,13697
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,,CHEMBL631135,,A,10116.0,1,,,13698
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,,CHEMBL631136,,A,10116.0,1,,,13699
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL631137,,A,10116.0,1,,,13700
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL631138,,A,10116.0,1,,,13701
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,N,,CHEMBL631139,,A,10116.0,1,,,13702
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL631140,,A,10116.0,1,,,13703
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,CHEMBL631141,,A,10116.0,1,,,13704
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,,CHEMBL631142,,A,10116.0,1,,,13705
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,,CHEMBL631143,,A,10116.0,1,,,13706
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6996,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,CHEMBL631144,,A,10116.0,1,,,13707
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,N,,CHEMBL631145,,A,9615.0,1,,,13708
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,,CHEMBL631146,,A,9615.0,1,,,13709
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,N,,CHEMBL631147,,A,9615.0,1,,,13710
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL631148,,A,9615.0,1,,,13711
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL631149,,A,9615.0,1,,,13712
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,,CHEMBL631150,,A,9615.0,1,,,13713
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL631151,,A,9615.0,1,,,13714
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL631152,,A,9615.0,1,,,13715
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL631443,,A,9615.0,1,,,13716
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,,CHEMBL631444,,A,9615.0,1,,,13717
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,,CHEMBL631445,,A,9615.0,1,,,13718
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,,CHEMBL631446,,A,9615.0,1,,,13719
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),N,,CHEMBL631447,,A,9615.0,1,,,13720
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,,CHEMBL631448,,A,9615.0,1,,,13721
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,N,,CHEMBL631449,,A,9615.0,1,,,13722
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,,CHEMBL631450,,A,9615.0,1,,,13723
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,6996,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,,CHEMBL629724,,A,9615.0,1,,,13724
,1,BAO_0000218,In vivo,Mus musculus,Zone of skin,14.0,Intermediate,9716,,50594,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL629725,,A,10090.0,1,,,13725
,1,BAO_0000218,In vivo,Mus musculus,Zone of skin,14.0,Intermediate,9716,,50594,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL629726,,A,10090.0,1,,,13726
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,9716,,50594,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL629727,,A,10090.0,1,,,13727
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,9716,,50594,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL630404,,A,10090.0,1,,,13728
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,9716,,50594,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL630405,,A,10090.0,1,,,13729
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,9716,,50594,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL630406,,A,10090.0,1,,,13730
,1,BAO_0000218,In vivo,Mus musculus,Stomach,945.0,Intermediate,9716,,50594,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL630407,,A,10090.0,1,,,13731
,1,BAO_0000218,In vivo,Mus musculus,Stomach,945.0,Intermediate,9716,,50594,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL630573,,A,10090.0,1,,,13732
,1,BAO_0000218,In vivo,Mus musculus,Stomach,945.0,Intermediate,9716,,50594,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL630574,,A,10090.0,1,,,13733
,1,BAO_0000218,In vivo,Mus musculus,Stomach,945.0,Intermediate,9716,,50594,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL630575,,A,10090.0,1,,,13734
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,9716,,50594,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL630576,,A,10090.0,1,,,13735
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,9716,,50594,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL630577,,A,10090.0,1,,,13736
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,9716,,50594,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL630578,,A,10090.0,1,,,13737
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,9716,,50594,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,CHEMBL630579,,A,10090.0,1,,,13738
,1,BAO_0000218,,Mus musculus,Kidney,2113.0,Intermediate,12192,,50594,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),N,,CHEMBL630580,,A,10090.0,1,,,13739
,1,BAO_0000218,,Mus musculus,Kidney,2113.0,Intermediate,12192,,50594,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,N,,CHEMBL630581,,A,10090.0,1,,,13740
,1,BAO_0000218,,Mus musculus,Kidney,2113.0,Intermediate,12192,,50594,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),N,,CHEMBL630582,,A,10090.0,1,,,13741
,1,BAO_0000218,,Mus musculus,,,Intermediate,12192,,50594,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,N,,CHEMBL630583,,A,10090.0,1,,,13742
,1,BAO_0000218,,Mus musculus,,,Intermediate,12192,,50594,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),N,,CHEMBL630584,,A,10090.0,1,,,13743
,1,BAO_0000218,,Mus musculus,,,Intermediate,12192,,50594,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,N,,CHEMBL630585,,A,10090.0,1,,,13744
,1,BAO_0000218,,Mus musculus,,,Intermediate,12192,,50594,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),N,,CHEMBL630586,,A,10090.0,1,,,13745
,1,BAO_0000218,,Mus musculus,,,Intermediate,12192,,50594,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,N,,CHEMBL630587,,A,10090.0,1,,,13746
,1,BAO_0000218,,Mus musculus,,,Intermediate,12192,,50594,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),N,,CHEMBL630588,,A,10090.0,1,,,13747
,1,BAO_0000218,,Mus musculus,,,Intermediate,12192,,50594,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,N,,CHEMBL630589,,A,10090.0,1,,,13748
,1,BAO_0000218,,Mus musculus,,,Intermediate,12192,,50594,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),N,,CHEMBL630590,,A,10090.0,1,,,13749
,0,BAO_0000019,,,Feces,1988.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in feces at 24 h,U,,CHEMBL630591,,A,,1,,,13750
,0,BAO_0000019,,,Feces,1988.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),U,,CHEMBL630592,,A,,1,,,13751
,0,BAO_0000019,,,,,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,U,,CHEMBL630593,,A,,1,,,13752
,0,BAO_0000019,,,,,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),U,,CHEMBL630594,,A,,1,,,13753
,0,BAO_0000019,,,Urine,1088.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),U,,CHEMBL630595,,A,,1,,,13754
,0,BAO_0000019,,,Urine,1088.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),U,,CHEMBL630596,,A,,1,,,13755
,0,BAO_0000019,,,Urine,1088.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in urine after 0-24 h,U,,CHEMBL630597,,A,,1,,,13756
,0,BAO_0000019,,,Urine,1088.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),U,,CHEMBL630598,,A,,1,,,13757
,0,BAO_0000019,,,Urine,1088.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in urine after 0-4 h,U,,CHEMBL630599,,A,,1,,,13758
,0,BAO_0000019,,,Urine,1088.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),U,,CHEMBL630600,,A,,1,,,13759
,0,BAO_0000019,,,Urine,1088.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in urine after 4-24 h,U,,CHEMBL630601,,A,,1,,,13760
,0,BAO_0000019,,,Urine,1088.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),U,,CHEMBL630602,,A,,1,,,13761
,0,BAO_0000019,,,Urine,1088.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),U,,CHEMBL630603,,A,,1,,,13762
,0,BAO_0000019,,,Urine,1088.0,Autocuration,12192,,22224,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),U,,CHEMBL630604,,A,,1,,,13763
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL624869,,A,10116.0,1,,,13764
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL624870,,A,10116.0,1,,,13765
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL623189,,A,10116.0,1,,,13766
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL623190,,A,10116.0,1,,,13767
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL623191,,A,10116.0,1,,,13768
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL623192,,A,10116.0,1,,,13769
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL623193,,A,10116.0,1,,,13770
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL623194,,A,10116.0,1,,,13771
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL623195,,A,10116.0,1,,,13772
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL623196,,A,10116.0,1,,,13773
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,N,,CHEMBL623197,,A,10116.0,1,,,13774
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,CHEMBL623198,,A,10116.0,1,,,13775
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,,CHEMBL623199,,A,10116.0,1,,,13776
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,N,,CHEMBL623200,,A,10116.0,1,,,13777
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,N,,CHEMBL623201,,A,10116.0,1,,,13778
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,N,,CHEMBL623202,,A,10116.0,1,,,13779
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,CHEMBL623203,,A,10116.0,1,,,13780
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,N,,CHEMBL623204,,A,10116.0,1,,,13781
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,N,,CHEMBL623205,,A,10116.0,1,,,13782
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,,CHEMBL623206,,A,10116.0,1,,,13783
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,N,,CHEMBL623207,,A,10116.0,1,,,13784
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,N,,CHEMBL623208,,A,10116.0,1,,,13785
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,CHEMBL623209,,A,10116.0,1,,,13786
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,,CHEMBL623210,,A,10116.0,1,,,13787
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,CHEMBL623211,,A,10116.0,1,,,13788
,1,BAO_0000218,,Rattus norvegicus,Uterus,995.0,Intermediate,11836,,50597,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,,CHEMBL623212,,A,10116.0,1,,,13789
,0,BAO_0000019,,,,,Autocuration,12640,,22224,,Tested in vitro for intrinsic activity relative to quinpirole,U,,CHEMBL623213,,A,,1,,,13790
,0,BAO_0000019,,,,,Autocuration,14218,,22224,,"Relative ion enhancement, determined in pulsed ultrafiltration",U,,CHEMBL623214,,A,,1,,,13791
,0,BAO_0000019,,,,,Autocuration,11296,,22224,,% ionization at the pH 7.4 at 37 degree Centigrade,U,,CHEMBL623215,,A,,1,,,13792
,0,BAO_0000019,,,,,Autocuration,10929,,22224,,Percentage ionization was measured,U,,CHEMBL623216,,A,,1,,,13793
,1,BAO_0000218,,Bos taurus,,,Intermediate,13841,,50591,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,N,,CHEMBL623217,,A,9913.0,1,,,13794
,0,BAO_0000019,,,,,Autocuration,10431,,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,U,,CHEMBL623218,,A,,1,,,13795
,0,BAO_0000019,,,,,Autocuration,10431,,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,U,,CHEMBL623913,,A,,1,,,13796
,0,BAO_0000019,,,,,Autocuration,10431,,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,U,,CHEMBL623914,,A,,1,,,13797
,0,BAO_0000100,,,,,Autocuration,8826,,22229,,Compound was evaluated for the partition coefficient in octanol/water,U,,CHEMBL623915,,P,,1,,,13798
,0,BAO_0000100,,,,,Autocuration,8826,,22229,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),U,,CHEMBL624080,,P,,1,,,13799
,0,BAO_0000019,,,,,Autocuration,9884,,22224,,Equilibrium constant measured by the pulse radiolysis at pH 7,U,,CHEMBL624081,,A,,1,,,13800
,1,BAO_0000218,,Homo sapiens,,,Intermediate,9827,,50587,,In vitro hydrolytic rate constant determined in human blood,N,,CHEMBL624082,,A,9606.0,1,,,13801
,1,BAO_0000218,,Homo sapiens,,,Intermediate,10009,,50587,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,N,,CHEMBL625054,,A,9606.0,1,,,13802
,0,BAO_0000019,,,,,Autocuration,10009,,22224,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,U,,CHEMBL877485,,A,,1,,,13803
,1,BAO_0000218,,Mus musculus,,,Intermediate,10009,,50594,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,N,,CHEMBL625055,,A,10090.0,1,,,13804
,1,BAO_0000218,,Mus musculus,,,Intermediate,10009,,50594,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,N,,CHEMBL625056,,A,10090.0,1,,,13805
,1,BAO_0000218,,Homo sapiens,,,Intermediate,10009,,50587,,In vitro oxidation of compound in presence of human plasma,N,,CHEMBL625057,,A,9606.0,1,,,13806
,0,BAO_0000019,,,,,Autocuration,10009,,22224,,In vitro oxidation of compound in presence of hydrogen peroxide,U,,CHEMBL625058,,A,,1,,,13807
,1,BAO_0000218,,Mus musculus,,,Intermediate,10009,,50594,,In vitro oxidation of compound in presence of mouse brain homogenate,N,,CHEMBL625059,,A,10090.0,1,,,13808
,1,BAO_0000218,,Mus musculus,,,Intermediate,10009,,50594,,In vitro oxidation of compound in presence of mouse liver homogenate,N,,CHEMBL629536,,A,10090.0,1,,,13809
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,,CHEMBL629537,,A,10116.0,1,,,13810
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,,CHEMBL629538,,A,10116.0,1,,,13811
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,,CHEMBL629539,,A,10116.0,1,,,13812
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,,CHEMBL874445,,A,10116.0,1,,,13813
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,,CHEMBL629540,,A,10116.0,1,,,13814
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,,CHEMBL629541,,A,10116.0,1,,,13815
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,,CHEMBL629542,,A,10116.0,1,,,13816
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,,CHEMBL630243,,A,10116.0,1,,,13817
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,,CHEMBL630244,,A,10116.0,1,,,13818
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,,CHEMBL630245,,A,10116.0,1,,,13819
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,,CHEMBL630246,,A,10116.0,1,,,13820
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,,CHEMBL630247,,A,10116.0,1,,,13821
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,,CHEMBL630248,,A,10116.0,1,,,13822
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13100,,50597,,Biodistribution in rat blood at 240 minutes after dose administration.,N,,CHEMBL630249,,A,10116.0,1,,,13823
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13100,,50597,,Biodistribution in rat blood at 30 minutes after dose administration.,N,,CHEMBL630250,,A,10116.0,1,,,13824
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13100,,50597,,Biodistribution in rat blood at 360 minutes after dose administration.,N,,CHEMBL630251,,A,10116.0,1,,,13825
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13100,,50597,,Biodistribution in rat blood at 3 hr after dose administration.,N,,CHEMBL630252,,A,10116.0,1,,,13826
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13100,,50597,,Biodistribution in rat blood at 60 minutes after dose administration.,N,,CHEMBL630408,,A,10116.0,1,,,13827
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,13100,,50597,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,N,,CHEMBL630409,,A,10116.0,1,,,13828
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,13100,,50597,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,N,,CHEMBL874446,,A,10116.0,1,,,13829
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,13100,,50597,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,N,,CHEMBL630410,,A,10116.0,1,,,13830
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,13100,,50597,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,N,,CHEMBL630411,,A,10116.0,1,,,13831
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,13100,,50597,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,N,,CHEMBL630412,,A,10116.0,1,,,13832
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,13100,,50597,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,N,,CHEMBL630413,,A,10116.0,1,,,13833
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,13100,,50597,,Biodistribution in rat cerebellum at 3 hr after dose administration.,N,,CHEMBL630414,,A,10116.0,1,,,13834
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,13100,,50597,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,N,,CHEMBL630415,,A,10116.0,1,,,13835
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat cortex at 120 minutes after dose administration.,N,,CHEMBL630416,,A,10116.0,1,,,13836
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat cortex at 1440 minutes after dose administration.,N,,CHEMBL630417,,A,10116.0,1,,,13837
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat cortex at 15 minutes after dose administration.,N,,CHEMBL630418,,A,10116.0,1,,,13838
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat cortex at 240 minutes after dose administration.,N,,CHEMBL630419,,A,10116.0,1,,,13839
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat cortex at 30 minutes after dose administration.,N,,CHEMBL630420,,A,10116.0,1,,,13840
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat cortex at 360 minutes after dose administration.,N,,CHEMBL630421,,A,10116.0,1,,,13841
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat cortex at 3 hr after dose administration.,N,,CHEMBL630422,,A,10116.0,1,,,13842
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat cortex at 60 minutes after dose administration.,N,,CHEMBL630423,,A,10116.0,1,,,13843
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13100,,50597,,Biodistribution in rat heart at 120 minutes after dose administration.,N,,CHEMBL630424,,A,10116.0,1,,,13844
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13100,,50597,,Biodistribution in rat heart at 15 minutes after dose administration.,N,,CHEMBL630425,,A,10116.0,1,,,13845
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13100,,50597,,Biodistribution in rat heart at 240 minutes after dose administration.,N,,CHEMBL629462,,A,10116.0,1,,,13846
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13100,,50597,,Biodistribution in rat heart at 30 minutes after dose administration.,N,,CHEMBL630426,,A,10116.0,1,,,13847
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13100,,50597,,Biodistribution in rat heart at 360 minutes after dose administration.,N,,CHEMBL630427,,A,10116.0,1,,,13848
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13100,,50597,,Biodistribution in rat heart at 3 hr after dose administration.,N,,CHEMBL625877,,A,10116.0,1,,,13849
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13100,,50597,,Biodistribution in rat heart at 60 minutes after dose administration.,N,,CHEMBL625878,,A,10116.0,1,,,13850
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,13100,,50597,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,N,,CHEMBL625879,,A,10116.0,1,,,13851
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,13100,,50597,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,N,,CHEMBL625880,,A,10116.0,1,,,13852
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,13100,,50597,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,N,,CHEMBL625881,,A,10116.0,1,,,13853
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,13100,,50597,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,N,,CHEMBL625882,,A,10116.0,1,,,13854
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,13100,,50597,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,N,,CHEMBL625883,,A,10116.0,1,,,13855
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13100,,50597,,Biodistribution in rat kidney at 120 minutes after dose administration.,N,,CHEMBL625884,,A,10116.0,1,,,13856
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13100,,50597,,Biodistribution in rat kidney at 1440 minutes after dose administration.,N,,CHEMBL625885,,A,10116.0,1,,,13857
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13100,,50597,,Biodistribution in rat kidney at 15 minutes after dose administration.,N,,CHEMBL628649,,A,10116.0,1,,,13858
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13100,,50597,,Biodistribution in rat kidney at 240 minutes after dose administration.,N,,CHEMBL628650,,A,10116.0,1,,,13859
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13100,,50597,,Biodistribution in rat kidney at 30 minutes after dose administration.,N,,CHEMBL628651,,A,10116.0,1,,,13860
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13100,,50597,,Biodistribution in rat kidney at 360 minutes after dose administration.,N,,CHEMBL628652,,A,10116.0,1,,,13861
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13100,,50597,,Biodistribution in rat kidney at 60 minutes after dose administration.,N,,CHEMBL628653,,A,10116.0,1,,,13862
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13100,,50597,,Biodistribution in rat liver at 120 minutes after dose administration.,N,,CHEMBL628654,,A,10116.0,1,,,13863
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13100,,50597,,Biodistribution in rat liver at 1440 minutes after dose administration.,N,,CHEMBL628655,,A,10116.0,1,,,13864
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13100,,50597,,Biodistribution in rat liver at 15 minutes after dose administration.,N,,CHEMBL625238,,A,10116.0,1,,,13865
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13100,,50597,,Biodistribution in rat liver at 240 minutes after dose administration.,N,,CHEMBL625239,,A,10116.0,1,,,13866
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13100,,50597,,Biodistribution in rat liver at 30 minutes after dose administration.,N,,CHEMBL625240,,A,10116.0,1,,,13867
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13100,,50597,,Biodistribution in rat liver at 360 minutes after dose administration.,N,,CHEMBL625241,,A,10116.0,1,,,13868
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13100,,50597,,Biodistribution in rat liver at 60 minutes after dose administration.,N,,CHEMBL625242,,A,10116.0,1,,,13869
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13100,,50597,,Biodistribution in rat lung at 120 minutes after dose administration.,N,,CHEMBL874587,,A,10116.0,1,,,13870
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13100,,50597,,Biodistribution in rat lung at 1440 minutes after dose administration.,N,,CHEMBL625405,,A,10116.0,1,,,13871
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13100,,50597,,Biodistribution in rat lung at 15 minutes after dose administration.,N,,CHEMBL625406,,A,10116.0,1,,,13872
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13100,,50597,,Biodistribution in rat lung at 240 minutes after dose administration.,N,,CHEMBL625407,,A,10116.0,1,,,13873
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13100,,50597,,Biodistribution in rat lung at 30 minutes after dose administration.,N,,CHEMBL625408,,A,10116.0,1,,,13874
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13100,,50597,,Biodistribution in rat lung at 360 minutes after dose administration.,N,,CHEMBL625409,,A,10116.0,1,,,13875
,1,BAO_0000218,,Rattus norvegicus,Thoracic aorta,1515.0,Intermediate,12361,,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,N,,CHEMBL625410,,A,10116.0,1,,,13876
,1,BAO_0000218,,Rattus norvegicus,Thoracic aorta,1515.0,Intermediate,12361,,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,N,,CHEMBL625411,,A,10116.0,1,,,13877
,1,BAO_0000218,,Rattus norvegicus,Thoracic aorta,1515.0,Intermediate,12361,,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,N,,CHEMBL625412,,A,10116.0,1,,,13878
,1,BAO_0000218,,Rattus norvegicus,Thoracic aorta,1515.0,Intermediate,12361,,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,N,,CHEMBL625413,,A,10116.0,1,,,13879
,1,BAO_0000218,,Rattus norvegicus,Thoracic aorta,1515.0,Intermediate,12361,,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,N,,CHEMBL625414,,A,10116.0,1,,,13880
,1,BAO_0000218,,Rattus norvegicus,Thoracic aorta,1515.0,Intermediate,12361,,50597,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,N,,CHEMBL625415,,A,10116.0,1,,,13881
,1,BAO_0000218,,Rattus norvegicus,Thoracic aorta,1515.0,Intermediate,12361,,50597,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,N,,CHEMBL625416,,A,10116.0,1,,,13882
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12712,,50597,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,N,,CHEMBL625417,,A,10116.0,1,,,13883
,1,BAO_0000218,,Rattus norvegicus,Feces,1988.0,Intermediate,7415,,50597,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,N,,CHEMBL625418,,A,10116.0,1,,,13884
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,7415,,50597,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,N,,CHEMBL625419,,A,10116.0,1,,,13885
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7415,,50597,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,N,,CHEMBL625420,,A,10116.0,1,,,13886
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7415,,50597,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,N,,CHEMBL626996,,A,10116.0,1,,,13887
,1,BAO_0000218,,Rattus norvegicus,Feces,1988.0,Intermediate,7415,,50597,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",N,,CHEMBL626997,,A,10116.0,1,,,13888
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,7415,,50597,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",N,,CHEMBL626998,,A,10116.0,1,,,13889
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7415,,50597,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",N,,CHEMBL626999,,A,10116.0,1,,,13890
,1,BAO_0000218,,Mus musculus,,,Intermediate,8050,,50594,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,N,,CHEMBL627000,,A,10090.0,1,,,13891
,1,BAO_0000218,,Mus musculus,,,Intermediate,8050,,50594,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,N,,CHEMBL627001,,A,10090.0,1,,,13892
,1,BAO_0000218,,Mus musculus,,,Intermediate,8050,,50594,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,N,,CHEMBL627002,,A,10090.0,1,,,13893
,1,BAO_0000218,,Mus musculus,,,Intermediate,8050,,50594,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,N,,CHEMBL627003,,A,10090.0,1,,,13894
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,N,,CHEMBL627004,,A,10090.0,1,,,13895
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,N,,CHEMBL627005,,A,10090.0,1,,,13896
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,N,,CHEMBL874594,,A,10090.0,1,,,13897
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,N,,CHEMBL627006,,A,10090.0,1,,,13898
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,N,,CHEMBL627007,,A,10090.0,1,,,13899
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,N,,CHEMBL627884,,A,10090.0,1,,,13900
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,N,,CHEMBL627885,,A,10090.0,1,,,13901
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,N,,CHEMBL627886,,A,10090.0,1,,,13902
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,N,,CHEMBL627887,,A,10090.0,1,,,13903
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,N,,CHEMBL627888,,A,10090.0,1,,,13904
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,N,,CHEMBL628057,,A,10090.0,1,,,13905
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,8050,,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,N,,CHEMBL627405,,A,10090.0,1,,,13906
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,,CHEMBL627406,,A,9615.0,1,,,13907
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,,CHEMBL627407,,A,9615.0,1,,,13908
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,,CHEMBL627408,,A,9615.0,1,,,13909
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,,CHEMBL627409,,A,9615.0,1,,,13910
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,,CHEMBL875486,,A,9615.0,1,,,13911
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,,CHEMBL627410,,A,9615.0,1,,,13912
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,,CHEMBL627411,,A,9615.0,1,,,13913
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,,CHEMBL627412,,A,9615.0,1,,,13914
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,,CHEMBL627413,,A,9615.0,1,,,13915
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,,CHEMBL627414,,A,9615.0,1,,,13916
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,,CHEMBL627415,,A,9615.0,1,,,13917
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,N,,CHEMBL627416,,A,9615.0,1,,,13918
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,,CHEMBL627417,,A,9615.0,1,,,13919
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,,CHEMBL627418,,A,9615.0,1,,,13920
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,,CHEMBL627419,,A,9615.0,1,,,13921
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,,CHEMBL627320,,A,9615.0,1,,,13922
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,,CHEMBL627321,,A,9615.0,1,,,13923
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL627322,,A,10116.0,1,,,13924
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL627323,,A,10116.0,1,,,13925
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL627491,,A,10116.0,1,,,13926
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL627492,,A,10116.0,1,,,13927
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL627493,,A,10116.0,1,,,13928
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL627494,,A,10116.0,1,,,13929
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL627495,,A,10116.0,1,,,13930
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL627496,,A,10116.0,1,,,13931
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL627497,,A,10116.0,1,,,13932
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL627498,,A,10116.0,1,,,13933
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL627499,,A,10116.0,1,,,13934
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL627500,,A,10116.0,1,,,13935
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL627501,,A,10116.0,1,,,13936
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL625616,,A,10116.0,1,,,13937
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL625617,,A,10116.0,1,,,13938
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL625618,,A,10116.0,1,,,13939
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL625619,,A,10116.0,1,,,13940
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL625620,,A,10116.0,1,,,13941
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL625621,,A,10116.0,1,,,13942
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL625622,,A,10116.0,1,,,13943
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL625788,,A,10116.0,1,,,13944
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL625789,,A,10116.0,1,,,13945
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL625790,,A,10116.0,1,,,13946
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL625791,,A,10116.0,1,,,13947
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL622334,,A,10116.0,1,,,13948
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,12017,,50597,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL622335,,A,10116.0,1,,,13949
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,12017,,50597,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL622336,,A,10116.0,1,,,13950
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,12017,,50597,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL622337,,A,10116.0,1,,,13951
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,12017,,50597,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL622338,,A,10116.0,1,,,13952
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,12017,,50597,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL622339,,A,10116.0,1,,,13953
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL624153,,A,10116.0,1,,,13954
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL628430,,A,10116.0,1,,,13955
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL628431,,A,10116.0,1,,,13956
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL628432,,A,10116.0,1,,,13957
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL628433,,A,10116.0,1,,,13958
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,CHEMBL628434,,A,10116.0,1,,,13959
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,CHEMBL626789,,A,10116.0,1,,,13960
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",N,,CHEMBL626790,,A,10116.0,1,,,13961
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,CHEMBL626791,,A,10116.0,1,,,13962
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,CHEMBL626792,,A,10116.0,1,,,13963
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,CHEMBL626793,,A,10116.0,1,,,13964
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,,CHEMBL627436,,A,10116.0,1,,,13965
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,,CHEMBL627437,,A,10116.0,1,,,13966
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,,CHEMBL627438,,A,10116.0,1,,,13967
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,,CHEMBL627439,,A,10116.0,1,,,13968
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,,CHEMBL627440,,A,10116.0,1,,,13969
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,,CHEMBL627602,,A,10116.0,1,,,13970
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,,CHEMBL627603,,A,10116.0,1,,,13971
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,,CHEMBL627604,,A,10116.0,1,,,13972
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,,CHEMBL627605,,A,10116.0,1,,,13973
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,,CHEMBL627606,,A,10116.0,1,,,13974
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,,CHEMBL627607,,A,10116.0,1,,,13975
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,,CHEMBL627608,,A,10116.0,1,,,13976
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,,CHEMBL627609,,A,10116.0,1,,,13977
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,,CHEMBL627610,,A,10116.0,1,,,13978
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,,CHEMBL627611,,A,10116.0,1,,,13979
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,,CHEMBL627612,,A,10116.0,1,,,13980
,0,BAO_0000100,,,,,Autocuration,8362,,22229,,Octanol:water partition coefficient is evaluated,U,,CHEMBL627613,,P,,1,,,13981
,0,BAO_0000100,,,,,Autocuration,8257,,22224,,Partition coefficient in 1-octanol/water system,U,,CHEMBL627614,,P,,1,,,13982
,0,BAO_0000100,,,,,Autocuration,8257,,22224,,Partition coefficient in 1-octanol/water system measured using radio active compounds,U,,CHEMBL627615,,P,,1,,,13983
,0,BAO_0000100,,,,,Autocuration,9468,,22224,,Partition coefficient in octanol/water system was determined,U,,CHEMBL627616,,P,,1,,,13984
,0,BAO_0000100,,,,,Autocuration,9468,,22224,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,U,,CHEMBL627617,,P,,1,,,13985
,0,BAO_0000019,,,,,Autocuration,10568,,22224,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,U,,CHEMBL627618,,A,,1,,,13986
,0,BAO_0000019,,,,,Autocuration,10568,,22224,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",U,,CHEMBL627619,,A,,1,,,13987
,0,BAO_0000019,,,,,Autocuration,15359,,22224,,Pseudo-first-order rate constant of the compound,U,,CHEMBL627620,,A,,1,,,13988
,0,BAO_0000019,,,,,Autocuration,15359,,22224,,Pseudo-first-order rate constant with 1-min time point,U,,CHEMBL627621,,A,,1,,,13989
,0,BAO_0000019,,,,,Autocuration,15359,,22224,,Pseudo-first-order rate constant without 1-min time point,U,,CHEMBL627622,,A,,1,,,13990
,0,BAO_0000019,,,,,Autocuration,10431,,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,U,,CHEMBL627623,,A,,1,,,13991
,0,BAO_0000019,,,,,Autocuration,10431,,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,U,,CHEMBL627624,,A,,1,,,13992
,0,BAO_0000019,,,,,Autocuration,10431,,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,U,,CHEMBL627625,,A,,1,,,13993
,0,BAO_0000019,,,,,Autocuration,15704,,22224,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,U,,CHEMBL628523,,A,,1,,,13994
,0,BAO_0000019,,,,,Autocuration,15287,,22224,,The alkaline hydrolysis second order rate constant(K OH) of the compound,U,,CHEMBL628524,,A,,1,,,13995
,0,BAO_0000019,,,,,Autocuration,7516,,22224,,The efflux rate constant of the compound,U,,CHEMBL628525,,A,,1,,,13996
,0,BAO_0000019,,,,,Autocuration,12973,,22224,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,CHEMBL625732,,A,,1,,,13997
,0,BAO_0000019,,,,,Autocuration,12973,,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,CHEMBL625733,,A,,1,,,13998
,0,BAO_0000019,,,,,Autocuration,12973,,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,CHEMBL625734,,F,,1,,,13999
,0,BAO_0000019,,,,,Autocuration,12973,,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,U,,CHEMBL625913,,A,,1,,,14000
,0,BAO_0000019,,,,,Autocuration,8696,,22224,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,U,,CHEMBL625914,,A,,1,,,14001
,0,BAO_0000019,,,,,Autocuration,15052,,22224,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,U,,CHEMBL625915,,A,,1,,,14002
,0,BAO_0000019,,,,,Autocuration,15052,,22224,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,U,,CHEMBL625916,,A,,1,,,14003
,0,BAO_0000019,,,,,Autocuration,10503,,22224,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),U,,CHEMBL625917,,A,,1,,,14004
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL625918,,A,,1,,,14005
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL625919,,A,,1,,,14006
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL625920,,A,,1,,,14007
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL874453,,A,,1,,,14008
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",U,,CHEMBL625921,,A,,1,,,14009
,0,BAO_0000019,,,,,Autocuration,10503,,22224,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,U,,CHEMBL625922,,A,,1,,,14010
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL625923,,A,,1,,,14011
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL625924,,A,,1,,,14012
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL625925,,A,,1,,,14013
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL625926,,A,,1,,,14014
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13100,,50597,,Biodistribution in rat lung at 60 minutes after dose administration.,N,,CHEMBL627704,,A,10116.0,1,,,14015
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,N,,CHEMBL627705,,A,10116.0,1,,,14016
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,N,,CHEMBL627706,,A,10116.0,1,,,14017
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,N,,CHEMBL627707,,A,10116.0,1,,,14018
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,N,,CHEMBL627708,,A,10116.0,1,,,14019
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,N,,CHEMBL628361,,A,10116.0,1,,,14020
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,13100,,50597,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,N,,CHEMBL628362,,A,10116.0,1,,,14021
,1,BAO_0000218,In vivo,Rattus norvegicus,Striatum,2435.0,Intermediate,13100,,50597,,Biodistribution in rat striatum at 120 minutes after dose administration.,N,,CHEMBL628363,,A,10116.0,1,,,14022
,1,BAO_0000218,In vivo,Rattus norvegicus,Striatum,2435.0,Intermediate,13100,,50597,,Biodistribution in rat striatum at 1440 minutes after dose administration.,N,,CHEMBL628364,,A,10116.0,1,,,14023
,1,BAO_0000218,In vivo,Rattus norvegicus,Striatum,2435.0,Intermediate,13100,,50597,,Biodistribution in rat striatum at 15 minutes after dose administration.,N,,CHEMBL628365,,A,10116.0,1,,,14024
,1,BAO_0000218,In vivo,Rattus norvegicus,Striatum,2435.0,Intermediate,13100,,50597,,Biodistribution in rat striatum at 240 minutes after dose administration.,N,,CHEMBL874454,,A,10116.0,1,,,14025
,1,BAO_0000218,In vivo,Rattus norvegicus,Striatum,2435.0,Intermediate,13100,,50597,,Biodistribution in rat striatum at 30 minutes after dose administration.,N,,CHEMBL628531,,A,10116.0,1,,,14026
,1,BAO_0000218,In vivo,Rattus norvegicus,Striatum,2435.0,Intermediate,13100,,50597,,Biodistribution in rat striatum at 360 minutes after dose administration.,N,,CHEMBL628532,,A,10116.0,1,,,14027
,1,BAO_0000218,In vivo,Rattus norvegicus,Striatum,2435.0,Intermediate,13100,,50597,,Biodistribution in rat striatum at 3 hr after dose administration.,N,,CHEMBL628533,,A,10116.0,1,,,14028
,1,BAO_0000218,In vivo,Rattus norvegicus,Striatum,2435.0,Intermediate,13100,,50597,,Biodistribution in rat striatum at 60 minutes after dose administration.,N,,CHEMBL628534,,A,10116.0,1,,,14029
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,13100,,50597,,Biodistribution in rat thyroid at 120 minutes after dose administration.,N,,CHEMBL628535,,A,10116.0,1,,,14030
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,13100,,50597,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,N,,CHEMBL628536,,A,10116.0,1,,,14031
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,13100,,50597,,Biodistribution in rat thyroid at 15 minutes after dose administration.,N,,CHEMBL628537,,A,10116.0,1,,,14032
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,13100,,50597,,Biodistribution in rat thyroid at 240 minutes after dose administration.,N,,CHEMBL628538,,A,10116.0,1,,,14033
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,13100,,50597,,Biodistribution in rat thyroid at 30 minutes after dose administration.,N,,CHEMBL628539,,A,10116.0,1,,,14034
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,13100,,50597,,Biodistribution in rat thyroid at 360 minutes after dose administration.,N,,CHEMBL630297,,A,10116.0,1,,,14035
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,13100,,50597,,Biodistribution in rat thyroid at 60 minutes after dose administration.,N,,CHEMBL630298,,A,10116.0,1,,,14036
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13100,,50597,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,N,,CHEMBL630299,,A,10116.0,1,,,14037
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13100,,50597,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,N,,CHEMBL628094,,A,10116.0,1,,,14038
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13100,,50597,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,N,,CHEMBL628095,,A,10116.0,1,,,14039
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13100,,50597,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,N,,CHEMBL874648,,A,10116.0,1,,,14040
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13100,,50597,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,N,,CHEMBL628096,,A,10116.0,1,,,14041
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13100,,50597,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,N,,CHEMBL628097,,A,10116.0,1,,,14042
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13100,,50597,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,N,,CHEMBL628098,,A,10116.0,1,,,14043
,0,BAO_0000019,,,,,Autocuration,13331,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",U,,CHEMBL628099,,A,,1,,,14044
,0,BAO_0000019,,,,,Autocuration,13331,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,,CHEMBL628100,,A,,1,,,14045
,0,BAO_0000019,,,,,Autocuration,13331,,22224,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),U,,CHEMBL628101,,A,,1,,,14046
,0,BAO_0000019,,,,,Autocuration,13331,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",U,,CHEMBL628102,,A,,1,,,14047
,0,BAO_0000019,,,,,Autocuration,13331,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",U,,CHEMBL628103,,A,,1,,,14048
,0,BAO_0000019,,,,,Autocuration,13331,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,,CHEMBL628104,,A,,1,,,14049
,0,BAO_0000019,,,,,Autocuration,13331,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",U,,CHEMBL628105,,A,,1,,,14050
,0,BAO_0000019,,,,,Autocuration,13331,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",U,,CHEMBL628106,,A,,1,,,14051
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,10086,,50597,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,N,,CHEMBL628107,,A,10116.0,1,,,14052
,0,BAO_0000218,,,Urine,1088.0,Autocuration,10086,,22224,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,U,,CHEMBL628108,,F,,1,,,14053
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,10086,,50597,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,N,,CHEMBL628109,,A,10116.0,1,,,14054
,0,BAO_0000218,,,Urine,1088.0,Autocuration,10086,,22224,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,U,,CHEMBL625299,,F,,1,,,14055
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,10086,,50597,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,N,,CHEMBL625300,,A,10116.0,1,,,14056
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,10086,,50597,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,N,,CHEMBL625301,,A,10116.0,1,,,14057
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,10086,,50597,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,N,,CHEMBL625302,,A,10116.0,1,,,14058
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,10086,,50597,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,N,,CHEMBL874649,,A,10116.0,1,,,14059
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13248,,50597,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,N,,CHEMBL625303,,A,10116.0,1,,,14060
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13248,,50597,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,N,,CHEMBL625463,,A,10116.0,1,,,14061
,1,BAO_0000218,,Homo sapiens,Liver,2107.0,Intermediate,14527,,50587,,In vitro metabolism in human liver microsomes,N,,CHEMBL625464,,A,9606.0,1,,,14062
,1,BAO_0000218,,Homo sapiens,,,Intermediate,3008,,50587,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,N,,CHEMBL625465,,A,9606.0,1,,,14063
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,,CHEMBL625466,,A,9615.0,1,,,14064
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,,CHEMBL625467,,A,9615.0,1,,,14065
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,,CHEMBL625468,,A,10116.0,1,,,14066
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,N,,CHEMBL625469,,A,10116.0,1,,,14067
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,,CHEMBL625470,,A,10116.0,1,,,14068
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,,CHEMBL632418,,A,10116.0,1,,,14069
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,,CHEMBL627250,,A,10116.0,1,,,14070
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,N,,CHEMBL627251,,A,10116.0,1,,,14071
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,N,,CHEMBL627252,,A,10116.0,1,,,14072
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,,CHEMBL627253,,A,10116.0,1,,,14073
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,N,,CHEMBL627254,,A,10116.0,1,,,14074
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,,CHEMBL875471,,A,10116.0,1,,,14075
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,N,,CHEMBL627255,,A,10116.0,1,,,14076
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,,CHEMBL627256,,A,10116.0,1,,,14077
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,N,,CHEMBL627257,,A,10116.0,1,,,14078
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,,CHEMBL627258,,A,10116.0,1,,,14079
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,N,,CHEMBL627259,,A,10116.0,1,,,14080
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,,CHEMBL627260,,A,10116.0,1,,,14081
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,N,,CHEMBL623256,,A,10116.0,1,,,14082
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,,CHEMBL874413,,A,10116.0,1,,,14083
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,N,,CHEMBL623257,,A,10116.0,1,,,14084
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,,CHEMBL623258,,A,10116.0,1,,,14085
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,N,,CHEMBL623259,,A,10116.0,1,,,14086
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,N,,CHEMBL623260,,A,10116.0,1,,,14087
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,,CHEMBL623261,,A,10116.0,1,,,14088
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,N,,CHEMBL623262,,A,10116.0,1,,,14089
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,N,,CHEMBL623263,,A,10116.0,1,,,14090
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,,CHEMBL623264,,A,10116.0,1,,,14091
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,,CHEMBL623265,,A,10116.0,1,,,14092
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,,CHEMBL623266,,A,10116.0,1,,,14093
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,N,,CHEMBL623267,,A,10116.0,1,,,14094
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,N,,CHEMBL623268,,A,10116.0,1,,,14095
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,,CHEMBL623269,,A,10116.0,1,,,14096
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,,CHEMBL623270,,A,10116.0,1,,,14097
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,,CHEMBL623271,,A,10116.0,1,,,14098
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,N,,CHEMBL623272,,A,10116.0,1,,,14099
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,,CHEMBL623273,,A,10116.0,1,,,14100
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,N,,CHEMBL623274,,A,10116.0,1,,,14101
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,,CHEMBL874414,,A,10116.0,1,,,14102
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,N,,CHEMBL623275,,A,10116.0,1,,,14103
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,,CHEMBL629150,,A,10116.0,1,,,14104
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,,CHEMBL623276,,A,10116.0,1,,,14105
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,,CHEMBL623277,,A,10116.0,1,,,14106
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,N,,CHEMBL623112,,A,10116.0,1,,,14107
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,N,,CHEMBL623113,,A,10116.0,1,,,14108
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,,CHEMBL623800,,A,10116.0,1,,,14109
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,,CHEMBL623801,,A,10116.0,1,,,14110
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,CHEMBL623802,,A,10116.0,1,,,14111
,1,BAO_0000218,In vivo,Rattus norvegicus,Uterus,995.0,Intermediate,12017,,50597,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL623803,,A,10116.0,1,,,14112
,1,BAO_0000218,In vivo,Rattus norvegicus,Uterus,995.0,Intermediate,12017,,50597,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL623970,,A,10116.0,1,,,14113
,1,BAO_0000218,In vivo,Rattus norvegicus,Uterus,995.0,Intermediate,12017,,50597,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL623971,,A,10116.0,1,,,14114
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),N,,CHEMBL623972,,A,10116.0,1,,,14115
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),N,,CHEMBL623973,,A,10116.0,1,,,14116
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),N,,CHEMBL623974,,A,10116.0,1,,,14117
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),N,,CHEMBL623975,,A,10116.0,1,,,14118
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),N,,CHEMBL623976,,A,10116.0,1,,,14119
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),N,,CHEMBL623977,,A,10116.0,1,,,14120
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),N,,CHEMBL623978,,A,10116.0,1,,,14121
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),N,,CHEMBL623979,,A,10116.0,1,,,14122
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),N,,CHEMBL623980,,A,10116.0,1,,,14123
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),N,,CHEMBL623981,,A,10116.0,1,,,14124
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),N,,CHEMBL626278,,A,10116.0,1,,,14125
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,14045,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),N,,CHEMBL626279,,A,10116.0,1,,,14126
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14045,,50594,,Biodistribution in mice bladder plus excreted urine was determined,N,,CHEMBL626280,,A,10090.0,1,,,14127
,1,BAO_0000218,,Mus musculus,,,Intermediate,14045,,50594,,"Percentage biodistribution in mouse blood, 10 minutes post injection",N,,CHEMBL626281,,A,10090.0,1,,,14128
,1,BAO_0000218,,Mus musculus,,,Intermediate,14045,,50594,,"Percentage biodistribution in mouse blood, 30 minutes post injection",N,,CHEMBL626282,,A,10090.0,1,,,14129
,1,BAO_0000218,,Mus musculus,,,Intermediate,14045,,50594,,"Percentage biodistribution in mouse blood, 5 minutes post injection",N,,CHEMBL626283,,A,10090.0,1,,,14130
,1,BAO_0000218,,Mus musculus,,,Intermediate,14045,,50594,,"Percentage biodistribution in mouse blood, 60 minutes post injection",N,,CHEMBL626284,,A,10090.0,1,,,14131
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,14045,,50594,,"Percentage biodistribution in mouse brain, 10 minutes post injection",N,,CHEMBL626285,,A,10090.0,1,,,14132
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,14045,,50594,,"Percentage biodistribution in mouse brain, 30 minutes post injection",N,,CHEMBL626286,,A,10090.0,1,,,14133
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,14045,,50594,,"Percentage biodistribution in mouse brain, 5 minutes post injection",N,,CHEMBL626287,,A,10090.0,1,,,14134
,1,BAO_0000218,,Mus musculus,Brain,955.0,Intermediate,14045,,50594,,"Percentage biodistribution in mouse brain, 60 minutes post injection",N,,CHEMBL626288,,A,10090.0,1,,,14135
,1,BAO_0000218,,Mus musculus,,,Intermediate,14045,,50594,,"Percentage biodistribution in mouse heart, 10 minutes post injection",N,,CHEMBL626289,,A,10090.0,1,,,14136
,1,BAO_0000218,,Mus musculus,,,Intermediate,14045,,50594,,"Percentage biodistribution in mouse heart, 30 minutes post injection",N,,CHEMBL626290,,A,10090.0,1,,,14137
,1,BAO_0000218,,Mus musculus,,,Intermediate,14045,,50594,,"Percentage biodistribution in mouse heart, 5 minutes post injection",N,,CHEMBL626291,,A,10090.0,1,,,14138
,1,BAO_0000218,,Mus musculus,,,Intermediate,14045,,50594,,"Percentage biodistribution in mouse heart, 60 minutes post injection",N,,CHEMBL839888,,A,10090.0,1,,,14139
,1,BAO_0000218,,Mus musculus,Intestine,160.0,Intermediate,14045,,50594,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",N,,CHEMBL626292,,A,10090.0,1,,,14140
,1,BAO_0000218,,Mus musculus,Intestine,160.0,Intermediate,14045,,50594,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",N,,CHEMBL626293,,A,10090.0,1,,,14141
,1,BAO_0000218,,Mus musculus,Intestine,160.0,Intermediate,14045,,50594,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",N,,CHEMBL626294,,A,10090.0,1,,,14142
,1,BAO_0000218,,Mus musculus,Intestine,160.0,Intermediate,14045,,50594,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",N,,CHEMBL626295,,A,10090.0,1,,,14143
,1,BAO_0000218,,Mus musculus,Liver,2107.0,Intermediate,14045,,50594,,"Percentage biodistribution in mouse liver, 10 minutes post injection",N,,CHEMBL627659,,A,10090.0,1,,,14144
,1,BAO_0000218,,Mus musculus,Liver,2107.0,Intermediate,14045,,50594,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",N,,CHEMBL627660,,A,10090.0,1,,,14145
,1,BAO_0000218,,Mus musculus,Liver,2107.0,Intermediate,14045,,50594,,"Percentage biodistribution in mouse liver, 5 minutes post injection",N,,CHEMBL627661,,A,10090.0,1,,,14146
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,14045,,50594,,Biodistribution in mice liver at 60 minutes of post injection,N,,CHEMBL627662,,A,10090.0,1,,,14147
,1,BAO_0000218,In vivo,Mus musculus,Lung,2048.0,Intermediate,14045,,50594,,Biodistribution in mice lungs at 10 min of post injection,N,,CHEMBL627663,,A,10090.0,1,,,14148
,1,BAO_0000218,,Mus musculus,,,Intermediate,14045,,50594,,"Percentage biodistribution in mouse lung, 30 minutes post injection",N,,CHEMBL627664,,A,10090.0,1,,,14149
,1,BAO_0000218,,Mus musculus,,,Intermediate,14045,,50594,,"Percentage biodistribution in mousee lung, 5 minutes post injection",N,,CHEMBL627665,,A,10090.0,1,,,14150
,1,BAO_0000218,In vivo,Mus musculus,Lung,2048.0,Intermediate,14045,,50594,,Biodistribution in mice lungs at 60 min of post injection,N,,CHEMBL627666,,A,10090.0,1,,,14151
,1,BAO_0000218,,Mus musculus,Spleen,2106.0,Intermediate,14045,,50594,,Percentage biodistribution in mouse spleen,N,,CHEMBL627667,,A,10090.0,1,,,14152
,1,BAO_0000218,,Mus musculus,Stomach,945.0,Intermediate,14045,,50594,,Percentage biodistribution in mouse stomach,N,,CHEMBL627668,,A,10090.0,1,,,14153
,1,BAO_0000218,,Mus musculus,Urine,1088.0,Intermediate,11745,,50594,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,N,,CHEMBL627669,,A,10090.0,1,,,14154
,0,BAO_0000218,In vivo,,Urinary bladder,1255.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,U,,CHEMBL627670,,A,,1,,,14155
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,U,,CHEMBL627671,,A,,1,,,14156
,0,BAO_0000218,In vivo,,Bone element,1474.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,U,,CHEMBL627672,,A,,1,,,14157
,0,BAO_0000218,In vivo,,,,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,U,,CHEMBL627673,,A,,1,,,14158
,0,BAO_0000218,In vivo,,Kidney,2113.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,U,,CHEMBL627674,,A,,1,,,14159
,0,BAO_0000218,In vivo,,Liver,2107.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,U,,CHEMBL627675,,A,,1,,,14160
,0,BAO_0000218,In vivo,,Lung,2048.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,U,,CHEMBL627676,,A,,1,,,14161
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,U,,CHEMBL627677,,A,,1,,,14162
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",U,,CHEMBL627678,,A,,1,,,14163
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,7095,,50597,,Affinity for protein binding expressed as association constant in fresh rat serum,N,,CHEMBL627679,,A,10116.0,1,,,14164
,0,BAO_0000019,,,,,Autocuration,12185,,22224,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,,CHEMBL627680,,A,,1,,,14165
,0,BAO_0000019,,,,,Autocuration,12185,,22224,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,,CHEMBL627681,,A,,1,,,14166
,0,BAO_0000019,,,,,Autocuration,12185,,22224,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,,CHEMBL627682,,A,,1,,,14167
,0,BAO_0000019,,,,,Autocuration,12185,,22224,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,,CHEMBL627683,,A,,1,,,14168
,0,BAO_0000019,,,,,Autocuration,12686,,22224,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,U,,CHEMBL627684,,A,,1,,,14169
,0,BAO_0000019,,,,,Autocuration,12686,,22224,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,,CHEMBL874441,,A,,1,,,14170
,0,BAO_0000019,,,,,Autocuration,12686,,22224,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,U,,CHEMBL627685,,A,,1,,,14171
,0,BAO_0000019,,,,,Autocuration,12686,,22224,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,,CHEMBL627686,,A,,1,,,14172
,0,BAO_0000019,,,,,Autocuration,8057,,22224,,Apparent rate constant Koff for inactivation of dTMP synthase.,U,,CHEMBL627687,,A,,1,,,14173
,0,BAO_0000019,,,,,Autocuration,15778,,22224,,The irreversible inhibitor activity by second order rate equation.,U,,CHEMBL627688,,A,,1,,,14174
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12375,,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,N,,CHEMBL628038,,A,10116.0,1,,,14175
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12375,,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,N,,CHEMBL628039,,A,10116.0,1,,,14176
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,12375,,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,N,,CHEMBL628040,,A,10116.0,1,,,14177
,0,BAO_0000019,,,,,Autocuration,13588,,22224,,Dissociation rate calculated from the first-order equation using t1/2 value,U,,CHEMBL628041,,A,,1,,,14178
,0,BAO_0000019,,,,,Autocuration,15039,,22224,,The compound was tested for Binding constant against DNA,U,,CHEMBL630226,,A,,1,,,14179
,0,BAO_0000019,,,,,Autocuration,9500,,22224,,First order rate constant for cyclization of the compound,U,,CHEMBL628042,,A,,1,,,14180
,0,BAO_0000019,,,,,Autocuration,10014,,22224,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,,CHEMBL625232,,A,,1,,,14181
,0,BAO_0000019,,,,,Autocuration,10014,,22224,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,,CHEMBL625233,,A,,1,,,14182
,0,BAO_0000019,,,,,Autocuration,568,,22224,,Hydrolysis rate constant was determined,U,,CHEMBL625979,,A,,1,,,14183
,0,BAO_0000019,,,,,Autocuration,10026,,22224,,Observed first order rate constant,U,,CHEMBL625980,,A,,1,,,14184
,0,BAO_0000019,,,,,Autocuration,10281,,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,CHEMBL625981,,A,,1,,,14185
,0,BAO_0000019,,,,,Autocuration,10281,,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,CHEMBL625982,,A,,1,,,14186
,0,BAO_0000019,,,,,Autocuration,9680,,22224,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,U,,CHEMBL625983,,A,,1,,,14187
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL625984,,A,,1,,,14188
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL625985,,A,,1,,,14189
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL625986,,A,,1,,,14190
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL625987,,A,,1,,,14191
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL625988,,A,,1,,,14192
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL625989,,A,,1,,,14193
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL625990,,A,,1,,,14194
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL625991,,A,,1,,,14195
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL625992,,A,,1,,,14196
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL625993,,A,,1,,,14197
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL631973,,A,,1,,,14198
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL632143,,A,,1,,,14199
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL632144,,A,,1,,,14200
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL632145,,A,,1,,,14201
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL632146,,A,,1,,,14202
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL632147,,A,,1,,,14203
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL632148,,A,,1,,,14204
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL632149,,A,,1,,,14205
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL632150,,A,,1,,,14206
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL632151,,A,,1,,,14207
,1,BAO_0000218,,Homo sapiens,,,Intermediate,3008,,50587,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,N,,CHEMBL632152,,A,9606.0,1,,,14208
,1,BAO_0000218,,Homo sapiens,,,Intermediate,4509,,50587,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,,CHEMBL632153,,A,9606.0,1,,,14209
,1,BAO_0000218,,Homo sapiens,,,Intermediate,4509,,50587,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,,CHEMBL632154,,A,9606.0,1,,,14210
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,N,,CHEMBL632155,,A,10298.0,1,,,14211
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,N,,CHEMBL632156,,A,10298.0,1,,,14212
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,N,,CHEMBL632157,,A,10298.0,1,,,14213
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,N,,CHEMBL632158,,A,10298.0,1,,,14214
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,N,,CHEMBL632159,,A,10298.0,1,,,14215
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,N,,CHEMBL626305,,A,10298.0,1,,,14216
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,N,,CHEMBL626306,,A,10298.0,1,,,14217
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,N,,CHEMBL626307,,A,10298.0,1,,,14218
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,N,,CHEMBL626308,,A,10298.0,1,,,14219
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,N,,CHEMBL626479,,A,10298.0,1,,,14220
,1,BAO_0000218,,Human herpesvirus 1,,,Intermediate,8613,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,N,,CHEMBL626480,,A,10298.0,1,,,14221
,0,BAO_0000100,,,,,Autocuration,6021,,22229,,Calculated partition coefficient (clogP) (MlogP),U,,CHEMBL626481,,P,,1,,,14222
,0,BAO_0000019,,,,,Autocuration,9348,,22224,,Equipotent potent ratio relative to carbachol (nicotinic activity),U,,CHEMBL626482,,A,,1,,,14223
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,15592,,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",N,,CHEMBL626483,,A,9615.0,1,,,14224
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,15592,,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",N,,CHEMBL626484,,A,9615.0,1,,,14225
,0,BAO_0000100,,,,,Autocuration,15592,,22229,,Solubility at pH 7.4 in micro g/mL;NA denotes available,U,,CHEMBL626485,,P,,1,,,14226
,0,BAO_0000100,,,,,Autocuration,15592,,22229,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,U,,CHEMBL626486,,P,,1,,,14227
,0,BAO_0000100,,,,,Autocuration,15592,,22229,,Solubility at pH 7.4 in ug/mL;NA denotes not available,U,,CHEMBL626487,,P,,1,,,14228
,1,BAO_0000218,In vivo,Canis lupus familiaris,Plasma,1969.0,Intermediate,15592,,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,,CHEMBL626488,,A,9615.0,1,,,14229
,1,BAO_0000218,,Rattus norvegicus,Serum,1977.0,Intermediate,7095,,50597,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,N,,CHEMBL626489,,A,10116.0,1,,,14230
,0,BAO_0000019,,,,,Autocuration,16618,,22224,,Area under the MAP curve measured over 5 min; ND means Not determined,U,,CHEMBL626490,,A,,1,,,14231
,0,BAO_0000100,,,,,Autocuration,16835,,22224,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,U,,CHEMBL626491,,P,,1,,,14232
,0,BAO_0000100,,,,,Autocuration,15284,,22229,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,U,,CHEMBL626492,,P,,1,,,14233
,0,BAO_0000019,,,,,Autocuration,15750,,22224,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,U,,CHEMBL626493,,A,,1,,,14234
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16618,,50597,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,N,,CHEMBL626494,,A,10116.0,1,,,14235
,0,BAO_0000218,In vivo,,,,Autocuration,16618,,22224,,Half life after oral tested,U,,CHEMBL626495,,A,,1,,,14236
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,15812,,50597,,Half life was determined in plasma of rat; NT indicates not tested,N,,CHEMBL626496,,A,10116.0,1,,,14237
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,16618,,50597,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,N,,CHEMBL626497,,A,10116.0,1,,,14238
,0,BAO_0000218,In vivo,,,,Autocuration,16618,,22224,,Oral bioavailability after oral tested,U,,CHEMBL626498,,A,,1,,,14239
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13098,,50597,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),N,,CHEMBL626499,,A,10116.0,1,,,14240
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13098,,50597,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),N,,CHEMBL626500,,A,10116.0,1,,,14241
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,15812,,50597,,half life was determined in plasma of rat; NT indicates not tested,N,,CHEMBL626501,,A,10116.0,1,,,14242
,1,BAO_0000218,,Rattus norvegicus,Plasma,1969.0,Intermediate,15812,,50597,,half life was determined in plasma of rat; NT means not tested,N,,CHEMBL626502,,A,10116.0,1,,,14243
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,N,,CHEMBL626503,,A,10116.0,1,,,14244
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,N,,CHEMBL626504,,A,10116.0,1,,,14245
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,N,,CHEMBL626505,,A,10116.0,1,,,14246
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,N,,CHEMBL626506,,A,10116.0,1,,,14247
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,N,,CHEMBL626507,,A,10116.0,1,,,14248
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,N,,CHEMBL626508,,A,10116.0,1,,,14249
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,N,,CHEMBL626509,,A,10116.0,1,,,14250
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,N,,CHEMBL875480,,A,10116.0,1,,,14251
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,N,,CHEMBL626510,,A,10116.0,1,,,14252
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,N,,CHEMBL626511,,A,10116.0,1,,,14253
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,N,,CHEMBL626512,,A,10116.0,1,,,14254
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,N,,CHEMBL628208,,A,10116.0,1,,,14255
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,N,,CHEMBL628209,,A,10116.0,1,,,14256
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,N,,CHEMBL628210,,A,10116.0,1,,,14257
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,N,,CHEMBL628211,,A,10116.0,1,,,14258
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,N,,CHEMBL628212,,A,10116.0,1,,,14259
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,N,,CHEMBL628213,,A,10116.0,1,,,14260
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,,CHEMBL628214,,A,10116.0,1,,,14261
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,,CHEMBL628215,,A,10116.0,1,,,14262
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,,CHEMBL628216,,A,10116.0,1,,,14263
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,,CHEMBL626595,,A,10116.0,1,,,14264
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,,CHEMBL626596,,A,10116.0,1,,,14265
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,,CHEMBL626597,,A,10116.0,1,,,14266
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,,CHEMBL626598,,A,10116.0,1,,,14267
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,,CHEMBL622242,,A,10116.0,1,,,14268
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,,CHEMBL622243,,A,10116.0,1,,,14269
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,,CHEMBL622244,,A,10116.0,1,,,14270
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,,CHEMBL622245,,A,10116.0,1,,,14271
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,,CHEMBL622246,,A,10116.0,1,,,14272
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,,CHEMBL622247,,A,10116.0,1,,,14273
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,,CHEMBL622248,,A,10116.0,1,,,14274
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,,CHEMBL877483,,A,10116.0,1,,,14275
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,,CHEMBL622249,,A,10116.0,1,,,14276
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,,CHEMBL622250,,A,9615.0,1,,,14277
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,,CHEMBL622251,,A,9615.0,1,,,14278
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,,CHEMBL622252,,A,9615.0,1,,,14279
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,,CHEMBL622253,,A,9615.0,1,,,14280
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,,CHEMBL622254,,A,9615.0,1,,,14281
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,,CHEMBL622255,,A,9615.0,1,,,14282
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,,CHEMBL622256,,A,9615.0,1,,,14283
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,,CHEMBL622257,,A,9615.0,1,,,14284
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,,CHEMBL622258,,A,9615.0,1,,,14285
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,,CHEMBL622259,,A,9615.0,1,,,14286
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,,CHEMBL622927,,A,9615.0,1,,,14287
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,,CHEMBL622928,,A,9615.0,1,,,14288
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,,CHEMBL622929,,A,9615.0,1,,,14289
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,,CHEMBL623182,,A,9615.0,1,,,14290
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,,CHEMBL623183,,A,9615.0,1,,,14291
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,N,,CHEMBL623184,,A,10116.0,1,,,14292
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,,CHEMBL623185,,A,10116.0,1,,,14293
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,,CHEMBL877484,,A,10116.0,1,,,14294
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,,CHEMBL627274,,A,10116.0,1,,,14295
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,N,,CHEMBL623186,,A,10116.0,1,,,14296
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,N,,CHEMBL623187,,A,10116.0,1,,,14297
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,,CHEMBL623188,,A,10116.0,1,,,14298
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,N,,CHEMBL628055,,A,10116.0,1,,,14299
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,,CHEMBL628056,,A,10116.0,1,,,14300
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,N,,CHEMBL628200,,A,10116.0,1,,,14301
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,,CHEMBL628201,,A,10116.0,1,,,14302
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,N,,CHEMBL628202,,A,10116.0,1,,,14303
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,,CHEMBL628203,,A,10116.0,1,,,14304
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,N,,CHEMBL628204,,A,10116.0,1,,,14305
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,,CHEMBL628205,,A,10116.0,1,,,14306
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,N,,CHEMBL628206,,A,10116.0,1,,,14307
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),U,,CHEMBL628207,,A,,1,,,14308
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,U,,CHEMBL627220,,A,,1,,,14309
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,U,,CHEMBL627221,,A,,1,,,14310
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),U,,CHEMBL627222,,A,,1,,,14311
,0,BAO_0000218,In vivo,,,,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,U,,CHEMBL627223,,A,,1,,,14312
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,U,,CHEMBL632062,,A,,1,,,14313
,0,BAO_0000218,In vivo,,Spleen,2106.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,U,,CHEMBL632063,,A,,1,,,14314
,0,BAO_0000218,In vivo,,Urinary bladder,1255.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,U,,CHEMBL632064,,A,,1,,,14315
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,U,,CHEMBL632065,,A,,1,,,14316
,0,BAO_0000218,In vivo,,Bone element,1474.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,U,,CHEMBL632066,,A,,1,,,14317
,0,BAO_0000218,In vivo,,,,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,U,,CHEMBL632067,,A,,1,,,14318
,0,BAO_0000218,In vivo,,Kidney,2113.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,U,,CHEMBL629188,,A,,1,,,14319
,0,BAO_0000218,In vivo,,Liver,2107.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,U,,CHEMBL629189,,A,,1,,,14320
,0,BAO_0000218,In vivo,,Lung,2048.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,U,,CHEMBL629190,,A,,1,,,14321
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,U,,CHEMBL629191,,A,,1,,,14322
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),U,,CHEMBL629192,,A,,1,,,14323
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,U,,CHEMBL629193,,A,,1,,,14324
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),U,,CHEMBL629194,,A,,1,,,14325
,0,BAO_0000218,In vivo,,,,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,U,,CHEMBL629195,,A,,1,,,14326
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,U,,CHEMBL629373,,A,,1,,,14327
,0,BAO_0000218,In vivo,,Spleen,2106.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,U,,CHEMBL629374,,A,,1,,,14328
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,U,,CHEMBL629375,,A,,1,,,14329
,0,BAO_0000218,In vivo,,Urinary bladder,1255.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,U,,CHEMBL629376,,A,,1,,,14330
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,U,,CHEMBL629377,,A,,1,,,14331
,0,BAO_0000218,In vivo,,Bone element,1474.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,U,,CHEMBL629378,,A,,1,,,14332
,0,BAO_0000218,In vivo,,,,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,U,,CHEMBL629379,,A,,1,,,14333
,0,BAO_0000218,In vivo,,Kidney,2113.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,U,,CHEMBL629151,,A,,1,,,14334
,0,BAO_0000218,In vivo,,Liver,2107.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,U,,CHEMBL629152,,A,,1,,,14335
,0,BAO_0000218,In vivo,,Lung,2048.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,U,,CHEMBL629153,,A,,1,,,14336
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,U,,CHEMBL629154,,A,,1,,,14337
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),U,,CHEMBL629155,,A,,1,,,14338
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,U,,CHEMBL629156,,A,,1,,,14339
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,U,,CHEMBL629157,,A,,1,,,14340
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),U,,CHEMBL629158,,A,,1,,,14341
,0,BAO_0000218,In vivo,,,,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,U,,CHEMBL629159,,A,,1,,,14342
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,U,,CHEMBL629160,,A,,1,,,14343
,0,BAO_0000218,In vivo,,Spleen,2106.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,U,,CHEMBL629161,,A,,1,,,14344
,0,BAO_0000218,In vivo,,Urinary bladder,1255.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,U,,CHEMBL629162,,A,,1,,,14345
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,U,,CHEMBL629163,,A,,1,,,14346
,0,BAO_0000218,In vivo,,Bone element,1474.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,U,,CHEMBL629164,,A,,1,,,14347
,0,BAO_0000218,In vivo,,,,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,U,,CHEMBL629165,,A,,1,,,14348
,0,BAO_0000218,In vivo,,Liver,2107.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,U,,CHEMBL629166,,A,,1,,,14349
,0,BAO_0000218,In vivo,,Lung,2048.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,U,,CHEMBL629167,,A,,1,,,14350
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,U,,CHEMBL629168,,A,,1,,,14351
,0,BAO_0000019,,,,,Autocuration,2193,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,U,,CHEMBL629169,,A,,1,,,14352
,0,BAO_0000019,,,,,Autocuration,2193,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,U,,CHEMBL629170,,A,,1,,,14353
,0,BAO_0000019,,,,,Autocuration,2193,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,U,,CHEMBL631153,,A,,1,,,14354
,0,BAO_0000019,,,,,Autocuration,2193,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,U,,CHEMBL875121,,A,,1,,,14355
,0,BAO_0000019,,,,,Autocuration,2193,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,U,,CHEMBL631154,,A,,1,,,14356
,0,BAO_0000019,,,,,Autocuration,2193,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,U,,CHEMBL631155,,A,,1,,,14357
,0,BAO_0000019,,,,,Autocuration,568,,22224,,Hydrolysis rate constant was determined,U,,CHEMBL631156,,A,,1,,,14358
,0,BAO_0000019,,,,,Autocuration,9680,,22224,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",U,,CHEMBL631157,,A,,1,,,14359
,0,BAO_0000019,,,,,Autocuration,9680,,22224,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,,CHEMBL631158,,A,,1,,,14360
,0,BAO_0000019,,,,,Autocuration,9680,,22224,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,,CHEMBL631159,,A,,1,,,14361
,0,BAO_0000019,,,,,Autocuration,10026,,22224,,Observed second order rate constant,U,,CHEMBL631160,,A,,1,,,14362
,0,BAO_0000019,,,,,Autocuration,10281,,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,CHEMBL631161,,A,,1,,,14363
,0,BAO_0000019,,,,,Autocuration,10014,,22224,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,,CHEMBL631162,,A,,1,,,14364
,0,BAO_0000019,,,,,Autocuration,10014,,22224,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,,CHEMBL630313,,A,,1,,,14365
,0,BAO_0000019,,,,,Autocuration,9680,,22224,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,,CHEMBL630314,,A,,1,,,14366
,0,BAO_0000019,,,,,Autocuration,9680,,22224,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,,CHEMBL630315,,A,,1,,,14367
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL630316,,A,,1,,,14368
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL630986,,A,,1,,,14369
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL630987,,A,,1,,,14370
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL630988,,A,,1,,,14371
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL630989,,A,,1,,,14372
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL630990,,A,,1,,,14373
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL630991,,A,,1,,,14374
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL630992,,A,,1,,,14375
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL630993,,A,,1,,,14376
,0,BAO_0000019,,,,,Autocuration,13028,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,CHEMBL630994,,A,,1,,,14377
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,10014,,50597,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,N,,CHEMBL630995,,A,10116.0,1,,,14378
,0,BAO_0000019,,,,,Autocuration,9962,,22224,,Association constant for compound at 31 degree C was determined,U,,CHEMBL629252,,A,,1,,,14379
,0,BAO_0000019,,,,,Autocuration,12029,,22224,,Calculated antagonist equilibrium dissociation constant of the compound,U,,CHEMBL629253,,A,,1,,,14380
,0,BAO_0000019,,,,,Autocuration,12029,,22224,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,U,,CHEMBL629944,,A,,1,,,14381
,1,BAO_0000218,,Cavia porcellus,Trachea,3126.0,Intermediate,10583,,50512,,Dissociation constants vs LTE4 on guinea pig trachea,N,,CHEMBL629945,,A,10141.0,1,,,14382
,0,BAO_0000019,,,,,Autocuration,568,,22224,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",U,,CHEMBL629946,,A,,1,,,14383
,0,BAO_0000019,,,,,Autocuration,568,,22224,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",U,,CHEMBL629947,,A,,1,,,14384
,0,BAO_0000019,,,,,Autocuration,568,,22224,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",U,,CHEMBL629948,,A,,1,,,14385
,0,BAO_0000019,,,,,Autocuration,568,,22224,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",U,,CHEMBL856024,,A,,1,,,14386
,0,BAO_0000019,,,,,Autocuration,7493,,22224,,Affinity constant KD value was derived from TMP,U,,CHEMBL629949,,A,,1,,,14387
,0,BAO_0000019,,,,,Autocuration,8371,,22224,,Apparent dissociation (binding) rate constant was evaluated,U,,CHEMBL629950,,A,,1,,,14388
,0,BAO_0000100,,,,,Autocuration,13114,,22224,,Dissociation constant (KD) of the compound,U,,CHEMBL630127,,P,,1,,,14389
,0,BAO_0000100,,,,,Autocuration,15515,,22224,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,U,,CHEMBL630128,,P,,1,,,14390
,0,BAO_0000100,,,,,Autocuration,522,,22224,,Dissociation constant from ESR titration experiments,U,,CHEMBL630129,,P,,1,,,14391
,0,BAO_0000019,,,,,Autocuration,13888,,22224,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),U,,CHEMBL630130,,,,1,,,14392
,0,BAO_0000100,,,,,Autocuration,2616,,22224,,Dissociation constant was evaluated.,U,,CHEMBL875234,,P,,1,,,14393
,0,BAO_0000100,,,,,Autocuration,3798,,22224,,Dissociation constant was reported,U,,CHEMBL630131,,P,,1,,,14394
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,8731,,50597,,Dissociation constant was determined in rat pituitary cells.,N,,CHEMBL630132,,A,10116.0,1,,,14395
,0,BAO_0000019,,,,,Autocuration,11892,,22224,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,U,,CHEMBL630133,,A,,1,,,14396
,0,BAO_0000019,,,,,Autocuration,11892,,22224,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,U,,CHEMBL630134,,A,,1,,,14397
,0,BAO_0000019,,,,,Autocuration,2582,,22224,,Equilibrium dissociation constant of the compound,U,,CHEMBL630135,,A,,1,,,14398
,0,BAO_0000019,,,,,Autocuration,11892,,22224,,Equilibrium dissociation constant was determined,U,,CHEMBL630136,,A,,1,,,14399
,0,BAO_0000019,,,,,Autocuration,13396,,22224,,Kinetic constant KD was evaluated,U,,CHEMBL630137,,A,,1,,,14400
,0,BAO_0000019,,,,,Autocuration,603,,22224,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,U,,CHEMBL630138,,A,,1,,,14401
,0,BAO_0000019,,,,,Autocuration,15673,,22224,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,U,,CHEMBL630139,,A,,1,,,14402
,0,BAO_0000019,,,,,Autocuration,10368,,22224,,Rate constant for hydrolysis in aqueous acetone.,U,,CHEMBL630140,,A,,1,,,14403
,0,BAO_0000019,,,,,Autocuration,14228,,22224,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,U,,CHEMBL875235,,A,,1,,,14404
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,N,,CHEMBL876439,,A,10116.0,1,,,14405
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,N,,CHEMBL630605,,A,10116.0,1,,,14406
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,N,,CHEMBL630606,,A,10116.0,1,,,14407
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,N,,CHEMBL630607,,A,10116.0,1,,,14408
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,N,,CHEMBL630608,,A,10116.0,1,,,14409
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,N,,CHEMBL630609,,A,10116.0,1,,,14410
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,N,,CHEMBL630610,,A,10116.0,1,,,14411
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,N,,CHEMBL630611,,A,10116.0,1,,,14412
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,N,,CHEMBL629552,,A,10116.0,1,,,14413
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,,CHEMBL629733,,A,10116.0,1,,,14414
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,,CHEMBL629734,,A,10116.0,1,,,14415
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,,CHEMBL629735,,A,10116.0,1,,,14416
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,,CHEMBL629736,,A,10116.0,1,,,14417
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,,CHEMBL629737,,A,10116.0,1,,,14418
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,,CHEMBL629738,,A,10116.0,1,,,14419
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,,CHEMBL629739,,A,10116.0,1,,,14420
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,,CHEMBL629740,,A,10116.0,1,,,14421
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,,CHEMBL629741,,A,10116.0,1,,,14422
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,,CHEMBL629742,,A,10116.0,1,,,14423
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,,CHEMBL629743,,A,10116.0,1,,,14424
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,,CHEMBL629744,,A,10116.0,1,,,14425
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,,CHEMBL629745,,A,10116.0,1,,,14426
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,,CHEMBL629746,,A,10116.0,1,,,14427
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,,CHEMBL629747,,A,10116.0,1,,,14428
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,,CHEMBL629748,,A,10116.0,1,,,14429
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,,CHEMBL629749,,A,10116.0,1,,,14430
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,,CHEMBL629750,,A,10116.0,1,,,14431
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,,CHEMBL629751,,A,10116.0,1,,,14432
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,,CHEMBL629752,,A,10116.0,1,,,14433
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,,CHEMBL629753,,A,10116.0,1,,,14434
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,,CHEMBL629754,,A,10116.0,1,,,14435
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,,CHEMBL629755,,A,10116.0,1,,,14436
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,,CHEMBL629756,,A,10116.0,1,,,14437
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,,CHEMBL629757,,A,10116.0,1,,,14438
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,,CHEMBL629758,,A,10116.0,1,,,14439
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,,CHEMBL629759,,A,10116.0,1,,,14440
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,,CHEMBL629760,,A,10116.0,1,,,14441
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11510,,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,,CHEMBL876443,,A,10116.0,1,,,14442
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8310,,50588,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,N,,CHEMBL629761,,A,9615.0,1,,,14443
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8310,,50588,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,N,,CHEMBL629762,,A,9615.0,1,,,14444
,1,BAO_0000218,,Mus musculus,,,Intermediate,8310,,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,CHEMBL629763,,A,10090.0,1,,,14445
,1,BAO_0000218,,Mus musculus,,,Intermediate,8310,,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,,CHEMBL629764,,A,10090.0,1,,,14446
,1,BAO_0000218,,Mus musculus,,,Intermediate,8310,,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,,CHEMBL629765,,A,10090.0,1,,,14447
,1,BAO_0000218,,Mus musculus,,,Intermediate,8310,,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,N,,CHEMBL629766,,A,10090.0,1,,,14448
,1,BAO_0000218,,Mus musculus,,,Intermediate,8310,,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,CHEMBL629767,,A,10090.0,1,,,14449
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8310,,50588,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,N,,CHEMBL629768,,A,9615.0,1,,,14450
,1,BAO_0000218,,Mus musculus,,,Intermediate,8310,,50594,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,N,,CHEMBL629769,,A,10090.0,1,,,14451
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8310,,50588,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,N,,CHEMBL629770,,A,9615.0,1,,,14452
,1,BAO_0000218,,Canis lupus familiaris,,,Intermediate,8310,,50588,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,N,,CHEMBL629771,,A,9615.0,1,,,14453
,1,BAO_0000218,,Mus musculus,,,Intermediate,8310,,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,CHEMBL629772,,A,10090.0,1,,,14454
,1,BAO_0000218,,Mus musculus,,,Intermediate,8310,,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,CHEMBL629773,,A,10090.0,1,,,14455
,1,BAO_0000218,,Mus musculus,,,Intermediate,8310,,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,,CHEMBL625455,,A,10090.0,1,,,14456
,1,BAO_0000218,,Mus musculus,,,Intermediate,8310,,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,N,,CHEMBL625456,,A,10090.0,1,,,14457
,1,BAO_0000218,,Mus musculus,,,Intermediate,8310,,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,N,,CHEMBL625457,,A,10090.0,1,,,14458
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,,CHEMBL625458,,A,10116.0,1,,,14459
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,N,,CHEMBL625459,,A,10116.0,1,,,14460
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,,CHEMBL875483,,A,10116.0,1,,,14461
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,N,,CHEMBL634779,,A,10116.0,1,,,14462
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,N,,CHEMBL625460,,A,10116.0,1,,,14463
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,,CHEMBL626117,,A,10116.0,1,,,14464
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,N,,CHEMBL626118,,A,10116.0,1,,,14465
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,N,,CHEMBL628342,,A,10116.0,1,,,14466
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,,CHEMBL628343,,A,10116.0,1,,,14467
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,,CHEMBL628344,,A,10116.0,1,,,14468
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,,CHEMBL628345,,A,10116.0,1,,,14469
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,N,,CHEMBL628346,,A,10116.0,1,,,14470
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,N,,CHEMBL628347,,A,10116.0,1,,,14471
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,,CHEMBL628348,,A,10116.0,1,,,14472
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,,CHEMBL628349,,A,10116.0,1,,,14473
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,,CHEMBL875611,,A,10116.0,1,,,14474
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,N,,CHEMBL628350,,A,10116.0,1,,,14475
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,,CHEMBL628351,,A,10116.0,1,,,14476
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,N,,CHEMBL628352,,A,10116.0,1,,,14477
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,,CHEMBL628353,,A,10116.0,1,,,14478
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,N,,CHEMBL628354,,A,10116.0,1,,,14479
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,,CHEMBL626667,,A,10116.0,1,,,14480
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,,CHEMBL626668,,A,10116.0,1,,,14481
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,,CHEMBL626669,,A,10116.0,1,,,14482
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,N,,CHEMBL626670,,A,10116.0,1,,,14483
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,N,,CHEMBL626671,,A,10116.0,1,,,14484
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,,CHEMBL626672,,A,10116.0,1,,,14485
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,N,,CHEMBL626673,,A,10116.0,1,,,14486
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,,CHEMBL626674,,A,10116.0,1,,,14487
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,,CHEMBL626675,,A,10116.0,1,,,14488
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,N,,CHEMBL626676,,A,10116.0,1,,,14489
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,N,,CHEMBL626677,,A,10116.0,1,,,14490
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,,CHEMBL626678,,A,10116.0,1,,,14491
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,,CHEMBL626679,,A,10116.0,1,,,14492
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,,CHEMBL875612,,A,10116.0,1,,,14493
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,,CHEMBL626680,,A,10116.0,1,,,14494
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,,CHEMBL626681,,A,10116.0,1,,,14495
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,,CHEMBL626682,,A,10116.0,1,,,14496
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,,CHEMBL626683,,A,10116.0,1,,,14497
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,,CHEMBL626684,,A,10116.0,1,,,14498
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,,CHEMBL626685,,A,10116.0,1,,,14499
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,,CHEMBL626686,,A,10116.0,1,,,14500
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,,CHEMBL626687,,A,10116.0,1,,,14501
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,,CHEMBL624978,,A,10116.0,1,,,14502
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,,CHEMBL624979,,A,10116.0,1,,,14503
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,,CHEMBL624980,,A,10116.0,1,,,14504
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,,CHEMBL624981,,A,10116.0,1,,,14505
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,,CHEMBL624982,,A,9615.0,1,,,14506
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),U,,CHEMBL627564,,A,,1,,,14507
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),U,,CHEMBL627565,,A,,1,,,14508
,0,BAO_0000218,In vivo,,,,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,U,,CHEMBL627566,,A,,1,,,14509
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,U,,CHEMBL627567,,A,,1,,,14510
,0,BAO_0000218,In vivo,,Spleen,2106.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,U,,CHEMBL627568,,A,,1,,,14511
,0,BAO_0000218,In vivo,,Kidney,2113.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,U,,CHEMBL627569,,A,,1,,,14512
,0,BAO_0000218,In vivo,,Urinary bladder,1255.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,U,,CHEMBL627570,,A,,1,,,14513
,0,BAO_0000218,In vivo,,Blood,178.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,U,,CHEMBL627571,,A,,1,,,14514
,0,BAO_0000218,In vivo,,Bone element,1474.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,U,,CHEMBL627572,,A,,1,,,14515
,0,BAO_0000218,In vivo,,,,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,U,,CHEMBL627573,,A,,1,,,14516
,0,BAO_0000218,In vivo,,Kidney,2113.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,U,,CHEMBL627574,,A,,1,,,14517
,0,BAO_0000218,In vivo,,Liver,2107.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,U,,CHEMBL627575,,A,,1,,,14518
,0,BAO_0000218,In vivo,,Lung,2048.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,U,,CHEMBL627576,,A,,1,,,14519
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,U,,CHEMBL627577,,A,,1,,,14520
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),U,,CHEMBL627578,,A,,1,,,14521
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,U,,CHEMBL627579,,A,,1,,,14522
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,U,,CHEMBL627580,,A,,1,,,14523
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),U,,CHEMBL627581,,A,,1,,,14524
,0,BAO_0000218,In vivo,,,,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,U,,CHEMBL627582,,A,,1,,,14525
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,U,,CHEMBL627583,,A,,1,,,14526
,0,BAO_0000218,In vivo,,Spleen,2106.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,U,,CHEMBL627584,,A,,1,,,14527
,0,BAO_0000218,In vivo,,Prostate gland,2367.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,U,,CHEMBL627585,,A,,1,,,14528
,0,BAO_0000218,In vivo,,Muscle tissue,2385.0,Autocuration,13257,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,U,,CHEMBL627586,,A,,1,,,14529
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,N,,CHEMBL627587,,A,10116.0,1,,,14530
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,,CHEMBL627588,,A,10116.0,1,,,14531
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,N,,CHEMBL628250,,A,10116.0,1,,,14532
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,,CHEMBL628251,,A,10116.0,1,,,14533
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,N,,CHEMBL628252,,A,10116.0,1,,,14534
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,,CHEMBL628253,,A,10116.0,1,,,14535
,1,BAO_0000218,In vivo,Rattus norvegicus,Hypothalamus,1898.0,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,N,,CHEMBL628254,,A,10116.0,1,,,14536
,1,BAO_0000218,In vivo,Rattus norvegicus,Hypothalamus,1898.0,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,,CHEMBL877493,,A,10116.0,1,,,14537
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,,CHEMBL628255,,A,10116.0,1,,,14538
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,,CHEMBL628256,,A,10116.0,1,,,14539
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,,CHEMBL628257,,A,10116.0,1,,,14540
,1,BAO_0000218,In vivo,Rattus norvegicus,Hypothalamus,1898.0,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,,CHEMBL628258,,A,10116.0,1,,,14541
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,,CHEMBL628259,,A,10116.0,1,,,14542
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,,CHEMBL628429,,A,10116.0,1,,,14543
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,,CHEMBL626862,,A,10116.0,1,,,14544
,1,BAO_0000218,In vivo,Rattus norvegicus,Hypothalamus,1898.0,Intermediate,15413,,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,N,,CHEMBL626863,,A,10116.0,1,,,14545
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,15413,,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,N,,CHEMBL625886,,A,10116.0,1,,,14546
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,15413,,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,N,,CHEMBL625887,,A,10116.0,1,,,14547
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15413,,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,N,,CHEMBL625888,,A,10116.0,1,,,14548
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15413,,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,N,,CHEMBL625889,,A,10116.0,1,,,14549
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,15413,,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,N,,CHEMBL625890,,A,10116.0,1,,,14550
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,15413,,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,N,,CHEMBL625891,,A,10116.0,1,,,14551
,1,BAO_0000218,In vivo,Rattus norvegicus,Hypothalamus,1898.0,Intermediate,15413,,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,N,,CHEMBL625892,,A,10116.0,1,,,14552
,1,BAO_0000218,In vivo,Rattus norvegicus,Hypothalamus,1898.0,Intermediate,15413,,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,N,,CHEMBL625893,,A,10116.0,1,,,14553
,1,BAO_0000218,In vivo,Rattus norvegicus,Cerebellum,2037.0,Intermediate,15413,,50597,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,N,,CHEMBL625894,,A,10116.0,1,,,14554
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,15413,,50597,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,N,,CHEMBL625895,,A,10116.0,1,,,14555
,0,BAO_0000019,,,,,Autocuration,12404,,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,CHEMBL625896,,A,,1,,,14556
,0,BAO_0000019,,,,,Autocuration,568,,22224,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",U,,CHEMBL625897,,A,,1,,,14557
,0,BAO_0000019,,,,,Autocuration,568,,22224,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,,CHEMBL625898,,A,,1,,,14558
,0,BAO_0000019,,,,,Autocuration,568,,22224,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,,CHEMBL625899,,A,,1,,,14559
,0,BAO_0000019,,,,,Autocuration,12404,,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,CHEMBL626124,,A,,1,,,14560
,1,BAO_0000218,,Escherichia coli,,,Intermediate,7624,,50212,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,N,,CHEMBL628500,,A,562.0,1,,,14561
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7624,,50597,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",N,,CHEMBL857856,,A,10116.0,1,,,14562
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7624,,50597,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",N,,CHEMBL628501,,A,10116.0,1,,,14563
,0,BAO_0000019,,,,,Autocuration,4643,,22224,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",U,,CHEMBL628502,,A,,1,,,14564
,0,BAO_0000019,,,,,Autocuration,11532,,22224,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,U,,CHEMBL628503,,A,,1,,,14565
,0,BAO_0000019,,,,,Autocuration,11018,,22224,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,U,,CHEMBL628504,,A,,1,,,14566
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,,CHEMBL628505,,A,,1,,,14567
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",U,,CHEMBL874452,,A,,1,,,14568
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",U,,CHEMBL628506,,A,,1,,,14569
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,,CHEMBL628507,,A,,1,,,14570
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",U,,CHEMBL628508,,A,,1,,,14571
,0,BAO_0000019,,,,,Autocuration,8949,,22224,,Michaelis constant (KM) was evaluated,U,,CHEMBL628509,,A,,1,,,14572
,0,BAO_0000019,,,,,Autocuration,12404,,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,CHEMBL628510,,A,,1,,,14573
,0,BAO_0000019,,,,,Autocuration,7625,,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,U,,CHEMBL628511,,B,,1,,,14574
,0,BAO_0000019,,,,,Autocuration,7625,,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,U,,CHEMBL628512,,B,,1,,,14575
,0,BAO_0000019,,,,,Autocuration,7625,,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,U,,CHEMBL628513,,B,,1,,,14576
,0,BAO_0000019,,,,,Autocuration,7625,,22224,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,U,,CHEMBL628514,,B,,1,,,14577
,0,BAO_0000019,,,,,Autocuration,12908,,22224,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,U,,CHEMBL628515,,A,,1,,,14578
,0,BAO_0000019,,,,,Autocuration,10368,,22224,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,U,,CHEMBL628516,,A,,1,,,14579
,0,BAO_0000019,,,,,Autocuration,13108,,22224,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,,CHEMBL628517,,A,,1,,,14580
,0,BAO_0000019,,,,,Autocuration,13108,,22224,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,,CHEMBL628518,,A,,1,,,14581
,0,BAO_0000019,,,,,Autocuration,15217,,22224,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,U,,CHEMBL628519,,A,,1,,,14582
,0,BAO_0000019,,,,,Autocuration,15217,,22224,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,U,,CHEMBL628520,,A,,1,,,14583
,0,BAO_0000019,,,,,Autocuration,10933,,22224,,Binding constant was determined,U,,CHEMBL628521,,A,,1,,,14584
,0,BAO_0000019,,,,,Autocuration,2363,,22224,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,U,,CHEMBL630443,,A,,1,,,14585
,0,BAO_0000019,,,,,Autocuration,2363,,22224,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,U,,CHEMBL630444,,A,,1,,,14586
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,U,,CHEMBL857732,,A,,1,,,14587
,0,BAO_0000100,,,,,Autocuration,14915,,22224,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,U,,CHEMBL630445,,P,,1,,,14588
,0,BAO_0000019,,,,,Autocuration,8847,,22224,,Catalytic rate constant of the compound,U,,CHEMBL630446,,A,,1,,,14589
,0,BAO_0000019,,,,,Autocuration,15357,,22224,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,U,,CHEMBL630447,,B,,1,,,14590
,0,BAO_0000019,,,,,Autocuration,2869,,22224,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),U,,CHEMBL630448,,A,,1,,,14591
,0,BAO_0000019,,,,,Autocuration,3484,,22224,,Catalytic rate constant against phospholipase A2 was determined,U,,CHEMBL630449,,A,,1,,,14592
,0,BAO_0000019,,,,,Autocuration,1373,,22224,,"Compound was evaluated for catalytic constant, Kcat",U,,CHEMBL630450,,A,,1,,,14593
,0,BAO_0000019,,,,,Autocuration,8142,,22224,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,U,,CHEMBL630451,,A,,1,,,14594
,0,BAO_0000019,,,,,Autocuration,14131,,22224,,Kcat calculated from 0.693/T1/2,U,,CHEMBL630452,,A,,1,,,14595
,0,BAO_0000019,,,,,Autocuration,17269,,22224,,Kcat was determined,U,,CHEMBL630453,,A,,1,,,14596
,0,BAO_0000019,,,,,Autocuration,3485,,22224,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,U,,CHEMBL630454,,A,,1,,,14597
,0,BAO_0000019,,,,,Autocuration,3485,,22224,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,U,,CHEMBL630455,,A,,1,,,14598
,0,BAO_0000019,,,,,Autocuration,3485,,22224,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,U,,CHEMBL631487,,A,,1,,,14599
,0,BAO_0000019,,,,,Autocuration,5962,,22224,,Kcat value was determined,U,,CHEMBL631488,,A,,1,,,14600
,0,BAO_0000019,,,,,Autocuration,3133,,22224,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,U,,CHEMBL876440,,A,,1,,,14601
,0,BAO_0000019,,,,,Autocuration,3133,,22224,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,U,,CHEMBL631489,,A,,1,,,14602
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,,CHEMBL857742,,A,,1,,,14603
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,,CHEMBL631490,,A,,1,,,14604
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",U,,CHEMBL631491,,A,,1,,,14605
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,,CHEMBL631492,,A,,1,,,14606
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,,CHEMBL631493,,A,,1,,,14607
,0,BAO_0000019,,,,,Autocuration,4892,,22224,,Kinetic parameter for rate of conversion to PABA was determined,U,,CHEMBL631494,,A,,1,,,14608
,0,BAO_0000019,,,,,Autocuration,3133,,22224,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,,CHEMBL631495,,A,,1,,,14609
,1,BAO_0000218,,Rattus norvegicus,Feces,1988.0,Intermediate,11488,,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,,CHEMBL631496,,A,10116.0,1,,,14610
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,11488,,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,,CHEMBL631497,,A,10116.0,1,,,14611
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,11488,,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,,CHEMBL631498,,A,10116.0,1,,,14612
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,11488,,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,,CHEMBL629776,,A,10116.0,1,,,14613
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,11488,,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,,CHEMBL629777,,A,10116.0,1,,,14614
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,11488,,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,,CHEMBL629778,,A,10116.0,1,,,14615
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,N,,CHEMBL630456,,A,10116.0,1,,,14616
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,N,,CHEMBL630457,,A,10116.0,1,,,14617
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,N,,CHEMBL630458,,A,10116.0,1,,,14618
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,N,,CHEMBL630459,,A,10116.0,1,,,14619
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,N,,CHEMBL630460,,A,10116.0,1,,,14620
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,N,,CHEMBL876550,,A,10116.0,1,,,14621
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,N,,CHEMBL630461,,A,10116.0,1,,,14622
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,N,,CHEMBL630462,,A,10116.0,1,,,14623
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,N,,CHEMBL630463,,A,10116.0,1,,,14624
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,N,,CHEMBL630464,,A,10116.0,1,,,14625
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,N,,CHEMBL630465,,A,10116.0,1,,,14626
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,N,,CHEMBL630466,,A,10116.0,1,,,14627
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,N,,CHEMBL630467,,A,10116.0,1,,,14628
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,N,,CHEMBL630633,,A,10116.0,1,,,14629
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,N,,CHEMBL630634,,A,10116.0,1,,,14630
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,N,,CHEMBL630635,,A,10116.0,1,,,14631
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,N,,CHEMBL630636,,A,10116.0,1,,,14632
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,11488,,50597,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,N,,CHEMBL630637,,A,10116.0,1,,,14633
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,,CHEMBL630638,,A,9986.0,1,,,14634
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,,CHEMBL630639,,A,9986.0,1,,,14635
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,,CHEMBL630640,,A,9986.0,1,,,14636
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,,CHEMBL876551,,A,9986.0,1,,,14637
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",N,,CHEMBL630641,,A,9986.0,1,,,14638
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,,CHEMBL630642,,A,9986.0,1,,,14639
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,,CHEMBL630643,,A,9986.0,1,,,14640
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,,CHEMBL630644,,A,9986.0,1,,,14641
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,,CHEMBL630645,,A,9986.0,1,,,14642
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,,CHEMBL625599,,A,9986.0,1,,,14643
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,,CHEMBL625600,,A,9986.0,1,,,14644
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,,CHEMBL625601,,A,9986.0,1,,,14645
,1,BAO_0000218,,Oryctolagus cuniculus,Feces,1988.0,Intermediate,7132,,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,,CHEMBL625602,,A,9986.0,1,,,14646
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",N,,CHEMBL627470,,A,9986.0,1,,,14647
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,,CHEMBL627471,,A,9986.0,1,,,14648
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,,CHEMBL627472,,A,9986.0,1,,,14649
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,,CHEMBL627473,,A,9986.0,1,,,14650
,1,BAO_0000218,,Oryctolagus cuniculus,Urine,1088.0,Intermediate,7132,,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,,CHEMBL627474,,A,9986.0,1,,,14651
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13925,,50597,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL627475,,A,10116.0,1,,,14652
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,13925,,50597,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL627476,,A,10116.0,1,,,14653
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,,CHEMBL627477,,A,9615.0,1,,,14654
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,,CHEMBL627478,,A,9615.0,1,,,14655
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,,CHEMBL627479,,A,9615.0,1,,,14656
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,,CHEMBL627480,,A,9615.0,1,,,14657
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,,CHEMBL627481,,A,9615.0,1,,,14658
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,,CHEMBL627482,,A,9615.0,1,,,14659
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,,CHEMBL627483,,A,9615.0,1,,,14660
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,,CHEMBL875636,,A,9615.0,1,,,14661
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,,CHEMBL625764,,A,9615.0,1,,,14662
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,,CHEMBL625765,,A,9615.0,1,,,14663
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,N,,CHEMBL625766,,A,9615.0,1,,,14664
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,,CHEMBL625767,,A,9615.0,1,,,14665
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,,CHEMBL625768,,A,9615.0,1,,,14666
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,,CHEMBL625769,,A,9615.0,1,,,14667
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,,CHEMBL625770,,A,9615.0,1,,,14668
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,,CHEMBL625771,,A,9615.0,1,,,14669
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,N,,CHEMBL625772,,A,9615.0,1,,,14670
,1,BAO_0000218,,Canis lupus familiaris,Urine,1088.0,Intermediate,12582,,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,,CHEMBL625773,,A,9615.0,1,,,14671
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,,CHEMBL625774,,A,10116.0,1,,,14672
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,N,,CHEMBL625775,,A,10116.0,1,,,14673
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,,CHEMBL625776,,A,10116.0,1,,,14674
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,,CHEMBL625777,,A,10116.0,1,,,14675
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,,CHEMBL625778,,A,10116.0,1,,,14676
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,N,,CHEMBL625779,,A,10116.0,1,,,14677
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,N,,CHEMBL625780,,A,10116.0,1,,,14678
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,,CHEMBL625781,,A,10116.0,1,,,14679
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,N,,CHEMBL875637,,A,10116.0,1,,,14680
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,,CHEMBL626473,,A,10116.0,1,,,14681
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,N,,CHEMBL626474,,A,10116.0,1,,,14682
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,,CHEMBL626475,,A,10116.0,1,,,14683
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,N,,CHEMBL626476,,A,10116.0,1,,,14684
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,,CHEMBL634397,,A,10116.0,1,,,14685
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,N,,CHEMBL626477,,A,10116.0,1,,,14686
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,,CHEMBL631069,,A,10116.0,1,,,14687
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,N,,CHEMBL631070,,A,10116.0,1,,,14688
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,,CHEMBL631071,,A,10116.0,1,,,14689
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,N,,CHEMBL631072,,A,10116.0,1,,,14690
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,,CHEMBL631073,,A,10116.0,1,,,14691
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,N,,CHEMBL631074,,A,10116.0,1,,,14692
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,N,,CHEMBL631075,,A,10116.0,1,,,14693
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,,CHEMBL631725,,A,10116.0,1,,,14694
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,N,,CHEMBL631726,,A,10116.0,1,,,14695
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,N,,CHEMBL631727,,A,10116.0,1,,,14696
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,,CHEMBL631728,,A,10116.0,1,,,14697
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,,CHEMBL631729,,A,10116.0,1,,,14698
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,N,,CHEMBL631730,,A,10116.0,1,,,14699
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,N,,CHEMBL631731,,A,10116.0,1,,,14700
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,,CHEMBL631910,,A,10116.0,1,,,14701
,1,BAO_0000218,In vivo,Rattus norvegicus,Hippocampus,10000000.0,Intermediate,15413,,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,N,,CHEMBL631911,,A,10116.0,1,,,14702
,1,BAO_0000218,In vivo,Rattus norvegicus,Hypothalamus,1898.0,Intermediate,15413,,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,N,,CHEMBL631912,,A,10116.0,1,,,14703
,1,BAO_0000218,In vivo,Rattus norvegicus,Hypothalamus,1898.0,Intermediate,15413,,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,N,,CHEMBL631913,,A,10116.0,1,,,14704
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631914,,A,10116.0,1,,,14705
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631915,,A,10116.0,1,,,14706
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL875778,,A,10116.0,1,,,14707
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631916,,A,10116.0,1,,,14708
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631917,,A,10116.0,1,,,14709
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631918,,A,10116.0,1,,,14710
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631919,,A,10116.0,1,,,14711
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL631920,,A,10116.0,1,,,14712
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631921,,A,10116.0,1,,,14713
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631922,,A,10116.0,1,,,14714
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,12017,,50597,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL631923,,A,10116.0,1,,,14715
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631924,,A,10116.0,1,,,14716
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630234,,A,10116.0,1,,,14717
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL630235,,A,10116.0,1,,,14718
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630236,,A,10116.0,1,,,14719
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630237,,A,10116.0,1,,,14720
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630238,,A,10116.0,1,,,14721
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630239,,A,10116.0,1,,,14722
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL630303,,A,10116.0,1,,,14723
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630304,,A,10116.0,1,,,14724
,1,BAO_0000218,In vivo,Rattus norvegicus,,,Intermediate,12017,,50597,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630305,,A,10116.0,1,,,14725
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630306,,A,10116.0,1,,,14726
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630307,,A,10116.0,1,,,14727
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL630308,,A,10116.0,1,,,14728
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630309,,A,10116.0,1,,,14729
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL629309,,A,10116.0,1,,,14730
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL629993,,A,10116.0,1,,,14731
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL629994,,A,10116.0,1,,,14732
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL629995,,A,10116.0,1,,,14733
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631993,,A,10116.0,1,,,14734
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631994,,A,10116.0,1,,,14735
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,12017,,50597,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631995,,A,10116.0,1,,,14736
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL631996,,A,10116.0,1,,,14737
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631997,,A,10116.0,1,,,14738
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631998,,A,10116.0,1,,,14739
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631999,,A,10116.0,1,,,14740
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL632000,,A,10116.0,1,,,14741
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL632001,,A,10116.0,1,,,14742
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL874424,,A,10116.0,1,,,14743
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL632002,,A,10116.0,1,,,14744
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL632003,,A,10116.0,1,,,14745
,0,BAO_0000019,,,,,Autocuration,3133,,22224,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,,CHEMBL632004,,A,,1,,,14746
,0,BAO_0000019,,,,,Autocuration,2742,,22224,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,U,,CHEMBL632005,,A,,1,,,14747
,0,BAO_0000019,,,,,Autocuration,2742,,22224,,Compound was tested for amidase rate in the presence of N62C screen enzyme,U,,CHEMBL632006,,A,,1,,,14748
,0,BAO_0000019,,,,,Autocuration,2742,,22224,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,U,,CHEMBL632007,,A,,1,,,14749
,0,BAO_0000019,,,,,Autocuration,2742,,22224,,Compound was tested for amidase rate in the presence of S166C screen enzyme,U,,CHEMBL632008,,A,,1,,,14750
,0,BAO_0000019,,,,,Autocuration,2742,,22224,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,U,,CHEMBL632009,,A,,1,,,14751
,0,BAO_0000019,,,,,Autocuration,2742,,22224,,Compound was tested for esterase rate in the presence of N62C screen enzyme,U,,CHEMBL632010,,A,,1,,,14752
,0,BAO_0000019,,,,,Autocuration,2742,,22224,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,U,,CHEMBL857750,,A,,1,,,14753
,0,BAO_0000019,,,,,Autocuration,2742,,22224,,Compound was tested for esterase rate in the presence of S166C screen enzyme,U,,CHEMBL632011,,A,,1,,,14754
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,CHEMBL632012,,A,,1,,,14755
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,CHEMBL632013,,A,,1,,,14756
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",U,,CHEMBL632014,,A,,1,,,14757
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,CHEMBL629622,,A,,1,,,14758
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,CHEMBL629623,,A,,1,,,14759
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",U,,CHEMBL629624,,A,,1,,,14760
,0,BAO_0000019,,,,,Autocuration,17269,,22224,,Ratio of Kcat to that of Km was determined,U,,CHEMBL629625,,A,,1,,,14761
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,,CHEMBL629626,,A,,1,,,14762
,0,BAO_0000019,,,,,Autocuration,2276,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,,CHEMBL629627,,A,,1,,,14763
,0,BAO_0000019,,,,,Autocuration,15917,,22224,,"Compound was evaluated for constant, Kd",U,,CHEMBL629628,,A,,1,,,14764
,0,BAO_0000019,,,,,Autocuration,10933,,22224,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,U,,CHEMBL629629,,A,,1,,,14765
,0,BAO_0000019,,,,,Autocuration,10933,,22224,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,U,,CHEMBL629630,,A,,1,,,14766
,0,BAO_0000019,,,,,Autocuration,14293,,22224,,Dissociation Constant of compound determined,U,,CHEMBL856030,,A,,1,,,14767
,0,BAO_0000019,,,,,Autocuration,6698,,22224,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,U,,CHEMBL629631,,B,,1,,,14768
,0,BAO_0000019,,,,,Autocuration,6698,,22224,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,U,,CHEMBL629632,,B,,1,,,14769
,0,BAO_0000100,,,,,Autocuration,4318,,22224,,Dissociation constant of compound with Fructose was determined,U,,CHEMBL629633,,P,,1,,,14770
,0,BAO_0000100,,,,,Autocuration,4318,,22224,,Dissociation constant of compound with Fructose was determined; Not determined,U,,CHEMBL629634,,P,,1,,,14771
,0,BAO_0000100,,,,,Autocuration,4318,,22224,,Dissociation constant of compound with Lactulose was determined,U,,CHEMBL629635,,P,,1,,,14772
,0,BAO_0000100,,,,,Autocuration,4318,,22224,,Dissociation constant of compound with Lactulose was determined; Not determined,U,,CHEMBL629636,,P,,1,,,14773
,0,BAO_0000100,,,,,Autocuration,14959,,22224,,Dissociation constant of the Compound,U,,CHEMBL629637,,P,,1,,,14774
,0,BAO_0000100,,,,,Autocuration,5913,,22224,,Dissociation constant by non-linear regression analysis,U,,CHEMBL629638,,P,,1,,,14775
,0,BAO_0000100,,,,,Autocuration,14218,,22224,,Dissociation constant was determined,U,,CHEMBL629639,,P,,1,,,14776
,0,BAO_0000100,,,,,Autocuration,10689,,22224,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,U,,CHEMBL629640,,P,,1,,,14777
,0,BAO_0000100,,,,,Autocuration,13925,,22224,,Dissociation constant was determined,U,,CHEMBL629641,,P,,1,,,14778
,0,BAO_0000100,,,,,Autocuration,16359,,22224,,Dissociation constant was determined,U,,CHEMBL631344,,P,,1,,,14779
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10944,,50597,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,N,,CHEMBL631345,,A,10116.0,1,,,14780
,0,BAO_0000019,,,,,Autocuration,11080,,22224,,The dissociation constant determined by fluorescence displacement assay,U,,CHEMBL631346,,A,,1,,,14781
,0,BAO_0000019,,,,,Autocuration,17805,,22224,,kd value surface plasmon resonance (SPR) method,U,,CHEMBL631524,,A,,1,,,14782
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,10944,,50597,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,N,,CHEMBL631525,,A,10116.0,1,,,14783
,0,BAO_0000019,,,,,Autocuration,16645,,22224,,First dissociation constant of the binding of compound to V30M TTR,U,,CHEMBL631526,,F,,1,,,14784
,0,BAO_0000019,,,,,Autocuration,16645,,22224,,Second dissociation constant of the binding of compound to V30M TTR,U,,CHEMBL631527,,F,,1,,,14785
,0,BAO_0000019,,,,,Autocuration,7793,,22224,,"Compound was evaluated for equilibrium constant, Ke",U,,CHEMBL631528,,A,,1,,,14786
,0,BAO_0000019,,,Hypothalamus,1898.0,Autocuration,12199,,22224,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,U,,CHEMBL631529,,A,,1,,,14787
,0,BAO_0000019,,,Hypothalamus,1898.0,Autocuration,12199,,22224,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,U,,CHEMBL631530,,A,,1,,,14788
,0,BAO_0000019,,,,,Autocuration,9680,,22224,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,U,,CHEMBL631531,,A,,1,,,14789
,0,BAO_0000019,,,,,Autocuration,9680,,22224,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,U,,CHEMBL631532,,A,,1,,,14790
,0,BAO_0000019,,,,,Autocuration,9680,,22224,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,U,,CHEMBL631533,,A,,1,,,14791
,1,BAO_0000218,,Mus musculus,,,Intermediate,13758,,50594,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,CHEMBL876552,,A,10090.0,1,,,14792
,1,BAO_0000218,,Mus musculus,,,Intermediate,13758,,50594,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,,CHEMBL631534,,A,10090.0,1,,,14793
,1,BAO_0000218,,Mus musculus,,,Intermediate,13758,,50594,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,CHEMBL631535,,A,10090.0,1,,,14794
,1,BAO_0000218,,Mus musculus,,,Intermediate,13758,,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,CHEMBL631536,,A,10090.0,1,,,14795
,1,BAO_0000218,,Mus musculus,,,Intermediate,13758,,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,N,,CHEMBL631537,,A,10090.0,1,,,14796
,1,BAO_0000218,,Mus musculus,,,Intermediate,13758,,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,,CHEMBL631538,,A,10090.0,1,,,14797
,1,BAO_0000218,,Mus musculus,,,Intermediate,13758,,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,N,,CHEMBL631539,,A,10090.0,1,,,14798
,1,BAO_0000218,,Mus musculus,,,Intermediate,13758,,50594,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,CHEMBL631540,,A,10090.0,1,,,14799
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14393,,50597,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,CHEMBL625637,,A,10116.0,1,,,14800
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14393,,50597,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,CHEMBL625638,,A,10116.0,1,,,14801
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,15078,,50597,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,,CHEMBL625639,,A,10116.0,1,,,14802
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13925,,50597,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625640,,A,10116.0,1,,,14803
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,13925,,50597,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625641,,A,10116.0,1,,,14804
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13925,,50597,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625642,,A,10116.0,1,,,14805
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,13925,,50597,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625643,,A,10116.0,1,,,14806
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13925,,50597,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625644,,A,10116.0,1,,,14807
,1,BAO_0000218,In vivo,Rattus norvegicus,Kidney,2113.0,Intermediate,13925,,50597,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625645,,A,10116.0,1,,,14808
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13925,,50597,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625646,,A,10116.0,1,,,14809
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,13925,,50597,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625647,,A,10116.0,1,,,14810
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13925,,50597,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625648,,A,10116.0,1,,,14811
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,13925,,50597,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625649,,A,10116.0,1,,,14812
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13925,,50597,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625650,,A,10116.0,1,,,14813
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,13925,,50597,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625651,,A,10116.0,1,,,14814
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,13925,,50597,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625652,,A,10116.0,1,,,14815
,1,BAO_0000218,In vivo,Rattus norvegicus,Zone of skin,14.0,Intermediate,13925,,50597,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625653,,A,10116.0,1,,,14816
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,13925,,50597,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625654,,A,10116.0,1,,,14817
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,13925,,50597,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,CHEMBL625655,,A,10116.0,1,,,14818
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat blood after 15 minutes of administration,N,,CHEMBL625656,,A,10116.0,1,,,14819
,1,BAO_0000218,In vivo,Rattus norvegicus,Blood,178.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat blood after 2 minutes of administration,N,,CHEMBL625657,,A,10116.0,1,,,14820
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat brain after 15 minutes of administration,N,,CHEMBL625658,,A,10116.0,1,,,14821
,1,BAO_0000218,In vivo,Rattus norvegicus,Brain,955.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat brain after 2 minutes of administration,N,,CHEMBL625659,,A,10116.0,1,,,14822
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat heart after 15 minutes of administration,N,,CHEMBL625660,,A,10116.0,1,,,14823
,1,BAO_0000218,In vivo,Rattus norvegicus,Heart,948.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat heart after 2 minutes of administration,N,,CHEMBL625661,,A,10116.0,1,,,14824
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat liver after 15 minutes of administration,N,,CHEMBL625662,,A,10116.0,1,,,14825
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat liver after 2 minutes of administration,N,,CHEMBL625663,,A,10116.0,1,,,14826
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat lung after 15 minutes of administration,N,,CHEMBL875621,,A,10116.0,1,,,14827
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat lung after 2 minutes of administration,N,,CHEMBL628382,,A,10116.0,1,,,14828
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat muscle after 15 minutes of administration,N,,CHEMBL628383,,A,10116.0,1,,,14829
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,9712,,50597,,Biodistribution of Compound in rat muscle after 2 minutes of administration,N,,CHEMBL628384,,A,10116.0,1,,,14830
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13925,,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,N,,CHEMBL628385,,A,10116.0,1,,,14831
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13925,,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,N,,CHEMBL875753,,A,10116.0,1,,,14832
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,13925,,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,N,,CHEMBL628386,,A,10116.0,1,,,14833
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat blood 2 minutes after intravenous injection,N,,CHEMBL628387,,A,10116.0,1,,,14834
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat blood 2 hr after intravenous injection,N,,CHEMBL628388,,A,10116.0,1,,,14835
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat blood 30 minutes after intravenous injection,N,,CHEMBL628389,,A,10116.0,1,,,14836
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat blood 30 min after intravenous injection,N,,CHEMBL632756,,A,10116.0,1,,,14837
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat brain 2 minutes after intravenous injection,N,,CHEMBL628390,,A,10116.0,1,,,14838
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat brain 2 hr after intravenous injection,N,,CHEMBL631811,,A,10116.0,1,,,14839
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat brain 30 minutes after intravenous injection,N,,CHEMBL631812,,A,10116.0,1,,,14840
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat heart 2 minutes after intravenous injection,N,,CHEMBL631813,,A,10116.0,1,,,14841
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat heart 2 hr after intravenous injection,N,,CHEMBL631814,,A,10116.0,1,,,14842
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat heart 30 minutes after intravenous injection,N,,CHEMBL631815,,A,10116.0,1,,,14843
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat kidney 2 minutes after intravenous injection,N,,CHEMBL631816,,A,10116.0,1,,,14844
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat kidney 2 hr after intravenous injection,N,,CHEMBL875758,,A,10116.0,1,,,14845
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat kidney 30 minutes after intravenous injection,N,,CHEMBL631817,,A,10116.0,1,,,14846
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,6941,,50597,,Organ distribution in rat liver 2 minutes after intravenous injection,N,,CHEMBL631818,,A,10116.0,1,,,14847
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,6941,,50597,,Organ distribution in rat liver 2 hr after intravenous injection,N,,CHEMBL631819,,A,10116.0,1,,,14848
,1,BAO_0000218,,Rattus norvegicus,Liver,2107.0,Intermediate,6941,,50597,,Organ distribution in rat liver 30 minutes after intravenous injection,N,,CHEMBL631820,,A,10116.0,1,,,14849
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat lung 2 minutes after intravenous injection,N,,CHEMBL631821,,A,10116.0,1,,,14850
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat lung 2 hr after intravenous injection,N,,CHEMBL631822,,A,10116.0,1,,,14851
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,6941,,50597,,Organ distribution in rat lung 30 minutes after intravenous injection,N,,CHEMBL631823,,A,10116.0,1,,,14852
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,6941,,50597,,Organ distribution in rat muscle 2 minutes after intravenous injection,N,,CHEMBL631824,,A,10116.0,1,,,14853
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,6941,,50597,,Organ distribution in rat muscle 2 hr after intravenous injection,N,,CHEMBL631825,,A,10116.0,1,,,14854
,1,BAO_0000218,,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,6941,,50597,,Organ distribution in rat muscle 30 minutes after intravenous injection,N,,CHEMBL631826,,A,10116.0,1,,,14855
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),N,,CHEMBL631827,,A,10090.0,1,,,14856
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),N,,CHEMBL631828,,A,10090.0,1,,,14857
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),N,,CHEMBL631829,,A,10090.0,1,,,14858
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,,CHEMBL875759,,A,10116.0,1,,,14859
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,N,,CHEMBL631830,,A,10116.0,1,,,14860
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,N,,CHEMBL631831,,A,10116.0,1,,,14861
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,,CHEMBL631832,,A,10116.0,1,,,14862
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,N,,CHEMBL631833,,A,10116.0,1,,,14863
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,,CHEMBL631834,,A,10116.0,1,,,14864
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,N,,CHEMBL631835,,A,10116.0,1,,,14865
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,,CHEMBL631836,,A,10116.0,1,,,14866
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,,CHEMBL631837,,A,10116.0,1,,,14867
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,,CHEMBL631838,,A,10116.0,1,,,14868
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,N,,CHEMBL631839,,A,10116.0,1,,,14869
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,N,,CHEMBL631840,,A,10116.0,1,,,14870
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,,CHEMBL631841,,A,10116.0,1,,,14871
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,,CHEMBL631842,,A,10116.0,1,,,14872
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,,CHEMBL631843,,A,10116.0,1,,,14873
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,,CHEMBL631844,,A,10116.0,1,,,14874
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,,CHEMBL631845,,A,10116.0,1,,,14875
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,,CHEMBL631846,,A,10116.0,1,,,14876
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,,CHEMBL875760,,A,10116.0,1,,,14877
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,,CHEMBL632199,,A,10116.0,1,,,14878
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,,CHEMBL631847,,A,10116.0,1,,,14879
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,,CHEMBL631848,,A,10116.0,1,,,14880
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,,CHEMBL628707,,A,10116.0,1,,,14881
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,,CHEMBL628708,,A,10116.0,1,,,14882
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,,CHEMBL628709,,A,10116.0,1,,,14883
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,,CHEMBL628710,,A,10116.0,1,,,14884
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,,CHEMBL628711,,A,10116.0,1,,,14885
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,,CHEMBL628712,,A,10116.0,1,,,14886
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,,CHEMBL628713,,A,10116.0,1,,,14887
,1,BAO_0000218,,Rattus norvegicus,Urine,1088.0,Intermediate,12582,,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,,CHEMBL628714,,A,10116.0,1,,,14888
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,7415,,50597,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",N,,CHEMBL628715,,A,10116.0,1,,,14889
,0,BAO_0000019,,,,,Autocuration,7313,,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,U,,CHEMBL629179,,A,,1,,,14890
,0,BAO_0000019,,,,,Autocuration,7313,,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,U,,CHEMBL629180,,A,,1,,,14891
,0,BAO_0000019,,,,,Autocuration,7313,,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,U,,CHEMBL875108,,A,,1,,,14892
,0,BAO_0000019,,,Adrenal cortex,1235.0,Autocuration,7570,,22224,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,,CHEMBL629181,,A,,1,,,14893
,0,BAO_0000019,,,Adrenal cortex,1235.0,Autocuration,7570,,22224,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,,CHEMBL629182,,A,,1,,,14894
,0,BAO_0000019,,,,,Autocuration,7570,,22224,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,U,,CHEMBL629183,,A,,1,,,14895
,0,BAO_0000019,,,,,Autocuration,7570,,22224,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,,CHEMBL629184,,A,,1,,,14896
,0,BAO_0000019,,,Adrenal cortex,1235.0,Autocuration,7570,,22224,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,,CHEMBL629185,,A,,1,,,14897
,0,BAO_0000019,,,Adrenal cortex,1235.0,Autocuration,7570,,22224,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,U,,CHEMBL629186,,A,,1,,,14898
,0,BAO_0000019,,,,,Autocuration,7570,,22224,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,U,,CHEMBL629187,,A,,1,,,14899
,0,BAO_0000019,,,,,Autocuration,7570,,22224,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,U,,CHEMBL629887,,A,,1,,,14900
,0,BAO_0000019,,,,,Autocuration,7570,,22224,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,U,,CHEMBL629888,,A,,1,,,14901
,0,BAO_0000019,,,,,Autocuration,7570,,22224,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,U,,CHEMBL629889,,A,,1,,,14902
,0,BAO_0000019,,,Adrenal cortex,1235.0,Autocuration,7570,,22224,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,U,,CHEMBL629890,,A,,1,,,14903
,0,BAO_0000019,,,,,Autocuration,7570,,22224,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,,CHEMBL629891,,A,,1,,,14904
,0,BAO_0000019,,,,,Autocuration,7570,,22224,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,U,,CHEMBL629892,,A,,1,,,14905
,0,BAO_0000019,,,Adrenal cortex,1235.0,Autocuration,7570,,22224,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,,CHEMBL629893,,A,,1,,,14906
,0,BAO_0000019,,,,,Autocuration,7570,,22224,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,U,,CHEMBL629894,,A,,1,,,14907
,0,BAO_0000019,,,,,Autocuration,7570,,22224,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,U,,CHEMBL629895,,A,,1,,,14908
,0,BAO_0000218,In vivo,Canis lupus familiaris,,,Autocuration,14122,,22224,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",U,,CHEMBL875109,,A,9615.0,1,,,14909
,0,BAO_0000218,In vivo,Macaca fascicularis,,,Autocuration,16449,,22224,,Absolute bioavailability in male cynomolgus monkeys,U,,CHEMBL629896,,A,9541.0,1,,,14910
,0,BAO_0000218,In vivo,Rattus norvegicus,,,Autocuration,16449,,22224,,Absolute bioavailability in maleSprague-Dawley rats,U,,CHEMBL629897,,A,10116.0,1,,,14911
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL629898,,A,10116.0,1,,,14912
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630057,,A,10116.0,1,,,14913
,1,BAO_0000218,In vivo,Rattus norvegicus,Liver,2107.0,Intermediate,12017,,50597,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630058,,A,10116.0,1,,,14914
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630059,,A,10116.0,1,,,14915
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630060,,A,10116.0,1,,,14916
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL630061,,A,10116.0,1,,,14917
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630062,,A,10116.0,1,,,14918
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630063,,A,10116.0,1,,,14919
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630064,,A,10116.0,1,,,14920
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630065,,A,10116.0,1,,,14921
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL630066,,A,10116.0,1,,,14922
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630067,,A,10116.0,1,,,14923
,1,BAO_0000218,In vivo,Rattus norvegicus,Lung,2048.0,Intermediate,12017,,50597,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630068,,A,10116.0,1,,,14924
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631113,,A,10116.0,1,,,14925
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631114,,A,10116.0,1,,,14926
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL631115,,A,10116.0,1,,,14927
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL631116,,A,10116.0,1,,,14928
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630528,,A,10116.0,1,,,14929
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630529,,A,10116.0,1,,,14930
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630530,,A,10116.0,1,,,14931
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL630531,,A,10116.0,1,,,14932
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630532,,A,10116.0,1,,,14933
,1,BAO_0000218,In vivo,Rattus norvegicus,Muscle tissue,2385.0,Intermediate,12017,,50597,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630533,,A,10116.0,1,,,14934
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,15045,,50594,,Biodistribution in normal mice blood after 120 hr,N,,CHEMBL630534,,A,10090.0,1,,,14935
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,15045,,50594,,Biodistribution in normal mice blood after 24 hr,N,,CHEMBL630535,,A,10090.0,1,,,14936
,1,BAO_0000218,In vivo,Mus musculus,Blood,178.0,Intermediate,15045,,50594,,Biodistribution in normal mice blood after 4 hr,N,,CHEMBL630536,,A,10090.0,1,,,14937
,1,BAO_0000218,In vivo,Mus musculus,Bone,10000001.0,Intermediate,15045,,50594,,Biodistribution in normal mice bone after 120 hr,N,,CHEMBL630537,,A,10090.0,1,,,14938
,1,BAO_0000218,In vivo,Mus musculus,Bone,10000001.0,Intermediate,15045,,50594,,Biodistribution in normal mice bone after 24 hr,N,,CHEMBL630538,,A,10090.0,1,,,14939
,1,BAO_0000218,In vivo,Mus musculus,Bone,10000001.0,Intermediate,15045,,50594,,Biodistribution in normal mice bone after 4 hr,N,,CHEMBL630539,,A,10090.0,1,,,14940
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,15045,,50594,,Biodistribution in normal mice heart after 120 hr,N,,CHEMBL630540,,A,10090.0,1,,,14941
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,15045,,50594,,Biodistribution in normal mice heart after 24 hr,N,,CHEMBL630541,,A,10090.0,1,,,14942
,1,BAO_0000218,In vivo,Mus musculus,Heart,948.0,Intermediate,15045,,50594,,Biodistribution in normal mice heart after 4 hr,N,,CHEMBL630542,,A,10090.0,1,,,14943
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,15045,,50594,,Biodistribution in normal mice kidney after 120 hr,N,,CHEMBL630543,,A,10090.0,1,,,14944
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,15045,,50594,,Biodistribution in normal mice kidney after 24 hr,N,,CHEMBL630544,,A,10090.0,1,,,14945
,1,BAO_0000218,In vivo,Mus musculus,Kidney,2113.0,Intermediate,15045,,50594,,Biodistribution in normal mice kidney after 4 hr,N,,CHEMBL630545,,A,10090.0,1,,,14946
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,15045,,50594,,Biodistribution in normal mice liver after 120 hr,N,,CHEMBL630546,,A,10090.0,1,,,14947
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,15045,,50594,,Biodistribution in normal mice liver after 24 hr,N,,CHEMBL630547,,A,10090.0,1,,,14948
,1,BAO_0000218,In vivo,Mus musculus,Liver,2107.0,Intermediate,15045,,50594,,Biodistribution in normal mice liver after 4 hr,N,,CHEMBL630548,,A,10090.0,1,,,14949
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,15045,,50594,,Biodistribution in normal mice spleen after 120 hr,N,,CHEMBL630549,,A,10090.0,1,,,14950
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,15045,,50594,,Biodistribution in normal mice spleen after 24 hr,N,,CHEMBL630550,,A,10090.0,1,,,14951
,1,BAO_0000218,In vivo,Mus musculus,Spleen,2106.0,Intermediate,15045,,50594,,Biodistribution in normal mice spleen after 4 hr,N,,CHEMBL876426,,A,10090.0,1,,,14952
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630551,,A,10116.0,1,,,14953
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630552,,A,10116.0,1,,,14954
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL630553,,A,10116.0,1,,,14955
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630554,,A,10116.0,1,,,14956
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630555,,A,10116.0,1,,,14957
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630556,,A,10116.0,1,,,14958
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630557,,A,10116.0,1,,,14959
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,CHEMBL630558,,A,10116.0,1,,,14960
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630559,,A,10116.0,1,,,14961
,1,BAO_0000218,In vivo,Rattus norvegicus,Spleen,2106.0,Intermediate,12017,,50597,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL630560,,A,10116.0,1,,,14962
,1,BAO_0000218,In vivo,Rattus norvegicus,Thyroid gland,2046.0,Intermediate,12017,,50597,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,CHEMBL876427,,A,10116.0,1,,,14963
,1,BAO_0000218,,Rattus norvegicus,,,Intermediate,14941,,50597,,The Kel values in female wistar rats.,N,,CHEMBL630561,,A,10116.0,1,,,14964
,0,BAO_0000019,,,,,Autocuration,4646,,22224,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,U,,CHEMBL630562,,A,,1,,,14965
,0,BAO_0000019,,,,,Autocuration,8847,,22224,,Hydrolysis rate constant of the compound,U,,CHEMBL630563,,A,,1,,,14966
,0,BAO_0000100,,,,,Autocuration,11778,,22229,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,U,,CHEMBL629673,,P,,1,,,14967
,0,BAO_0000019,,,,,Autocuration,2363,,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",U,,CHEMBL629674,,A,,1,,,14968
,0,BAO_0000019,,,,,Autocuration,2363,,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",U,,CHEMBL629675,,A,,1,,,14969
,0,BAO_0000019,,,,,Autocuration,2363,,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",U,,CHEMBL629676,,A,,1,,,14970
,0,BAO_0000019,,,,,Autocuration,2363,,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",U,,CHEMBL629677,,A,,1,,,14971
,0,BAO_0000019,,,,,Autocuration,8371,,22224,,Apparent inactivation rate constant was evaluated,U,,CHEMBL629678,,A,,1,,,14972
,0,BAO_0000019,,,,,Autocuration,14883,,22224,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,U,,CHEMBL629679,,A,,1,,,14973
,0,BAO_0000019,,,,,Autocuration,14883,,22224,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,U,,CHEMBL629680,,A,,1,,,14974
,0,BAO_0000019,,,,,Autocuration,4643,,22224,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,U,,CHEMBL629681,,A,,1,,,14975
,0,BAO_0000019,,,,,Autocuration,3519,,22224,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,U,,CHEMBL629682,,A,,1,,,14976
,0,BAO_0000019,,,,,Autocuration,10600,,22224,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,U,,CHEMBL629683,,A,,1,,,14977
,0,BAO_0000019,,,,,Autocuration,8501,,22224,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,U,,CHEMBL629684,,F,,1,,,14978
,0,BAO_0000100,,,,,Autocuration,8505,,22224,,Dissociation constant was determined,U,,CHEMBL629685,,P,,1,,,14979
,0,BAO_0000100,,,,,Autocuration,9778,,22224,,Dissociation constant was determined,U,,CHEMBL629686,,P,,1,,,14980
,0,BAO_0000100,,,,,Autocuration,9778,,22224,,Dissociation constant at pH 7.4,U,,CHEMBL872932,,P,,1,,,14981
,0,BAO_0000100,,,,,Autocuration,9778,,22224,,Dissociation constant in presence of 1 mM dithiothreitol,U,,CHEMBL629687,,P,,1,,,14982
,0,BAO_0000019,,,,,Autocuration,13007,,22224,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,,CHEMBL872931,,A,,1,,,14983
,0,BAO_0000019,,,,,Autocuration,13007,,22224,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,,CHEMBL628151,,A,,1,,,14984
,0,BAO_0000019,,,,,Autocuration,13007,,22224,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,,CHEMBL628152,,A,,1,,,14985
,0,BAO_0000019,,,,,Autocuration,13007,,22224,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,,CHEMBL628153,,A,,1,,,14986
,0,BAO_0000019,,,,,Autocuration,11482,,22224,,Kinetic constant for aromatization of androstenedione,U,,CHEMBL628154,,A,,1,,,14987
,0,BAO_0000019,,,,,Autocuration,11482,,22224,,Kinetic constant for aromatization of testosterone,U,,CHEMBL628155,,A,,1,,,14988
,0,BAO_0000019,,,,,Autocuration,2303,,22224,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,U,,CHEMBL628156,,A,,1,,,14989
,0,BAO_0000019,,,,,Autocuration,11964,,22224,,Local inhibition constant was determined,U,,CHEMBL628157,,A,,1,,,14990
,1,BAO_0000218,,Saccharomyces cerevisiae,,,Intermediate,3140,,50347,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,N,,CHEMBL857533,,A,4932.0,1,,,14991
,0,BAO_0000100,,,,,Autocuration,10650,,22224,,Dissociation constant value of the compound,U,,CHEMBL628158,,P,,1,,,14992
,0,BAO_0000019,,,Cornea,964.0,Autocuration,4667,,22224,,In vitro permeability through cornea without epithelium,U,,CHEMBL628159,,A,,1,,,14993
,0,BAO_0000019,,,Cornea,964.0,Autocuration,4667,,22224,,In vitro permeability through intact cornea,U,,CHEMBL875616,,A,,1,,,14994
,1,BAO_0000218,,Oryctolagus cuniculus,Cornea,964.0,Intermediate,9199,,50592,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,N,,CHEMBL628160,,A,9986.0,1,,,14995
,0,BAO_0000019,,,,,Autocuration,11966,,22224,,Rate of enzyme inactivation for the compound was determined,U,,CHEMBL628161,,A,,1,,,14996
,0,BAO_0000019,,,Cornea,964.0,Autocuration,4667,,22224,,In vitro permeability through cornea without epithelium,U,,CHEMBL628162,,A,,1,,,14997
,0,BAO_0000019,,,Cornea,964.0,Autocuration,4667,,22224,,In vitro permeability through intact cornea,U,,CHEMBL628163,,A,,1,,,14998
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628164,,A,,1,,,14999
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628165,,A,,1,,,15000
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628166,,A,,1,,,15001
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628167,,A,,1,,,15002
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628168,,A,,1,,,15003
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628169,,A,,1,,,15004
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628170,,A,,1,,,15005
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628171,,A,,1,,,15006
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL627434,,A,,1,,,15007
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL627435,,A,,1,,,15008
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628110,,A,,1,,,15009
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628111,,A,,1,,,15010
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628112,,A,,1,,,15011
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628260,,A,,1,,,15012
,0,BAO_0000019,,,,,Autocuration,8354,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,CHEMBL628261,,A,,1,,,15013
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),N,,CHEMBL628262,,A,10090.0,1,,,15014
,1,BAO_0000218,In vivo,Homo sapiens,,,Intermediate,14439,,50587,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,N,,CHEMBL628263,,A,9606.0,1,,,15015
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),N,,CHEMBL628264,,A,10090.0,1,,,15016
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),N,,CHEMBL628265,,A,10090.0,1,,,15017
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),N,,CHEMBL628266,,A,10090.0,1,,,15018
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),N,,CHEMBL628267,,A,10090.0,1,,,15019
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,N,,CHEMBL628268,,A,10090.0,1,,,15020
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),N,,CHEMBL628269,,A,10090.0,1,,,15021
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),N,,CHEMBL628270,,A,10090.0,1,,,15022
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),N,,CHEMBL628271,,A,10090.0,1,,,15023
,1,BAO_0000218,In vivo,Mus musculus,,,Intermediate,14439,,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),N,,CHEMBL628272,,A,10090.0,1,,,15024
